data_2rml_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rml _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 3.7 109.788 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 4.14 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 3.36 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 2.56 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 3.44 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.45 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 2.83 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.71 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.2 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 2.74 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 4.81 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.41 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 3.51 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 2.08 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 2.62 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.99 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 2.46 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 6.76 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 3.21 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 5.51 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.32 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 2.49 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 6.4 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.79 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 3.64 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.31 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.64 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 3.19 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 2.51 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 1.52 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 3.08 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 4.58 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 3.61 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 5.53 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.11 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.05 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.93 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 2.32 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 2.62 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 2.03 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 4.4 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.38 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 2.73 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.62 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.95 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.93 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.84 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 2.01 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 2.19 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 3.29 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 3.01 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 3.52 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 1.9 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 6.09 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 2.3 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.8 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 4.92 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 3.64 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 3.67 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 2.76 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.95 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 2.48 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 3.05 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 2.85 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.92 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.9 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 4.07 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.92 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.75 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 2.85 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 2.91 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.95 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 2.09 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.66 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 5.08 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 2.24 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 4.09 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 6.29 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 2.25 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 4.5 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.75 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 3.06 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 2.58 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.98 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.47 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 2.2 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 5.27 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 2.62 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 2.91 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 2.16 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 1.9 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 2.18 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 2.14 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 3.52 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 3.23 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 4.26 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 3.42 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 3.7 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 2.47 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.72 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 2.58 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 4.45 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 2.3 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 2.34 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 3.79 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 2.56 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.45 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 4.07 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 5.5 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 2.94 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 5.34 108.544 158.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 4.04 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.91 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.183 0.515 . . . . 3.6 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 4.61 112.132 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 3.58 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 2.29 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 3.49 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.35 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.9 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 4.39 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.37 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 3.69 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 4.37 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 2.75 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 2.68 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 2.99 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 1.77 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 2.14 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.96 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 3.53 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 5.3 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.78 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 2.46 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 4.43 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 8.17 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 3.02 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 2.01 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.21 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 2.86 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.71 110.134 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 1.43 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.24 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 3.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 3.41 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 3.87 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.9 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.72 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 2.13 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 3.59 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 2.89 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 1.88 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 3.69 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 2.35 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.96 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 2.09 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 4.4 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 2.12 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 1.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 3.1 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 4.34 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 2.37 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.73 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 3.05 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 6.0 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 4.59 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.9 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 3.72 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 3.04 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.81 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 1.7 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 142' ' ' LYS . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 3.0 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 2.8 110.006 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 3.47 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.82 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 3.16 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 2.8 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 2.52 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.88 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 2.49 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 4.26 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 5.77 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 1.91 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 4.16 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 4.0 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 1.81 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 2.32 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 4.83 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.38 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 3.12 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.85 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.44 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.72 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 1.05 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 1.69 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 5.37 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 2.65 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 2.87 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 2.53 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 1.66 109.375 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 1.62 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 1.57 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 4.67 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.58 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 4.56 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 3.24 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.86 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 2.31 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.55 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 3.8 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 5.15 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.83 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 2.25 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 4.73 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 2.11 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 5.87 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 5.37 109.845 165.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 2.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 3.87 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.99 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 77' ' ' GLU . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 4.8 105.735 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.93 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.62 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 3.77 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 6.62 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 4.36 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 HG21 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 3.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.67 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.98 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 12' ' ' VAL . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.52 108.793 169.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' H ' ' CD ' ' A' ' 11' ' ' GLN . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 2.69 107.052 -169.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 3.75 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.73 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.99 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 4.29 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.89 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 3.46 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 2.48 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 2.76 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 4.39 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 2.99 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 7.52 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.37 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 2.55 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 6.57 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 6.08 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 3.6 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 2.09 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 2.79 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 3.23 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.9 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.82 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 2.79 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 3.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 3.52 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 4.03 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.99 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.92 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.75 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 3.58 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 3.16 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 4.29 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.43 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.93 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.17 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.65 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 3.31 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 3.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 2.89 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 3.01 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.6 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 3.66 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 2.49 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 5.14 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.93 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.49 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 6.36 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.53 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 4.66 112.967 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 3.6 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 3.58 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.97 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 2.6 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 3.49 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 2.83 109.59 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.71 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.7 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 3.76 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 4.16 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 3.7 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 4.27 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.84 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 2.83 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.55 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.81 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 2.19 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 5.46 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 5.27 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 1.85 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 6.31 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.406 ' H ' HG21 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 3.81 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 2.13 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.97 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.66 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 2.13 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 2.03 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 7.51 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 3.58 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 3.16 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 2.31 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 2.08 109.273 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 2.44 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 1.88 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 3.81 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 4.06 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 4.22 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.76 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.91 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 2.56 111.522 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 2.31 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 2.75 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 3.21 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 2.46 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 2.18 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 4.21 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 2.29 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.55 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 4.83 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.92 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 2.09 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 4.84 110.732 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 3.73 113.326 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 5.5 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.79 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.75 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.881 0.326 . . . . 3.9 111.881 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 8.0 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 3.51 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.88 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 3.16 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 4.32 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 2.81 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 3.26 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 1.05 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 3.0 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 3.74 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.86 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 3.4 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 2.07 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 3.13 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 1.79 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 1.92 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.77 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 2.88 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 4.04 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 2.6 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.88 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 5.23 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 3.21 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 3.4 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.51 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 3.06 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 2.69 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 1.33 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 2.75 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 2.04 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 3.31 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.83 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 3.23 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 2.37 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.97 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 3.47 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 2.26 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 3.73 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.34 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.93 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 2.6 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.57 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 3.46 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 2.47 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.92 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 3.0 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.65 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 3.25 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 2.77 111.109 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 6.81 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 3.07 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 11.39 115.883 -169.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 6.06 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.9 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 3.84 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 2.69 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 4.42 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 2.14 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 3.05 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 3.07 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.23 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 3.75 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 2.41 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 3.66 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 2.95 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 3.53 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 3.23 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 2.52 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.74 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 4.51 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 2.13 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 3.44 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 4.98 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 2.16 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 2.2 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 3.43 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.432 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.19 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.432 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 3.05 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 1.85 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 1.87 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.52 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 2.3 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 6.89 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 2.21 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 2.26 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 1.99 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 2.04 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 1.85 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 1.74 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 3.75 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.86 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.56 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 4.08 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 2.28 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.71 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 2.76 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 3.08 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 2.57 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 5.38 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.94 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 2.9 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.96 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.89 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.17 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 4.43 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 4.25 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 3.6 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 3.7 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 2.68 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 5.03 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 4.27 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 107.201 -1.407 . . . . 4.05 107.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 4.47 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 5.53 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 2.19 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 3.44 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 3.71 109.829 164.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 2.52 110.691 -171.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 2.4 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.18 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 3.25 116.519 -167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.95 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.29 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.94 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 2.56 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 3.14 112.075 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 3.04 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 2.14 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 5.34 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 2.99 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 4.06 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 1.12 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 2.68 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 5.27 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 6.4 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 3.35 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 3.43 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.43 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 2.86 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 3.02 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.91 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.88 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.03 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 3.87 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.56 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 3.31 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.98 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 3.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 2.14 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 4.25 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 4.39 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 2.34 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.39 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 3.36 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 2.05 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 2.27 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 4.61 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.52 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 5.62 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 2.16 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 4.82 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 2.4 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 6.48 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 5.91 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 4.52 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 3.96 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.95 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 4.32 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 2.11 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 3.02 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 2.48 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.34 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 3.09 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 2.43 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 3.51 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 2.34 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 2.13 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 2.42 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 1.75 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 3.48 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 5.88 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 2.21 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 3.7 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 6.29 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 2.05 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.86 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.45 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 3.07 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 2.0 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.84 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 2.03 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.2 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 1.72 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 5.04 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 2.42 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 2.48 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 2.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 2.22 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 2.71 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 2.32 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 3.87 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 3.34 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 4.3 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 3.27 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 3.55 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 2.42 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 2.51 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 2.41 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 6.05 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 2.08 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 2.11 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 7.23 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 2.57 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 4.57 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 3.07 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 2.62 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 5.09 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 3.44 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 5.49 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 5.23 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 3.2 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 4.39 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 3.84 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 2.51 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.88 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 4.8 108.323 161.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 2.75 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.66 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.44 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 4.34 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 5.4 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 4.55 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 2.61 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 2.87 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 2.58 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.97 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 4.14 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 3.7 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.89 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 4.22 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.77 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 8.39 112.159 171.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 3.19 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.36 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 3.87 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 3.47 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 2.03 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.24 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 3.8 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 4.4 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.94 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 4.19 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.97 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.62 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 3.32 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 2.6 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 3.84 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.18 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.71 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.7 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.96 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 3.29 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 2.31 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 2.71 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 2.84 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.22 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 4.03 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 3.11 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 7.12 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 2.87 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 6.02 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.91 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 4.66 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 4.69 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 3.02 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 4.63 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 2.34 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 3.64 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 2.45 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.61 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.82 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 3.25 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 3.44 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 2.17 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 2.69 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.91 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 1.7 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 3.13 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 5.0 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.87 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 4.35 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 4.71 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.94 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.42 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.6 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 3.19 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 3.2 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.84 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.97 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.18 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 1.75 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 4.37 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 2.52 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 2.45 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 2.3 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 1.84 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 2.16 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 2.15 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 4.14 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 3.67 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 2.0 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.98 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.67 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.74 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 2.33 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.77 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 2.54 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 4.21 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.84 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 2.2 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 4.89 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 3.38 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.81 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 4.18 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 4.02 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 2.13 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 3.67 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 3.17 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 5.55 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.45 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.431 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.75 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.73 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.057 -0.349 . . . . 3.22 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 7.67 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 4.74 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 2.01 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 3.77 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 4.11 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 2.55 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.99 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.45 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 3.91 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.24 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 4.06 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.88 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 2.02 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 3.13 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 1.93 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 1.7 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 3.55 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 3.08 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 4.68 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 2.84 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 4.5 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 6.46 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 3.06 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.54 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 3.27 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 2.7 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.52 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 3.32 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 2.21 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 3.96 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.52 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.87 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.82 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 2.41 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 2.75 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 2.45 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 4.09 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 3.5 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 2.37 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 2.13 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 4.2 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 2.62 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 2.31 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 3.25 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 5.2 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 2.08 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 5.15 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.9 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.48 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 6.23 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 4.51 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 4.67 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 3.45 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 3.15 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 5.4 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 2.4 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 3.1 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 2.36 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.87 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 3.9 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 2.59 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 4.0 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 2.15 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 2.62 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 2.15 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 1.62 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.56 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 4.03 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 2.09 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 4.57 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 4.15 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 2.1 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 4.0 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 3.78 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 2.59 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.8 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.34 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.75 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 5.52 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 2.37 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 2.86 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 2.07 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 1.86 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.91 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 2.19 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 5.11 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 4.12 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 5.52 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.92 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 4.42 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 2.82 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.78 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 2.84 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 4.18 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 2.35 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 2.2 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 4.37 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 2.58 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 4.99 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 3.72 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 2.34 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 3.29 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 3.07 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 147' ' ' SER . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 6.35 108.533 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.86 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.77 107.878 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 5.14 107.313 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 5.63 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.93 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 2.25 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 3.98 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 3.14 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 2.95 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 3.48 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 2.82 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.79 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 5.4 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.98 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.96 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 3.27 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 2.15 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 2.1 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.77 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 3.11 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 3.53 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.89 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 3.15 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.8 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 6.16 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 3.5 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 3.31 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.49 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 3.21 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.72 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 1.86 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.03 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 2.97 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 3.86 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 3.06 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 3.3 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.99 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.85 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 3.3 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 2.31 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 4.52 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.43 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 3.88 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.64 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 2.11 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.98 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 2.23 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.88 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 3.92 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 6.14 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 3.44 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 2.39 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.9 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 2.24 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.58 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.95 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 5.1 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 5.17 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 3.67 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 3.1 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 6.58 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 2.16 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 3.75 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 3.43 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 140' ' ' LYS . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 3.72 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 2.3 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 3.53 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 2.67 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 2.99 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.82 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.89 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 4.56 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.77 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 2.18 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 5.67 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 5.8 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 2.07 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.28 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 3.61 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.44 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.37 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.44 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 3.2 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.91 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.57 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.96 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.46 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 2.24 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 7.14 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.97 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.84 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 2.21 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 1.9 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.98 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 1.69 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 3.89 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 4.52 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 4.46 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 2.44 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.87 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 2.19 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.66 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 2.63 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 4.84 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 2.64 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 2.06 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 4.57 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 2.38 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 4.41 110.317 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 3.77 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 2.21 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 4.17 109.341 161.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.501 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 2.24 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 4.79 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.67 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 3.0 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.248 0.547 . . . . 4.06 110.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 5.38 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 5.03 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.95 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 4.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 6.48 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 46' ' ' SER . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 3.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 3.25 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.29 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 3.4 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 3.73 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 4.93 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 3.63 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 2.08 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 2.75 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 2.12 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 1.69 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 4.63 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 3.31 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 3.68 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 1.04 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 2.86 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 5.69 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 5.26 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 3.13 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.59 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.71 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 2.98 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 2.48 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 1.52 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 3.1 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 4.75 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 3.2 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 3.26 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 2.3 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HG ' HG12 ' A' ' 12' ' ' VAL . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 3.05 110.292 163.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 4.18 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 2.05 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 4.86 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 4.73 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 3.21 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 4.19 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 1.92 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 2.14 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 3.36 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.69 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 3.27 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 3.33 110.004 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 4.69 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 2.4 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.35 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 10.69 112.794 168.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 6.37 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 3.7 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 3.71 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 2.54 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 4.28 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 2.02 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 3.1 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 2.76 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.16 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 3.56 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 3.78 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 2.45 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 2.96 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 2.78 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.64 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.98 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 3.13 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 5.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 2.61 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 4.76 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 4.59 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 2.31 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.94 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 5.79 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.486 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.4 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.486 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 3.2 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.8 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 1.92 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.17 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 2.14 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 4.7 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 3.08 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 2.93 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 2.4 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 1.86 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 1.8 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 1.82 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 3.78 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 3.09 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 4.49 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 3.54 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.73 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 2.33 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 2.82 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 2.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 3.39 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.46 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 2.35 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.92 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 3.1 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 2.06 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 4.73 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 4.08 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 2.54 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 4.64 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 3.07 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 6.01 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.24 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.75 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.81 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.983 0.42 . . . . 4.23 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 4.76 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 4.43 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.17 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 4.34 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.82 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 2.65 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 3.15 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.27 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 3.11 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 3.72 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.53 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 3.14 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 2.43 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 2.56 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 2.01 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.68 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 3.5 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 3.92 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 5.07 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 1.03 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 2.77 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 4.34 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 4.52 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 3.28 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.98 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 3.03 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 2.68 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 2.03 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 2.87 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 3.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.32 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.92 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 2.04 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 2.27 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 3.53 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 2.67 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 4.04 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 3.0 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 4.12 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.89 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 3.27 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 2.07 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 2.1 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 2.49 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.91 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.8 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 3.07 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 2.0 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 71' ' ' VAL . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.82 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 2.58 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.89 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 5.36 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.44 114.923 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 3.2 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.8 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 5.83 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 2.09 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 3.6 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 2.63 109.009 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.58 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.98 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 3.18 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 4.13 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 2.27 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 2.86 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 2.42 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.94 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 3.57 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 4.08 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 2.12 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 4.35 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 4.03 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 2.71 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 2.25 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 4.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 2.66 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.96 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 2.35 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.63 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.87 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 8.17 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 2.8 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 2.48 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 2.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 1.57 108.608 165.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 2.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 1.77 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 3.36 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 3.33 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 7.0 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 2.69 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.92 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 2.58 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.66 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 2.56 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 5.37 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 2.53 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 1.91 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 3.5 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 3.18 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.24 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 4.63 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 3.58 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.94 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 5.16 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 2.94 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 5.18 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.62 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.755 0.312 . . . . 3.42 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.93 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 3.65 108.843 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 1.74 110.812 169.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 3.62 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 3.56 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 2.43 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 2.34 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.31 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 2.6 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 6.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 6.47 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 5.38 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 2.76 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 2.46 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 2.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 2.27 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.87 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 2.67 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 4.32 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.23 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 2.58 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 6.88 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.83 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 4.33 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 2.02 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 2.36 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 2.86 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.83 108.437 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 2.03 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 2.96 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.34 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 4.62 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 3.15 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 3.3 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.83 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 2.05 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 2.87 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 2.13 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 4.31 115.568 -175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 2.96 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 3.08 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.79 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 3.07 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 1.66 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 1.75 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 2.47 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 4.45 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 3.76 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 2.11 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 5.6 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 2.55 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.98 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 5.65 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.24 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 3.76 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 2.8 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 4.56 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 1.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 4.1 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 2.8 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 3.3 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 2.74 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.57 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 2.54 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 2.23 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.9 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 1.69 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 3.15 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 5.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 1.94 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 4.38 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 5.47 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 1.93 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 3.37 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.443 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.7 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 2.59 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 2.17 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 2.07 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.22 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.6 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 5.1 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 2.3 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 2.5 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 2.19 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 1.89 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 2.26 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 2.27 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 4.01 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 5.01 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 3.11 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 5.04 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.75 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 4.37 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 3.04 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 3.34 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 2.37 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.95 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 2.45 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.91 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 4.91 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 3.28 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.47 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 4.22 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 3.87 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 2.21 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 3.71 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 2.7 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 5.39 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 4.07 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 3.02 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.304 0.573 . . . . 2.8 110.583 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.99 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 3.78 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 2.4 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 4.05 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.69 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 3.58 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 3.81 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 3.17 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.21 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 4.08 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 3.06 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 2.04 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 3.92 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 2.65 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 1.67 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 4.2 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 3.08 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 3.65 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 1.0 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 3.56 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 4.72 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 8.31 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 4.6 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.93 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 3.43 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 2.74 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 1.54 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 3.41 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.16 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 3.48 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 2.63 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.96 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 2.03 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 2.39 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 3.53 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.96 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 3.94 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.85 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 2.5 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 3.71 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.46 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 3.96 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 2.03 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 2.09 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 3.13 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 3.14 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 3.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 2.11 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.92 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 2.16 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.43 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.85 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 4.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 4.25 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 3.41 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 2.38 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 5.04 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 1.71 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 3.46 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 3.04 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.31 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 3.75 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 2.38 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 2.41 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 2.8 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 3.26 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.9 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.99 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 3.01 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 6.05 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 2.52 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 5.6 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 4.25 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 2.3 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.76 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 4.36 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 4.01 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.58 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 3.84 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 2.26 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.65 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 2.1 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.37 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 2.02 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 3.03 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 6.39 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 3.66 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 4.08 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 2.46 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 1.72 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 2.12 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 2.17 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 3.91 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 3.61 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 2.29 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 4.0 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 3.03 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 3.22 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 5.4 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.78 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 3.11 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 4.21 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.93 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 2.43 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 3.8 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 2.66 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 2.09 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 4.57 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 3.92 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 2.49 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 4.63 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 4.48 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 4.84 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.37 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.8 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.344 -0.613 . . . . 3.01 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 4.46 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 3.44 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 1.89 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 4.13 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.77 110.461 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 2.89 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 3.27 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.34 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 2.9 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.63 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 4.53 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 3.19 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.88 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 2.76 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 2.01 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 2.14 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 4.29 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 2.59 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 5.35 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.91 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 2.57 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 4.21 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 6.03 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 3.25 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 2.07 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 2.74 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 2.81 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 1.39 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 2.82 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.68 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 3.78 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 2.41 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 2.11 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 2.22 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 2.82 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 2.03 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 4.11 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 2.91 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 2.56 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.67 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 3.27 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.99 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 2.32 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 5.18 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 4.07 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 2.1 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 4.6 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 2.51 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.67 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 5.85 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 3.61 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 3.64 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.33 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.21 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 6.46 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 2.39 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 3.01 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.8 107.935 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.22 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 3.94 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.92 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 2.49 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 2.7 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 2.66 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.96 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 2.3 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 2.57 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 5.87 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 1.95 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 5.37 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 5.43 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 1.97 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.47 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 3.38 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 2.32 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 3.54 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 2.08 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 1.92 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 1.05 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 1.75 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 4.5 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 7.26 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 3.63 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 3.37 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 1.92 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 1.99 110.215 172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 2.19 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.83 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 3.25 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 3.72 110.068 162.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 4.63 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 4.65 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 2.82 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 5.5 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 2.24 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 3.37 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 3.51 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 2.51 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 5.05 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 3.3 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.69 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 4.14 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 3.52 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 2.28 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 4.32 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 2.74 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 5.72 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.83 112.457 -174.296 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 CA--C 1.545 0.78 0 CA-C-O 120.949 0.404 . . . . 4.54 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.88 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 3.82 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 2.25 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 3.84 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 5.66 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 3.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.87 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 3.55 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 5.37 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 3.0 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 2.14 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 4.16 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 2.53 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 2.4 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 4.25 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 3.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 3.98 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.35 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 2.58 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 6.39 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 5.34 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 3.39 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 3.06 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.72 114.707 168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 2.82 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.5 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 1.78 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 3.44 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.46 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 3.53 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 2.35 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 3.36 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 2.09 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 2.01 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 3.23 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 2.17 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 3.88 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.34 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.59 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 3.35 112.579 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 2.03 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 4.11 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 2.02 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 2.01 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 2.72 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.78 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 4.11 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 2.06 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 5.95 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 2.09 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 6.19 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 5.33 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 4.07 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 3.45 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 2.91 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 4.32 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 2.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 3.36 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 2.77 111.11 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 2.27 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 3.92 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 3.36 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.74 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 2.56 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 2.71 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 2.61 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 1.57 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 4.34 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 4.09 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 2.21 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 4.65 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 6.26 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.98 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.8 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 4.32 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 3.04 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.54 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 2.66 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.97 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.46 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.71 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.2 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 1.69 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.36 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 7.91 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 2.35 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 2.71 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.97 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 1.61 108.477 167.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.86 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.96 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 5.32 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 4.26 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.71 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 3.0 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.57 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 2.31 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.59 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 2.61 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 3.52 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 2.25 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 2.19 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 4.42 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 2.53 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 4.85 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 4.41 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 2.78 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 4.08 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 2.34 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.92 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.92 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.74 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.31 0.576 . . . . 3.35 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.96 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 4.31 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 5.18 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 2.44 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 3.63 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 3.69 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 2.24 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 3.48 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.69 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.87 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 4.07 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 3.57 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 3.28 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 2.73 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 2.27 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 2.5 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 2.65 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 4.54 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 2.95 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 3.61 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.99 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 2.54 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 4.8 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 5.49 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 3.42 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 2.28 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.28 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 2.73 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 4.33 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 2.19 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 4.57 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.97 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 4.43 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.46 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.74 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 2.04 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 2.63 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 3.29 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 2.22 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 4.36 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 3.11 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 2.42 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 2.02 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 4.08 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.92 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 2.09 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 3.11 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.76 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 3.67 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 2.13 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 5.28 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 2.24 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.96 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 72' ' ' VAL . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 4.14 110.287 -171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 3.88 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 70' ' ' HIS . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 4.1 114.083 -171.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 3.94 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 4.83 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 1.9 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 3.63 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 2.73 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 4.94 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 3.98 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 3.6 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 2.25 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 2.87 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 2.28 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 1.66 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 5.82 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.74 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 2.29 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 4.71 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 4.63 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 2.24 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 2.17 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 4.44 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.473 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 4.16 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 2.22 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.73 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.98 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 1.73 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 5.02 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 2.32 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 2.35 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 2.34 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 1.66 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 2.12 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 1.95 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.63 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 3.74 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 5.37 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.95 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 3.53 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 2.15 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 2.48 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 2.69 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 4.72 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.94 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 1.74 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.88 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 2.4 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 4.38 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 4.52 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 2.41 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 3.32 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 2.74 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.86 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.81 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 3.43 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 4.0 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 121.58 0.705 . . . . 2.94 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 5.25 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 3.43 107.23 161.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 1.77 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 3.11 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 3.63 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 2.44 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 3.13 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.82 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 3.9 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.99 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 5.89 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 3.33 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 2.29 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 4.88 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 2.31 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.92 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 4.1 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 3.35 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 4.59 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 3.69 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 4.97 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 4.49 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 4.71 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 2.18 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 2.85 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.87 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.52 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.89 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.38 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 3.22 111.113 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 4.18 113.324 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 3.67 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 3.02 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 2.34 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 3.13 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 3.53 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 2.15 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 3.51 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 2.7 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.84 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 2.16 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 3.66 112.466 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 2.19 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 2.27 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 3.34 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 3.13 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 2.26 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 5.29 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 2.16 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.57 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 6.17 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 6.4 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.95 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 3.53 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 3.23 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.88 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 1.92 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 3.67 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 2.95 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.21 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 4.01 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 2.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 2.65 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 2.34 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 2.26 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.94 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 1.77 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 3.14 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 4.45 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 2.02 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 4.77 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 4.5 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 2.94 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 5.59 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.59 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.91 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.09 111.067 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.86 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.87 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.47 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 1.97 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 4.96 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 3.02 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 3.69 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 1.87 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 1.67 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 2.27 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 1.95 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 4.08 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 3.07 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.88 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 5.73 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 2.46 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 4.37 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 2.22 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 2.46 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 2.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 6.62 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 2.29 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 1.88 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 4.41 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 2.11 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 4.38 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 3.38 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 2.07 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 3.77 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 2.41 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 5.31 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 4.16 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 3.41 109.321 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 4.5 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 3.26 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 2.34 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 4.9 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.83 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 4.24 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.98 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 2.22 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.81 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 4.09 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.64 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.7 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 2.71 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 3.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 1.78 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 2.37 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 4.3 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 3.14 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 5.04 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.22 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 3.62 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 5.79 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 5.18 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 4.46 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 3.25 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 2.09 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 2.92 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 2.48 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.92 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.52 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 3.4 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 3.61 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.84 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 4.18 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.45 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 3.14 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 2.04 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 3.37 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 2.2 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 4.11 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.84 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 3.05 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 3.3 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.3 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 3.42 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 2.52 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 2.12 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 3.67 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.59 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 2.66 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 2.59 110.584 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.7 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 2.43 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 11.14 113.408 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 5.6 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 5.51 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 5.1 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 3.79 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.71 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 2.01 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 3.53 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 2.82 108.474 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 2.08 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 3.79 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 2.68 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 2.74 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 2.41 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 2.49 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 2.03 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 2.09 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 3.15 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 5.56 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 2.48 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 4.86 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 5.39 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 2.02 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.28 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 3.68 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' H ' HG23 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.56 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 3.71 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.79 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.58 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 2.19 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.4 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 2.22 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 5.07 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 2.82 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 2.4 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.86 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 2.14 108.913 168.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 2.38 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 1.69 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 3.8 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 4.58 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 7.58 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 2.61 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 4.26 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 2.92 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 3.11 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 3.27 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 3.71 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 2.42 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.84 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 3.72 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 2.23 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.58 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 4.46 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 3.58 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 2.09 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 4.57 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 2.52 111.97 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 5.23 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 3.32 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 3.1 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 4.04 110.726 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 7.09 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 3.69 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.418 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 2.05 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 4.23 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 3.29 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 2.56 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 2.55 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 3.05 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 5.6 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 19' ' ' ALA . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 5.04 115.404 165.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 3.03 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 17' ' ' CYS . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 2.43 113.317 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 2.6 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 1.89 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 1.91 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 6.15 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 3.77 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 4.61 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 3.83 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 5.43 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 5.24 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 3.42 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 3.19 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.57 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 2.71 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 2.81 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.52 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 3.04 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.91 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 3.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.52 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.87 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 2.34 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 2.82 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 3.26 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.94 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 3.59 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 3.55 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 3.29 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 2.09 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 3.83 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 2.31 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 1.88 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 3.38 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 3.74 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 2.05 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 5.14 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 2.54 113.429 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.65 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 5.03 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 3.41 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 3.22 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 3.31 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 4.27 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 2.23 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 3.24 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 3.25 109.579 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.56 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 3.19 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.99 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.47 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 2.35 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 2.11 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 2.07 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 2.09 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.67 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 4.5 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 2.9 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.97 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 4.58 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 2.11 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.86 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HZ2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 6.44 111.767 163.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.544 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.88 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 2.3 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.73 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.93 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.98 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 2.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 4.69 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.408 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 7.62 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.95 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 2.54 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 2.58 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 1.91 108.406 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 1.74 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 2.04 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 3.96 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 3.01 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 4.09 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.78 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.65 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 2.31 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 3.04 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 3.21 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 3.66 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 2.61 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 2.6 113.51 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 4.35 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 2.63 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.94 111.576 175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 3.42 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 2.83 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 3.25 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 3.13 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 6.39 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.89 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 107.904 -1.147 . . . . 3.63 107.904 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 5.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 3.19 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.78 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 3.91 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 7.73 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 2.86 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 2.83 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.72 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 2.84 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 4.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 4.33 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 3.5 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 3.04 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.48 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 2.08 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 2.65 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 6.8 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 3.01 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 6.65 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.48 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 2.54 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 4.12 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 5.22 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 3.33 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 2.1 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 3.9 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.86 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.79 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 3.98 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 3.02 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 4.58 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 4.38 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 4.14 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.98 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 3.14 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 2.26 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 4.95 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.57 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 3.06 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.98 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 3.95 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 2.75 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 2.77 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 3.04 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 3.31 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 3.48 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 2.57 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 7.66 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 3.13 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.64 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.7 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 6.7 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 4.05 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.9 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 3.19 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 4.71 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 2.08 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 2.87 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.92 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.38 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 3.16 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 2.87 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 3.14 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 2.6 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 2.74 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 2.81 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.87 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 3.08 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 6.21 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 2.12 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.9 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 4.85 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 1.88 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.63 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 3.57 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.4 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.54 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 3.85 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 2.66 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.62 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 2.09 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.22 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.9 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 5.5 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 2.75 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 2.84 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 2.52 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 1.78 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.96 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.83 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 4.09 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 4.88 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 4.52 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.78 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.92 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 2.33 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 2.35 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 3.12 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 4.05 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 2.1 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 2.01 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 3.59 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 2.14 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.71 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 4.17 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 3.27 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 2.39 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.89 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 2.49 112.225 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 5.36 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.67 110.651 155.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.48 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.489 ' NE2' ' HG1' ' A' ' 35' ' ' THR . 78.3 mt-30 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.638 -0.875 . . . . 2.85 108.638 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 4.1 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' CD1' ' HH ' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 4.22 108.52 164.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 2.14 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 3.34 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 3.53 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 2.32 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 3.1 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.99 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 4.35 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.89 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 3.04 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 2.08 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 2.76 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 2.03 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 1.7 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 5.77 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 3.52 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 3.46 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 1.03 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 3.93 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 4.73 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.99 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 3.05 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.86 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 3.22 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.489 ' HG1' ' NE2' ' A' ' 5' ' ' GLN . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 3.58 110.95 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 1.47 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 3.57 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 4.07 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 3.09 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 4.29 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.92 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 2.32 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 3.13 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 2.43 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HH ' ' CD1' ' A' ' 8' ' ' ILE . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 4.41 115.988 -157.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.73 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 2.33 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 3.04 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.68 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 4.05 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 2.58 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 3.22 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 5.25 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.78 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 3.01 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 2.08 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.87 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 2.44 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.73 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 5.18 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 3.28 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 3.67 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.74 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.83 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 1.78 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 3.68 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.59 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 4.57 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 2.79 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 3.37 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 2.32 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 2.59 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 2.39 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.74 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.91 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.96 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 2.13 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 4.76 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 5.15 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 2.9 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.92 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 3.65 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.448 HG21 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' H ' HG21 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.63 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 2.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 1.74 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.95 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.94 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.43 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 2.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 4.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 2.16 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 2.55 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 2.31 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 2.28 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 2.36 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 2.16 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 3.7 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 3.13 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.84 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 3.23 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 3.67 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 2.38 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 2.39 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 2.67 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 4.76 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 2.18 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 2.29 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 3.55 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.98 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 4.83 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 6.82 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 2.16 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 4.17 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 3.33 111.131 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 5.52 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.51 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.45 112.053 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.65 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.864 0.364 . . . . 3.58 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 4.68 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 3.75 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 2.29 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 3.27 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 4.06 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 2.61 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 3.34 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 4.02 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 4.67 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 4.25 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 3.61 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 2.55 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 4.27 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 2.34 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 2.39 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 3.5 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 2.56 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 3.67 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.83 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 2.68 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 4.18 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 5.69 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 3.04 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.93 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 2.93 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 2.3 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 1.79 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 2.85 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.18 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 3.23 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 2.36 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 3.06 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.87 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 2.1 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 2.87 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 2.06 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 4.61 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 3.0 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 3.37 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.76 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 4.72 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 2.21 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 2.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 3.46 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 3.55 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 2.52 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 4.47 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.86 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 2.31 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.67 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 4.82 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 3.28 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 4.08 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.92 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 4.48 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 2.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 3.04 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 2.43 110.34 176.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.88 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 3.08 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 3.1 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.67 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 2.89 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 2.62 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 2.55 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.95 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.44 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.92 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 2.26 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 6.25 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.92 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 2.11 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 2.16 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 4.41 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.52 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 3.34 108.861 157.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 2.49 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 2.18 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.34 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 2.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 5.32 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.83 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 3.09 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 2.73 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 1.71 109.768 170.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 2.09 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 2.08 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 3.64 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 3.68 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.8 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 2.6 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.49 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 2.2 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 2.4 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 3.43 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 4.03 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 2.25 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 2.1 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 3.38 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.74 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 2.04 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 4.17 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 3.89 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 2.2 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 4.19 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 2.69 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 4.49 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.41 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.441 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 3.31 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.89 113.738 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.95 110.615 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 3.38 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.88 111.056 179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 3.76 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 5.16 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.98 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 3.12 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.92 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 4.12 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 5.42 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.87 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 2.63 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 2.57 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 2.59 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 2.1 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 2.38 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.67 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 2.98 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 5.31 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.82 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 3.37 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 5.62 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.85 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 3.44 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.89 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.61 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 2.99 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 2.25 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 1.49 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.74 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 3.18 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.76 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 3.75 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 3.08 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.86 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 2.45 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.97 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 3.39 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 2.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 3.74 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 3.22 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 2.79 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.69 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 3.39 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 2.12 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 2.1 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 3.21 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 3.14 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 2.88 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 4.51 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 2.96 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 6.18 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 4.24 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 3.35 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 3.57 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 3.03 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 4.43 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 2.27 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 3.65 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 3.05 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.26 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 3.15 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.99 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 4.47 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 2.46 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 2.72 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 2.25 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.8 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 3.31 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 4.9 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 2.57 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 5.12 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 4.7 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 2.23 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.54 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 4.13 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 2.71 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 2.43 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.77 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.93 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.41 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 2.07 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 4.57 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 2.57 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 3.06 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 2.31 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 1.78 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 1.76 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 1.62 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 3.23 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.99 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 5.61 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 2.76 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.9 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 2.43 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.71 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 2.7 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.84 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 2.38 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 3.34 113.342 -177.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 5.79 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 3.64 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.76 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.87 112.398 -177.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 3.62 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 2.14 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 3.35 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 2.5 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 5.57 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.66 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 3.03 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.202 0.525 . . . . 4.65 111.7 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 5.22 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 3.62 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 2.17 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 3.76 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.99 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.96 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 2.53 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 3.87 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 4.72 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 4.82 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 3.27 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 2.61 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 2.64 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 2.48 111.602 175.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.95 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 4.45 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 2.81 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 5.21 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.13 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 2.92 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.98 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 6.57 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.83 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.65 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.51 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 3.38 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.98 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 2.13 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 2.55 111.157 -178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.22 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 3.91 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.67 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.95 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 2.29 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.85 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 2.64 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 2.41 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 4.93 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.35 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.83 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 3.0 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.85 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 4.24 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 1.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 2.65 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 2.95 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.86 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 2.91 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 5.31 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 2.73 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.67 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 7.11 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 4.28 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 4.02 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 2.63 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 6.78 111.751 163.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 3.01 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 3.69 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 2.99 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 3.11 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 2.7 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 2.46 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 2.48 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.75 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 2.06 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 2.21 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.76 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 4.54 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 2.23 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 4.23 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 5.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 2.01 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.76 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 4.1 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.88 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 5.16 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.59 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 3.0 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 2.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 2.1 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.59 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 2.11 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 4.14 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 4.74 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 3.1 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 3.05 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 2.31 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 2.2 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 2.01 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 2.89 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 3.93 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 3.46 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 4.04 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 3.42 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 4.08 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 3.98 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.57 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 2.95 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 4.2 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 2.51 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 2.13 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 3.71 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 3.03 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 3.92 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 3.25 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 2.62 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 3.49 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 2.57 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 5.91 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.78 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 105.58 -2.008 . . . . 4.26 105.58 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 4.54 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 3.71 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 2.2 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 3.18 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.466 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 4.54 108.299 158.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 2.4 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 3.14 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.49 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 2.8 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.94 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 4.28 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 3.08 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 2.58 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 3.32 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 2.23 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.92 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 5.54 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 2.58 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 3.53 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.27 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 2.63 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 4.54 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 7.25 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 3.87 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.92 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.47 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 2.68 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 2.66 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 2.3 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 2.8 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.07 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 3.97 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.56 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.91 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.83 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 2.73 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 2.78 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 2.36 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 4.01 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.86 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 3.19 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 4.06 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 2.64 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 2.99 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 3.27 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.18 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 3.13 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 2.78 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 5.08 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 2.89 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.65 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 12.45 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.98 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 5.17 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 4.73 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 3.0 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 4.15 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 1.81 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 3.11 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 2.83 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 3.37 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 2.48 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 4.04 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 2.65 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 2.47 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 2.35 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.47 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 5.34 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 3.42 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.93 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 5.46 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 2.27 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.96 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 4.22 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.548 HG21 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' H ' HG21 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 2.94 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 2.11 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.89 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.32 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 2.12 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 4.59 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 2.44 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 3.01 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 2.16 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 1.91 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 2.41 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 2.02 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 3.63 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 20.5 t-20 -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 3.48 110.414 176.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.63 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 5.51 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.92 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.78 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 2.29 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 4.16 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 3.94 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.9 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.91 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 2.15 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 3.41 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 2.77 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 3.99 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 3.56 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 2.42 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 3.47 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 2.44 111.759 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 5.13 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.5 112.639 164.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.81 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.78 106.69 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 4.35 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 4.18 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 1.88 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 4.31 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.86 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 2.3 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.84 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.17 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 4.29 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 3.45 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.93 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 2.67 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 2.5 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 2.46 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 2.0 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.96 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 3.62 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 2.88 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 4.35 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.94 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 2.68 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 5.1 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 5.26 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 5.15 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.49 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 3.43 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 3.97 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 1.47 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 3.55 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 2.06 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 4.16 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 2.28 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 3.04 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.89 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.81 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 2.81 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 1.69 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 3.9 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 2.7 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 2.75 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.52 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 3.8 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 2.05 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 2.37 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 2.62 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.51 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 3.55 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 2.49 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 5.24 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 2.53 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.57 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 6.36 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 5.24 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 4.1 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 4.3 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 2.5 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 4.57 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 2.05 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 3.06 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.9 111.329 -156.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 6.06 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 4.03 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 2.36 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 2.06 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 2.08 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.96 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 1.55 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.83 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 5.23 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 2.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 3.4 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 4.59 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 2.62 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.81 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 4.37 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.519 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 3.57 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 2.15 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.8 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.65 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 2.01 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 8.34 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 3.5 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 3.94 112.836 173.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 1.9 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 1.9 108.093 155.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 2.1 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 2.08 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 3.73 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 4.12 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 6.45 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.55 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 3.52 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 2.19 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 3.12 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 2.69 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 5.06 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 2.51 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 2.34 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 4.5 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 3.48 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 4.61 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 3.62 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 2.33 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.83 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 2.69 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 4.66 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 3.35 113.405 172.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.239 -0.886 . . . . 11.39 110.115 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.32 174.14 6.0 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.597 1.559 . . . . 9.86 113.124 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m 134.62 155.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 1 C-N-CA 133.826 4.85 . . . . 6.67 106.279 -168.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.27 97.0 1.61 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.916 1.689 . . . . 5.44 111.427 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -93.46 115.74 28.27 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 3.7 109.788 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 4.14 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 3.36 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 2.56 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 3.44 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.45 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 2.83 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.71 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.2 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 2.74 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 4.81 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.41 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 3.51 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 2.08 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 2.62 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.99 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 2.46 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 6.76 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 3.21 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 5.51 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.32 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 2.49 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 6.4 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.79 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 3.64 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.31 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.64 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 3.19 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 2.51 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 1.52 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 3.08 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 4.58 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 3.61 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 5.53 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.11 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.05 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.93 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 2.32 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 2.62 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 2.03 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 4.4 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.38 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 2.73 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.62 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.95 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.93 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.84 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 2.01 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 2.19 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 3.29 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 3.01 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 3.52 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 1.9 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 6.09 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 2.3 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.8 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 4.92 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 3.64 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 3.67 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 2.76 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.95 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 2.48 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 3.05 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 2.85 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.92 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.9 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 4.07 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.92 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.75 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 2.85 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 2.91 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.95 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 2.09 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.66 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 5.08 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 2.24 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 4.09 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 6.29 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 2.25 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 4.5 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.75 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 3.06 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 2.58 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.98 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.47 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 2.2 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 5.27 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 2.62 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 2.91 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 2.16 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 1.9 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 2.18 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 2.14 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 3.52 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 3.23 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 4.26 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 3.42 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 3.7 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 2.47 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.72 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 2.58 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 4.45 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 2.3 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 2.34 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 3.79 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 2.56 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.45 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 4.07 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 5.5 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 2.94 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 5.34 108.544 158.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 4.04 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.91 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.054 -0.721 . . . . 13.52 109.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.13 169.5 10.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.779 0.718 . . . . 9.95 111.088 163.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.1 p 169.81 112.81 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.75 2.82 . . . . 6.22 107.755 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.454 ' CD ' ' HZ3' ' A' ' 6' ' ' LYS . 3.4 pt-20 -175.44 93.09 0.06 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.428 1.891 . . . . 4.82 110.703 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -70.28 121.83 18.37 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.516 -0.74 . . . . 3.6 110.89 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HZ3' ' CD ' ' A' ' 4' ' ' GLU . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 4.61 112.132 -171.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 3.58 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 2.29 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 3.49 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.35 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.9 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 4.39 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.37 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 3.69 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 4.37 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 2.75 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 2.68 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 2.99 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 1.77 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 2.14 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.96 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 3.53 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 5.3 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.78 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 2.46 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 4.43 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 8.17 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 3.02 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 2.01 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.21 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 2.86 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.71 110.134 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 1.43 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.24 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 3.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 3.41 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 3.87 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.9 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.72 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 2.13 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 3.59 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 2.89 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 1.88 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 3.69 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 2.35 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.96 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 2.09 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 4.4 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 2.12 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 1.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 3.1 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 4.34 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 2.37 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.73 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 3.05 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 6.0 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 4.59 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.9 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 3.72 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 3.04 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.81 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 1.7 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 142' ' ' LYS . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 3.0 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 2.8 110.006 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 3.47 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.82 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 3.16 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 2.8 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 2.52 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.88 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 2.49 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 4.26 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 5.77 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 1.91 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 4.16 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 4.0 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 1.81 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 2.32 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 4.83 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.38 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 3.12 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.85 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.44 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.72 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 1.05 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 1.69 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 5.37 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 2.65 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 2.87 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 2.53 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 1.66 109.375 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 1.62 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 1.57 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 4.67 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.58 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 4.56 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 3.24 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.86 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 2.31 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.55 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 3.8 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 5.15 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.83 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 2.25 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 4.73 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 2.11 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 5.87 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 5.37 109.845 165.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 2.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 3.87 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.99 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 77' ' ' GLU . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 4.8 105.735 175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.93 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.62 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 108.63 -0.878 . . . . 11.98 108.63 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.05 115.53 28.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.64 0.776 . . . . 9.02 109.169 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 t -169.61 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.534 1.679 . . . . 5.86 115.534 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.71 144.73 21.79 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.139 1.336 . . . . 7.57 110.386 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -102.16 152.47 20.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 3.77 111.323 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 6.62 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 4.36 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 HG21 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 3.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.67 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.98 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.407 ' CD ' ' H ' ' A' ' 12' ' ' VAL . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.52 108.793 169.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' H ' ' CD ' ' A' ' 11' ' ' GLN . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 2.69 107.052 -169.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 3.75 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.73 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.99 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 4.29 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.89 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 3.46 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 2.48 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 2.76 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 4.39 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 2.99 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 7.52 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.37 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 2.55 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 6.57 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 6.08 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 3.6 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 2.09 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 2.79 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 3.23 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.9 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.82 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 2.79 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 3.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 3.52 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 4.03 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.99 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.92 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.75 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 3.58 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 3.16 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 4.29 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.43 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.93 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.17 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.65 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 3.31 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 3.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 2.89 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 3.01 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.6 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 3.66 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 2.49 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 5.14 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.93 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.49 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 6.36 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.53 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 4.66 112.967 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 3.6 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 3.58 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.97 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 2.6 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 3.49 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 2.83 109.59 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.71 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.7 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 3.76 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 4.16 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 3.7 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 4.27 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.84 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 2.83 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.55 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.81 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 2.19 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 5.46 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 5.27 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 1.85 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 6.31 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.406 ' H ' HG21 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 3.81 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 2.13 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.97 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.66 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 2.13 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 2.03 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 7.51 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 3.58 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 3.16 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 2.31 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 2.08 109.273 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 2.44 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 1.88 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 3.81 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 4.06 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 4.22 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.76 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.91 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 2.56 111.522 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 2.31 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 2.75 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 3.21 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 2.46 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 2.18 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 4.21 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 2.29 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.55 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 4.83 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.92 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 2.09 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 4.84 110.732 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 3.73 113.326 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 5.5 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.79 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.75 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 117.308 -1.329 . . . . 10.99 113.399 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.74 -50.04 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.876 1.671 . . . . 9.6 113.037 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -153.38 -65.34 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.302 -1.74 . . . . 6.65 106.302 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 92.34 111.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 130.856 3.662 . . . . 5.89 109.451 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.95 159.84 14.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.766 1.227 . . . . 3.9 111.881 -162.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 8.0 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 3.51 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.88 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 3.16 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 4.32 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 2.81 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 3.26 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 1.05 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 3.0 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 3.74 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.86 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 3.4 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 2.07 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 3.13 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 1.79 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 1.92 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.77 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 2.88 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 4.04 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 2.6 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.88 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 5.23 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 3.21 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 3.4 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.51 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 3.06 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 2.69 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 1.33 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 2.75 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 2.04 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 3.31 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.83 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 3.23 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 2.37 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.97 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 3.47 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 2.26 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 3.73 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.34 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.93 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 2.6 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.57 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 3.46 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 2.47 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.92 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 3.0 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.65 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 3.25 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 2.77 111.109 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 6.81 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 3.07 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 11.39 115.883 -169.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 6.06 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.9 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 3.84 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 2.69 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 4.42 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 2.14 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 3.05 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 3.07 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.23 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 3.75 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 2.41 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 3.66 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 2.95 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 3.53 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 3.23 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 2.52 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.74 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 4.51 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 2.13 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 3.44 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 4.98 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 2.16 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 2.2 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 3.43 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.432 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.19 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.432 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 3.05 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 1.85 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 1.87 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.52 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 2.3 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 6.89 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 2.21 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 2.26 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 1.99 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 2.04 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 1.85 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 1.74 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 3.75 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.86 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.56 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 4.08 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 2.28 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.71 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 2.76 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 3.08 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 2.57 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 5.38 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.94 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 2.9 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.96 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.89 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.17 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 4.43 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 4.25 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 3.6 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 3.7 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 2.68 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 5.03 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 4.27 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.893 -0.575 . . . . 15.79 109.962 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.13 125.33 23.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.743 1.217 . . . . 10.37 111.559 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 m 114.99 -130.48 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 1 C-N-CA 131.723 4.009 . . . . 7.6 104.155 -162.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -153.9 -172.31 4.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 121.12 1.782 . . . . 5.39 111.292 151.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -136.17 141.02 44.03 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.201 -1.407 . . . . 4.05 107.201 160.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 4.47 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 5.53 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 2.19 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 3.44 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 3.71 109.829 164.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' H ' ' NE2' ' A' ' 11' ' ' GLN . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 2.52 110.691 -171.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 2.4 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.18 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 3.25 116.519 -167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.95 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.29 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.94 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 2.56 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 3.14 112.075 170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 3.04 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 2.14 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 5.34 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 2.99 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 4.06 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 1.12 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 2.68 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 5.27 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 6.4 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 3.35 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 3.43 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.43 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 2.86 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 3.02 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.91 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.88 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.03 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 3.87 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.56 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 3.31 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.98 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 3.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 2.14 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 4.25 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 4.39 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 2.34 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.39 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 3.36 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 2.05 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 2.27 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 4.61 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.52 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 5.62 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 2.16 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 4.82 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 2.4 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 6.48 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 5.91 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 4.52 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 3.96 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.95 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 4.32 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 2.11 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 3.02 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 2.48 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.34 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 3.09 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 2.43 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 3.51 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 2.34 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 2.13 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 2.42 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 1.75 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 3.48 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 5.88 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 2.21 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 3.7 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 6.29 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 2.05 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.86 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.45 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 3.07 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 2.0 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.84 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 2.03 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.2 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 1.72 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 5.04 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 2.42 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 2.48 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 2.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 2.22 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 2.71 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 2.32 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 3.87 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 3.34 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 4.3 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 3.27 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 3.55 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 2.42 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 2.51 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 2.41 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 6.05 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 2.08 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 2.11 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 7.23 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 2.57 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 4.57 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 3.07 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 2.62 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 5.09 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 3.44 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 5.49 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 5.23 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.204 -1.036 . . . . 15.8 108.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.18 -76.76 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.802 1.241 . . . . 9.48 109.938 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m 73.91 93.84 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.847 2.059 . . . . 7.04 113.235 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.65 4.15 53.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.281 -0.887 . . . . 7.94 112.817 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -95.99 109.09 21.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 3.2 107.242 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 4.39 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 3.84 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 2.51 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.88 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 4.8 108.323 161.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 2.75 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.66 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.44 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 4.34 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 5.4 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 4.55 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 2.61 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 2.87 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 2.58 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.97 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 4.14 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 3.7 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.89 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 4.22 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.77 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 8.39 112.159 171.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 3.19 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.36 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 3.87 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 3.47 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 2.03 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.24 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 3.8 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 4.4 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.94 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 4.19 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.97 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.62 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 3.32 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 2.6 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 3.84 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.18 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.71 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.7 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.96 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 3.29 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 2.31 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 2.71 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 2.84 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.22 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 4.03 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 3.11 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 7.12 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 2.87 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 6.02 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.91 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 4.66 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 4.69 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 3.02 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 4.63 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 2.34 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 3.64 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 2.45 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.61 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.82 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 3.25 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 3.44 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 2.17 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 2.69 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.91 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 1.7 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 3.13 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 5.0 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.87 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 4.35 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 4.71 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.94 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.42 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.6 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 3.19 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 3.2 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.84 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.97 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.18 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 1.75 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 4.37 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 2.52 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 2.45 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 2.3 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 1.84 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 2.16 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 2.15 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 4.14 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 3.67 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 2.0 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.98 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.67 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.74 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 2.33 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.77 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 2.54 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 4.21 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.84 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 2.2 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 4.89 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 3.38 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.81 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 4.18 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 4.02 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 2.13 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 3.67 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.431 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 3.17 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 5.55 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.45 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.431 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.75 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.73 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.557 -0.534 . . . . 12.65 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.64 -60.57 3.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.201 1.0 . . . . 11.38 110.714 168.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.4 m 149.05 -105.16 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 131.368 3.867 . . . . 6.35 108.261 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -148.05 21.03 1.11 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.363 1.246 . . . . 8.53 114.363 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -140.09 149.99 43.78 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 119.451 -2.031 . . . . 3.22 110.057 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 7.67 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 4.74 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 2.01 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 3.77 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 4.11 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 2.55 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.99 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.45 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 3.91 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.24 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 4.06 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.88 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 2.02 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 3.13 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 1.93 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 1.7 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 3.55 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 3.08 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 4.68 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 2.84 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 4.5 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 6.46 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 3.06 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.54 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 3.27 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 2.7 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.52 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 3.32 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 2.21 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 3.96 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.52 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.87 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.82 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 2.41 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 2.75 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 2.45 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 4.09 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 3.5 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 2.37 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 2.13 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 4.2 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 2.62 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 2.31 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 3.25 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 5.2 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 2.08 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 5.15 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.9 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.48 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 6.23 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 4.51 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 4.67 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 3.45 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 3.15 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 5.4 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 2.4 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 3.1 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 2.36 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.87 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 3.9 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 2.59 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 4.0 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 2.15 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 2.62 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 2.15 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 1.62 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.56 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 4.03 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 2.09 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 4.57 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 4.15 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 2.1 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 4.0 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 3.78 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 2.59 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.8 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.34 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.75 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 5.52 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 2.37 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 2.86 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 2.07 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 1.86 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.91 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 2.19 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 5.11 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 4.12 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 5.52 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.92 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 4.42 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 2.82 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.78 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 2.84 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 4.18 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 2.35 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 2.2 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 4.37 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 2.58 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 4.99 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 3.72 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 2.34 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 3.29 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 3.07 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 147' ' ' SER . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 6.35 108.533 -178.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.86 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 142' ' ' LYS . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.77 107.878 -173.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.469 -0.567 . . . . 12.6 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 tp 34.39 60.45 0.59 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.064 2.945 . . . . 10.56 115.414 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.2 t -62.94 -17.09 61.45 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.446 1.647 . . . . 5.35 115.446 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -179.02 146.07 0.29 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.41 2.284 . . . . 5.5 108.853 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -96.2 136.97 35.95 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 5.14 107.313 172.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 5.63 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.93 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 2.25 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 3.98 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 3.14 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 2.95 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 3.48 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 2.82 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.79 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 5.4 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.98 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.96 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 3.27 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 2.15 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 2.1 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.77 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 3.11 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 3.53 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.89 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 3.15 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.8 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 6.16 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 3.5 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 3.31 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.49 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 3.21 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.72 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 1.86 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.03 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 2.97 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 3.86 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 3.06 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 3.3 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.99 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.85 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 3.3 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 2.31 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 4.52 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.43 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 3.88 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.64 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 2.11 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.98 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 2.23 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.88 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 3.92 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 6.14 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 3.44 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 2.39 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.9 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 2.24 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.58 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.95 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 5.1 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 5.17 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 3.67 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 3.1 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 6.58 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 2.16 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 3.75 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 3.43 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 140' ' ' LYS . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 3.72 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 2.3 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 3.53 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 2.67 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 2.99 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.82 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.89 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 4.56 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.77 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 2.18 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 5.67 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 5.8 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 2.07 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.28 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 3.61 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.44 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.37 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.44 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 3.2 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.91 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.57 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.96 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.46 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 2.24 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 7.14 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.97 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.84 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 2.21 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 1.9 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.98 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 1.69 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 3.89 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 4.52 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 4.46 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 2.44 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.87 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 2.19 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.66 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 2.63 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 4.84 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 2.64 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 2.06 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 4.57 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 2.38 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 4.41 110.317 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 3.77 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 2.21 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 4.17 109.341 161.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.501 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 2.24 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 4.79 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.501 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.67 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 3.0 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 119.276 -0.392 . . . . 15.43 110.245 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -131.17 165.65 22.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.538 1.535 . . . . 13.46 109.911 166.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 167.92 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.85 2.46 . . . . 7.82 107.426 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 169.7 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.858 2.463 . . . . 5.68 109.207 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -84.66 120.63 26.6 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.597 -0.689 . . . . 4.06 110.099 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 5.38 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 5.03 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.95 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 4.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 6.48 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 46' ' ' SER . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 3.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 3.25 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.29 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 3.4 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 3.73 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 4.93 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 3.63 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 2.08 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 2.75 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 2.12 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 1.69 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 4.63 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 3.31 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 3.68 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 1.04 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 2.86 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 5.69 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 5.26 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 3.13 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.59 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.71 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 2.98 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 2.48 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 1.52 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 3.1 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 4.75 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 3.2 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 3.26 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 2.3 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HG ' HG12 ' A' ' 12' ' ' VAL . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 3.05 110.292 163.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 4.18 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 2.05 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 4.86 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 4.73 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 3.21 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 4.19 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 1.92 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 2.14 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 3.36 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.69 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 3.27 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 3.33 110.004 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 4.69 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 2.4 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.35 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 10.69 112.794 168.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 6.37 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 3.7 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 3.71 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 2.54 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 4.28 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 2.02 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 3.1 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 2.76 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.16 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 3.56 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 3.78 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 2.45 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 2.96 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 2.78 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.64 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.98 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 3.13 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 5.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 2.61 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 4.76 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 4.59 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 2.31 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.94 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 5.79 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.486 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.4 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.486 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 3.2 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.8 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 1.92 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.17 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 2.14 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 4.7 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 3.08 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 2.93 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 2.4 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 1.86 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 1.8 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 1.82 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 3.78 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 3.09 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 4.49 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 3.54 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.73 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 2.33 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 2.82 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 2.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 3.39 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.46 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 2.35 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.92 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 3.1 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 2.06 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 4.73 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 4.08 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 2.54 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 4.64 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 3.07 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 6.01 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.24 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.75 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.81 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 118.215 -0.897 . . . . 15.27 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 pp -81.03 176.57 9.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.464 0.574 . . . . 9.36 110.73 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 m 164.83 -40.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 128.934 2.894 . . . . 6.6 111.951 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -149.84 155.27 39.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.571 1.548 . . . . 6.16 110.477 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -104.32 171.88 7.1 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.661 1.184 . . . . 4.23 111.291 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 4.76 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 4.43 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.17 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 4.34 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.82 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 2.65 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 3.15 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.27 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 3.11 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 3.72 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.53 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 3.14 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 2.43 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 2.56 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 2.01 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.68 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 3.5 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 3.92 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 5.07 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 1.03 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 2.77 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 4.34 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 4.52 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 3.28 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.98 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 3.03 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 2.68 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 2.03 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 2.87 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 3.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.32 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.92 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 2.04 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 2.27 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 3.53 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 2.67 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 4.04 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 3.0 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 4.12 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.89 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 3.27 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 2.07 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 2.1 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 2.49 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.91 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.8 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 3.07 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 2.0 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 71' ' ' VAL . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.82 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 2.58 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.89 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 5.36 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.44 114.923 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 3.2 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.8 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 5.83 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 2.09 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 3.6 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 2.63 109.009 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.58 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.98 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 3.18 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 4.13 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 2.27 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 2.86 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 2.42 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.94 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 3.57 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 4.08 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 2.12 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 4.35 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 4.03 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 2.71 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 2.25 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 4.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 2.66 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.96 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 2.35 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.63 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.87 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 8.17 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 2.8 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 2.48 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 2.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 1.57 108.608 165.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 2.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 1.77 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 3.36 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 3.33 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 7.0 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 2.69 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.92 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 2.58 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.66 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 2.56 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 5.37 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 2.53 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 1.91 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 3.5 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 3.18 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.24 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 4.63 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 3.58 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.94 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 5.16 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 2.94 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 5.18 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.62 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 119.471 -0.3 . . . . 11.25 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.79 -163.65 0.15 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.393 1.877 . . . . 11.0 111.485 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.5 p -84.07 59.66 5.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.002 1.321 . . . . 6.42 111.875 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.13 60.42 1.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.628 1.204 . . . . 5.57 110.266 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -92.71 159.14 15.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.565 1.946 . . . . 3.42 110.256 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.93 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 3.65 108.843 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 1.74 110.812 169.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 3.62 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 3.56 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 2.43 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 2.34 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.31 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 2.6 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 6.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 6.47 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 5.38 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 2.76 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 2.46 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 2.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 2.27 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.87 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 2.67 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 4.32 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.23 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 2.58 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 6.88 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.83 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 4.33 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 2.02 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 2.36 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 2.86 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.83 108.437 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 2.03 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 2.96 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.34 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 4.62 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 3.15 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 3.3 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.83 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 2.05 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 2.87 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 2.13 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 4.31 115.568 -175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 2.96 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 3.08 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.79 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 3.07 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 1.66 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 1.75 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 2.47 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 4.45 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 3.76 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 2.11 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 5.6 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 2.55 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.98 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 5.65 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.24 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 3.76 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 2.8 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 4.56 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 1.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 4.1 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 2.8 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 3.3 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 2.74 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.57 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 2.54 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 2.23 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.9 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 1.69 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 3.15 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 5.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 1.94 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 4.38 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 5.47 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 1.93 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 3.37 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.443 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.7 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 2.59 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 2.17 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 2.07 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.22 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.6 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 5.1 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 2.3 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 2.5 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 2.19 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 1.89 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 2.26 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 2.27 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 4.01 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 5.01 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 3.11 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 5.04 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.75 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 4.37 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 3.04 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 3.34 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 2.37 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.95 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 2.45 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.91 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 4.91 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 3.28 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.47 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 4.22 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 3.87 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 2.21 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 3.71 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 2.7 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 5.39 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 4.07 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 3.02 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.864 -0.588 . . . . 16.86 109.476 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.35 117.28 26.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.863 0.865 . . . . 15.27 110.107 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -174.81 35.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.721 2.008 . . . . 9.61 110.141 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.013 -1.054 . . . . 6.72 108.812 -165.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.64 166.59 22.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.062 0.945 . . . . 2.8 110.583 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.99 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 3.78 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 2.4 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 4.05 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.69 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 3.58 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 3.81 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 3.17 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.21 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 4.08 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 3.06 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 2.04 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 3.92 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 2.65 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 1.67 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 4.2 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 3.08 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 3.65 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 1.0 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 3.56 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 4.72 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 8.31 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 4.6 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.93 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 3.43 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 2.74 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 1.54 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 3.41 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.16 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 3.48 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 2.63 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.96 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 2.03 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 2.39 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 3.53 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.96 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 3.94 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.85 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 2.5 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 3.71 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.46 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 3.96 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 2.03 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 2.09 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 3.13 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 3.14 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 3.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 2.11 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.92 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 2.16 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.43 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.85 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 4.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 4.25 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 3.41 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 2.38 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 5.04 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 1.71 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 3.46 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 3.04 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.31 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 3.75 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 2.38 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 2.41 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 2.8 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 3.26 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.9 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.99 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 3.01 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 6.05 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 2.52 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 5.6 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 4.25 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 2.3 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.76 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 4.36 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 4.01 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.58 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 3.84 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 2.26 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.65 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 2.1 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.37 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 2.02 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 3.03 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 6.39 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 3.66 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 4.08 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 2.46 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 1.72 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 2.12 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 2.17 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 3.91 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 3.61 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 2.29 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 4.0 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 3.03 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 3.22 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 5.4 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.78 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 3.11 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 4.21 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.93 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 2.43 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 3.8 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 2.66 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 2.09 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 4.57 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 3.92 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 2.49 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 4.63 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 4.48 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 4.84 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.37 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.8 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.446 -0.576 . . . . 16.42 109.446 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.93 157.85 20.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.531 -0.914 . . . . 13.56 108.531 162.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.8 m -62.32 -37.86 87.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.678 0.992 . . . . 6.25 113.678 -167.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.37 -13.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.852 1.427 . . . . 7.71 114.852 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.65 138.26 56.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.789 1.631 . . . . 3.01 109.344 169.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 4.46 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 3.44 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 1.89 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 4.13 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.77 110.461 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 2.89 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 3.27 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.34 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 2.9 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.63 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 4.53 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 3.19 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.88 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 2.76 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 2.01 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 2.14 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 4.29 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 2.59 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 5.35 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.91 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 2.57 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 4.21 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 6.03 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 3.25 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 2.07 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 2.74 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 2.81 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 1.39 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 2.82 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.68 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 3.78 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 2.41 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 2.11 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 2.22 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 2.82 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 2.03 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 4.11 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 2.91 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 2.56 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.67 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 3.27 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.99 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 2.32 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 5.18 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 4.07 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 2.1 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 4.6 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 2.51 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.67 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 5.85 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 3.61 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 3.64 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.33 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.21 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 6.46 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 2.39 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 3.01 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.8 107.935 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.22 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 3.94 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.92 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 2.49 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 2.7 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 2.66 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.96 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 2.3 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 2.57 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 5.87 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 1.95 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 5.37 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 5.43 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 1.97 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.47 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 3.38 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 2.32 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 3.54 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 2.08 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 1.92 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 1.05 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 1.75 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 4.5 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 7.26 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 3.63 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 3.37 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 1.92 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 1.99 110.215 172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 2.19 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.83 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 3.25 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 3.72 110.068 162.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 4.63 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 4.65 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 2.82 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 5.5 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 2.24 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 3.37 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 3.51 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 2.51 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 5.05 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 3.3 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.69 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 4.14 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 3.52 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 2.28 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 4.32 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 2.74 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 5.72 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.83 112.457 -174.296 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 118.929 -0.558 . . . . 15.72 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.48 -176.62 4.27 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.758 1.623 . . . . 8.73 110.011 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -156.23 68.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.0 -1.687 . . . . 6.57 110.955 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -162.12 27.33 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.916 1.45 . . . . 5.93 114.916 -163.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.4 155.29 23.56 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.601 -1.312 . . . . 4.54 110.369 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.88 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 3.82 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 2.25 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 3.84 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 5.66 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 3.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.87 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 3.55 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 5.37 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 3.0 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 2.14 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 4.16 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 2.53 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 2.4 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 4.25 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 3.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 3.98 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.35 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 2.58 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 6.39 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 5.34 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 3.39 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 3.06 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.72 114.707 168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 2.82 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.5 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 1.78 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 3.44 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.46 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 3.53 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 2.35 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 3.36 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 2.09 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 2.01 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 3.23 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 2.17 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 3.88 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.34 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.59 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 3.35 112.579 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 2.03 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 4.11 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 2.02 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 2.01 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 2.72 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.78 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 4.11 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 2.06 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 5.95 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 2.09 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 6.19 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 5.33 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 4.07 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 3.45 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 2.91 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 4.32 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 2.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 3.36 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 2.77 111.11 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 2.27 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 3.92 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 3.36 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.74 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 2.56 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 2.71 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 2.61 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 1.57 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 4.34 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 4.09 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 2.21 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 4.65 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 6.26 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.98 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.8 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 4.32 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 3.04 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.54 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 2.66 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.97 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.46 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.71 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.2 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 1.69 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.36 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 7.91 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 2.35 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 2.71 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.97 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 1.61 108.477 167.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.86 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.96 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 5.32 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 4.26 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.71 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 3.0 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.57 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 2.31 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.59 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 2.61 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 3.52 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 2.25 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 2.19 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 4.42 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 2.53 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 4.85 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 4.41 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 2.78 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 4.08 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 2.34 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.92 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.92 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.74 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.133 -0.321 . . . . 18.12 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.2 tp -162.17 141.68 9.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.769 1.627 . . . . 10.17 109.622 -175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t 166.78 -169.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 130.9 3.68 . . . . 6.51 105.578 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.63 148.56 36.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.676 -1.231 . . . . 5.16 107.676 153.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -139.3 148.34 42.86 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.744 -0.598 . . . . 3.35 109.811 -167.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.96 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 4.31 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 5.18 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 2.44 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 3.63 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 3.69 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 2.24 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 3.48 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.69 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.87 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 4.07 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 3.57 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 3.28 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 2.73 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 2.27 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 2.5 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 2.65 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 4.54 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 2.95 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 3.61 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.99 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 2.54 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 4.8 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 5.49 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 3.42 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 2.28 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.28 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 2.73 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 4.33 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 2.19 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 4.57 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.97 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 4.43 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.46 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.74 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 2.04 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 2.63 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 3.29 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 2.22 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 4.36 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 3.11 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 2.42 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 2.02 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 4.08 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.92 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 2.09 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 3.11 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.76 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 3.67 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 2.13 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 5.28 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 2.24 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.96 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 72' ' ' VAL . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 4.14 110.287 -171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 3.88 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 70' ' ' HIS . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 4.1 114.083 -171.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 3.94 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 4.83 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 1.9 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 3.63 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 2.73 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 4.94 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 3.98 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 3.6 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 2.25 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 2.87 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 2.28 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 1.66 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 5.82 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.74 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 2.29 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 4.71 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 4.63 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 2.24 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 2.17 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 4.44 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.473 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.473 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 4.16 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 2.22 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.73 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.98 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 1.73 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 5.02 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 2.32 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 2.35 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 2.34 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 1.66 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 2.12 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 1.95 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.63 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 3.74 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 5.37 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.95 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 3.53 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 2.15 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 2.48 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 2.69 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 4.72 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.94 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 1.74 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.88 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 2.4 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 4.38 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 4.52 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 2.41 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 3.32 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 2.74 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.86 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.81 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 3.43 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 4.0 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.41 -0.589 . . . . 11.46 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.77 145.49 52.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.477 0.581 . . . . 10.59 109.458 155.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -179.0 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.589 1.699 . . . . 5.56 115.589 -167.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.8 121.06 4.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 120.436 1.471 . . . . 4.93 111.643 -166.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -97.18 130.11 44.46 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.447 -0.783 . . . . 2.94 109.474 -169.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 5.25 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 3.43 107.23 161.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 1.77 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 3.11 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 3.63 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 2.44 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 3.13 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.82 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 3.9 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.99 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 5.89 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 3.33 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 2.29 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 4.88 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 2.31 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.92 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 4.1 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 3.35 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 4.59 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 3.69 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 4.97 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 4.49 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 4.71 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 2.18 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 2.85 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.87 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.52 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.89 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.38 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 3.22 111.113 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 4.18 113.324 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 3.67 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 3.02 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 2.34 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 3.13 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 3.53 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 2.15 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 3.51 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 2.7 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.84 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 2.16 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 3.66 112.466 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 2.19 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 2.27 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 3.34 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 3.13 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 2.26 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 5.29 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 2.16 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.57 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 6.17 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 6.4 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.95 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 3.53 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 3.23 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.88 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 1.92 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 3.67 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 2.95 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.21 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 4.01 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 2.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 2.65 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 2.34 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 2.26 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.94 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 1.77 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 3.14 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 4.45 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 2.02 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 4.77 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 4.5 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 2.94 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 5.59 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.59 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.91 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.09 111.067 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.86 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.87 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.47 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 1.97 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 4.96 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 3.02 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 3.69 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 1.87 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 1.67 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 2.27 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 1.95 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 4.08 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 3.07 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.88 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 5.73 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 2.46 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 4.37 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 2.22 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 2.46 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 2.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 6.62 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 2.29 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 1.88 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 4.41 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 2.11 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 4.38 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 3.38 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 2.07 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 3.77 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 2.41 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 5.31 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 4.16 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 mtt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.324 -1.322 . . . . 15.51 109.116 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.99 60.51 3.57 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.279 1.854 . . . . 12.23 112.951 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m 141.06 124.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 1 C-N-CA 132.861 4.464 . . . . 6.93 109.995 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 178.42 98.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.578 2.751 . . . . 6.11 108.928 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -81.47 129.96 34.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.442 -0.786 . . . . 3.41 109.321 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 4.5 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 3.26 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 2.34 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 4.9 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.83 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 4.24 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.98 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 2.22 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.81 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 4.09 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.64 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.7 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 2.71 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 3.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 1.78 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 2.37 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 4.3 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 3.14 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 5.04 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.22 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 3.62 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 5.79 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 5.18 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 4.46 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 3.25 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 2.09 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 2.92 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 2.48 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.92 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.52 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 3.4 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 3.61 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.84 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 4.18 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.45 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 3.14 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 2.04 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 3.37 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 2.2 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 4.11 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.84 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 3.05 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 3.3 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.3 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 3.42 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 2.52 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 2.12 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 3.67 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.59 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 2.66 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 2.59 110.584 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.7 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 2.43 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 11.14 113.408 -177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 5.6 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 5.51 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 5.1 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 3.79 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.71 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 2.01 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 3.53 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 2.82 108.474 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 2.08 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 3.79 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 2.68 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 2.74 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 2.41 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 2.49 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 2.03 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 2.09 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 3.15 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 5.56 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 2.48 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 4.86 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 5.39 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 2.02 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.28 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 3.68 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.516 ' H ' HG23 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.56 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 3.71 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.79 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.58 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 2.19 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.4 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 2.22 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 5.07 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 2.82 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 2.4 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.86 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 2.14 108.913 168.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 2.38 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 1.69 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 3.8 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 4.58 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 7.58 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 2.61 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 4.26 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 2.92 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 3.11 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 3.27 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 3.71 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 2.42 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.84 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 3.72 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 2.23 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.58 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 4.46 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 3.58 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 2.09 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 4.57 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 2.52 111.97 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 5.23 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 3.32 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 3.1 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 117.702 -1.142 . . . . 17.82 108.241 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 mt 137.11 151.69 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 131.665 3.986 . . . . 13.05 109.815 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m -78.6 36.01 0.25 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.088 1.755 . . . . 7.27 112.997 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 85.9 -32.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.012 2.925 . . . . 7.96 109.947 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -64.22 114.98 4.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 4.04 110.726 157.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 7.09 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 3.69 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.418 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 2.05 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 4.23 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 3.29 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 2.56 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 2.55 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 3.05 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 5.6 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 19' ' ' ALA . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 5.04 115.404 165.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 3.03 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 17' ' ' CYS . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 2.43 113.317 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 2.6 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 1.89 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 1.91 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 6.15 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 3.77 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 4.61 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 3.83 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 5.43 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 5.24 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 3.42 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 3.19 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.57 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 2.71 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 2.81 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.52 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 3.04 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.91 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 3.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.52 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.87 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 2.34 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 2.82 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 3.26 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.94 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 3.59 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 3.55 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 3.29 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 2.09 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 3.83 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 2.31 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 1.88 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 3.38 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 3.74 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 2.05 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 5.14 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 2.54 113.429 169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.65 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 5.03 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 3.41 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 3.22 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 3.31 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 4.27 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 2.23 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 3.24 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 3.25 109.579 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.56 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 3.19 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.99 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.47 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 2.35 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 2.11 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 2.07 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 2.09 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.67 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 4.5 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 2.9 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.97 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 4.58 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 2.11 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.86 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HZ2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 6.44 111.767 163.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.544 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.88 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 2.3 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.73 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.93 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.98 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 2.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 4.69 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.408 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 7.62 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.95 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 2.54 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 2.58 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 1.91 108.406 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 1.74 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 2.04 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 3.96 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 3.01 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 4.09 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.78 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.65 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 2.31 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 3.04 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 3.21 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 3.66 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 2.61 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 2.6 113.51 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 4.35 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 2.63 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.94 111.576 175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 3.42 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 2.83 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 3.25 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 3.13 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 6.39 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.89 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.992 -0.527 . . . . 11.38 109.736 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.87 -153.12 0.45 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.616 1.566 . . . . 8.47 110.156 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -176.39 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.506 2.323 . . . . 5.76 111.042 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -124.07 165.85 16.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.505 1.922 . . . . 6.9 109.407 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -131.34 149.63 52.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.245 1.418 . . . . 3.63 107.904 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 5.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 3.19 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.78 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 3.91 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 7.73 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 2.86 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 2.83 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.72 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 2.84 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 4.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 4.33 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 3.5 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 3.04 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.48 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 2.08 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 2.65 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 6.8 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 3.01 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 6.65 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.48 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 2.54 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 4.12 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 5.22 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 3.33 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 2.1 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 3.9 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.86 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.79 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 3.98 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 3.02 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 4.58 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 4.38 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 4.14 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.98 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 3.14 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 2.26 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 4.95 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.57 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 3.06 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.98 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 3.95 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 2.75 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 2.77 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 3.04 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 3.31 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 3.48 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 2.57 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 7.66 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 3.13 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.64 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.7 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 6.7 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 4.05 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.9 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 3.19 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 4.71 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 2.08 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 2.87 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.92 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.38 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 3.16 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 2.87 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 3.14 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 2.6 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 2.74 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 2.81 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.87 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 3.08 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 6.21 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 2.12 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.9 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 4.85 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 1.88 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.63 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 3.57 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.496 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.4 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.54 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 3.85 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 2.66 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.62 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 2.09 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.22 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.9 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 5.5 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 2.75 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 2.84 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 2.52 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 1.78 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.96 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.83 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 4.09 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 4.88 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 4.52 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.78 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.92 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 2.33 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 2.35 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 3.12 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 4.05 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 2.1 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 2.01 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 3.59 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 2.14 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.71 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 4.17 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 3.27 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 2.39 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.89 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 2.49 112.225 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 5.36 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.67 110.651 155.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.48 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 108.885 -0.784 . . . . 12.92 108.885 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.6 tp -142.07 108.88 5.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.226 1.01 . . . . 8.82 109.706 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 t -103.34 59.5 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.751 0.82 . . . . 5.81 111.804 -172.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.49 155.56 13.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.113 1.365 . . . . 4.83 110.507 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.489 ' NE2' ' HG1' ' A' ' 35' ' ' THR . 78.3 mt-30 -128.73 159.42 35.71 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.757 1.223 . . . . 2.85 108.638 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 4.1 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' CD1' ' HH ' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 4.22 108.52 164.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 2.14 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 3.34 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 3.53 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 2.32 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 3.1 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.99 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 4.35 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.89 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 3.04 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 2.08 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 2.76 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 2.03 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 1.7 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 5.77 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 3.52 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 3.46 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 1.03 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 3.93 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 4.73 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.99 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 3.05 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.86 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 3.22 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.489 ' HG1' ' NE2' ' A' ' 5' ' ' GLN . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 3.58 110.95 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 1.47 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 3.57 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 4.07 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 3.09 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 4.29 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.92 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 2.32 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 3.13 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 2.43 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HH ' ' CD1' ' A' ' 8' ' ' ILE . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 4.41 115.988 -157.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.73 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 2.33 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 3.04 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.68 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 4.05 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 2.58 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 3.22 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 5.25 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.78 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 3.01 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 2.08 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.87 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 2.44 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.73 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 5.18 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 3.28 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 3.67 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.74 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.83 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 1.78 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 3.68 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.59 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 4.57 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 2.79 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 3.37 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 2.32 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 2.59 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 2.39 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.74 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.91 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.96 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 2.13 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 4.76 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 5.15 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 2.9 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.92 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 3.65 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.448 HG21 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' H ' HG21 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.63 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 2.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 1.74 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.95 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.94 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.43 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 2.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 4.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 2.16 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 2.55 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 2.31 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 2.28 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 2.36 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 2.16 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 3.7 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 3.13 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.84 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 3.23 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 3.67 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 2.38 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 2.39 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 2.67 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 4.76 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 2.18 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 2.29 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 3.55 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.98 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 4.83 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 6.82 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 2.16 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 4.17 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 3.33 111.131 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 5.52 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.51 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.45 112.053 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.65 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 116.774 -1.584 . . . . 11.65 112.42 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 47.66 -151.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.016 1.726 . . . . 8.92 113.383 -177.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -164.78 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.792 -1.193 . . . . 7.33 114.16 162.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 172.37 140.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.868 2.067 . . . . 5.64 111.009 -171.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -79.97 162.47 24.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.09 1.356 . . . . 3.58 111.532 -177.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 4.68 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 3.75 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 2.29 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 3.27 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 4.06 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 2.61 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 3.34 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 4.02 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 4.67 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 4.25 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 3.61 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 2.55 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 4.27 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 2.34 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 2.39 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 3.5 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 2.56 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 3.67 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.83 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 2.68 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 4.18 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 5.69 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 3.04 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.93 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 2.93 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 2.3 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 1.79 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 2.85 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.18 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 3.23 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 2.36 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 3.06 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.87 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 2.1 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 2.87 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 2.06 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 4.61 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 3.0 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 3.37 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.76 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 4.72 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 2.21 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 2.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 3.46 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 3.55 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 2.52 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 4.47 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.86 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 2.31 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.67 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 4.82 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 3.28 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 4.08 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.92 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 4.48 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 2.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 3.04 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 2.43 110.34 176.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.88 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 3.08 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 3.1 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.67 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 2.89 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 2.62 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 2.55 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.95 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.44 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.92 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 2.26 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 6.25 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.92 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 2.11 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 2.16 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 4.41 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.52 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 3.34 108.861 157.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 2.49 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 2.18 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.34 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 2.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 5.32 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.83 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 3.09 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 2.73 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 1.71 109.768 170.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 2.09 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 2.08 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 3.64 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 3.68 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.8 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 2.6 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.49 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 2.2 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 2.4 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 3.43 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 4.03 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 2.25 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 2.1 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 3.38 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.74 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 2.04 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 4.17 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 3.89 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 2.2 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 4.19 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 2.69 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 4.49 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.41 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.441 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 3.31 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.023 -0.513 . . . . 12.07 111.221 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.9 150.48 39.86 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.568 1.547 . . . . 9.72 110.466 174.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -77.84 -26.29 49.34 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.684 0.794 . . . . 6.86 112.994 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 3.6 pt-20 76.99 18.04 1.56 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.476 2.71 . . . . 7.57 114.242 148.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -66.17 151.6 46.61 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.89 113.738 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.95 110.615 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 3.38 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.88 111.056 179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 3.76 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 5.16 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.98 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 3.12 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.92 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 4.12 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 5.42 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.87 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 2.63 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 2.57 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 2.59 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 2.1 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 2.38 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.67 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 2.98 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 5.31 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.82 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 3.37 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 5.62 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.85 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 3.44 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.89 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.61 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 2.99 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 2.25 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 1.49 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.74 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 3.18 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.76 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 3.75 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 3.08 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.86 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 2.45 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.97 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 3.39 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 2.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 3.74 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 3.22 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 2.79 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.69 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 3.39 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 2.12 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 2.1 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 3.21 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 3.14 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 2.88 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 4.51 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 2.96 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 6.18 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 4.24 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 3.35 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 3.57 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 3.03 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 4.43 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 2.27 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 3.65 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 3.05 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.26 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 3.15 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.99 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 4.47 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 2.46 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 2.72 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 2.25 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.8 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 3.31 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 4.9 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 2.57 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 5.12 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 4.7 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 2.23 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.54 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 4.13 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 2.71 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 2.43 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.77 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.93 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.41 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 2.07 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 4.57 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 2.57 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 3.06 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 2.31 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 1.78 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 1.76 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 1.62 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 3.23 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.99 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 5.61 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 2.76 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.9 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 2.43 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.71 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 2.7 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.84 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 2.38 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 3.34 113.342 -177.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 5.79 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 3.64 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.76 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.87 112.398 -177.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 3.62 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 2.14 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 3.35 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 2.5 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 5.57 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.66 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 3.03 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.17 -0.307 . . . . 11.66 110.17 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.49 153.62 31.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.456 1.102 . . . . 10.44 109.597 170.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.3 p 179.24 75.24 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.974 1.31 . . . . 5.73 108.586 -168.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.27 89.8 2.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.758 1.223 . . . . 5.78 109.068 -173.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -70.26 131.97 45.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.774 -0.578 . . . . 4.65 111.7 -175.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 5.22 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 3.62 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 2.17 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 3.76 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.99 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.96 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 2.53 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 3.87 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 4.72 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 4.82 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 3.27 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 2.61 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 2.64 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 2.48 111.602 175.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.95 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 4.45 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 2.81 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 5.21 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.13 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 2.92 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.98 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 6.57 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.83 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.65 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.51 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 3.38 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.98 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 2.13 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 2.55 111.157 -178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.22 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 3.91 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.67 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.95 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 2.29 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.85 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 2.64 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 2.41 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 4.93 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.35 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.83 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 3.0 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.85 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 4.24 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 1.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 2.65 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 2.95 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.86 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 2.91 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 5.31 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 2.73 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.67 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 7.11 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 4.28 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 4.02 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 2.63 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 6.78 111.751 163.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 3.01 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 3.69 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 2.99 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 3.11 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 2.7 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 2.46 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 2.48 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.75 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 2.06 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 2.21 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.76 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 4.54 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 2.23 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 4.23 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 5.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 2.01 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.76 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 4.1 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.88 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 5.16 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.59 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.564 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 3.0 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 2.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 2.1 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.59 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 2.11 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 4.14 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 4.74 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 3.1 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 3.05 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 2.31 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 2.2 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 2.01 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 2.89 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 3.93 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 3.46 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 4.04 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 3.42 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 4.08 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 3.98 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.57 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 2.95 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 4.2 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 2.51 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 2.13 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 3.71 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 3.03 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 3.92 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 3.25 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 2.62 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 3.49 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 2.57 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 5.91 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.78 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 118.357 -0.83 . . . . 11.93 112.507 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -169.89 -161.32 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.752 1.16 . . . . 9.46 110.006 -150.669 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.511 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 19.2 m -162.41 93.45 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.342 -1.474 . . . . 6.67 112.529 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -156.63 130.22 8.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.246 0.618 . . . . 5.28 110.894 148.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.23 159.79 41.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.866 2.466 . . . . 4.26 105.58 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 4.54 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 3.71 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 2.2 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 3.18 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.466 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 4.54 108.299 158.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 2.4 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 3.14 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.49 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 2.8 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.94 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 4.28 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 3.08 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 2.58 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 3.32 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 2.23 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.92 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 5.54 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 2.58 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 3.53 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.27 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 2.63 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 4.54 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 7.25 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 3.87 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.92 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.47 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 2.68 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 2.66 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 2.3 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 2.8 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.07 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 3.97 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.56 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.91 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.83 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 2.73 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 2.78 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 2.36 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 4.01 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.86 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 3.19 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 4.06 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 2.64 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 2.99 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 3.27 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.18 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 3.13 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 2.78 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 5.08 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 2.89 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.65 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 12.45 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.98 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 5.17 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 4.73 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 3.0 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 4.15 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 1.81 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 3.11 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 2.83 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 3.37 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 2.48 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 4.04 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 2.09 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 2.65 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 2.47 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 2.35 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.47 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 5.34 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 3.42 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.93 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 5.46 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 2.27 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.96 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 4.22 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.548 HG21 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' H ' HG21 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 2.94 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 2.11 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.89 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.32 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 2.12 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 4.59 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 2.44 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 3.01 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 2.16 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 1.91 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 2.41 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 2.02 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 3.63 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 11' ' ' GLN . 20.5 t-20 -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 3.48 110.414 176.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.63 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 5.51 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.92 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.78 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 2.29 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 4.16 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 3.94 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.9 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.91 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 2.15 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 3.41 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 2.77 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 3.99 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 3.56 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 2.42 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 3.47 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 2.44 111.759 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 5.13 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.5 112.639 164.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.81 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 118.995 -0.526 . . . . 12.15 111.394 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -177.79 4.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.872 2.069 . . . . 9.45 110.473 177.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -106.4 -28.06 10.58 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.867 1.062 . . . . 7.3 113.867 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -169.75 158.95 7.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.876 2.07 . . . . 5.89 108.549 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -120.41 160.26 23.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.78 106.69 160.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 4.35 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 4.18 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 1.88 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 4.31 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.86 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 2.3 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.84 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.17 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 4.29 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 3.45 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.93 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 2.67 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 2.5 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 2.46 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 2.0 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.96 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 3.62 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 2.88 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 4.35 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.94 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 2.68 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 5.1 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 5.26 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 5.15 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.49 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 3.43 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 3.97 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 1.47 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 3.55 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 2.06 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 4.16 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 2.28 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 3.04 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.89 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.81 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 2.81 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 1.69 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 3.9 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 2.7 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 2.75 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.52 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 3.8 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 2.05 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 2.37 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 2.62 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.51 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 3.55 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 2.49 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 5.24 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 2.53 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.57 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 6.36 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 5.24 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 4.1 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 4.3 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 2.5 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 4.57 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 2.05 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 3.06 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.9 111.329 -156.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 6.06 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 4.03 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 2.36 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 2.06 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 2.08 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.96 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 1.55 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.83 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 5.23 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 2.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 3.4 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 4.59 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 2.62 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.81 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 4.37 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.519 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 3.57 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 2.15 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.8 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.65 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 2.01 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 8.34 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 3.5 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 3.94 112.836 173.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 1.9 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 1.9 108.093 155.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 2.1 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 2.08 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 3.73 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 4.12 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 6.45 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.55 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 3.52 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 2.19 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 3.12 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 2.69 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 5.06 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 2.51 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 2.34 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 4.5 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 3.48 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 4.61 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 3.62 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 2.33 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.83 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 2.69 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 4.66 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 3.35 113.405 172.499 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 2.95 109.788 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 3.44 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 2.44 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 1.4 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 2.52 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.15 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 1.75 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.05 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.09 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 1.86 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 3.79 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.24 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 2.66 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 1.53 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 1.6 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.04 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 1.72 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 5.97 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 2.08 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 4.04 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.16 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 1.61 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 5.22 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.18 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 2.7 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.01 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.46 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 2.04 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 1.84 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 0.94 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 1.97 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 3.23 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 2.7 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 4.62 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.09 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.02 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.3 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 1.41 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 1.71 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 1.17 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 2.91 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.26 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 1.92 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.25 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.32 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.54 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.43 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 1.17 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 1.07 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 2.05 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 2.41 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 2.46 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 0.95 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 5.11 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 1.36 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.21 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 3.75 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 2.68 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 2.66 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 1.77 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.07 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 1.4 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 1.86 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 1.79 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.6 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.82 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 3.21 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.43 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.38 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 1.98 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 1.88 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.53 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 1.23 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.08 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 4.3 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 1.19 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 3.37 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 5.14 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 1.26 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 3.39 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.31 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 1.99 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 1.51 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.33 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.29 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 1.39 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 4.15 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 1.88 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 1.95 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 0.92 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 0.76 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 1.1 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 1.18 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 2.77 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 2.77 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 3.45 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 2.44 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 2.85 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 1.6 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.24 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 1.65 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 3.59 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 1.42 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 1.22 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 2.97 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 1.45 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.37 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 2.78 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 4.09 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 1.72 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 146' ' ' ASP . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 4.34 108.544 158.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 2.69 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.03 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' CB ' ' HE3' ' A' ' 140' ' ' LYS . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.183 0.515 . . . . 2.67 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 3.95 112.132 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 2.59 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 1.17 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 2.46 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.14 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.08 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 3.48 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.2 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 2.93 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 3.39 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 1.99 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 1.6 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 1.75 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 0.86 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 1.01 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.29 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 2.42 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 4.2 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.71 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 1.5 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 3.68 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 7.16 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 2.08 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 1.64 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.13 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 1.6 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.01 110.134 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 0.74 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.22 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 2.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 2.91 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 2.77 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.52 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.05 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 1.6 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 2.34 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 1.67 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 0.86 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 2.33 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 1.63 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.21 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 1.73 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 3.39 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 1.23 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 0.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 2.08 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 3.35 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 1.2 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.08 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 2.0 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 5.62 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 3.65 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.05 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 2.5 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 2.05 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.15 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 0.85 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 1.81 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.615 HD11 HG12 ' A' ' 114' ' ' VAL . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 1.56 110.006 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.429 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 2.75 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.71 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 2.93 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 1.98 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 1.64 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.04 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 1.07 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 3.6 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 4.87 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 0.83 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 3.2 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 3.41 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 0.87 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 1.94 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 3.88 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.34 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 2.09 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.07 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.43 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.02 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 0.96 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 0.89 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 4.14 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 1.57 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 1.94 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 1.13 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.615 HG12 HD11 ' A' ' 80' ' ' ILE . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 0.51 109.375 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 0.78 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 0.76 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 3.17 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.2 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 3.94 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 2.33 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.41 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 1.45 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.09 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 2.73 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 4.17 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.36 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 0.98 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 3.9 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 1.32 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 4.43 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 4.17 109.845 165.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 1.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 2.96 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.11 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 3.95 105.735 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.27 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.25 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 2.89 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 5.82 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 2.89 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 2.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.13 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.25 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.18 108.793 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 1.7 107.052 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 2.72 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.17 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.02 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 3.4 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.37 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 2.45 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 1.61 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 1.85 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 3.26 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 1.9 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 6.5 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.19 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 1.59 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 5.45 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 5.35 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 2.83 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 1.78 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 1.53 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 2.52 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.08 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.72 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 1.72 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 2.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 2.9 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 3.25 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.25 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.41 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.57 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 2.27 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 1.95 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 3.16 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.21 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.03 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.0 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.34 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 2.38 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 2.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 1.83 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 2.14 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.2 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 2.9 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 1.43 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 4.23 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.18 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.43 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 5.64 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.01 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 71' ' ' VAL . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 3.79 112.967 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 2.63 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 2.96 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.13 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 1.78 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 2.18 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 114' ' ' VAL . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 1.68 109.59 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.67 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.05 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 2.62 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 3.28 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 2.98 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 3.18 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.73 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 1.84 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.27 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.29 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 1.37 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 4.56 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 4.41 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 0.97 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 5.19 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 2.76 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 1.23 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.36 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.13 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 1.84 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 1.44 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 6.2 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 2.49 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 2.3 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 1.25 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 80' ' ' ILE . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 0.93 109.273 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 1.67 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.89 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 2.71 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 2.88 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 3.5 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.03 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.33 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 141' ' ' LEU . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 1.45 111.522 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 1.9 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 1.67 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 2.64 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 1.33 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 1.09 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 3.23 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 1.58 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.31 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 3.5 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.31 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 1.23 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 3.75 110.732 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 125' ' ' VAL . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 2.8 113.326 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 4.36 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.0 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.23 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.881 0.326 . . . . 3.16 111.881 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 6.93 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 2.64 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.17 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 2.25 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 3.58 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 1.85 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 2.48 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 0.98 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 2.07 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 2.85 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.34 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 2.49 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 1.24 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 1.55 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 0.85 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.95 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.13 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 1.87 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 3.16 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 1.67 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.2 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 4.72 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 2.33 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 2.73 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.39 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 1.63 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 1.62 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 0.94 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 1.74 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 1.87 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 2.43 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.37 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 2.56 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 1.65 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.15 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 2.15 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 1.32 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 2.43 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.09 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.05 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 1.85 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.21 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 2.51 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 1.16 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.04 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 1.85 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.01 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 2.23 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.481 HG22 ' CG ' ' A' ' 69' ' ' TYR . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 1.51 111.109 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 5.62 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 2.24 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CG ' HG22 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 10.76 115.883 -169.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 4.93 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.02 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 2.91 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 1.81 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 3.62 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 1.03 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 1.85 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 1.81 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.1 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 2.57 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 1.67 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 2.59 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 1.78 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 2.39 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 1.6 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 1.36 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.38 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 3.95 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 1.03 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 2.88 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 3.9 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 0.97 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 1.8 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 2.65 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.13 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 2.12 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 0.93 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 0.96 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.33 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 1.37 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 5.47 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 1.4 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 1.52 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 0.94 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 0.77 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 0.8 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 0.77 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 2.62 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.11 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.53 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 3.5 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 1.66 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.0 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 1.59 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 2.41 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 1.54 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 4.35 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.5 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 1.96 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.12 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.06 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.08 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 3.16 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 3.39 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 2.19 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 2.81 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 1.47 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 4.42 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 3.61 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 107.201 -1.407 . . . . 2.87 107.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 3.75 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 4.55 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 1.37 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 2.42 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 2.99 109.829 164.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 1.49 110.691 -171.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 1.8 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.05 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.406 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 2.49 116.519 -167.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.15 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.14 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.05 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 1.75 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 15' ' ' MET . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 1.96 112.075 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 1.75 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 4.68 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 1.85 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 3.26 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 0.92 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 1.67 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 4.29 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 5.31 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 2.46 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 2.78 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.36 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 1.71 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 1.65 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.14 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.07 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.01 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 2.75 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.13 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 2.73 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.6 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 2.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 1.18 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 2.8 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 3.34 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 1.9 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.13 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 2.38 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 1.18 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 1.16 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 3.44 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.44 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 4.75 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 1.14 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 3.92 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 1.34 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 5.85 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 4.75 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 3.5 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 2.83 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.15 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 3.54 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 1.23 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 1.83 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 1.54 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.3 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 2.42 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 1.81 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 2.23 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 1.32 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 1.31 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 1.18 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 0.92 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 2.86 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 4.43 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 1.14 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 2.93 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 5.27 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 1.11 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.74 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.37 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 2.17 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 1.35 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.81 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 0.91 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.07 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 0.97 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 3.79 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 1.6 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 1.55 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 1.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 0.79 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 1.48 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 1.44 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 2.5 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 2.39 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 3.57 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 2.51 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 2.98 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 1.38 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 1.82 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 1.44 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 5.09 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 1.22 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 1.02 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 6.17 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 1.76 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 3.19 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 2.19 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 1.42 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 4.39 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 2.17 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 4.72 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 4.65 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 2.94 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 3.47 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 2.98 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 1.42 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.1 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 3.87 108.323 161.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 1.84 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.23 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.32 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 3.35 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 4.36 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 3.67 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 1.72 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 1.51 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 1.36 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.1 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 3.13 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 2.53 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.16 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 3.08 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.14 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HG3' HH11 ' A' ' 30' ' ' ARG . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 6.88 112.159 171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 2.39 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.0 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 2.64 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 2.25 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 0.95 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.05 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 2.54 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 3.22 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.3 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 3.13 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.22 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.61 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 2.35 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 1.41 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 2.41 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.04 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.07 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.1 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.7 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 2.51 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 1.24 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 1.58 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 1.8 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.21 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 3.09 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 1.91 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 6.03 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 1.92 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 5.47 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.12 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 3.7 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 3.71 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 2.42 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 3.79 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 1.32 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 2.17 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 1.44 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.33 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.15 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 2.16 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 2.54 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 1.26 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 1.55 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.69 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 0.89 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 2.5 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 4.43 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.05 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 3.47 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 3.89 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.29 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.15 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.11 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 2.38 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 2.46 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.52 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.11 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.04 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 0.98 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 3.35 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 1.51 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 1.52 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 1.56 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 0.65 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 1.29 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 1.34 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 2.65 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 2.64 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 1.93 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.13 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.03 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.24 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 1.5 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.19 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 1.46 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 3.33 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.01 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 1.54 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 3.92 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 2.47 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.7 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 3.36 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 3.06 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 1.39 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 2.89 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.503 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 1.93 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 4.58 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.19 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.54 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.18 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.057 -0.349 . . . . 2.47 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 6.78 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 3.75 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 1.31 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 2.71 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 3.35 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 1.74 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.14 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.33 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 2.94 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.15 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 3.35 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.12 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 1.18 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 1.69 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 0.88 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 0.99 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 2.75 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 2.14 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 3.83 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 1.68 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 3.77 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 5.92 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 2.25 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.08 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 2.2 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 1.96 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.13 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 2.16 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 1.83 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 2.78 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.02 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.4 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.43 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 1.32 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 1.85 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 1.43 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 2.75 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 2.48 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 1.8 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 1.84 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 3.0 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 1.72 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 1.35 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 2.12 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 3.84 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 1.05 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 4.36 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.19 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.41 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 5.55 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 3.41 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 3.6 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 2.44 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 2.43 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 4.48 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 1.41 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 1.97 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 1.55 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.68 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 2.91 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 1.73 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 2.97 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 1.3 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 1.47 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 1.31 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 0.85 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.0 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 3.43 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 0.98 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 3.9 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 3.56 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 1.03 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 3.3 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 2.66 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 1.54 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.3 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.18 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.07 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 4.29 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 1.56 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 1.76 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 1.13 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 0.9 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.04 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 1.37 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 3.66 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 3.1 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 4.76 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.32 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 3.76 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 1.73 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.22 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 1.7 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 3.23 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 1.77 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 1.1 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 3.67 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 1.56 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 3.57 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 2.87 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 1.53 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 2.53 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 2.26 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 5.1 108.533 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.19 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.13 107.878 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 4.12 107.313 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 4.95 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.0 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 1.23 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 2.97 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 2.52 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 1.8 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 2.45 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 1.86 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.27 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 4.26 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.24 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.01 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 2.13 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 1.16 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 1.18 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.07 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 2.01 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 2.75 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.78 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 2.07 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.19 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 5.36 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 2.52 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 2.72 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.31 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 1.93 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.17 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 0.81 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.0 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 1.88 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 2.73 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 1.97 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 2.7 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.34 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.27 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 2.02 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 1.29 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 3.28 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.25 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 2.84 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.03 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 1.84 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.09 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 1.84 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.22 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 2.89 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 5.18 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 2.43 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 1.33 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.07 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 1.63 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.51 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.39 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 3.98 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 4.23 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 2.77 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 2.24 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 5.63 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 1.0 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 2.28 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 2.31 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 2.77 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 1.58 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 2.68 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 1.85 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 1.96 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.56 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.09 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 3.84 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.3 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 1.04 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 4.5 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 4.83 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 1.1 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.23 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 2.78 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.1 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 2.19 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.17 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.52 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.13 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.32 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 1.62 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 5.6 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.25 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.25 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 1.32 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 0.86 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 0.8 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 2.72 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 3.32 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 3.45 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 1.73 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.27 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 1.34 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.06 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 1.52 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 3.8 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 1.68 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 1.13 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 3.75 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 1.63 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 3.06 110.317 174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 2.84 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 1.04 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 3.31 109.341 161.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 1.47 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 3.91 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.574 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.32 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 2.58 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.248 0.547 . . . . 4.06 110.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 4.71 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 3.96 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.48 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 3.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 4.87 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 69' ' ' TYR . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 2.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 2.24 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.2 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 2.37 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 2.94 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 3.81 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 2.59 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 1.3 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 1.61 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 1.0 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 0.99 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 3.77 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 2.17 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 2.85 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 0.96 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 1.92 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 4.74 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 4.63 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 2.11 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.19 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.59 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 1.66 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 1.74 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 0.9 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 2.05 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 3.79 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 2.25 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 2.84 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 1.39 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 1.82 110.292 163.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 2.83 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 1.11 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 3.54 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 3.64 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 1.72 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 3.14 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 1.07 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 2.29 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.05 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 2.31 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.444 HG22 ' CE1' ' A' ' 69' ' ' TYR . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 2.01 110.004 174.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 3.9 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 1.36 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.32 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 9.94 112.794 168.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 4.98 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 2.8 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 2.53 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 1.91 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 3.32 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 1.0 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 1.93 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 1.51 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.02 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 2.86 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 2.74 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 1.8 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 1.74 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 1.69 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.3 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.13 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 2.92 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 4.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 1.55 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 3.86 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 3.86 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 1.28 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.45 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 4.68 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.528 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.07 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.528 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 1.87 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.16 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 0.94 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.06 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 1.04 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 3.64 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 1.95 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 1.85 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 1.22 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 0.66 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 0.83 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.83 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 2.66 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 2.41 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 3.67 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 2.26 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.29 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 1.36 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 1.91 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 1.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 2.57 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.0 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 1.4 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.17 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 2.15 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 1.74 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 3.43 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 3.2 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 1.64 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 3.65 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 1.87 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 5.29 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.05 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.24 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.28 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.983 0.42 . . . . 3.1 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 3.85 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 3.3 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.1 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 3.27 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.06 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 1.89 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 2.07 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.05 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 2.13 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 2.95 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.3 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 2.28 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 1.27 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 1.48 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 1.05 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.03 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 2.81 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 2.78 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 3.98 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 0.93 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 1.75 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 3.49 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 3.97 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 2.45 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.35 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 2.09 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 1.97 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 1.12 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 1.83 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 2.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.2 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.27 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 1.6 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 1.52 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 2.21 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 1.48 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 2.78 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 2.02 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 3.25 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.15 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 2.24 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 0.97 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 0.96 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 1.66 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.67 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.77 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 2.08 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 1.07 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.17 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 1.67 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.27 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 4.09 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.11 114.923 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 2.29 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.21 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 4.78 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 1.18 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 2.14 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 114' ' ' VAL . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 1.88 109.009 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.24 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.27 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 2.38 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 2.83 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 1.45 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 1.66 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 1.53 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.02 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 2.7 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 3.52 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 1.11 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 2.99 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 3.38 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 1.81 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 1.95 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 3.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 1.65 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.01 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 1.3 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.44 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.05 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 6.77 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 1.73 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 1.51 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 1.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 0.89 108.608 165.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 1.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 0.89 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 2.25 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 2.39 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 6.15 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 1.84 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.64 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 1.56 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.29 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 1.63 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 4.29 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 1.3 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 0.88 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 2.81 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 2.06 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.09 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 3.25 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 2.64 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.45 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 4.18 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 1.81 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 4.48 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.35 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.755 0.312 . . . . 2.64 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.05 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 2.77 108.843 177.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 0.94 110.812 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 2.66 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 2.8 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 1.62 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 1.79 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.06 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 1.72 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 5.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 5.98 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 4.14 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 1.93 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 1.75 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 1.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 1.09 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.1 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 1.58 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 3.46 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.04 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 1.59 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 5.69 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.11 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 3.32 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 1.74 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 1.56 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 1.6 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.439 ' H ' ' HA ' ' A' ' 50' ' ' TYR . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.38 108.437 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 0.94 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 1.92 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.14 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 3.52 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 2.12 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 2.61 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.6 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 1.41 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 1.69 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 1.1 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 35' ' ' THR . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 3.0 115.568 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 1.92 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 2.31 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.35 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 2.09 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 0.92 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 0.96 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 1.61 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 3.32 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 2.67 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 1.23 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 4.57 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 1.66 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.41 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 4.41 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.07 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 2.67 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 1.79 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 3.65 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 0.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 2.62 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 1.53 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 2.34 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 1.91 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.18 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 1.53 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 1.38 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.33 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 0.82 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 2.88 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 4.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 0.93 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 3.35 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 4.29 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 0.94 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 2.55 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.48 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 1.66 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 1.27 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 1.11 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.14 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.13 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 3.83 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 1.4 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 1.61 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 1.1 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 0.61 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 1.03 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 1.08 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 3.89 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 3.5 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 2.31 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 3.77 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.04 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 3.56 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 1.87 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 2.43 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 1.48 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.04 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 1.6 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.03 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 3.89 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 2.07 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.36 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 2.92 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 2.83 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 1.14 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 2.95 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 1.73 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 4.65 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 3.73 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 2.98 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.304 0.573 . . . . 2.55 110.583 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.15 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 2.92 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 1.3 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 3.02 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.08 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 2.42 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 2.68 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 2.4 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.13 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 3.31 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 1.94 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 1.38 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 2.93 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 1.48 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 0.97 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 3.38 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 1.99 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 2.91 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 0.93 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 2.35 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 3.94 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 7.39 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 3.72 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.56 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 2.02 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 1.76 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 0.92 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 2.27 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.01 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 2.3 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 1.87 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.23 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 1.74 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 1.55 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 2.43 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.01 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 2.53 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.77 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 1.61 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 2.66 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.18 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 2.91 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 0.99 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 2.05 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 2.86 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 2.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 1.05 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.0 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 1.26 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.39 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.43 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 3.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 3.27 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 2.49 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 1.68 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 4.09 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 0.83 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 2.06 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 1.99 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.25 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 2.74 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 1.69 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 1.96 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 1.74 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 2.15 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.55 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.31 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 2.48 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 5.14 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 1.53 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 4.63 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 3.54 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 1.38 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.51 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 3.2 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 3.45 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.46 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 2.5 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 1.22 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.5 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 1.2 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.27 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 1.36 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 2.84 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 5.48 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 2.69 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 3.24 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 1.37 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 0.64 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 1.07 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 0.91 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 2.53 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 2.5 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 1.93 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 3.28 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 2.49 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 2.45 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 3.86 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.48 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 1.93 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 3.23 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.44 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 1.58 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 2.96 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 1.84 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 1.77 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 3.26 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 2.85 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 1.71 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 3.67 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 3.31 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 3.98 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.08 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.51 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.344 -0.613 . . . . 2.64 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 3.66 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 2.64 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 0.97 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 3.3 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HB3' HD21 ' A' ' 119' ' ' ASN . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.17 110.461 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 1.64 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 2.23 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.3 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 1.88 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.03 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 3.58 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 2.46 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.22 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 1.68 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 0.99 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 1.07 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 3.39 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 1.68 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 4.27 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.81 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 1.54 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 3.39 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 5.33 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 2.37 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 1.77 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 1.67 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 1.64 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 0.71 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 1.81 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.16 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 2.87 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 1.99 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 1.56 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 1.42 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 1.68 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 1.17 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 2.82 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 1.85 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 1.99 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.3 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 2.22 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.26 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 1.45 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 4.19 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 3.14 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 1.07 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 3.98 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 1.35 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.04 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 4.63 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 2.75 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.08 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.01 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 5.28 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 1.32 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 1.79 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 114' ' ' VAL . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.3 107.935 172.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.14 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 2.87 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.03 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 1.79 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 1.73 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 1.65 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.31 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 0.98 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 1.97 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 4.67 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 0.96 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 4.33 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 4.62 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 0.96 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.16 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 2.51 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 1.87 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 2.13 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 1.03 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 0.95 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 0.94 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 0.9 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 3.41 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 5.94 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 2.35 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 2.49 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 0.98 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 80' ' ' ILE . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 0.7 110.215 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 0.97 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.16 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 2.18 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 11' ' ' GLN . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 2.5 110.068 162.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 3.86 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 3.9 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 1.7 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 4.49 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 1.33 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 2.73 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 2.42 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 1.8 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 4.0 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 2.47 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.64 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 2.85 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 2.71 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 1.26 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 3.3 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 1.81 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 4.91 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 147' ' ' SER . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 143' ' ' GLY . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.14 112.457 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 CA--C 1.545 0.78 0 CA-C-O 120.949 0.404 . . . . 3.83 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.03 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 2.83 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 1.16 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 2.78 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 4.86 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 2.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.08 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 2.57 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 4.49 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 2.05 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 1.19 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 2.67 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 1.38 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 1.44 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 3.46 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 2.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 2.92 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.25 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 1.55 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 5.36 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 4.74 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 2.27 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 2.34 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 55' ' ' THR . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.24 114.707 168.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 1.85 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.0 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 0.98 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 2.41 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.06 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 2.5 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 1.82 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 2.82 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 1.36 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 1.25 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 1.91 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 1.07 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 2.56 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.11 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.12 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.405 ' HB ' ' HA3' ' A' ' 33' ' ' GLY . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 2.89 112.579 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 1.69 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 3.33 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 1.21 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 1.0 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 1.78 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.24 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 3.08 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 0.97 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 4.99 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 1.55 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 5.55 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 4.12 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 2.96 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 2.51 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 1.86 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 3.36 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 1.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 2.13 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 1.72 111.11 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 1.82 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 2.87 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 2.41 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.45 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 1.52 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 1.75 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 1.53 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 0.83 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 3.27 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 3.54 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 0.94 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 3.75 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 5.66 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.01 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.55 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 3.64 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 2.64 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.3 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 1.67 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.06 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.41 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.06 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.11 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 0.87 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.34 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 6.31 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 1.56 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 1.86 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.15 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 80' ' ' ILE . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 0.83 108.477 167.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.13 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.51 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 3.81 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 3.21 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.14 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 1.91 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.08 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 1.29 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.43 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 1.5 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 2.87 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 1.9 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 1.43 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 3.35 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 1.71 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 3.48 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 3.45 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 1.44 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 3.41 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 1.44 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.02 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.87 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.66 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.31 0.576 . . . . 2.65 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.12 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 3.69 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 4.1 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 1.54 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 2.62 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 1.35 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 2.73 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.42 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.0 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 3.17 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 2.84 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 2.37 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 1.71 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 1.65 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 1.43 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 1.41 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 3.61 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 1.94 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 2.91 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.92 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 1.44 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 3.82 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 4.82 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 2.54 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 1.99 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.24 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 1.53 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 3.08 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 0.93 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 3.24 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.51 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 3.19 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.27 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.09 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 1.47 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 1.73 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 2.09 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 1.12 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 3.06 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 2.3 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 1.76 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 1.49 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 2.93 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.08 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 1.08 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 2.06 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.17 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 2.7 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 1.17 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 4.5 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 1.4 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.63 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 3.41 110.287 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 2.96 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 2.88 114.083 -171.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 2.83 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 3.95 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 0.88 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 2.18 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 1.53 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 3.96 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 2.8 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 2.45 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 1.42 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 1.77 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 1.44 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 0.85 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 4.81 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.13 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 1.07 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 3.77 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 3.87 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 1.03 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 1.79 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 3.53 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 2.83 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 1.2 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.44 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.96 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 0.85 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 3.72 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.44 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 1.5 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 1.06 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 0.63 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 0.94 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 0.79 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.62 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 2.88 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 4.31 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.38 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 2.78 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 1.35 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 1.8 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 1.63 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 3.55 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.44 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 0.9 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.12 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 1.35 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 3.03 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 3.44 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 1.2 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 2.58 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 1.89 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.11 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.44 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 2.7 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 3.73 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 121.58 0.705 . . . . 2.76 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 4.32 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 57' ' ' THR . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 2.49 107.23 161.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 0.95 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 2.14 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 2.8 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 1.67 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 2.72 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.4 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 2.87 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.3 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 4.92 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 2.55 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 1.5 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 3.29 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 1.19 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.23 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 3.33 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 2.43 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 3.77 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 2.31 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 3.96 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 3.91 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 3.73 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 1.78 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 1.62 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.22 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.21 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.09 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.36 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 41' ' ' LEU . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 2.31 111.113 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 2.92 113.324 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 2.86 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 2.56 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 1.66 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 2.11 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 2.32 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 1.23 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 2.3 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 1.99 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.42 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 1.69 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 103' ' ' ALA . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 2.75 112.466 -173.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 1.38 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 1.26 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 2.17 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 2.24 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 1.21 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 4.37 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 1.85 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.45 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 5.77 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 5.25 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.08 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 2.6 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 2.17 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.16 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 0.95 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 2.22 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 1.68 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.1 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 3.33 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 1.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 1.97 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 1.37 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 1.4 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.28 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 0.88 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 2.3 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 3.9 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 0.93 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 3.88 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 3.63 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 1.67 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 4.64 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.0 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.02 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' THR . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.0 111.067 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.83 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.31 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.25 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 0.94 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 3.79 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 2.11 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 2.47 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 0.96 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 0.74 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 1.22 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 0.88 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 2.66 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 2.56 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.62 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 4.97 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 1.75 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 3.51 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 1.32 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 1.84 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 1.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 5.55 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 1.24 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 0.89 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 3.3 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 1.5 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 3.02 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 2.53 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 1.12 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 2.96 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 1.45 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 4.35 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 3.41 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 2.63 109.321 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 3.73 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 2.54 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 1.85 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 3.78 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.07 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 3.23 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.45 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 1.85 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.68 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 3.58 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.12 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.03 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 1.83 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 2.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 0.95 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 1.6 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 3.31 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 2.07 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 4.13 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.21 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 2.48 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 4.65 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 4.43 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 3.58 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 2.86 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 1.87 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 1.54 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 1.77 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.12 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.32 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 2.16 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 2.6 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.29 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 3.57 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.15 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 2.3 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 1.98 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 2.32 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 1.11 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 2.76 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.55 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 2.08 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 2.1 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.05 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 2.34 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 1.26 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 1.39 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 2.71 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.26 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 1.98 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 69' ' ' TYR . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 1.38 110.584 172.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.0 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 1.56 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 10.5 113.408 -177.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 4.47 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 4.63 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 4.18 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 2.84 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.12 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 1.02 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 2.06 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.42 HD11 ' CG1' ' A' ' 114' ' ' VAL . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 1.87 108.474 175.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 1.89 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 2.82 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 1.84 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 1.98 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 1.63 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 1.67 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 1.68 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 1.22 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 2.65 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 4.62 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 1.31 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 3.95 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 4.52 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 0.96 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.08 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 2.78 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.554 ' H ' HG21 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 2.45 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.04 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.47 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 1.7 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.19 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 1.5 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 3.91 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 1.67 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 1.68 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.34 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 0.95 108.913 168.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 1.28 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 0.86 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 2.63 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 3.27 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 6.63 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 1.72 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 3.82 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 1.9 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 2.19 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 2.14 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 2.92 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 1.69 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.01 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 2.84 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 1.57 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.55 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 3.2 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 2.59 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 1.47 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 3.74 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 144' ' ' GLU . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 1.71 111.97 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 4.48 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 141' ' ' LEU . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 2.88 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 2.72 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 3.9 110.726 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 6.33 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 2.5 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 1.14 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 3.12 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 2.67 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 1.43 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 1.83 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 2.44 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 4.78 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 4.08 115.404 165.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 2.26 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 1.5 113.317 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 1.59 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 0.91 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 0.95 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 5.25 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 2.53 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 3.81 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 2.49 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 4.35 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 4.68 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 2.44 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 2.65 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.33 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 1.75 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 1.84 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.13 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 1.87 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.89 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 2.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.02 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.42 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 1.77 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 1.83 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 1.95 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.02 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 2.36 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 2.37 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 2.19 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 1.6 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 2.67 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 1.15 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 0.93 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 2.29 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 2.95 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 1.04 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 4.25 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 67' ' ' LEU . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 1.77 113.429 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.22 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 3.83 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 2.59 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 2.25 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 2.35 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 3.32 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 1.27 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 2.05 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.446 HD11 HG12 ' A' ' 114' ' ' VAL . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 2.75 109.579 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.19 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 2.47 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.13 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.27 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 1.44 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 1.34 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 1.29 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 1.13 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.09 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 3.92 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 1.73 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.03 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 3.68 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 0.99 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.52 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 5.32 111.767 163.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.727 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.02 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 1.15 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.67 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.03 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.87 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 1.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 3.98 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.489 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 6.01 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.13 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 1.53 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 1.19 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 80' ' ' ILE . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 0.64 108.406 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 0.83 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 0.85 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 2.77 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 2.45 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 3.37 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.23 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.15 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 1.41 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 2.27 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 2.1 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 2.8 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 1.39 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 137' ' ' TYR . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 1.38 113.51 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 3.4 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 1.57 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' A' ' 132' ' ' VAL . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.63 111.576 175.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 2.58 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 1.52 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 2.58 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 1.84 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 5.57 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.2 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 107.904 -1.147 . . . . 3.63 107.904 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 4.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 2.24 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.05 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 2.88 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 6.09 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 1.54 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 1.91 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.36 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 1.99 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 3.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 3.61 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 2.74 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 2.18 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.02 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 1.07 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 1.83 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 5.82 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 2.03 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 5.69 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.42 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 1.52 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 3.5 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 4.52 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 2.67 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 1.71 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 2.51 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.18 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 2.88 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 2.83 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 3.46 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 3.03 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 3.59 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.23 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 1.82 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 1.03 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 3.48 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.34 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 2.09 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.87 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 2.99 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 1.58 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 1.63 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 2.11 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 2.59 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 2.83 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 1.45 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 6.79 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 2.35 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.51 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.2 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 5.36 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 2.88 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.11 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 2.61 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 3.74 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 1.21 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 1.7 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.14 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.18 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 2.49 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 1.92 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 1.93 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 1.57 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 1.68 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 1.41 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.02 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 2.42 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 4.98 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 0.97 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.24 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 3.86 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 0.97 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.62 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 2.79 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.12 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.45 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 2.41 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 1.43 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.46 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 1.06 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.11 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.05 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 4.26 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 1.92 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 1.88 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 1.25 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 0.61 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.11 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.02 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 2.64 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 3.75 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 3.77 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.17 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.31 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 1.32 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 1.87 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 1.96 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 3.25 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 1.62 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 1.16 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 2.74 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 1.48 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.55 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 2.9 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 2.46 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 1.47 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.04 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.463 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 1.39 112.225 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 4.56 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.45 110.651 155.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.01 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.638 -0.875 . . . . 2.31 108.638 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 3.54 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 3.13 108.52 164.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 1.23 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 2.21 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 2.8 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 1.48 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 2.35 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.04 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 3.5 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.07 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 2.15 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 1.23 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 1.52 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 0.97 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 0.91 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 4.57 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 2.42 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 2.81 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 0.85 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 2.73 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 3.89 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.1 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 2.16 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.54 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 2.08 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 2.26 110.95 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 0.93 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 2.84 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 2.91 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 2.25 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 3.76 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.57 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 1.63 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 1.92 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 1.17 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 2.95 115.988 -157.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.65 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 1.7 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 2.73 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.49 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 3.06 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 1.53 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 1.84 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 3.85 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.24 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 2.08 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 1.22 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.0 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 1.43 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.13 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 4.15 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 2.5 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 2.73 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.08 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.08 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 0.87 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 2.22 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.42 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 3.49 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 1.91 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 1.99 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 1.48 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 1.45 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 1.12 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.02 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.25 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.29 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 1.21 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 3.86 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 4.48 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 1.79 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.65 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 2.89 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.57 ' H ' HG22 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.51 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 1.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 0.99 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.81 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.26 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.3 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 1.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 3.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 1.49 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 1.54 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 1.26 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 0.94 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 1.43 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 0.93 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 2.56 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 2.46 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.02 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 2.17 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 2.73 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 1.4 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 1.91 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 1.57 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 3.67 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 1.42 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 1.04 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 2.73 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.24 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 3.41 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 5.55 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 1.31 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 3.37 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 2.13 111.131 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 4.49 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.41 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.22 112.053 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.46 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.864 0.364 . . . . 2.84 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 3.86 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 2.74 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 1.18 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 2.28 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 3.32 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 1.66 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 2.36 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 2.78 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 3.83 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 3.85 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 2.65 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 1.72 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 2.81 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 1.16 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 1.46 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 2.77 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 1.62 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 2.98 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.74 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 1.66 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 3.29 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 4.97 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 2.1 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.58 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 1.86 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 1.65 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 0.72 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 1.75 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.12 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 2.19 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 1.91 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 2.29 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.68 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 1.36 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 1.76 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 0.86 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 3.12 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 2.27 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 2.23 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.31 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 3.52 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 1.48 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 1.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 2.34 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 2.54 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 1.28 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 3.93 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.16 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 1.89 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.41 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 3.63 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 2.39 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 3.17 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.16 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 3.57 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 1.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 1.88 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 114' ' ' VAL . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 1.64 110.34 176.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.8 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 2.3 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 2.19 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.02 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 1.76 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 1.94 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 1.82 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.13 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.03 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.08 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 1.1 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 5.37 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.06 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 1.13 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 1.8 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 3.43 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.442 ' H ' ' HB ' ' A' ' 102' ' ' VAL 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.49 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 99' ' ' ILE . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 2.47 108.861 157.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 1.4 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 0.95 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.17 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 1.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 4.01 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.05 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 2.07 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 1.39 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 0.76 109.768 170.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 1.15 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 1.04 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 2.78 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 2.72 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.22 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 1.77 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.03 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 1.35 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 1.85 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 2.1 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 3.05 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 1.37 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 1.13 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 2.61 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.31 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 1.67 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 3.01 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 2.93 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 1.37 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 3.3 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 1.77 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 3.81 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.39 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.445 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 2.9 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.74 113.738 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.2 110.615 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 2.54 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.435 ' H ' ' HA2' ' A' ' 101' ' ' GLY . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.03 111.056 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 2.68 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 4.13 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.32 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 2.25 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.58 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 3.14 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 4.93 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.35 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 1.98 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 1.64 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 1.45 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 1.0 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 1.21 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.04 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 1.93 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 4.26 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.74 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 2.11 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 4.57 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.3 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 2.55 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.36 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.46 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 1.9 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 1.86 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.75 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.31 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 2.25 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.62 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 2.55 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 2.49 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.31 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 1.5 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.13 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 2.28 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 1.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 2.46 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 2.34 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 1.9 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.31 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 2.38 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 1.06 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 1.14 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 1.91 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 2.37 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 1.97 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 3.77 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 1.81 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 5.56 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 3.3 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 2.43 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 2.63 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 2.19 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 3.42 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 1.16 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 2.18 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 2.43 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.2 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 2.39 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.19 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 3.63 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 1.43 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 1.58 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 1.52 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.06 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 2.68 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 3.96 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 1.43 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 4.06 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 3.72 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 1.28 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.53 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 3.32 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 9' ' ' ALA . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 1.73 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 1.46 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.66 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.15 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.29 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 0.99 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 3.48 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 1.76 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 2.03 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 1.16 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 0.63 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 0.8 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 0.94 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 2.22 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.62 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 4.47 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 1.7 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.53 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 1.45 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.13 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 1.57 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.22 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 1.73 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 137' ' ' TYR . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 2.02 113.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 4.65 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 2.37 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.63 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 132' ' ' VAL . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.07 112.398 -177.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 2.73 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 1.06 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 2.51 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 1.41 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 4.62 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.53 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 2.61 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.202 0.525 . . . . 3.49 111.7 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 4.48 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 2.69 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 1.22 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 2.79 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.19 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.02 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 1.97 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 2.84 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 3.83 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 3.85 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 2.49 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 1.66 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 1.72 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 1.4 111.602 175.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.13 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 3.43 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 1.69 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 4.35 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.01 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 1.89 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.34 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 5.76 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.34 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.19 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.38 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 2.41 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.26 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 0.96 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 21' ' ' ALA . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 1.58 111.157 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.1 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 2.74 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.06 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.09 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 1.58 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.17 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 1.7 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 1.43 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 3.5 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.13 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.03 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 1.8 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.25 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 3.22 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 0.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 1.48 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 1.87 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.09 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 1.64 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 4.53 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 1.85 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.01 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 5.69 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 3.43 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 2.9 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 1.84 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 5.85 111.751 163.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 1.88 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 2.44 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 1.92 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 2.3 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 1.93 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 1.9 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 1.55 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.19 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 1.53 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 1.25 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.51 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 3.73 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 1.07 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 3.31 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 4.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 1.04 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.44 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 3.36 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.12 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 4.82 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.54 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 1.95 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 1.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 1.43 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.45 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 1.37 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 3.06 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 3.77 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 1.87 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 2.11 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 1.3 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 0.98 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 1.23 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 1.39 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 2.91 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 2.65 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 2.53 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 3.24 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 2.85 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.16 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 1.98 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 3.32 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 1.53 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 1.15 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 2.92 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 1.85 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 2.65 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 2.28 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 1.73 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 2.44 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 1.45 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 4.97 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.0 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 105.58 -2.008 . . . . 3.47 105.58 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 3.79 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 2.95 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 1.36 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 2.21 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 3.72 108.299 158.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 1.66 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 2.37 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.42 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 1.82 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.08 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 3.66 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 2.11 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 1.65 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 1.8 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 1.2 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.63 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 4.97 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 1.57 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 2.96 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.15 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 1.56 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 3.86 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 6.35 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 2.82 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.55 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.33 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 1.71 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 1.62 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 1.62 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 1.87 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.03 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 2.94 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.03 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.14 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.59 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 1.68 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 1.7 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 1.18 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 2.7 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.26 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 2.04 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 2.95 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 1.7 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 1.76 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 2.36 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.15 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 2.34 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 1.49 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 4.26 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 1.82 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.5 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 11.87 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.22 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 4.23 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 3.87 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 2.2 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 3.37 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 0.88 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 1.95 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 1.62 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 2.54 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 1.66 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 3.14 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 1.32 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 1.88 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 1.67 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 1.26 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.0 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 4.55 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 2.1 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.0 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 4.42 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 1.22 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.42 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 3.19 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 1.91 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 1.17 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.04 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.2 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 1.3 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 3.48 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 1.45 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 1.96 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 1.25 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 0.82 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 1.36 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 0.98 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 2.52 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 2.43 110.414 176.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.58 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 4.79 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.08 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.43 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 1.46 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 3.13 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 2.75 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.12 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.32 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 1.02 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 2.81 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 1.69 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 2.85 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 2.64 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 1.13 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 2.76 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 1.56 111.759 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 4.18 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.47 112.639 164.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.13 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.4 106.69 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 3.58 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 2.98 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 0.98 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 3.42 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.16 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 1.38 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.69 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.11 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 3.1 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 2.62 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.1 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 1.97 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 1.49 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 1.51 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 0.98 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.48 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 2.95 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 1.77 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 3.17 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.86 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 1.65 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 4.16 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 4.54 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 4.28 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.08 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 2.15 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 2.98 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 0.76 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 2.3 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 1.85 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 2.98 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 1.98 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 2.54 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.39 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.11 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 1.65 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 0.88 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 2.6 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 1.89 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 1.81 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.2 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 2.81 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 1.21 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 1.38 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 1.8 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.24 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 2.57 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 1.5 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 4.28 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 1.69 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.52 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 5.96 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 4.13 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 3.17 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 3.08 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 1.87 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 3.62 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 0.97 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 1.88 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 114' ' ' VAL . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.0 111.329 -156.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 5.14 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 3.06 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 1.93 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 1.2 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 1.29 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.14 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 0.78 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.41 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 4.33 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 1.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 2.88 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 3.51 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 1.32 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.71 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 3.58 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 2.25 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 1.18 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.3 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.48 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 1.11 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 6.77 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 2.71 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 2.69 112.836 173.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 0.89 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 80' ' ' ILE . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 0.67 108.093 155.231 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 1.2 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 1.04 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 2.6 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 3.53 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 5.29 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.15 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 2.92 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 1.37 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 2.48 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 1.62 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 4.15 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 1.61 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 1.22 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 3.51 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 2.42 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 3.24 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 2.7 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 1.23 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.01 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 1.61 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 3.9 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 2.81 113.405 172.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.239 -0.886 . . . . 10.44 110.115 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.32 174.14 6.0 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.597 1.559 . . . . 9.06 113.124 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m 134.62 155.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 1 C-N-CA 133.826 4.85 . . . . 6.67 106.279 -168.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.27 97.0 1.61 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.916 1.689 . . . . 5.44 111.427 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -93.46 115.74 28.27 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 2.95 109.788 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 3.44 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 2.44 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 1.4 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 2.52 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.15 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 1.75 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.05 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.09 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 1.86 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 3.79 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.24 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 2.66 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 1.53 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 1.6 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.04 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 1.72 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 5.97 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 2.08 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 4.04 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.16 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 1.61 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 5.22 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.18 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 2.7 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.01 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.46 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 2.04 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 1.84 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 0.94 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 1.97 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 3.23 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 2.7 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 4.62 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.09 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.02 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.3 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 1.41 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 1.71 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 1.17 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 2.91 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.26 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 1.92 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.25 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.32 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.54 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.43 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 1.17 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 1.07 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 2.05 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 2.41 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 2.46 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 0.95 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 5.11 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 1.36 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.21 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 3.75 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 2.68 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 2.66 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 1.77 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.07 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 1.4 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 1.86 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 1.79 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.6 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.82 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 3.21 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.43 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.38 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 1.98 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 1.88 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.53 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 1.23 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.08 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 4.3 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 1.19 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 3.37 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 5.14 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 1.26 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 3.39 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.31 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 1.99 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 1.51 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.33 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.29 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 1.39 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 4.15 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 1.88 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 1.95 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 0.92 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 0.76 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 1.1 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 1.18 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 2.77 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 2.77 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 3.45 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 2.44 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 2.85 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 1.6 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.24 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 1.65 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 3.59 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 1.42 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 1.22 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 2.97 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 1.45 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.37 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 2.78 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 4.09 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 1.72 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 146' ' ' ASP . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 4.34 108.544 158.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 2.69 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.03 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' CB ' ' HE3' ' A' ' 140' ' ' LYS . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.054 -0.721 . . . . 12.85 109.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.13 169.5 10.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.779 0.718 . . . . 9.14 111.088 163.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.1 p 169.81 112.81 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.75 2.82 . . . . 5.4 107.755 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -175.44 93.09 0.06 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.428 1.891 . . . . 4.82 110.703 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -70.28 121.83 18.37 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.516 -0.74 . . . . 2.67 110.89 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 3.95 112.132 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 2.59 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 1.17 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 2.46 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.14 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.08 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 3.48 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.2 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 2.93 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 3.39 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 1.99 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 1.6 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 1.75 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 0.86 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 1.01 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.29 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 2.42 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 4.2 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.71 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 1.5 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 3.68 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 7.16 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 2.08 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 1.64 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.13 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 1.6 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.01 110.134 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 0.74 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.22 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 2.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 2.91 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 2.77 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.52 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.05 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 1.6 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 2.34 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 1.67 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 0.86 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 2.33 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 1.63 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.21 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 1.73 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 3.39 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 1.23 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 0.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 2.08 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 3.35 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 1.2 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.08 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 2.0 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 5.62 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 3.65 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.05 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 2.5 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 2.05 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.15 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 0.85 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 1.81 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.615 HD11 HG12 ' A' ' 114' ' ' VAL . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 1.56 110.006 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.429 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 2.75 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.71 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 2.93 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 1.98 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 1.64 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.04 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 1.07 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 3.6 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 4.87 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 0.83 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 3.2 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 3.41 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 0.87 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 1.94 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 3.88 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.34 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 2.09 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.07 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.43 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.02 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 0.96 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 0.89 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 4.14 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 1.57 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 1.94 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 1.13 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.615 HG12 HD11 ' A' ' 80' ' ' ILE . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 0.51 109.375 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 0.78 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 0.76 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 3.17 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.2 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 3.94 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 2.33 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.41 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 1.45 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.09 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 2.73 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 4.17 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.36 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 0.98 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 3.9 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 1.32 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 4.43 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 4.17 109.845 165.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 1.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 2.96 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.11 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 3.95 105.735 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.27 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.25 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 108.63 -0.878 . . . . 11.36 108.63 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.05 115.53 28.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.64 0.776 . . . . 8.42 109.169 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 t -169.61 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.534 1.679 . . . . 5.76 115.534 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.71 144.73 21.79 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.139 1.336 . . . . 7.57 110.386 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -102.16 152.47 20.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 2.89 111.323 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 5.82 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 2.89 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 2.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.13 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.25 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.18 108.793 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 1.7 107.052 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 2.72 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.17 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.02 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 3.4 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.37 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 2.45 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 1.61 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 1.85 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 3.26 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 1.9 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 6.5 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.19 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 1.59 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 5.45 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 5.35 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 2.83 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 1.78 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 1.53 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 2.52 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.08 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.72 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 1.72 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 2.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 2.9 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 3.25 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.25 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.41 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.57 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 2.27 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 1.95 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 3.16 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.21 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.03 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.0 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.34 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 2.38 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 2.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 1.83 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 2.14 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.2 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 2.9 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 1.43 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 4.23 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.18 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.43 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 5.64 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.01 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 71' ' ' VAL . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 3.79 112.967 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 2.63 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 2.96 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.13 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 1.78 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 2.18 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 114' ' ' VAL . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 1.68 109.59 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.67 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.05 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 2.62 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 3.28 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 2.98 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 3.18 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.73 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 1.84 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.27 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.29 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 1.37 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 4.56 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 4.41 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 0.97 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 5.19 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 2.76 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 1.23 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.36 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.13 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 1.84 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 1.44 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 6.2 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 2.49 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 2.3 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 1.25 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 80' ' ' ILE . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 0.93 109.273 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 1.67 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.89 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 2.71 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 2.88 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 3.5 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.03 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.33 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 141' ' ' LEU . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 1.45 111.522 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 1.9 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 1.67 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 2.64 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 1.33 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 1.09 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 3.23 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 1.58 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.31 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 3.5 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.31 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 1.23 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 3.75 110.732 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 125' ' ' VAL . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 2.8 113.326 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 4.36 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.0 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.23 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 117.308 -1.329 . . . . 10.29 113.399 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.74 -50.04 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.876 1.671 . . . . 8.68 113.037 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -153.38 -65.34 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.302 -1.74 . . . . 5.89 106.302 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 92.34 111.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 130.856 3.662 . . . . 5.89 109.451 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.95 159.84 14.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.766 1.227 . . . . 3.16 111.881 -162.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 6.93 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 2.64 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.17 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 2.25 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 3.58 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 1.85 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 2.48 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 0.98 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 2.07 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 2.85 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.34 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 2.49 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 1.24 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 1.55 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 0.85 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.95 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.13 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 1.87 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 3.16 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 1.67 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.2 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 4.72 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 2.33 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 2.73 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.39 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 1.63 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 1.62 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 0.94 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 1.74 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 1.87 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 2.43 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.37 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 2.56 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 1.65 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.15 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 2.15 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 1.32 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 2.43 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.09 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.05 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 1.85 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.21 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 2.51 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 1.16 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.04 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 1.85 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.01 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 2.23 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.481 HG22 ' CG ' ' A' ' 69' ' ' TYR . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 1.51 111.109 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 5.62 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 2.24 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CG ' HG22 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 10.76 115.883 -169.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 4.93 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.02 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 2.91 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 1.81 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 3.62 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 1.03 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 1.85 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 1.81 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.1 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 2.57 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 1.67 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 2.59 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 1.78 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 2.39 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 1.6 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 1.36 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.38 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 3.95 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 1.03 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 2.88 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 3.9 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 0.97 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 1.8 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 2.65 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.13 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 2.12 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 0.93 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 0.96 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.33 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 1.37 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 5.47 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 1.4 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 1.52 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 0.94 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 0.77 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 0.8 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 0.77 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 2.62 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.11 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.53 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 3.5 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 1.66 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.0 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 1.59 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 2.41 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 1.54 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 4.35 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.5 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 1.96 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.12 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.06 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.08 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 3.16 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 3.39 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 2.19 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 2.81 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 1.47 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 4.42 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 3.61 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.893 -0.575 . . . . 14.98 109.962 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.13 125.33 23.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.743 1.217 . . . . 9.73 111.559 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 m 114.99 -130.48 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 1 C-N-CA 131.723 4.009 . . . . 7.6 104.155 -162.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -153.9 -172.31 4.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 121.12 1.782 . . . . 5.39 111.292 151.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -136.17 141.02 44.03 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.201 -1.407 . . . . 2.87 107.201 160.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 3.75 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 4.55 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 1.37 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 2.42 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 2.99 109.829 164.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 1.49 110.691 -171.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 1.8 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.05 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.406 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 2.49 116.519 -167.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.15 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.14 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.05 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 1.75 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 15' ' ' MET . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 1.96 112.075 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 1.75 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 4.68 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 1.85 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 3.26 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 0.92 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 1.67 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 4.29 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 5.31 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 2.46 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 2.78 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.36 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 1.71 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 1.65 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.14 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.07 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.01 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 2.75 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.13 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 2.73 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.6 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 2.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 1.18 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 2.8 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 3.34 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 1.9 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.13 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 2.38 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 1.18 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 1.16 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 3.44 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.44 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 4.75 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 1.14 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 3.92 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 1.34 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 5.85 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 4.75 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 3.5 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 2.83 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.15 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 3.54 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 1.23 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 1.83 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 1.54 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.3 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 2.42 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 1.81 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 2.23 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 1.32 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 1.31 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 1.18 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 0.92 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 2.86 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 4.43 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 1.14 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 2.93 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 5.27 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 1.11 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.74 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.37 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 2.17 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 1.35 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.81 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 0.91 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.07 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 0.97 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 3.79 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 1.6 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 1.55 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 1.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 0.79 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 1.48 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 1.44 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 2.5 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 2.39 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 3.57 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 2.51 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 2.98 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 1.38 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 1.82 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 1.44 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 5.09 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 1.22 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 1.02 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 6.17 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 1.76 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 3.19 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 2.19 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 1.42 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 4.39 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 2.17 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 4.72 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 4.65 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.204 -1.036 . . . . 14.8 108.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.18 -76.76 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.802 1.241 . . . . 8.84 109.938 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m 73.91 93.84 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.847 2.059 . . . . 7.04 113.235 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.65 4.15 53.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.281 -0.887 . . . . 7.94 112.817 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -95.99 109.09 21.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 2.94 107.242 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 3.47 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 2.98 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 1.42 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.1 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 3.87 108.323 161.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 1.84 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.23 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.32 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 3.35 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 4.36 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 3.67 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 1.72 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 1.51 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 1.36 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.1 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 3.13 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 2.53 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.16 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 3.08 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.14 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HG3' HH11 ' A' ' 30' ' ' ARG . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 6.88 112.159 171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 2.39 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.0 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 2.64 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 2.25 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 0.95 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.05 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 2.54 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 3.22 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.3 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 3.13 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.22 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.61 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 2.35 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 1.41 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 2.41 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.04 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.07 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.1 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.7 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 2.51 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 1.24 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 1.58 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 1.8 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.21 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 3.09 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 1.91 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 6.03 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 1.92 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 5.47 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.12 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 3.7 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 3.71 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 2.42 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 3.79 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 1.32 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 2.17 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 1.44 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.33 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.15 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 2.16 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 2.54 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 1.26 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 1.55 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.69 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 0.89 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 2.5 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 4.43 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.05 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 3.47 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 3.89 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.29 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.15 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.11 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 2.38 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 2.46 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.52 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.11 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.04 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 0.98 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 3.35 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 1.51 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 1.52 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 1.56 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 0.65 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 1.29 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 1.34 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 2.65 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 2.64 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 1.93 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.13 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.03 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.24 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 1.5 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.19 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 1.46 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 3.33 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.01 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 1.54 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 3.92 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 2.47 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.7 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 3.36 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 3.06 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 1.39 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 2.89 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.503 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 1.93 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 4.58 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.19 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.54 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.18 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.557 -0.534 . . . . 11.72 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.64 -60.57 3.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.201 1.0 . . . . 10.69 110.714 168.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.4 m 149.05 -105.16 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 131.368 3.867 . . . . 5.84 108.261 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -148.05 21.03 1.11 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.363 1.246 . . . . 8.53 114.363 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -140.09 149.99 43.78 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 119.451 -2.031 . . . . 2.47 110.057 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 6.78 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 3.75 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 1.31 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 2.71 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 3.35 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 1.74 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.14 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.33 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 2.94 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.15 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 3.35 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.12 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 1.18 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 1.69 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 0.88 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 0.99 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 2.75 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 2.14 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 3.83 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 1.68 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 3.77 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 5.92 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 2.25 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.08 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 2.2 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 1.96 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.13 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 2.16 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 1.83 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 2.78 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.02 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.4 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.43 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 1.32 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 1.85 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 1.43 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 2.75 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 2.48 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 1.8 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 1.84 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 3.0 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 1.72 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 1.35 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 2.12 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 3.84 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 1.05 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 4.36 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.19 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.41 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 5.55 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 3.41 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 3.6 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 2.44 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 2.43 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 4.48 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 1.41 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 1.97 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 1.55 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.68 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 2.91 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 1.73 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 2.97 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 1.3 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 1.47 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 1.31 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 0.85 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.0 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 3.43 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 0.98 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 3.9 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 3.56 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 1.03 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 3.3 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 2.66 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 1.54 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.3 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.18 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.07 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 4.29 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 1.56 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 1.76 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 1.13 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 0.9 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.04 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 1.37 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 3.66 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 3.1 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 4.76 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.32 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 3.76 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 1.73 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.22 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 1.7 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 3.23 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 1.77 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 1.1 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 3.67 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 1.56 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 3.57 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 2.87 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 1.53 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 2.53 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 2.26 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 5.1 108.533 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.19 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.13 107.878 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.469 -0.567 . . . . 12.07 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 tp 34.39 60.45 0.59 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.064 2.945 . . . . 9.96 115.414 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.2 t -62.94 -17.09 61.45 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.446 1.647 . . . . 5.25 115.446 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -179.02 146.07 0.29 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.41 2.284 . . . . 5.5 108.853 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -96.2 136.97 35.95 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 4.12 107.313 172.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 4.95 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.0 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 1.23 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 2.97 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 2.52 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 1.8 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 2.45 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 1.86 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.27 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 4.26 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.24 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.01 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 2.13 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 1.16 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 1.18 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.07 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 2.01 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 2.75 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.78 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 2.07 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.19 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 5.36 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 2.52 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 2.72 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.31 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 1.93 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.17 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 0.81 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.0 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 1.88 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 2.73 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 1.97 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 2.7 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.34 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.27 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 2.02 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 1.29 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 3.28 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.25 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 2.84 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.03 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 1.84 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.09 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 1.84 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.22 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 2.89 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 5.18 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 2.43 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 1.33 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.07 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 1.63 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.51 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.39 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 3.98 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 4.23 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 2.77 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 2.24 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 5.63 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 1.0 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 2.28 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 2.31 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 2.77 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 1.58 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 2.68 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 1.85 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 1.96 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.56 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.09 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 3.84 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.3 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 1.04 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 4.5 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 4.83 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 1.1 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.23 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 2.78 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.1 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 2.19 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.17 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.52 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.13 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.32 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 1.62 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 5.6 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.25 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.25 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 1.32 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 0.86 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 0.8 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 2.72 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 3.32 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 3.45 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 1.73 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.27 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 1.34 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.06 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 1.52 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 3.8 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 1.68 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 1.13 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 3.75 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 1.63 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 3.06 110.317 174.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 2.84 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 1.04 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 3.31 109.341 161.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 1.47 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 3.91 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.574 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.32 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 2.58 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 119.276 -0.392 . . . . 14.7 110.245 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -131.17 165.65 22.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.538 1.535 . . . . 12.46 109.911 166.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 167.92 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.85 2.46 . . . . 7.25 107.426 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 169.7 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.858 2.463 . . . . 5.68 109.207 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -84.66 120.63 26.6 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.597 -0.689 . . . . 4.06 110.099 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 4.71 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 3.96 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.48 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 3.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 4.87 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 69' ' ' TYR . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 2.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 2.24 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.2 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 2.37 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 2.94 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 3.81 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 2.59 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 1.3 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 1.61 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 1.0 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 0.99 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 3.77 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 2.17 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 2.85 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 0.96 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 1.92 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 4.74 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 4.63 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 2.11 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.19 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.59 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 1.66 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 1.74 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 0.9 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 2.05 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 3.79 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 2.25 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 2.84 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 1.39 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 1.82 110.292 163.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 2.83 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 1.11 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 3.54 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 3.64 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 1.72 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 3.14 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 1.07 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 2.29 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.05 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 2.31 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.444 HG22 ' CE1' ' A' ' 69' ' ' TYR . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 2.01 110.004 174.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 3.9 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 1.36 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.32 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 9.94 112.794 168.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 4.98 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 2.8 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 2.53 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 1.91 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 3.32 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 1.0 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 1.93 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 1.51 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.02 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 2.86 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 2.74 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 1.8 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 1.74 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 1.69 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.3 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.13 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 2.92 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 4.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 1.55 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 3.86 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 3.86 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 1.28 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.45 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 4.68 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.528 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.07 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.528 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 1.87 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.16 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 0.94 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.06 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 1.04 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 3.64 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 1.95 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 1.85 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 1.22 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 0.66 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 0.83 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.83 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 2.66 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 2.41 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 3.67 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 2.26 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.29 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 1.36 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 1.91 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 1.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 2.57 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.0 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 1.4 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.17 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 2.15 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 1.74 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 3.43 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 3.2 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 1.64 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 3.65 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 1.87 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 5.29 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.05 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.24 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.28 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 118.215 -0.897 . . . . 14.28 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 pp -81.03 176.57 9.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.464 0.574 . . . . 8.72 110.73 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 m 164.83 -40.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 128.934 2.894 . . . . 6.22 111.951 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -149.84 155.27 39.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.571 1.548 . . . . 6.16 110.477 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -104.32 171.88 7.1 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.661 1.184 . . . . 3.1 111.291 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 3.85 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 3.3 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.1 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 3.27 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.06 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 1.89 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 2.07 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.05 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 2.13 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 2.95 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.3 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 2.28 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 1.27 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 1.48 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 1.05 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.03 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 2.81 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 2.78 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 3.98 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 0.93 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 1.75 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 3.49 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 3.97 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 2.45 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.35 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 2.09 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 1.97 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 1.12 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 1.83 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 2.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.2 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.27 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 1.6 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 1.52 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 2.21 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 1.48 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 2.78 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 2.02 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 3.25 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.15 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 2.24 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 0.97 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 0.96 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 1.66 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.67 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.77 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 2.08 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 1.07 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.17 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 1.67 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.27 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 4.09 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.11 114.923 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 2.29 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.21 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 4.78 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 1.18 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 2.14 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 114' ' ' VAL . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 1.88 109.009 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.24 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.27 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 2.38 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 2.83 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 1.45 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 1.66 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 1.53 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.02 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 2.7 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 3.52 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 1.11 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 2.99 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 3.38 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 1.81 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 1.95 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 3.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 1.65 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.01 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 1.3 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.44 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.05 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 6.77 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 1.73 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 1.51 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 1.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 0.89 108.608 165.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 1.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 0.89 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 2.25 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 2.39 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 6.15 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 1.84 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.64 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 1.56 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.29 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 1.63 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 4.29 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 1.3 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 0.88 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 2.81 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 2.06 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.09 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 3.25 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 2.64 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.45 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 4.18 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 1.81 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 4.48 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.35 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 119.471 -0.3 . . . . 10.6 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.79 -163.65 0.15 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.393 1.877 . . . . 10.12 111.485 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.5 p -84.07 59.66 5.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.002 1.321 . . . . 6.42 111.875 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.13 60.42 1.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.628 1.204 . . . . 5.57 110.266 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -92.71 159.14 15.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.565 1.946 . . . . 2.64 110.256 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.05 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 2.77 108.843 177.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 0.94 110.812 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 2.66 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 2.8 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 1.62 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 1.79 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.06 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 1.72 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 5.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 5.98 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 4.14 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 1.93 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 1.75 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 1.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 1.09 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.1 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 1.58 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 3.46 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.04 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 1.59 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 5.69 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.11 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 3.32 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 1.74 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 1.56 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 1.6 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.439 ' H ' ' HA ' ' A' ' 50' ' ' TYR . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.38 108.437 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 0.94 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 1.92 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.14 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 3.52 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 2.12 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 2.61 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.6 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 1.41 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 1.69 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 1.1 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 35' ' ' THR . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 3.0 115.568 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 1.92 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 2.31 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.35 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 2.09 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 0.92 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 0.96 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 1.61 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 3.32 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 2.67 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 1.23 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 4.57 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 1.66 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.41 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 4.41 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.07 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 2.67 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 1.79 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 3.65 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 0.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 2.62 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 1.53 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 2.34 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 1.91 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.18 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 1.53 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 1.38 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.33 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 0.82 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 2.88 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 4.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 0.93 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 3.35 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 4.29 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 0.94 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 2.55 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.48 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 1.66 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 1.27 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 1.11 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.14 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.13 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 3.83 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 1.4 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 1.61 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 1.1 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 0.61 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 1.03 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 1.08 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 3.89 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 3.5 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 2.31 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 3.77 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.04 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 3.56 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 1.87 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 2.43 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 1.48 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.04 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 1.6 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.03 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 3.89 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 2.07 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.36 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 2.92 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 2.83 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 1.14 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 2.95 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 1.73 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 4.65 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 3.73 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 2.98 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.864 -0.588 . . . . 16.02 109.476 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.35 117.28 26.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.863 0.865 . . . . 14.66 110.107 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -174.81 35.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.721 2.008 . . . . 9.08 110.141 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.013 -1.054 . . . . 6.72 108.812 -165.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.64 166.59 22.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.062 0.945 . . . . 2.55 110.583 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.15 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 2.92 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 1.3 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 3.02 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.08 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 2.42 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 2.68 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 2.4 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.13 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 3.31 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 1.94 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 1.38 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 2.93 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 1.48 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 0.97 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 3.38 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 1.99 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 2.91 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 0.93 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 2.35 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 3.94 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 7.39 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 3.72 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.56 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 2.02 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 1.76 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 0.92 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 2.27 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.01 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 2.3 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 1.87 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.23 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 1.74 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 1.55 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 2.43 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.01 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 2.53 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.77 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 1.61 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 2.66 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.18 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 2.91 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 0.99 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 2.05 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 2.86 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 2.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 1.05 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.0 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 1.26 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.39 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.43 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 3.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 3.27 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 2.49 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 1.68 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 4.09 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 0.83 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 2.06 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 1.99 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.25 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 2.74 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 1.69 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 1.96 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 1.74 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 2.15 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.55 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.31 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 2.48 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 5.14 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 1.53 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 4.63 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 3.54 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 1.38 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.51 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 3.2 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 3.45 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.46 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 2.5 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 1.22 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.5 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 1.2 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.27 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 1.36 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 2.84 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 5.48 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 2.69 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 3.24 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 1.37 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 0.64 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 1.07 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 0.91 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 2.53 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 2.5 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 1.93 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 3.28 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 2.49 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 2.45 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 3.86 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.48 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 1.93 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 3.23 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.44 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 1.58 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 2.96 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 1.84 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 1.77 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 3.26 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 2.85 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 1.71 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 3.67 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 3.31 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 3.98 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.08 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.51 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.446 -0.576 . . . . 15.5 109.446 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.93 157.85 20.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.531 -0.914 . . . . 12.62 108.531 162.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.8 m -62.32 -37.86 87.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.678 0.992 . . . . 5.98 113.678 -167.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.37 -13.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.852 1.427 . . . . 7.71 114.852 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.65 138.26 56.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.789 1.631 . . . . 2.64 109.344 169.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 3.66 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 2.64 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 0.97 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 3.3 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HB3' HD21 ' A' ' 119' ' ' ASN . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.17 110.461 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 1.64 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 2.23 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.3 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 1.88 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.03 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 3.58 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 2.46 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.22 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 1.68 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 0.99 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 1.07 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 3.39 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 1.68 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 4.27 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.81 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 1.54 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 3.39 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 5.33 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 2.37 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 1.77 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 1.67 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 1.64 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 0.71 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 1.81 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.16 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 2.87 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 1.99 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 1.56 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 1.42 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 1.68 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 1.17 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 2.82 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 1.85 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 1.99 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.3 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 2.22 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.26 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 1.45 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 4.19 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 3.14 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 1.07 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 3.98 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 1.35 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.04 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 4.63 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 2.75 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.08 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.01 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 5.28 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 1.32 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 1.79 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 114' ' ' VAL . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.3 107.935 172.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.14 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 2.87 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.03 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 1.79 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 1.73 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 1.65 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.31 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 0.98 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 1.97 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 4.67 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 0.96 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 4.33 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 4.62 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 0.96 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.16 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 2.51 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 1.87 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 2.13 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 1.03 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 0.95 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 0.94 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 0.9 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 3.41 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 5.94 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 2.35 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 2.49 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 0.98 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 80' ' ' ILE . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 0.7 110.215 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 0.97 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.16 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 2.18 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 11' ' ' GLN . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 2.5 110.068 162.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 3.86 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 3.9 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 1.7 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 4.49 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 1.33 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 2.73 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 2.42 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 1.8 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 4.0 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 2.47 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.64 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 2.85 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 2.71 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 1.26 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 3.3 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 1.81 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 4.91 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 147' ' ' SER . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 143' ' ' GLY . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.14 112.457 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 118.929 -0.558 . . . . 14.82 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.48 -176.62 4.27 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.758 1.623 . . . . 7.97 110.011 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -156.23 68.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.0 -1.687 . . . . 6.57 110.955 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -162.12 27.33 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.916 1.45 . . . . 5.93 114.916 -163.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.4 155.29 23.56 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.601 -1.312 . . . . 3.83 110.369 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.03 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 2.83 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 1.16 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 2.78 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 4.86 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 2.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.08 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 2.57 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 4.49 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 2.05 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 1.19 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 2.67 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 1.38 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 1.44 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 3.46 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 2.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 2.92 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.25 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 1.55 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 5.36 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 4.74 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 2.27 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 2.34 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 55' ' ' THR . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.24 114.707 168.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 1.85 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.0 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 0.98 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 2.41 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.06 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 2.5 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 1.82 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 2.82 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 1.36 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 1.25 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 1.91 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 1.07 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 2.56 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.11 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.12 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.405 ' HB ' ' HA3' ' A' ' 33' ' ' GLY . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 2.89 112.579 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 1.69 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 3.33 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 1.21 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 1.0 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 1.78 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.24 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 3.08 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 0.97 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 4.99 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 1.55 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 5.55 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 4.12 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 2.96 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 2.51 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 1.86 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 3.36 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 1.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 2.13 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 1.72 111.11 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 1.82 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 2.87 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 2.41 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.45 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 1.52 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 1.75 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 1.53 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 0.83 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 3.27 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 3.54 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 0.94 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 3.75 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 5.66 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.01 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.55 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 3.64 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 2.64 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.3 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 1.67 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.06 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.41 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.06 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.11 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 0.87 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.34 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 6.31 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 1.56 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 1.86 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.15 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 80' ' ' ILE . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 0.83 108.477 167.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.13 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.51 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 3.81 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 3.21 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.14 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 1.91 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.08 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 1.29 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.43 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 1.5 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 2.87 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 1.9 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 1.43 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 3.35 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 1.71 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 3.48 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 3.45 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 1.44 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 3.41 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 1.44 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.02 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.87 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.66 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.133 -0.321 . . . . 17.26 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.2 tp -162.17 141.68 9.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.769 1.627 . . . . 9.45 109.622 -175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t 166.78 -169.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 130.9 3.68 . . . . 5.94 105.578 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.63 148.56 36.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.676 -1.231 . . . . 5.16 107.676 153.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -139.3 148.34 42.86 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.744 -0.598 . . . . 2.65 109.811 -167.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.12 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 3.69 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 4.1 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 1.54 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 2.62 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 1.35 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 2.73 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.42 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.0 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 3.17 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 2.84 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 2.37 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 1.71 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 1.65 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 1.43 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 1.41 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 3.61 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 1.94 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 2.91 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.92 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 1.44 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 3.82 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 4.82 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 2.54 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 1.99 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.24 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 1.53 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 3.08 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 0.93 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 3.24 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.51 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 3.19 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.27 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.09 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 1.47 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 1.73 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 2.09 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 1.12 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 3.06 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 2.3 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 1.76 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 1.49 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 2.93 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.08 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 1.08 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 2.06 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.17 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 2.7 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 1.17 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 4.5 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 1.4 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.63 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 3.41 110.287 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 2.96 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 2.88 114.083 -171.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 2.83 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 3.95 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 0.88 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 2.18 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 1.53 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 3.96 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 2.8 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 2.45 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 1.42 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 1.77 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 1.44 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 0.85 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 4.81 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.13 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 1.07 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 3.77 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 3.87 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 1.03 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 1.79 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 3.53 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 2.83 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 1.2 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.44 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.96 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 0.85 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 3.72 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.44 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 1.5 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 1.06 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 0.63 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 0.94 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 0.79 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.62 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 2.88 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 4.31 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.38 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 2.78 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 1.35 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 1.8 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 1.63 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 3.55 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.44 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 0.9 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.12 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 1.35 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 3.03 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 3.44 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 1.2 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 2.58 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 1.89 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.11 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.44 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 2.7 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 3.73 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.41 -0.589 . . . . 10.99 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.77 145.49 52.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.477 0.581 . . . . 9.81 109.458 155.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -179.0 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.589 1.699 . . . . 5.24 115.589 -167.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.8 121.06 4.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 120.436 1.471 . . . . 4.93 111.643 -166.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -97.18 130.11 44.46 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.447 -0.783 . . . . 2.76 109.474 -169.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 4.32 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 57' ' ' THR . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 2.49 107.23 161.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 0.95 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 2.14 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 2.8 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 1.67 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 2.72 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.4 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 2.87 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.3 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 4.92 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 2.55 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 1.5 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 3.29 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 1.19 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.23 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 3.33 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 2.43 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 3.77 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 2.31 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 3.96 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 3.91 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 3.73 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 1.78 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 1.62 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.22 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.21 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.09 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.36 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 41' ' ' LEU . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 2.31 111.113 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 2.92 113.324 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 2.86 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 2.56 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 1.66 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 2.11 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 2.32 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 1.23 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 2.3 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 1.99 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.42 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 1.69 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 103' ' ' ALA . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 2.75 112.466 -173.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 1.38 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 1.26 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 2.17 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 2.24 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 1.21 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 4.37 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 1.85 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.45 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 5.77 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 5.25 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.08 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 2.6 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 2.17 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.16 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 0.95 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 2.22 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 1.68 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.1 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 3.33 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 1.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 1.97 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 1.37 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 1.4 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.28 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 0.88 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 2.3 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 3.9 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 0.93 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 3.88 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 3.63 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 1.67 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 4.64 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.0 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.02 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' THR . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.0 111.067 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.83 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.31 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.25 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 0.94 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 3.79 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 2.11 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 2.47 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 0.96 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 0.74 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 1.22 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 0.88 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 2.66 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 2.56 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.62 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 4.97 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 1.75 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 3.51 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 1.32 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 1.84 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 1.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 5.55 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 1.24 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 0.89 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 3.3 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 1.5 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 3.02 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 2.53 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 1.12 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 2.96 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 1.45 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 4.35 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 3.41 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 mtt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.324 -1.322 . . . . 14.88 109.116 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.99 60.51 3.57 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.279 1.854 . . . . 11.35 112.951 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m 141.06 124.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 1 C-N-CA 132.861 4.464 . . . . 6.44 109.995 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 178.42 98.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.578 2.751 . . . . 6.11 108.928 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -81.47 129.96 34.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.442 -0.786 . . . . 2.63 109.321 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 3.73 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 2.54 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 1.85 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 3.78 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.07 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 3.23 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.45 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 1.85 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.68 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 3.58 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.12 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.03 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 1.83 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 2.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 0.95 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 1.6 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 3.31 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 2.07 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 4.13 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.21 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 2.48 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 4.65 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 4.43 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 3.58 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 2.86 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 1.87 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 1.54 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 1.77 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.12 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.32 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 2.16 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 2.6 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.29 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 3.57 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.15 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 2.3 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 1.98 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 2.32 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 1.11 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 2.76 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.55 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 2.08 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 2.1 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.05 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 2.34 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 1.26 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 1.39 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 2.71 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.26 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 1.98 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 69' ' ' TYR . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 1.38 110.584 172.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.0 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 1.56 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 10.5 113.408 -177.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 4.47 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 4.63 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 4.18 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 2.84 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.12 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 1.02 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 2.06 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.42 HD11 ' CG1' ' A' ' 114' ' ' VAL . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 1.87 108.474 175.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 1.89 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 2.82 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 1.84 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 1.98 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 1.63 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 1.67 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 1.68 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 1.22 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 2.65 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 4.62 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 1.31 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 3.95 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 4.52 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 0.96 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.08 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 2.78 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.554 ' H ' HG21 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 2.45 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.04 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.47 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 1.7 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.19 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 1.5 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 3.91 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 1.67 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 1.68 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.34 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 0.95 108.913 168.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 1.28 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 0.86 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 2.63 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 3.27 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 6.63 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 1.72 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 3.82 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 1.9 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 2.19 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 2.14 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 2.92 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 1.69 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.01 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 2.84 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 1.57 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.55 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 3.2 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 2.59 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 1.47 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 3.74 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 144' ' ' GLU . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 1.71 111.97 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 4.48 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 141' ' ' LEU . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 2.88 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 2.72 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 117.702 -1.142 . . . . 16.7 108.241 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 mt 137.11 151.69 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 131.665 3.986 . . . . 11.88 109.815 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m -78.6 36.01 0.25 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.088 1.755 . . . . 6.77 112.997 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 85.9 -32.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.012 2.925 . . . . 7.96 109.947 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -64.22 114.98 4.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 3.9 110.726 157.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 6.33 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 2.5 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 1.14 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 3.12 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 2.67 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 1.43 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 1.83 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 2.44 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 4.78 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 4.08 115.404 165.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 2.26 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 1.5 113.317 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 1.59 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 0.91 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 0.95 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 5.25 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 2.53 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 3.81 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 2.49 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 4.35 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 4.68 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 2.44 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 2.65 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.33 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 1.75 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 1.84 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.13 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 1.87 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.89 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 2.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.02 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.42 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 1.77 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 1.83 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 1.95 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.02 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 2.36 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 2.37 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 2.19 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 1.6 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 2.67 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 1.15 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 0.93 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 2.29 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 2.95 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 1.04 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 4.25 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 67' ' ' LEU . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 1.77 113.429 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.22 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 3.83 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 2.59 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 2.25 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 2.35 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 3.32 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 1.27 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 2.05 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.446 HD11 HG12 ' A' ' 114' ' ' VAL . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 2.75 109.579 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.19 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 2.47 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.13 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.27 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 1.44 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 1.34 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 1.29 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 1.13 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.09 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 3.92 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 1.73 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.03 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 3.68 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 0.99 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.52 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 5.32 111.767 163.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.727 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.02 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 1.15 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.67 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.03 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.87 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 1.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 3.98 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.489 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 6.01 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.13 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 1.53 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 1.19 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 80' ' ' ILE . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 0.64 108.406 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 0.83 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 0.85 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 2.77 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 2.45 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 3.37 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.23 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.15 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 1.41 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 2.27 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 2.1 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 2.8 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 1.39 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 137' ' ' TYR . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 1.38 113.51 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 3.4 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 1.57 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' A' ' 132' ' ' VAL . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.63 111.576 175.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 2.58 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 1.52 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 2.58 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 1.84 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 5.57 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.2 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.992 -0.527 . . . . 10.8 109.736 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.87 -153.12 0.45 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.616 1.566 . . . . 7.81 110.156 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -176.39 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.506 2.323 . . . . 5.68 111.042 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -124.07 165.85 16.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.505 1.922 . . . . 6.9 109.407 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -131.34 149.63 52.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.245 1.418 . . . . 3.63 107.904 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 4.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 2.24 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.05 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 2.88 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 6.09 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 1.54 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 1.91 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.36 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 1.99 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 3.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 3.61 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 2.74 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 2.18 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.02 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 1.07 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 1.83 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 5.82 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 2.03 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 5.69 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.42 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 1.52 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 3.5 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 4.52 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 2.67 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 1.71 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 2.51 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.18 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 2.88 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 2.83 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 3.46 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 3.03 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 3.59 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.23 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 1.82 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 1.03 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 3.48 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.34 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 2.09 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.87 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 2.99 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 1.58 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 1.63 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 2.11 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 2.59 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 2.83 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 1.45 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 6.79 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 2.35 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.51 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.2 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 5.36 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 2.88 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.11 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 2.61 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 3.74 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 1.21 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 1.7 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.14 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.18 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 2.49 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 1.92 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 1.93 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 1.57 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 1.68 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 1.41 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.02 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 2.42 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 4.98 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 0.97 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.24 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 3.86 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 0.97 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.62 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 2.79 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.12 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.45 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 2.41 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 1.43 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.46 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 1.06 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.11 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.05 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 4.26 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 1.92 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 1.88 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 1.25 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 0.61 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.11 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.02 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 2.64 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 3.75 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 3.77 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.17 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.31 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 1.32 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 1.87 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 1.96 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 3.25 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 1.62 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 1.16 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 2.74 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 1.48 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.55 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 2.9 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 2.46 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 1.47 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.04 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 1.39 112.225 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 4.56 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.45 110.651 155.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.01 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 108.885 -0.784 . . . . 12.35 108.885 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.6 tp -142.07 108.88 5.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.226 1.01 . . . . 8.24 109.706 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 t -103.34 59.5 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.751 0.82 . . . . 5.46 111.804 -172.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.49 155.56 13.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.113 1.365 . . . . 4.83 110.507 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -128.73 159.42 35.71 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.757 1.223 . . . . 2.31 108.638 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 3.54 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 3.13 108.52 164.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 1.23 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 2.21 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 2.8 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 1.48 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 2.35 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.04 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 3.5 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.07 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 2.15 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 1.23 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 1.52 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 0.97 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 0.91 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 4.57 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 2.42 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 2.81 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 0.85 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 2.73 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 3.89 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.1 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 2.16 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.54 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 2.08 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 2.26 110.95 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 0.93 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 2.84 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 2.91 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 2.25 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 3.76 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.57 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 1.63 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 1.92 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 1.17 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 2.95 115.988 -157.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.65 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 1.7 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 2.73 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.49 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 3.06 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 1.53 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 1.84 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 3.85 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.24 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 2.08 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 1.22 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.0 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 1.43 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.13 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 4.15 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 2.5 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 2.73 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.08 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.08 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 0.87 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 2.22 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.42 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 3.49 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 1.91 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 1.99 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 1.48 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 1.45 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 1.12 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.02 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.25 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.29 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 1.21 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 3.86 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 4.48 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 1.79 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.65 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 2.89 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.57 ' H ' HG22 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.51 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 1.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 0.99 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.81 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.26 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.3 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 1.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 3.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 1.49 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 1.54 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 1.26 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 0.94 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 1.43 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 0.93 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 2.56 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 2.46 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.02 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 2.17 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 2.73 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 1.4 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 1.91 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 1.57 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 3.67 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 1.42 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 1.04 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 2.73 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.24 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 3.41 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 5.55 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 1.31 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 3.37 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 2.13 111.131 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 4.49 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.41 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.22 112.053 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.46 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 116.774 -1.584 . . . . 10.94 112.42 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 47.66 -151.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.016 1.726 . . . . 8.3 113.383 -177.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -164.78 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.792 -1.193 . . . . 7.21 114.16 162.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 172.37 140.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.868 2.067 . . . . 5.64 111.009 -171.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -79.97 162.47 24.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.09 1.356 . . . . 2.84 111.532 -177.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 3.86 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 2.74 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 1.18 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 2.28 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 3.32 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 1.66 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 2.36 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 2.78 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 3.83 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 3.85 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 2.65 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 1.72 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 2.81 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 1.16 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 1.46 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 2.77 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 1.62 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 2.98 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.74 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 1.66 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 3.29 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 4.97 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 2.1 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.58 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 1.86 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 1.65 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 0.72 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 1.75 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.12 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 2.19 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 1.91 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 2.29 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.68 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 1.36 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 1.76 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 0.86 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 3.12 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 2.27 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 2.23 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.31 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 3.52 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 1.48 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 1.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 2.34 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 2.54 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 1.28 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 3.93 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.16 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 1.89 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.41 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 3.63 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 2.39 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 3.17 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.16 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 3.57 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 1.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 1.88 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 114' ' ' VAL . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 1.64 110.34 176.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.8 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 2.3 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 2.19 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.02 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 1.76 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 1.94 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 1.82 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.13 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.03 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.08 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 1.1 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 5.37 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.06 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 1.13 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 1.8 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 3.43 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.442 ' H ' ' HB ' ' A' ' 102' ' ' VAL 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.49 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 99' ' ' ILE . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 2.47 108.861 157.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 1.4 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 0.95 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.17 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 1.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 4.01 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.05 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 2.07 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 1.39 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 0.76 109.768 170.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 1.15 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 1.04 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 2.78 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 2.72 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.22 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 1.77 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.03 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 1.35 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 1.85 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 2.1 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 3.05 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 1.37 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 1.13 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 2.61 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.31 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 1.67 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 3.01 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 2.93 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 1.37 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 3.3 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 1.77 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 3.81 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.39 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.445 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 2.9 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.023 -0.513 . . . . 11.2 111.221 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.9 150.48 39.86 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.568 1.547 . . . . 8.88 110.466 174.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -77.84 -26.29 49.34 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.684 0.794 . . . . 6.82 112.994 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 3.6 pt-20 76.99 18.04 1.56 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.476 2.71 . . . . 7.57 114.242 148.196 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -66.17 151.6 46.61 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.74 113.738 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.2 110.615 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 2.54 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' H ' ' HA2' ' A' ' 101' ' ' GLY . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.03 111.056 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 2.68 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 4.13 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.32 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 2.25 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.58 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 3.14 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 4.93 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.35 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 1.98 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 1.64 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 1.45 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 1.0 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 1.21 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.04 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 1.93 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 4.26 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.74 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 2.11 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 4.57 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.3 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 2.55 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.36 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.46 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 1.9 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 1.86 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.75 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.31 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 2.25 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.62 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 2.55 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 2.49 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.31 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 1.5 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.13 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 2.28 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 1.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 2.46 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 2.34 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 1.9 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.31 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 2.38 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 1.06 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 1.14 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 1.91 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 2.37 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 1.97 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 3.77 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 1.81 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 5.56 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 3.3 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 2.43 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 2.63 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 2.19 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 3.42 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 1.16 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 2.18 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 2.43 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.2 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 2.39 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.19 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 3.63 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 1.43 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 1.58 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 1.52 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.06 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 2.68 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 3.96 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 1.43 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 4.06 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 3.72 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 1.28 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.53 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 3.32 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 9' ' ' ALA . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 1.73 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 1.46 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.66 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.15 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.29 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 0.99 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 3.48 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 1.76 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 2.03 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 1.16 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 0.63 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 0.8 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 0.94 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 2.22 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.62 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 4.47 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 1.7 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.53 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 1.45 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.13 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 1.57 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.22 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 1.73 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 137' ' ' TYR . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 2.02 113.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 4.65 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 2.37 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.63 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 132' ' ' VAL . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.07 112.398 -177.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 2.73 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 1.06 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 2.51 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 1.41 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 4.62 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.53 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 2.61 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.17 -0.307 . . . . 10.95 110.17 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.49 153.62 31.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.456 1.102 . . . . 9.69 109.597 170.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.3 p 179.24 75.24 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.974 1.31 . . . . 5.09 108.586 -168.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.27 89.8 2.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.758 1.223 . . . . 5.78 109.068 -173.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -70.26 131.97 45.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.774 -0.578 . . . . 3.49 111.7 -175.157 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 4.48 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 2.69 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 1.22 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 2.79 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.19 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.02 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 1.97 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 2.84 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 3.83 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 3.85 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 2.49 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 1.66 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 1.72 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 1.4 111.602 175.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.13 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 3.43 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 1.69 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 4.35 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.01 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 1.89 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.34 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 5.76 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.34 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.19 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.38 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 2.41 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.26 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 0.96 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 21' ' ' ALA . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 1.58 111.157 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.1 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 2.74 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.06 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.09 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 1.58 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.17 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 1.7 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 1.43 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 3.5 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.13 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.03 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 1.8 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.25 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 3.22 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 0.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 1.48 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 1.87 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.09 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 1.64 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 4.53 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 1.85 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.01 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 5.69 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 3.43 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 2.9 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 1.84 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 5.85 111.751 163.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 1.88 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 2.44 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 1.92 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 2.3 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 1.93 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 1.9 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 1.55 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.19 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 1.53 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 1.25 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.51 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 3.73 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 1.07 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 3.31 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 4.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 1.04 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.44 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 3.36 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.12 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 4.82 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.54 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 1.95 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 1.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 1.43 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.45 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 1.37 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 3.06 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 3.77 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 1.87 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 2.11 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 1.3 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 0.98 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 1.23 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 1.39 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 2.91 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 2.65 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 2.53 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 3.24 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 2.85 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.16 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 1.98 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 3.32 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 1.53 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 1.15 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 2.92 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 1.85 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 2.65 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 2.28 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 1.73 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 2.44 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 1.45 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 4.97 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.0 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 118.357 -0.83 . . . . 11.17 112.507 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -169.89 -161.32 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.752 1.16 . . . . 8.72 110.006 -150.669 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.48 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 19.2 m -162.41 93.45 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.342 -1.474 . . . . 6.51 112.529 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -156.63 130.22 8.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.246 0.618 . . . . 5.28 110.894 148.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.23 159.79 41.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.866 2.466 . . . . 3.47 105.58 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 3.79 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 2.95 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 1.36 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 2.21 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 3.72 108.299 158.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 1.66 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 2.37 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.42 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 1.82 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.08 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 3.66 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 2.11 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 1.65 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 1.8 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 1.2 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.63 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 4.97 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 1.57 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 2.96 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.15 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 1.56 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 3.86 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 6.35 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 2.82 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.55 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.33 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 1.71 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 1.62 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 1.62 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 1.87 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.03 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 2.94 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.03 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.14 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.59 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 1.68 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 1.7 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 1.18 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 2.7 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.26 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 2.04 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 2.95 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 1.7 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 1.76 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 2.36 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.15 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 2.34 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 1.49 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 4.26 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 1.82 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.5 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 11.87 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.22 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 4.23 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 3.87 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 2.2 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 3.37 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 0.88 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 1.95 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 1.62 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 2.54 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 1.66 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 3.14 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 1.32 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 1.88 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 1.67 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 1.26 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.0 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 4.55 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 2.1 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.0 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 4.42 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 1.22 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.42 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 3.19 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 1.91 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 1.17 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.04 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.2 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 1.3 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 3.48 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 1.45 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 1.96 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 1.25 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 0.82 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 1.36 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 0.98 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 2.52 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 2.43 110.414 176.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.58 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 4.79 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.08 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.43 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 1.46 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 3.13 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 2.75 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.12 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.32 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 1.02 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 2.81 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 1.69 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 2.85 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 2.64 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 1.13 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 2.76 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 1.56 111.759 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 4.18 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.47 112.639 164.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.13 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 118.995 -0.526 . . . . 11.41 111.394 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -177.79 4.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.872 2.069 . . . . 8.87 110.473 177.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -106.4 -28.06 10.58 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.867 1.062 . . . . 6.51 113.867 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -169.75 158.95 7.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.876 2.07 . . . . 5.89 108.549 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -120.41 160.26 23.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.4 106.69 160.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 3.58 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 2.98 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 0.98 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 3.42 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.16 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 1.38 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.69 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.11 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 3.1 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 2.62 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.1 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 1.97 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 1.49 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 1.51 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 0.98 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.48 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 2.95 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 1.77 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 3.17 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.86 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 1.65 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 4.16 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 4.54 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 4.28 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.08 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 2.15 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 2.98 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 0.76 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 2.3 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 1.85 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 2.98 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 1.98 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 2.54 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.39 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.11 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 1.65 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 0.88 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 2.6 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 1.89 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 1.81 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.2 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 2.81 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 1.21 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 1.38 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 1.8 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.24 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 2.57 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 1.5 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 4.28 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 1.69 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.52 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 5.96 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 4.13 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 3.17 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 3.08 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 1.87 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 3.62 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 0.97 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 1.88 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 114' ' ' VAL . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.0 111.329 -156.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 5.14 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 3.06 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 1.93 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 1.2 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 1.29 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.14 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 0.78 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.41 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 4.33 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 1.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 2.88 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 3.51 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 1.32 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.71 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 3.58 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 2.25 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 1.18 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.3 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.48 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 1.11 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 6.77 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 2.71 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 2.69 112.836 173.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 0.89 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 80' ' ' ILE . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 0.67 108.093 155.231 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 1.2 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 1.04 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 2.6 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 3.53 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 5.29 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.15 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 2.92 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 1.37 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 2.48 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 1.62 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 4.15 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 1.61 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 1.22 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 3.51 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 2.42 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 3.24 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 2.7 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 1.23 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.01 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 1.61 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 3.9 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 2.81 113.405 172.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 2.95 109.788 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 3.44 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 2.44 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 1.4 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 2.52 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.15 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 1.75 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.05 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.09 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 1.86 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 3.79 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.24 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 2.66 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 1.53 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 1.6 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.04 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 1.72 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 5.97 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 2.08 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 4.04 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.16 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 1.61 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 5.22 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.18 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 2.7 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.01 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.46 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 2.04 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 1.84 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 0.94 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 1.97 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 3.23 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 2.7 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 4.62 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.09 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.02 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.3 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 1.41 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 1.71 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 1.17 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 2.91 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.26 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 1.92 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.25 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.32 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.54 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.43 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 1.17 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 1.07 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 2.05 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 2.41 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 2.46 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 0.95 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 5.11 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 1.36 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.21 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 3.75 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 2.68 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 2.66 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 1.77 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.07 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 1.4 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 1.86 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 1.79 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.6 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.82 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 3.21 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.43 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.38 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 1.98 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 1.88 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.53 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 1.23 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.08 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 4.3 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 1.19 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 3.37 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 5.14 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 1.26 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 3.39 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.31 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 1.99 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 1.51 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.33 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.29 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 1.39 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 4.15 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 1.88 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 1.95 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 0.92 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 0.76 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 1.1 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 1.18 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 2.77 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 2.77 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 3.45 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 2.44 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 2.85 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 1.6 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.24 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 1.65 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 3.59 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 1.42 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 1.22 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 2.97 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 1.45 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.37 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 2.78 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 4.09 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 1.72 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 146' ' ' ASP . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 4.34 108.544 158.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 2.69 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.03 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' CB ' ' HE3' ' A' ' 140' ' ' LYS . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 35' ' ' THR . 7.8 mt-30 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.183 0.515 . . . . 2.67 110.89 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 3.95 112.132 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 2.59 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 1.17 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 2.46 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.14 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.08 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 3.48 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.2 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 2.93 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 3.39 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 1.99 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 1.6 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 1.75 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 0.86 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 1.01 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.29 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 2.42 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 4.2 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.71 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 1.5 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 3.68 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 7.16 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 2.08 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 1.64 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.13 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 1.6 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.457 HG21 HE21 ' A' ' 5' ' ' GLN . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.01 110.134 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 0.74 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.22 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 2.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 2.91 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 2.77 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.52 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.05 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 1.6 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 2.34 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 1.67 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 0.86 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 2.33 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 1.63 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.21 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 1.73 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 3.39 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 1.23 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 0.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 2.08 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 3.35 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 1.2 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.08 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 2.0 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 5.62 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 3.65 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.05 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 2.5 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 2.05 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.15 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 0.85 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 1.81 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.615 HD11 HG12 ' A' ' 114' ' ' VAL . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 1.56 110.006 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.429 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 2.75 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.71 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 2.93 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 1.98 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 1.64 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.04 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 1.07 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 3.6 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 4.87 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 0.83 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 3.2 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 3.41 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 0.87 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 1.94 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 3.88 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.34 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 2.09 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.07 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.43 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.02 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 0.96 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 0.89 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 4.14 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 1.57 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 1.94 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 1.13 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.615 HG12 HD11 ' A' ' 80' ' ' ILE . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 0.51 109.375 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 0.78 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 0.76 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 3.17 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.2 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 3.94 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 2.33 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.41 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 1.45 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.09 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 2.73 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 4.17 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.36 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 0.98 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 3.9 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 1.32 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 4.43 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 4.17 109.845 165.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 1.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 2.96 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.11 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 3.95 105.735 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.27 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.25 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 2.89 111.323 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 5.82 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 2.89 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 2.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.13 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.25 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.18 108.793 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 1.7 107.052 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 2.72 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.17 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.02 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 3.4 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.37 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 2.45 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 1.61 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 1.85 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 3.26 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 1.9 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 6.5 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.19 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 1.59 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 5.45 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 5.35 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 2.83 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 1.78 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 1.53 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 2.52 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.08 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.72 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 1.72 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 2.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 2.9 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 3.25 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.25 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.41 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.57 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 2.27 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 1.95 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 3.16 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.21 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.03 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.0 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.34 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 2.38 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 2.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 1.83 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 2.14 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.2 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 2.9 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 1.43 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 4.23 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.18 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.43 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 5.64 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.01 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 71' ' ' VAL . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 3.79 112.967 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 2.63 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 2.96 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.13 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 1.78 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 2.18 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 114' ' ' VAL . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 1.68 109.59 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.67 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.05 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 2.62 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 3.28 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 2.98 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 3.18 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.73 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 1.84 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.27 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.29 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 1.37 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 4.56 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 4.41 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 0.97 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 5.19 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 2.76 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 1.23 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.36 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.13 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 1.84 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 1.44 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 6.2 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 2.49 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 2.3 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 1.25 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 80' ' ' ILE . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 0.93 109.273 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 1.67 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.89 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 2.71 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 2.88 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 3.5 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.03 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.33 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 141' ' ' LEU . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 1.45 111.522 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 1.9 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 1.67 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 2.64 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 1.33 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 1.09 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 3.23 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 1.58 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.31 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 3.5 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.31 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 1.23 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 3.75 110.732 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 125' ' ' VAL . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 2.8 113.326 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 4.36 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.0 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.23 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 111.881 0.326 . . . . 3.16 111.881 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 6.93 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 2.64 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.17 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 2.25 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 3.58 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 1.85 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 2.48 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 0.98 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 2.07 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 2.85 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.34 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 2.49 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 1.24 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 1.55 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 0.85 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.95 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.13 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 1.87 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 3.16 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 1.67 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.2 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 4.72 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 2.33 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 2.73 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.39 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 1.63 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 1.62 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 0.94 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 1.74 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 1.87 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 2.43 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.37 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 2.56 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 1.65 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.15 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 2.15 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 1.32 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 2.43 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.09 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.05 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 1.85 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.21 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 2.51 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 1.16 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.04 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 1.85 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.01 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 2.23 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.481 HG22 ' CG ' ' A' ' 69' ' ' TYR . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 1.51 111.109 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 5.62 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 2.24 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CG ' HG22 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 10.76 115.883 -169.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 4.93 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.02 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 2.91 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 1.81 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 3.62 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 1.03 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 1.85 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 1.81 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.1 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 2.57 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 1.67 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 2.59 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 1.78 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 2.39 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 1.6 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 1.36 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.38 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 3.95 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 1.03 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 2.88 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 3.9 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 0.97 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 1.8 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 2.65 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.13 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 2.12 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 0.93 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 0.96 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.33 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 1.37 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 5.47 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 1.4 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 1.52 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 0.94 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 0.77 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 0.8 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 0.77 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 2.62 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.11 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.53 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 3.5 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 1.66 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.0 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 1.59 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 2.41 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 1.54 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 4.35 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.5 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 1.96 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.12 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.06 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.08 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 3.16 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 3.39 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 2.19 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 2.81 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 1.47 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 4.42 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 3.61 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 107.201 -1.407 . . . . 2.87 107.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 3.75 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 4.55 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 1.37 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 2.42 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 2.99 109.829 164.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 1.49 110.691 -171.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 1.8 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.05 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.406 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 2.49 116.519 -167.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.15 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.14 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.05 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 1.75 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 15' ' ' MET . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 1.96 112.075 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 1.75 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 4.68 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 1.85 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 3.26 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 0.92 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 1.67 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 4.29 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 5.31 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 2.46 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 2.78 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.36 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 1.71 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 1.65 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.14 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.07 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.01 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 2.75 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.13 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 2.73 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.6 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 2.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 1.18 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 2.8 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 3.34 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 1.9 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.13 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 2.38 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 1.18 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 1.16 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 3.44 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.44 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 4.75 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 1.14 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 3.92 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 1.34 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 5.85 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 4.75 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 3.5 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 2.83 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.15 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 3.54 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 1.23 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 1.83 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 1.54 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.3 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 2.42 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 1.81 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 2.23 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 1.32 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 1.31 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 1.18 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 0.92 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 2.86 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 4.43 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 1.14 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 2.93 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 5.27 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 1.11 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.74 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.37 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 2.17 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 1.35 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.81 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 0.91 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.07 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 0.97 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 3.79 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 1.6 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 1.55 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 1.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 0.79 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 1.48 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 1.44 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 2.5 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 2.39 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 3.57 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 2.51 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 2.98 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 1.38 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 1.82 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 1.44 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 5.09 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 1.22 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 1.02 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 6.17 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 1.76 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 3.19 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 2.19 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 1.42 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 4.39 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 2.17 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 4.72 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 4.65 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 2.94 107.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 3.47 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 2.98 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 1.42 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.1 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 3.87 108.323 161.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 1.84 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.23 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.32 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 3.35 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 4.36 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 3.67 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 1.72 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 1.51 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 1.36 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.1 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 3.13 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 2.53 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.16 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 3.08 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.14 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HG3' HH11 ' A' ' 30' ' ' ARG . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 6.88 112.159 171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 2.39 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.0 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 2.64 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 2.25 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 0.95 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.05 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 2.54 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 3.22 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.3 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 3.13 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.22 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.61 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 2.35 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 1.41 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 2.41 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.04 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.07 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.1 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.7 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 2.51 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 1.24 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 1.58 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 1.8 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.21 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 3.09 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 1.91 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 6.03 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 1.92 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 5.47 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.12 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 3.7 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 3.71 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 2.42 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 3.79 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 1.32 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 2.17 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 1.44 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.33 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.15 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 2.16 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 2.54 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 1.26 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 1.55 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.69 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 0.89 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 2.5 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 4.43 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.05 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 3.47 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 3.89 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.29 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.15 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.11 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 2.38 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 2.46 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.52 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.11 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.04 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 0.98 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 3.35 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 1.51 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 1.52 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 1.56 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 0.65 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 1.29 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 1.34 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 2.65 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 2.64 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 1.93 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.13 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.03 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.24 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 1.5 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.19 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 1.46 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 3.33 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.01 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 1.54 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 3.92 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 2.47 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.7 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 3.36 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 3.06 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 1.39 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 2.89 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.503 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 1.93 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 4.58 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.19 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.54 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.18 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 110.057 -0.349 . . . . 2.47 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 6.78 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 3.75 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 1.31 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 2.71 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 3.35 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 1.74 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.14 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.33 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 2.94 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.15 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 3.35 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.12 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 1.18 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 1.69 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 0.88 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 0.99 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 2.75 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 2.14 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 3.83 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 1.68 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 3.77 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 5.92 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 2.25 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.08 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 2.2 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 1.96 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.13 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 2.16 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 1.83 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 2.78 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.02 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.4 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.43 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 1.32 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 1.85 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 1.43 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 2.75 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 2.48 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 1.8 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 1.84 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 3.0 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 1.72 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 1.35 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 2.12 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 3.84 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 1.05 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 4.36 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.19 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.41 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 5.55 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 3.41 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 3.6 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 2.44 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 2.43 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 4.48 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 1.41 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 1.97 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 1.55 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.68 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 2.91 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 1.73 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 2.97 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 1.3 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 1.47 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 1.31 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 0.85 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.0 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 3.43 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 0.98 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 3.9 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 3.56 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 1.03 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 3.3 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 2.66 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 1.54 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.3 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.18 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.07 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 4.29 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 1.56 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 1.76 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 1.13 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 0.9 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.04 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 1.37 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 3.66 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 3.1 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 4.76 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.32 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 3.76 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 1.73 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.22 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 1.7 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 3.23 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 1.77 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 1.1 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 3.67 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 1.56 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 3.57 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 2.87 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 1.53 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 2.53 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 2.26 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 5.1 108.533 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.19 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.13 107.878 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 4.12 107.313 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 4.95 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.0 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 1.23 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 2.97 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 2.52 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 1.8 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 2.45 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 1.86 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.27 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 4.26 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.24 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.01 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 2.13 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 1.16 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 1.18 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.07 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 2.01 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 2.75 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.78 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 2.07 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.19 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 5.36 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 2.52 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 2.72 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.31 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 1.93 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.17 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 0.81 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.0 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 1.88 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 2.73 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 1.97 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 2.7 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.34 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.27 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 2.02 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 1.29 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 3.28 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.25 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 2.84 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.03 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 1.84 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.09 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 1.84 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.22 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 2.89 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 5.18 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 2.43 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 1.33 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.07 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 1.63 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.51 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.39 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 3.98 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 4.23 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 2.77 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 2.24 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 5.63 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 1.0 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 2.28 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 2.31 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 2.77 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 1.58 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 2.68 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 1.85 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 1.96 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.56 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.09 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 3.84 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.3 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 1.04 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 4.5 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 4.83 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 1.1 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.23 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 2.78 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.4 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.1 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 2.19 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.17 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.52 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.13 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.32 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 1.62 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 5.6 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.25 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.25 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 1.32 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 0.86 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 0.8 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 2.72 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 3.32 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 3.45 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 1.73 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.27 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 1.34 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.06 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 1.52 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 3.8 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 1.68 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 1.13 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 3.75 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 1.63 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 3.06 110.317 174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 2.84 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 1.04 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 3.31 109.341 161.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 1.47 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 3.91 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.574 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.32 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 2.58 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 121.248 0.547 . . . . 4.06 110.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 4.71 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 3.96 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.48 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 3.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 4.87 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 69' ' ' TYR . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 2.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 2.24 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.2 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 2.37 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 2.94 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 3.81 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 2.59 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 1.3 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 1.61 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 1.0 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 0.99 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 3.77 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 2.17 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 2.85 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 0.96 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 1.92 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 4.74 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 4.63 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 2.11 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.19 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.59 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 1.66 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 1.74 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 0.9 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 2.05 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 3.79 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 2.25 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 2.84 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 1.39 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 1.82 110.292 163.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 2.83 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 1.11 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 3.54 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 3.64 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 1.72 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 3.14 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 1.07 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 2.29 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.05 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 2.31 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.444 HG22 ' CE1' ' A' ' 69' ' ' TYR . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 2.01 110.004 174.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 3.9 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 1.36 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.32 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 9.94 112.794 168.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 4.98 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 2.8 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 2.53 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 1.91 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 3.32 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 1.0 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 1.93 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 1.51 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.02 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 2.86 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 2.74 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 1.8 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 1.74 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 1.69 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.3 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.13 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 2.92 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 4.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 1.55 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 3.86 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 3.86 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 1.28 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.45 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 4.68 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.528 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.07 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.528 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 1.87 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.16 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 0.94 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.06 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 1.04 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 3.64 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 1.95 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 1.85 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 1.22 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 0.66 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 0.83 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.83 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 2.66 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 2.41 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 3.67 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 2.26 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.29 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 1.36 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 1.91 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 1.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 2.57 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.0 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 1.4 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.17 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 2.15 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 1.74 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 3.43 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 3.2 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 1.64 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 3.65 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 1.87 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 5.29 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.05 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.24 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.28 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 120.983 0.42 . . . . 3.1 111.291 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 3.85 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 3.3 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.1 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 3.27 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.06 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 1.89 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 2.07 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.05 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 2.13 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 2.95 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.3 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 2.28 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 1.27 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 1.48 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 1.05 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.03 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 2.81 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 2.78 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 3.98 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 0.93 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 1.75 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 3.49 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 3.97 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 2.45 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.35 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 2.09 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 1.97 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 1.12 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 1.83 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 2.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.2 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.27 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 1.6 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 1.52 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 2.21 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 1.48 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 2.78 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 2.02 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 3.25 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.15 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 2.24 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 0.97 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 0.96 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 1.66 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.67 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.77 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 2.08 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 1.07 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.17 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 1.67 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.27 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 4.09 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.11 114.923 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 2.29 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.21 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 4.78 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 1.18 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 2.14 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 114' ' ' VAL . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 1.88 109.009 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.24 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.27 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 2.38 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 2.83 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 1.45 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 1.66 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 1.53 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.02 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 2.7 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 3.52 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 1.11 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 2.99 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 3.38 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 1.81 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 1.95 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 3.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 1.65 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.01 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 1.3 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.44 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.05 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 6.77 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 1.73 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 1.51 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 1.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 0.89 108.608 165.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 1.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 0.89 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 2.25 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 2.39 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 6.15 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 1.84 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.64 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 1.56 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.29 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 1.63 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 4.29 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 1.3 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 0.88 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 2.81 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 2.06 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.09 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 3.25 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 2.64 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.45 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 4.18 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 1.81 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 4.48 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.35 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.755 0.312 . . . . 2.64 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.05 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 2.77 108.843 177.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 0.94 110.812 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 2.66 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 2.8 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 1.62 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 1.79 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.06 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 1.72 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 5.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 5.98 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 4.14 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 1.93 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 1.75 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 1.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 1.09 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.1 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 1.58 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 3.46 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.04 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 1.59 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 5.69 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.11 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 3.32 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 1.74 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 1.56 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 1.6 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.439 ' H ' ' HA ' ' A' ' 50' ' ' TYR . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.38 108.437 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 0.94 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 1.92 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.14 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 3.52 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 2.12 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 2.61 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.6 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 1.41 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 1.69 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 1.1 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 35' ' ' THR . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 3.0 115.568 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 1.92 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 2.31 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.35 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 2.09 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 0.92 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 0.96 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 1.61 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 3.32 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 2.67 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 1.23 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 4.57 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 1.66 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.41 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 4.41 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.07 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 2.67 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 1.79 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 3.65 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 0.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 2.62 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 1.53 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 2.34 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 1.91 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.18 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 1.53 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 1.38 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.33 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 0.82 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 2.88 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 4.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 0.93 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 3.35 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 4.29 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 0.94 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 2.55 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.48 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 1.66 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 1.27 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 1.11 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.14 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.13 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 3.83 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 1.4 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 1.61 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 1.1 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 0.61 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 1.03 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 1.08 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 3.89 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 3.5 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 2.31 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 3.77 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.04 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 3.56 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 1.87 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 2.43 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 1.48 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.04 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 1.6 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.03 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 3.89 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 2.07 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.36 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 2.92 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 2.83 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 1.14 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 2.95 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 1.73 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 4.65 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 3.73 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 2.98 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 121.304 0.573 . . . . 2.55 110.583 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.15 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 2.92 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 1.3 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 3.02 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.08 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 2.42 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 2.68 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 2.4 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.13 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 3.31 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 1.94 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 1.38 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 2.93 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 1.48 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 0.97 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 3.38 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 1.99 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 2.91 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 0.93 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 2.35 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 3.94 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 7.39 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 3.72 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.56 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 2.02 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 1.76 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 0.92 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 2.27 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.01 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 2.3 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 1.87 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.23 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 1.74 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 1.55 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 2.43 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.01 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 2.53 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.77 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 1.61 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 2.66 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.18 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 2.91 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 0.99 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 2.05 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 2.86 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 2.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 1.05 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.0 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 1.26 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.39 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.43 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 3.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 3.27 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 2.49 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 1.68 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 4.09 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 0.83 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 2.06 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 1.99 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.25 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 2.74 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 1.69 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 1.96 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 1.74 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 2.15 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.55 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.31 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 2.48 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 5.14 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 1.53 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 4.63 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 3.54 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 1.38 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.51 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 3.2 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 3.45 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.46 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 2.5 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 1.22 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.5 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 1.2 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.27 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 1.36 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 2.84 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 5.48 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 2.69 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 3.24 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 1.37 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 0.64 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 1.07 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 0.91 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 2.53 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 2.5 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 1.93 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 3.28 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 2.49 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 2.45 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 3.86 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.48 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 1.93 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 3.23 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.44 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 1.58 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 2.96 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 1.84 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 1.77 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 3.26 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 2.85 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 1.71 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 3.67 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 3.31 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 3.98 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.08 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.51 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 109.344 -0.613 . . . . 2.64 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 3.66 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 2.64 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 0.97 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 3.3 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HB3' HD21 ' A' ' 119' ' ' ASN . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.17 110.461 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 1.64 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 2.23 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.3 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 1.88 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.03 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 3.58 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 2.46 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.22 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 1.68 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 0.99 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 1.07 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 3.39 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 1.68 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 4.27 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.81 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 1.54 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 3.39 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 5.33 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 2.37 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 1.77 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 1.67 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 1.64 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 0.71 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 1.81 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.16 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 2.87 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 1.99 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 1.56 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 1.42 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 1.68 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 1.17 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 2.82 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 1.85 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 1.99 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.3 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 2.22 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.26 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 1.45 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 4.19 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 3.14 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 1.07 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 3.98 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 1.35 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.04 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 4.63 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 2.75 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.08 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.01 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 5.28 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 1.32 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 1.79 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 114' ' ' VAL . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.3 107.935 172.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.14 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 2.87 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.03 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 1.79 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 1.73 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 1.65 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.31 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 0.98 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 1.97 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 4.67 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 0.96 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 4.33 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 4.62 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 0.96 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.16 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 2.51 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 1.87 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 2.13 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 1.03 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 0.95 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 0.94 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 0.9 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 3.41 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 5.94 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 2.35 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 2.49 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 0.98 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 80' ' ' ILE . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 0.7 110.215 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 0.97 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.16 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 2.18 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 11' ' ' GLN . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 2.5 110.068 162.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 3.86 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 3.9 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 1.7 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 4.49 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 1.33 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 2.73 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 2.42 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 1.8 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 4.0 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 2.47 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.64 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 2.85 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 2.71 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 1.26 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 3.3 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 1.81 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 4.91 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 147' ' ' SER . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 143' ' ' GLY . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.14 112.457 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 CA--C 1.545 0.78 0 CA-C-O 120.949 0.404 . . . . 3.83 110.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.03 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 2.83 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 1.16 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 2.78 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 4.86 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 2.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.08 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 2.57 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 4.49 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 2.05 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 1.19 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 2.67 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 1.38 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 1.44 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 3.46 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 2.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 2.92 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.25 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 1.55 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 5.36 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 4.74 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 2.27 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 2.34 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 55' ' ' THR . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.24 114.707 168.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 1.85 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.0 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 0.98 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 2.41 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.06 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 2.5 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 1.82 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 2.82 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 1.36 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 1.25 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 1.91 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 1.07 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 2.56 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.11 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.12 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.405 ' HB ' ' HA3' ' A' ' 33' ' ' GLY . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 2.89 112.579 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 1.69 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 3.33 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 1.21 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 1.0 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 1.78 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.24 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 3.08 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 0.97 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 4.99 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 1.55 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 5.55 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 4.12 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 2.96 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 2.51 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 1.86 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 3.36 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 1.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 2.13 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 1.72 111.11 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 1.82 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 2.87 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 2.41 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.45 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 1.52 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 1.75 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 1.53 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 0.83 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 3.27 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 3.54 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 0.94 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 3.75 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 5.66 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.01 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.55 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 3.64 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 2.64 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.3 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 1.67 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.06 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.41 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.06 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.11 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 0.87 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.34 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 6.31 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 1.56 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 1.86 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.15 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 80' ' ' ILE . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 0.83 108.477 167.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.13 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.51 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 3.81 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 3.21 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.14 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 1.91 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.08 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 1.29 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.43 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 1.5 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 2.87 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 1.9 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 1.43 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 3.35 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 1.71 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 3.48 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 3.45 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 1.44 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 3.41 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 1.44 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.02 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.87 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.66 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.31 0.576 . . . . 2.65 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.12 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 3.69 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 4.1 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 1.54 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 2.62 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 1.35 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 2.73 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.42 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.0 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 3.17 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 2.84 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 2.37 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 1.71 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 1.65 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 1.43 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 1.41 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 3.61 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 1.94 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 2.91 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.92 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 1.44 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 3.82 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 4.82 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 2.54 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 1.99 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.24 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 1.53 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 3.08 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 0.93 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 3.24 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.51 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 3.19 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.27 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.09 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 1.47 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 1.73 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 2.09 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 1.12 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 3.06 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 2.3 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 1.76 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 1.49 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 2.93 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.08 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 1.08 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 2.06 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.17 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 2.7 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 1.17 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 4.5 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 1.4 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.63 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 3.41 110.287 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 2.96 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 2.88 114.083 -171.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 2.83 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 3.95 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 0.88 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 2.18 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 1.53 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 3.96 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 2.8 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 2.45 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 1.42 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 1.77 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 1.44 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 0.85 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 4.81 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.13 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 1.07 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 3.77 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 3.87 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 1.03 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 1.79 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 3.53 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.545 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 2.83 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 1.2 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.44 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.96 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 0.85 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 3.72 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.44 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 1.5 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 1.06 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 0.63 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 0.94 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 0.79 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.62 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 2.88 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 4.31 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.38 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 2.78 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 1.35 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 1.8 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 1.63 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 3.55 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.44 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 0.9 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.12 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 1.35 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 3.03 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 3.44 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 1.2 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 2.58 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 1.89 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.11 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.44 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 2.7 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 3.73 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 121.58 0.705 . . . . 2.76 109.474 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 4.32 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 57' ' ' THR . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 2.49 107.23 161.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 0.95 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 2.14 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 2.8 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 1.67 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 2.72 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.4 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 2.87 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.3 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 4.92 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 2.55 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 1.5 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 3.29 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 1.19 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.23 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 3.33 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 2.43 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 3.77 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 2.31 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 3.96 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 3.91 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 3.73 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 1.78 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 1.62 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.22 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.21 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.09 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.36 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 41' ' ' LEU . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 2.31 111.113 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 2.92 113.324 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 2.86 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 2.56 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 1.66 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 2.11 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 2.32 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 1.23 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 2.3 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 1.99 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.42 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 1.69 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 103' ' ' ALA . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 2.75 112.466 -173.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 1.38 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 1.26 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 2.17 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 2.24 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 1.21 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 4.37 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 1.85 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.45 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 5.77 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 5.25 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.08 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 2.6 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 2.17 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.16 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 0.95 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 2.22 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 1.68 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.1 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 3.33 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 1.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 1.97 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 1.37 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 1.4 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.28 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 0.88 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 2.3 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 3.9 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 0.93 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 3.88 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 3.63 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 1.67 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 4.64 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.0 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.02 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' THR . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.0 111.067 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.83 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.31 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.25 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 0.94 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 3.79 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 2.11 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 2.47 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 0.96 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 0.74 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 1.22 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 0.88 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 2.66 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 2.56 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.62 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 4.97 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 1.75 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 3.51 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 1.32 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 1.84 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 1.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 5.55 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 1.24 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 0.89 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 3.3 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 1.5 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 3.02 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 2.53 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 1.12 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 2.96 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 1.45 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 4.35 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 3.41 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.321 -0.622 . . . . 2.63 109.321 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 3.73 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 2.54 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 1.85 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 3.78 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.07 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 3.23 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.45 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 1.85 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.68 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 3.58 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.12 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.03 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 1.83 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 2.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 0.95 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 1.6 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 3.31 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 2.07 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 4.13 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.21 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 2.48 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 4.65 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 4.43 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 3.58 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 2.86 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 1.87 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 1.54 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 1.77 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.12 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.32 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 2.16 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 2.6 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.29 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 3.57 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.15 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 2.3 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 1.98 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 2.32 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 1.11 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 2.76 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.55 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 2.08 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 2.1 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.05 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 2.34 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 1.26 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 1.39 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 2.71 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.26 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 1.98 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 69' ' ' TYR . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 1.38 110.584 172.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.0 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 1.56 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 10.5 113.408 -177.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 4.47 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 4.63 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 4.18 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 2.84 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.12 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 1.02 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 2.06 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.42 HD11 ' CG1' ' A' ' 114' ' ' VAL . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 1.87 108.474 175.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 1.89 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 2.82 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 1.84 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 1.98 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 1.63 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 1.67 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 1.68 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 1.22 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 2.65 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 4.62 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 1.31 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 3.95 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 4.52 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 0.96 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.08 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 2.78 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.554 ' H ' HG21 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 2.45 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.04 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.47 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 1.7 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.19 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 1.5 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 3.91 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 1.67 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 1.68 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.34 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 0.95 108.913 168.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 1.28 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 0.86 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 2.63 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 3.27 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 6.63 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 1.72 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 3.82 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 1.9 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 2.19 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 2.14 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 2.92 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 1.69 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.01 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 2.84 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 1.57 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.55 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 3.2 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 2.59 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 1.47 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 3.74 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 144' ' ' GLU . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 1.71 111.97 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 4.48 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 141' ' ' LEU . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 2.88 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 2.72 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 3.9 110.726 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 6.33 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 2.5 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 1.14 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 3.12 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 2.67 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 1.43 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 1.83 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 2.44 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 4.78 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 4.08 115.404 165.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 2.26 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 1.5 113.317 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 1.59 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 0.91 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 0.95 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 5.25 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 2.53 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 3.81 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 2.49 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 4.35 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 4.68 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 2.44 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 2.65 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.33 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 1.75 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 1.84 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.13 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 1.87 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.89 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 2.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.02 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.42 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 1.77 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 1.83 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 1.95 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.02 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 2.36 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 2.37 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 2.19 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 1.6 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 2.67 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 1.15 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 0.93 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 2.29 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 2.95 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 1.04 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 4.25 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 67' ' ' LEU . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 1.77 113.429 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.22 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 3.83 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 2.59 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 2.25 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 2.35 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 3.32 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 1.27 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 2.05 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.446 HD11 HG12 ' A' ' 114' ' ' VAL . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 2.75 109.579 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.19 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 2.47 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.13 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.27 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 1.44 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 1.34 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 1.29 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 1.13 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.09 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 3.92 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 1.73 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.03 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 3.68 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 0.99 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.52 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 5.32 111.767 163.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.727 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.02 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 1.15 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.67 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.03 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.87 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 1.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 3.98 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.489 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 6.01 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.13 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 1.53 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 1.19 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 80' ' ' ILE . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 0.64 108.406 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 0.83 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 0.85 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 2.77 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 2.45 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 3.37 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.23 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.15 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 1.41 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 2.27 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 2.1 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 2.8 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 1.39 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 137' ' ' TYR . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 1.38 113.51 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 3.4 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 1.57 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' A' ' 132' ' ' VAL . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.63 111.576 175.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 2.58 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 1.52 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 2.58 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 1.84 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 5.57 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.2 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 107.904 -1.147 . . . . 3.63 107.904 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 4.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 2.24 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.05 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 2.88 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 6.09 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 1.54 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 1.91 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.36 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 1.99 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 3.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 3.61 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 2.74 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 2.18 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.02 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 1.07 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 1.83 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 5.82 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 2.03 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 5.69 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.42 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 1.52 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 3.5 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 4.52 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 2.67 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 1.71 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 2.51 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.18 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 2.88 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 2.83 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 3.46 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 3.03 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 3.59 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.23 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 1.82 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 1.03 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 3.48 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.34 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 2.09 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.87 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 2.99 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 1.58 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 1.63 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 2.11 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 2.59 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 2.83 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 1.45 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 6.79 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 2.35 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.51 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.2 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 5.36 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 2.88 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.11 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 2.61 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 3.74 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 1.21 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 1.7 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.14 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.18 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 2.49 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 1.92 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 1.93 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 1.57 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 1.68 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 1.41 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.02 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 2.42 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 4.98 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 0.97 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.24 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 3.86 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 0.97 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.62 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 2.79 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.12 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.45 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 2.41 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 1.43 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.46 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 1.06 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.11 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.05 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 4.26 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 1.92 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 1.88 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 1.25 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 0.61 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.11 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.02 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 2.64 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 3.75 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 3.77 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.17 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.31 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 1.32 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 1.87 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 1.96 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 3.25 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 1.62 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 1.16 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 2.74 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 1.48 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.55 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 2.9 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 2.46 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 1.47 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.04 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.463 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 1.39 112.225 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 4.56 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.45 110.651 155.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.01 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.638 -0.875 . . . . 2.31 108.638 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 3.54 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 3.13 108.52 164.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 1.23 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 2.21 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 2.8 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 1.48 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 2.35 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.04 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 3.5 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.07 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 2.15 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 1.23 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 1.52 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 0.97 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 0.91 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 4.57 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 2.42 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 2.81 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 0.85 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 2.73 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 3.89 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.1 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 2.16 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.54 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 2.08 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 2.26 110.95 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 0.93 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 2.84 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 2.91 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 2.25 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 3.76 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.57 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 1.63 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 1.92 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 1.17 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 2.95 115.988 -157.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.65 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 1.7 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 2.73 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.49 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 3.06 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 1.53 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 1.84 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 3.85 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.24 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 2.08 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 1.22 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.0 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 1.43 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.13 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 4.15 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 2.5 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 2.73 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.08 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.08 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 0.87 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 2.22 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.42 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 3.49 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 1.91 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 1.99 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 1.48 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 1.45 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 1.12 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.02 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.25 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.29 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 1.21 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 3.86 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 4.48 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 1.79 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.65 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 2.89 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.57 ' H ' HG22 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.51 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 1.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 0.99 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.81 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.26 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.3 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 1.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 3.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 1.49 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 1.54 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 1.26 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 0.94 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 1.43 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 0.93 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 2.56 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 2.46 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.02 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 2.17 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 2.73 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 1.4 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 1.91 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 1.57 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 3.67 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 1.42 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 1.04 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 2.73 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.24 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 3.41 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 5.55 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 1.31 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 3.37 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 HE21 ' A' ' 145' ' ' GLN . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 2.13 111.131 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 4.49 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.41 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.404 HE21 HD13 ' A' ' 141' ' ' LEU . 36.3 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.22 112.053 174.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.46 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.864 0.364 . . . . 2.84 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 3.86 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 2.74 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 1.18 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 2.28 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 3.32 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 1.66 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 2.36 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 2.78 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 3.83 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 3.85 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 2.65 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 1.72 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 2.81 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 1.16 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 1.46 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 2.77 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 1.62 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 2.98 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.74 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 1.66 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 3.29 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 4.97 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 2.1 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.58 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 1.86 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 1.65 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 0.72 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 1.75 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.12 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 2.19 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 1.91 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 2.29 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.68 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 1.36 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 1.76 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 0.86 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 3.12 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 2.27 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 2.23 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.31 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 3.52 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 1.48 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 1.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 2.34 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 2.54 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 1.28 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 3.93 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.16 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 1.89 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.41 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 3.63 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 2.39 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 3.17 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.16 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 3.57 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 1.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 1.88 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 114' ' ' VAL . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 1.64 110.34 176.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.8 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 2.3 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 2.19 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.02 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 1.76 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 1.94 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 1.82 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.13 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.03 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.08 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 1.1 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 5.37 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.06 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 1.13 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 1.8 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 3.43 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.442 ' H ' ' HB ' ' A' ' 102' ' ' VAL 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.49 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 99' ' ' ILE . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 2.47 108.861 157.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 1.4 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 0.95 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.17 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 1.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 4.01 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.05 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 2.07 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 1.39 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 0.76 109.768 170.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 1.15 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 1.04 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 2.78 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 2.72 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.22 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 1.77 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.03 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 1.35 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 1.85 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 2.1 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 3.05 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 1.37 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 1.13 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 2.61 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.31 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 1.67 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 3.01 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 2.93 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 1.37 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 3.3 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 1.77 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 3.81 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.39 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.445 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 2.9 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.74 113.738 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.2 110.615 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 2.54 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.435 ' H ' ' HA2' ' A' ' 101' ' ' GLY . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.03 111.056 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 2.68 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 4.13 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.32 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 2.25 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.58 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 3.14 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 4.93 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.35 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 1.98 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 1.64 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 1.45 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 1.0 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 1.21 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.04 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 1.93 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 4.26 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.74 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 2.11 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 4.57 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.3 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 2.55 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.36 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.46 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 1.9 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 1.86 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.75 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.31 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 2.25 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.62 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 2.55 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 2.49 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.31 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 1.5 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.13 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 2.28 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 1.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 2.46 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 2.34 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 1.9 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.31 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 2.38 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 1.06 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 1.14 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 1.91 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 2.37 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 1.97 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 3.77 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 1.81 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 5.56 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 3.3 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 2.43 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 2.63 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 2.19 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 3.42 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 1.16 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 2.18 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 2.43 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.2 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 2.39 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.19 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 3.63 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 1.43 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 1.58 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 1.52 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.06 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 2.68 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 3.96 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 1.43 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 4.06 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 3.72 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 1.28 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.53 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 3.32 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 9' ' ' ALA . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 1.73 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 1.46 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.66 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.15 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.29 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 0.99 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 3.48 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 1.76 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 2.03 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 1.16 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 0.63 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 0.8 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 0.94 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 2.22 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.62 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 4.47 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 1.7 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.53 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 1.45 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.13 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 1.57 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.22 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 1.73 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 137' ' ' TYR . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 2.02 113.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 4.65 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 2.37 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.63 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 132' ' ' VAL . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.07 112.398 -177.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 2.73 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 1.06 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 2.51 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 1.41 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 4.62 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.53 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 2.61 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.202 0.525 . . . . 3.49 111.7 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 4.48 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 2.69 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 1.22 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 2.79 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.19 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.02 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 1.97 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 2.84 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 3.83 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 3.85 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 2.49 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 1.66 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 1.72 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 1.4 111.602 175.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.13 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 3.43 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 1.69 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 4.35 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.01 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 1.89 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.34 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 5.76 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.34 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.19 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.38 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 2.41 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.26 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 0.96 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 21' ' ' ALA . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 1.58 111.157 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.1 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 2.74 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.06 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.09 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 1.58 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.17 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 1.7 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 1.43 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 3.5 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.13 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.03 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 1.8 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.25 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 3.22 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 0.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 1.48 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 1.87 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.09 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 1.64 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 4.53 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 1.85 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.01 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 5.69 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 3.43 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 2.9 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 1.84 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 5.85 111.751 163.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 1.88 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 2.44 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 1.92 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 2.3 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 1.93 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 1.9 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 1.55 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.19 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 1.53 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 1.25 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.51 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 3.73 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 1.07 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 3.31 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 4.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 1.04 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.44 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 3.36 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.12 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 4.82 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.54 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 1.95 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 1.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 1.43 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.45 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 1.37 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 3.06 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 3.77 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 1.87 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 2.11 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 1.3 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 0.98 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 1.23 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 1.39 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 2.91 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 2.65 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 2.53 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 3.24 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 2.85 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.16 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 1.98 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 3.32 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 1.53 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 1.15 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 2.92 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 1.85 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 2.65 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 2.28 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 1.73 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 2.44 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 1.45 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 4.97 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.0 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 105.58 -2.008 . . . . 3.47 105.58 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 3.79 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 2.95 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 1.36 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 2.21 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 3.72 108.299 158.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 1.66 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 2.37 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.42 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 1.82 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.08 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 3.66 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 2.11 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 1.65 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 1.8 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 1.2 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.63 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 4.97 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 1.57 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 2.96 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.15 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 1.56 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 3.86 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 6.35 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 2.82 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.55 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.33 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 1.71 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 1.62 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 1.62 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 1.87 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.03 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 2.94 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.03 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.14 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.59 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 1.68 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 1.7 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 1.18 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 2.7 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.26 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 2.04 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 2.95 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 1.7 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 1.76 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 2.36 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.15 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 2.34 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 1.49 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 4.26 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 1.82 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.5 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 11.87 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.22 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 4.23 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 3.87 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 2.2 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 3.37 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 0.88 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 1.95 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 1.62 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 2.54 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 1.66 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 3.14 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 1.32 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 1.88 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 1.67 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 1.26 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.0 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 4.55 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 2.1 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.0 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 4.42 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 1.22 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.42 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 3.19 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 1.91 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 1.17 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.04 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.2 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 1.3 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 3.48 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 1.45 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 1.96 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 1.25 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 0.82 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 1.36 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 0.98 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 2.52 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 2.43 110.414 176.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.58 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 4.79 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.08 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.43 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 1.46 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 3.13 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 2.75 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.12 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.32 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 1.02 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 2.81 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 1.69 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 2.85 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 2.64 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 1.13 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 2.76 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 1.56 111.759 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 4.18 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.47 112.639 164.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.13 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.4 106.69 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 3.58 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 2.98 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 0.98 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 3.42 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.16 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 1.38 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.69 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.11 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 3.1 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 2.62 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.1 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 1.97 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 1.49 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 1.51 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 0.98 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.48 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 2.95 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 1.77 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 3.17 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.86 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 1.65 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 4.16 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 4.54 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 4.28 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.08 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 2.15 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 2.98 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 0.76 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 2.3 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 1.85 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 2.98 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 1.98 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 2.54 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.39 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.11 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 1.65 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 0.88 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 2.6 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 1.89 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 1.81 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.2 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 2.81 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 1.21 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 1.38 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 1.8 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.24 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 2.57 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 1.5 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 4.28 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 1.69 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.52 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 5.96 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 4.13 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 3.17 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 3.08 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 1.87 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 3.62 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 0.97 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 1.88 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 114' ' ' VAL . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.0 111.329 -156.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 5.14 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 3.06 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 1.93 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 1.2 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 1.29 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.14 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 0.78 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.41 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 4.33 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 1.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 2.88 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 3.51 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 1.32 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.71 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 3.58 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 2.25 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 1.18 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.3 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.48 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 1.11 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 6.77 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 2.71 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 2.69 112.836 173.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 0.89 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 80' ' ' ILE . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 0.67 108.093 155.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 1.2 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 1.04 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 2.6 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 3.53 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 5.29 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.15 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 2.92 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 1.37 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 2.48 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 1.62 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 4.15 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 1.61 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 1.22 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 3.51 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 2.42 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 3.24 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 2.7 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 1.23 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.01 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 1.61 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 3.9 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 2.81 113.405 172.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.239 -0.886 . . . . 10.44 110.115 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 pp -109.32 174.14 6.0 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.597 1.559 . . . . 9.06 113.124 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m 134.62 155.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 1 C-N-CA 133.826 4.85 . . . . 6.67 106.279 -168.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.27 97.0 1.61 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.916 1.689 . . . . 5.44 111.427 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -93.46 115.74 28.27 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.258 0.551 . . . . 2.95 109.788 -172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.94 147.85 25.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.9 1.68 . . . . 3.44 110.549 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -94.15 168.42 10.94 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.418 1.487 . . . . 3.12 112.869 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.12 147.39 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.342 2.257 . . . . 2.44 109.235 165.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.45 146.29 33.36 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.184 1.394 . . . . 1.4 109.577 162.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 52.8 ttm -157.04 168.23 28.1 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.836 2.054 . . . . 2.52 109.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.36 135.37 35.28 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.196 1.816 . . . . 4.15 112.68 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.29 136.18 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 124.706 1.202 . . . . 1.75 112.09 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -102.7 141.11 36.06 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.768 0.827 . . . . 2.05 112.907 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.9 -3.61 7.96 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.338 1.923 . . . . 1.09 114.317 -176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 75.6 mtm -84.19 65.33 8.74 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.085 1.442 . . . . 1.86 113.188 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.07 8.46 17.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.631 0.974 . . . . 3.79 113.631 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.5 t -149.11 152.29 35.89 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.649 1.58 . . . . 4.24 110.318 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.8 -28.94 52.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.368 1.067 . . . . 2.66 113.197 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.19 -28.94 69.74 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.921 0.712 . . . . 1.53 112.921 176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.63 -47.86 68.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.983 0.913 . . . . 1.6 110.89 175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.2 -50.52 73.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 1.04 110.907 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.09 -52.91 30.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.417 1.087 . . . . 1.72 111.572 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -63.07 -22.33 66.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.648 1.722 . . . . 5.97 115.648 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.2 mt -73.02 -49.82 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.627 1.558 . . . . 2.08 110.65 168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -64.88 -48.47 74.12 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 122.247 1.022 . . . . 1.6 110.39 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -66.51 -20.0 65.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.417 1.887 . . . . 4.04 113.678 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.74 -50.59 3.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.182 1.372 . . . . 1.16 112.011 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.48 -42.06 96.11 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.809 0.843 . . . . 1.61 111.84 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -56.96 -12.74 2.17 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.324 1.231 . . . . 5.22 114.324 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -82.8 -16.83 46.28 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.534 1.309 . . . . 4.18 114.534 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.5 133.75 82.63 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 121.547 1.976 . . . . 2.7 110.038 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.35 -25.99 63.77 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.197 1.932 . . . . 2.01 114.081 -168.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.39 -9.4 72.76 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.717 -1.046 . . . . 1.46 114.3 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.5 t -90.48 142.27 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.904 1.852 . . . . 2.04 109.076 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.3 t -105.86 -46.7 4.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.037 -0.982 . . . . 1.84 110.783 166.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -143.98 154.19 43.03 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.499 0.925 . . . . 3.73 113.499 -164.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.51 145.14 24.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.169 1.388 . . . . 0.94 110.877 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -140.39 126.82 20.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.573 1.949 . . . . 1.82 107.8 172.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.56 126.41 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 120.48 1.491 . . . . 1.97 110.762 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.35 110.11 17.2 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.094 0.474 . . . . 3.23 110.135 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.6 tp -52.32 144.52 12.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.837 1.255 . . . . 2.7 110.746 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.79 -41.75 0.49 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.523 2.329 . . . . 4.62 114.406 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 m -73.97 -32.05 63.28 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.131 1.772 . . . . 3.09 112.145 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 90.98 0.27 0.17 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 129.224 3.009 . . . . 3.02 114.515 166.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -89.73 118.35 29.27 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.685 1.194 . . . . 1.3 109.953 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.0 t -103.3 132.86 49.22 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.787 2.035 . . . . 1.41 110.936 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -129.51 112.23 13.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.582 1.553 . . . . 1.47 107.959 -167.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.63 141.9 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.434 0.694 . . . . 1.71 111.028 -158.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -134.45 125.82 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.223 1.409 . . . . 1.17 111.918 -172.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -150.95 154.64 37.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.83 2.052 . . . . 2.91 115.433 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.31 109.76 12.58 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.717 2.007 . . . . 2.85 109.826 162.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.87 14.99 1.18 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.919 3.08 . . . . 2.26 113.902 -171.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.71 -22.05 24.85 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.206 -0.934 . . . . 1.92 112.216 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -130.45 -20.84 2.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.217 1.407 . . . . 4.25 112.278 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.5 m -146.92 106.63 3.95 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.036 -1.665 . . . . 2.32 109.507 171.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.3 177.31 27.28 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.274 1.416 . . . . 1.54 113.553 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -54.25 -44.66 71.99 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.399 1.629 . . . . 2.43 115.399 -162.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.96 71.99 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.04 0.837 . . . . 1.17 112.615 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.12 -26.89 68.4 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.285 -0.885 . . . . 1.07 112.409 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.45 -46.43 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.409 1.004 . . . . 2.05 110.335 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -64.41 -38.54 91.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.744 0.702 . . . . 2.41 110.778 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.1 -40.35 82.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.252 0.478 . . . . 2.68 111.654 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -32.08 73.28 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 120.352 -1.468 . . . . 2.46 112.275 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.91 -48.36 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.096 . . . . 0.95 110.953 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -54.98 -39.1 68.65 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.741 0.816 . . . . 2.85 112.284 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.64 -9.28 2.53 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.277 1.584 . . . . 5.11 115.277 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.32 -17.34 46.09 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.655 1.57 . . . . 1.36 113.437 169.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.4 29.92 8.05 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 119.463 1.029 . . . . 1.52 113.851 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -95.56 -166.51 1.46 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.24 1.416 . . . . 5.21 111.762 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -126.59 115.27 19.24 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.466 -0.771 . . . . 3.75 109.65 156.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -71.05 115.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.512 -0.921 . . . . 2.68 108.512 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.66 77.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-O 122.511 1.148 . . . . 2.66 110.845 -158.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 p -119.07 156.88 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.311 -1.768 . . . . 1.77 110.992 -163.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.26 153.41 42.76 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.178 1.791 . . . . 3.79 107.168 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -127.88 153.24 46.87 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.388 -0.82 . . . . 4.07 112.916 167.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.91 165.34 29.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.892 1.677 . . . . 1.4 110.244 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.98 143.1 37.12 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.944 0.898 . . . . 2.05 110.822 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -128.02 145.29 51.03 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.498 1.519 . . . . 1.86 110.301 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -112.3 126.66 55.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.716 2.007 . . . . 2.45 112.381 -171.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.3 mm -125.0 67.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.61 1.164 . . . . 1.79 112.739 -154.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CB ' ' HE2' ' A' ' 138' ' ' LYS . 35.9 tt0 -63.59 120.7 12.25 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.82 -1.175 . . . . 3.6 110.84 172.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.06 -20.43 11.49 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.875 1.702 . . . . 1.82 112.499 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.98 124.91 25.93 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.864 -1.161 . . . . 3.21 107.864 159.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.8 p -130.29 -7.15 4.28 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.9 1.444 . . . . 2.43 114.9 -175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -172.12 166.95 6.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.788 1.635 . . . . 2.38 110.772 -168.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.05 -39.87 72.68 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.977 1.103 . . . . 1.98 113.977 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.73 74.52 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.681 0.673 . . . . 1.88 112.764 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 8.8 m -69.99 -44.85 68.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.406 1.482 . . . . 1.53 111.2 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.79 -55.39 32.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.083 0.553 . . . . 1.23 110.145 169.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.4 -37.27 64.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.678 0.791 . . . . 2.08 112.997 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -57.4 -49.18 77.03 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 120.056 1.298 . . . . 4.3 113.848 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.7 -33.98 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.765 1.166 . . . . 1.19 112.707 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -54.1 -46.18 72.04 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.06 1.344 . . . . 2.26 110.656 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -68.15 11.71 0.15 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 115.268 1.581 . . . . 3.37 115.268 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -119.92 -52.31 2.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.284 1.033 . . . . 5.14 111.449 151.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -51.64 -36.92 48.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.271 1.829 . . . . 1.26 113.997 -176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -46.78 -38.88 10.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.458 1.503 . . . . 1.84 113.675 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -143.29 -17.02 0.65 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.853 1.427 . . . . 3.39 114.853 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 31.2 mt 34.09 -110.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 127.574 2.35 . . . . 2.31 111.044 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -144.89 65.37 1.27 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.636 1.974 . . . . 4.04 106.121 173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 134.82 5.6 2.45 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 117.565 1.786 . . . . 1.92 117.565 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.3 t -97.56 137.55 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 119.266 1.533 . . . . 1.99 107.771 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.71 20.41 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.088 0.955 . . . . 1.51 111.88 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -164.73 145.11 7.54 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.621 1.168 . . . . 3.38 112.941 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.65 107.58 2.9 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.251 1.021 . . . . 1.33 111.802 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -91.73 125.62 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.321 3.347 . . . . 1.29 110.139 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.86 133.31 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-O 121.053 0.454 . . . . 1.39 110.571 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -79.06 137.12 37.39 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.152 0.797 . . . . 2.73 113.152 -176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -98.04 2.05 48.4 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.05 1.5 . . . . 4.15 115.05 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.25 -33.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.505 0.928 . . . . 1.88 113.505 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.51 -1.21 57.42 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.282 1.433 . . . . 1.95 112.49 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 57.39 36.91 27.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.198 1.399 . . . . 2.62 112.855 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.37 162.2 35.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.144 1.778 . . . . 0.92 109.357 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -141.04 137.31 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.02 0.928 . . . . 0.76 109.764 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -87.79 119.72 28.4 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 106.956 -1.498 . . . . 1.1 106.956 170.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.4 t -114.09 119.85 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.07 0.948 . . . . 1.18 108.812 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -111.74 121.56 45.43 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.599 1.56 . . . . 2.64 109.596 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -149.37 170.86 17.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.497 1.119 . . . . 2.77 113.797 -162.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -99.85 113.35 65.07 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.016 0.926 . . . . 2.77 110.841 171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.57 63.21 7.26 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.35 3.367 . . . . 2.61 111.085 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -135.73 -41.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.76 1.392 . . . . 3.45 114.76 -167.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -135.29 -0.61 2.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 116.489 2.033 . . . . 3.81 116.489 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -142.34 175.14 10.0 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.022 1.283 . . . . 2.44 110.26 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.2 t -156.69 -171.29 3.62 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.732 1.151 . . . . 2.85 114.045 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.09 -27.9 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 126.349 1.86 . . . . 1.6 112.847 -168.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -59.14 -46.23 88.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.74 0.816 . . . . 2.24 112.524 170.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -70.88 -36.12 72.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.842 0.857 . . . . 3.13 111.219 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.01 -47.87 81.22 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.902 0.881 . . . . 1.65 110.539 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -52.21 -57.5 9.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.671 0.788 . . . . 3.59 110.568 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.03 -30.15 70.76 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.493 0.923 . . . . 2.4 113.493 -176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.8 -32.26 71.86 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.175 0.805 . . . . 1.42 113.175 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.5 t -87.25 -35.24 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.933 1.293 . . . . 1.22 112.592 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.48 -35.78 68.34 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.146 1.778 . . . . 2.76 111.978 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -59.59 -34.15 72.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.961 1.705 . . . . 2.97 113.216 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.93 -26.87 23.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.556 1.143 . . . . 1.45 112.209 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.85 35.68 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.87 1.224 . . . . 1.37 115.996 172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 -84.75 -154.21 0.17 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.372 1.586 . . . . 2.78 109.072 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.98 169.73 17.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 119.934 -1.729 . . . . 4.09 109.794 169.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.1 mt -120.14 129.99 54.4 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.059 0.944 . . . . 1.72 108.953 169.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.41 ' HE3' ' CB ' ' A' ' 146' ' ' ASP . 29.4 mmmt -121.03 151.32 39.92 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.544 -0.91 . . . . 4.34 108.544 158.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.07 137.3 42.22 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.9 -1.125 . . . . 2.69 109.61 -168.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -80.69 101.24 9.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.386 -0.968 . . . . 5.03 108.386 -162.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.47 -47.37 3.61 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.085 -1.397 . . . . 1.68 112.474 -159.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.299 1.4 tt0 -81.87 -5.96 58.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 116.233 1.938 . . . . 3.39 116.233 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.92 96.64 0.73 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.076 0.95 . . . . 3.3 108.771 164.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' CB ' ' HE3' ' A' ' 140' ' ' LYS . 6.2 t70 81.48 -32.25 0.1 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.684 1.994 . . . . 4.32 113.015 167.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.247 0.953 0 C-N-CA 128.422 2.689 . . . . 4.82 114.462 174.598 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.054 -0.721 . . . . 12.85 109.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -91.13 169.5 10.8 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.779 0.718 . . . . 9.14 111.088 163.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.1 p 169.81 112.81 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 128.75 2.82 . . . . 5.4 107.755 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -175.44 93.09 0.06 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.428 1.891 . . . . 4.82 110.703 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.457 HE21 HG21 ' A' ' 35' ' ' THR . 7.8 mt-30 -70.28 121.83 18.37 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.516 -0.74 . . . . 2.67 110.89 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -134.06 162.87 30.89 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.768 1.627 . . . . 3.95 112.132 -171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -95.12 165.91 12.18 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.064 1.505 . . . . 2.93 115.064 -160.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tp -153.33 146.04 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 127.632 2.373 . . . . 2.59 108.83 154.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.46 141.22 46.47 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.896 1.278 . . . . 1.17 108.482 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.9 mtt -153.29 162.67 41.04 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.378 1.071 . . . . 2.46 112.488 -164.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.14 161.81 37.23 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.605 1.562 . . . . 3.14 110.666 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 p -165.38 145.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.635 1.574 . . . . 2.08 110.084 -162.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -84.01 126.52 33.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.232 1.013 . . . . 3.48 110.914 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.29 19.33 8.5 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 116.476 1.35 . . . . 1.2 116.476 166.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.3 mtm -77.25 55.75 1.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 120.186 1.993 . . . . 2.93 112.704 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.3 p -90.43 12.82 17.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.674 1.59 . . . . 3.39 113.327 -173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.8 t -161.87 144.93 11.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.89 1.676 . . . . 3.4 110.364 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.58 -23.18 10.08 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.202 1.186 . . . . 1.99 114.202 172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.38 -25.13 65.81 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.704 -1.247 . . . . 1.6 113.234 173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.4 m -66.05 -49.57 67.19 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.997 0.919 . . . . 1.75 109.933 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.1 -56.05 14.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.9 1.28 . . . . 0.86 111.62 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.27 71.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.568 0.747 . . . . 1.01 112.765 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -43.36 95.44 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.391 1.077 . . . . 3.29 112.672 176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.5 mt -66.1 -50.5 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.205 0.911 . . . . 2.42 110.22 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.06 -50.84 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.992 0.517 . . . . 1.3 111.39 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -34.12 77.44 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.727 -1.233 . . . . 4.2 112.857 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.62 -38.71 96.03 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.459 1.028 . . . . 0.71 114.07 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.51 -43.42 12.76 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.017 1.409 . . . . 1.5 112.82 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -53.9 -19.75 4.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.837 1.255 . . . . 3.68 113.848 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -81.65 -16.44 51.38 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.268 1.581 . . . . 7.16 115.268 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 14.5 mtp -72.5 131.89 84.21 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 121.343 1.883 . . . . 2.08 110.092 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.33 -24.73 79.18 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.445 2.096 . . . . 1.64 113.522 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.03 78.78 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 117.893 -1.504 . . . . 1.13 115.19 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -105.56 125.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 120.484 2.142 . . . . 1.6 108.398 -175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.457 HG21 HE21 ' A' ' 5' ' ' GLN . 3.7 t -87.14 -48.03 8.39 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 118.545 -0.74 . . . . 2.01 110.134 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -145.26 144.56 30.86 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.73 0.644 . . . . 3.29 111.492 -168.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.04 128.36 22.61 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.721 1.208 . . . . 0.74 107.833 166.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -139.5 124.22 18.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.521 1.129 . . . . 2.22 108.546 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.71 128.06 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.506 1.048 . . . . 2.12 110.85 172.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -94.74 78.13 3.71 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.668 1.187 . . . . 2.91 108.356 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.62 -29.13 69.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.784 0.833 . . . . 2.77 112.038 -167.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -18.43 10.59 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 115.26 1.578 . . . . 2.52 115.26 169.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -124.77 20.48 8.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.738 1.615 . . . . 3.05 111.852 168.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 55.35 19.38 3.01 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 127.826 2.45 . . . . 3.64 114.739 173.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.5 m -116.8 130.26 56.61 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.843 -1.161 . . . . 1.6 110.968 -168.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.3 m -94.19 133.3 37.84 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.274 1.03 . . . . 2.34 111.062 174.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -118.14 123.0 44.47 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.791 1.236 . . . . 1.31 108.364 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.08 140.91 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.365 0.666 . . . . 1.67 109.821 -173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.14 126.64 56.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.064 1.346 . . . . 0.86 109.387 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -146.11 157.39 43.84 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.626 1.97 . . . . 2.33 112.716 -169.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.32 125.92 54.56 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.8 1.24 . . . . 3.2 110.537 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.02 26.63 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.528 3.485 . . . . 1.69 114.501 -164.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -117.48 -55.48 2.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.092 0.957 . . . . 1.63 111.656 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -68.0 -18.97 64.87 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.509 1.123 . . . . 4.41 112.676 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -157.2 175.43 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.729 1.212 . . . . 2.21 112.14 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.1 164.12 30.37 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.289 1.9 . . . . 1.73 111.659 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -47.61 -49.0 28.2 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.448 1.099 . . . . 3.39 113.073 -168.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.09 -14.94 27.57 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 115.564 1.69 . . . . 1.23 115.564 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.14 -19.03 58.85 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.11 0.964 . . . . 0.99 113.082 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.26 -49.9 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.34 1.456 . . . . 2.08 111.011 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -64.38 -28.51 69.74 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.34 0.973 . . . . 2.88 112.448 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.69 -44.07 96.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.464 1.029 . . . . 3.2 111.242 168.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -39.93 90.2 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.539 -1.351 . . . . 3.35 112.052 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.03 -47.6 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.423 1.011 . . . . 1.2 110.617 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -62.24 -37.71 86.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.899 1.279 . . . . 3.49 113.198 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -72.6 -37.57 68.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.325 0.966 . . . . 4.08 113.51 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.06 -27.54 65.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.869 0.868 . . . . 2.0 110.679 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.59 40.98 0.69 Allowed Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.24 0.924 . . . . 1.91 114.541 159.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -133.56 140.53 47.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.579 1.552 . . . . 5.62 109.073 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -96.28 118.14 32.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.627 -1.296 . . . . 3.65 112.263 -156.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.15 128.09 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.789 -0.569 . . . . 4.05 111.645 -170.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -104.6 51.49 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.97 1.308 . . . . 2.5 110.262 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -99.06 135.23 40.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.07 0.938 . . . . 2.05 110.451 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -103.06 146.32 28.55 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.507 2.323 . . . . 3.77 108.445 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -99.73 134.95 41.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.236 0.614 . . . . 3.15 111.04 166.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.65 46.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.606 1.162 . . . . 0.85 110.711 171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -116.04 139.62 50.09 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.775 1.63 . . . . 2.97 109.976 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -126.03 155.6 41.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.642 1.577 . . . . 1.81 110.972 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.71 137.12 47.97 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.832 2.453 . . . . 2.56 109.895 174.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.615 HD11 HG12 ' A' ' 114' ' ' VAL . 1.6 mp -118.95 59.88 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.686 1.194 . . . . 1.56 110.006 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.429 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 4.0 mt-10 -43.36 90.56 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.846 2.059 . . . . 3.86 111.734 166.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.94 -48.71 0.48 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.743 -1.031 . . . . 2.09 114.305 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -79.81 70.29 6.31 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.581 1.326 . . . . 2.75 114.581 -165.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.9 p -72.38 32.63 0.06 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.24 1.816 . . . . 2.71 114.176 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.6 t -161.98 138.03 7.76 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.608 1.563 . . . . 2.93 111.841 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.17 65.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.537 1.135 . . . . 1.98 113.236 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.25 77.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.824 0.738 . . . . 1.64 112.538 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 72.4 m -70.37 -42.43 71.79 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.648 -0.657 . . . . 2.04 111.456 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -51.01 70.98 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.489 0.716 . . . . 1.07 111.644 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -54.77 -44.64 73.85 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.549 0.74 . . . . 3.6 111.86 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -68.04 -34.38 76.35 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.385 0.883 . . . . 4.87 113.385 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.4 pt -73.89 -41.98 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 120.308 1.413 . . . . 0.83 112.535 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.33 -42.97 67.27 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.376 1.07 . . . . 2.55 112.034 -176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.37 -32.57 39.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.516 1.526 . . . . 3.2 113.596 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -100.05 -37.56 8.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.148 0.979 . . . . 3.41 112.775 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.17 -36.76 52.67 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.499 1.52 . . . . 0.87 112.768 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.44 -25.92 0.1 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 117.98 2.585 . . . . 1.94 117.98 -174.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -159.03 39.28 0.22 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.604 0.964 . . . . 3.88 113.604 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 mt -68.05 79.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.833 -1.167 . . . . 3.81 111.538 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 58.49 60.61 2.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.421 1.089 . . . . 5.33 111.594 144.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.33 -28.59 13.08 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 118.255 -1.303 . . . . 1.34 112.191 -164.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 94.2 t -66.86 126.61 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 119.428 1.614 . . . . 2.09 110.664 165.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.01 -44.59 4.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.053 1.741 . . . . 1.07 112.689 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -137.56 147.83 45.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.1 0.96 . . . . 1.43 110.634 172.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.72 74.77 3.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.331 0.863 . . . . 1.02 113.331 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 127.28 9.97 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.464 2.776 . . . . 0.96 110.816 173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.41 136.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.553 1.141 . . . . 0.89 110.258 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -81.84 113.34 19.72 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.585 1.183 . . . . 2.62 112.538 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -81.0 2.07 28.55 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.742 2.017 . . . . 4.14 114.927 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.14 -31.24 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.661 1.185 . . . . 1.57 113.666 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 mt -95.14 6.92 47.73 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.761 1.624 . . . . 1.94 112.669 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.252 9.0 mp0 45.2 40.3 4.87 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.991 2.517 . . . . 3.57 115.476 174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 171.82 11.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 127.927 2.491 . . . . 1.13 109.38 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.615 HG12 HD11 ' A' ' 80' ' ' ILE . 4.9 p -144.33 141.66 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.55 1.14 . . . . 0.51 109.375 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.6 m -103.35 131.91 50.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.775 -1.195 . . . . 0.78 107.775 170.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.4 134.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.656 1.182 . . . . 0.76 109.721 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.12 122.7 47.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.998 2.119 . . . . 3.43 108.527 170.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -159.07 154.37 25.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.721 1.008 . . . . 3.17 113.721 -165.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.52 108.24 8.33 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.601 -1.312 . . . . 3.2 110.328 168.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -67.31 -18.87 50.35 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.308 2.005 . . . . 1.59 111.993 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -52.61 -29.03 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.816 1.246 . . . . 3.94 113.158 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.35 45.64 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.889 1.276 . . . . 3.89 111.819 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.67 151.32 31.31 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 120.735 -1.228 . . . . 2.33 111.415 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 91.3 p -157.37 167.29 30.7 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.161 1.385 . . . . 2.41 109.866 -175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -60.45 -15.48 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 O-C-N 121.624 -0.672 . . . . 1.45 112.782 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.5 m -57.9 -52.51 65.19 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.042 -1.037 . . . . 2.09 112.675 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -56.46 -43.79 79.88 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.318 1.047 . . . . 3.47 110.935 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.36 -51.79 53.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.247 1.819 . . . . 2.73 110.658 -178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -62.89 -46.62 86.95 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 118.239 -0.886 . . . . 4.17 112.339 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.6 -28.55 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.494 1.043 . . . . 2.8 112.621 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.29 -46.82 54.13 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.601 0.963 . . . . 1.36 113.601 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.91 -24.35 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.297 0.851 . . . . 0.98 113.297 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -47.92 -43.81 29.28 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.271 1.429 . . . . 3.38 113.049 171.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -34.87 79.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.517 1.527 . . . . 3.9 112.626 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.51 -28.68 33.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.628 0.771 . . . . 1.32 111.8 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 112.94 22.88 5.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.149 1.62 . . . . 1.3 117.149 160.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -119.46 -145.39 0.37 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.805 1.802 . . . . 4.43 111.308 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -140.65 -179.84 6.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.345 -1.472 . . . . 4.17 109.845 165.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.1 mt -130.95 128.67 40.93 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.222 1.009 . . . . 1.03 110.386 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -99.68 147.44 25.41 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.398 1.079 . . . . 2.96 109.557 160.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 mt -73.38 155.38 39.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.833 -1.167 . . . . 2.11 110.687 156.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -109.31 125.94 52.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.326 2.25 . . . . 3.95 105.735 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.09 -30.73 5.0 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.046 1.308 . . . . 2.12 112.502 -161.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.252 20.0 mt-10 -133.68 38.18 3.25 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.22 1.933 . . . . 3.73 116.22 -173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 179.5 -51.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.159 2.184 . . . . 2.27 111.274 166.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.19 -34.78 73.37 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.23 1.012 . . . . 5.13 112.931 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 131.401 3.88 . . . . 3.25 111.319 -179.053 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 108.63 -0.878 . . . . 11.36 108.63 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.2 mp -91.05 115.53 28.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.64 0.776 . . . . 8.42 109.169 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.9 t -169.61 -20.48 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.534 1.679 . . . . 5.76 115.534 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.71 144.73 21.79 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 120.139 1.336 . . . . 7.57 110.386 -176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -102.16 152.47 20.98 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.985 0.898 . . . . 2.89 111.323 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.8 mmtm -135.48 177.13 8.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.405 1.882 . . . . 5.82 111.306 -169.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.2 158.34 36.03 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.673 1.36 . . . . 2.89 114.673 -157.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 101' ' ' GLY . 70.1 mt -139.1 145.95 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.139 1.776 . . . . 2.81 108.362 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -111.11 109.12 19.05 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 107.716 -1.216 . . . . 2.13 107.716 166.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.8 ttt -117.6 152.95 34.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.686 1.595 . . . . 2.25 110.837 -164.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -85.33 176.28 8.39 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.232 -0.917 . . . . 3.18 108.793 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p 171.67 93.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 128.286 2.634 . . . . 1.7 107.052 -169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 p -101.22 157.82 16.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.948 0.88 . . . . 2.72 112.643 -169.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.44 9.99 59.74 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.736 -1.036 . . . . 2.04 114.075 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 60.1 mtm -72.09 22.8 0.05 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.396 1.628 . . . . 2.17 115.396 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -69.48 -6.68 32.08 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.951 1.7 . . . . 4.02 115.341 -163.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.43 7.33 46.76 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.79 1.177 . . . . 5.76 112.505 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -53.03 0.68 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.34 2.656 . . . . 3.4 113.424 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.04 -13.51 36.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.957 1.303 . . . . 2.37 113.249 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 m -49.97 -43.06 50.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.347 1.459 . . . . 2.45 111.993 162.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.69 -51.07 70.2 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.825 1.25 . . . . 1.61 111.687 173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.1 -41.77 68.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.764 0.826 . . . . 1.85 111.559 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -66.32 -29.88 70.17 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 114.608 1.336 . . . . 3.26 114.608 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.7 mm -70.63 -52.01 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.126 1.33 . . . . 1.9 111.262 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.15 -47.15 80.99 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.377 0.535 . . . . 1.55 111.332 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -12.92 61.51 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 120.904 -1.123 . . . . 6.5 113.859 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.1 -59.96 2.22 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.749 1.166 . . . . 1.19 111.79 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.5 mt -70.91 -40.5 72.11 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.828 0.677 . . . . 1.59 112.828 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -69.73 15.63 0.08 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.299 1.439 . . . . 5.45 113.976 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -114.42 -11.95 12.42 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.492 1.917 . . . . 5.35 113.485 172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtm -71.58 137.63 83.3 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 120.886 1.675 . . . . 2.83 110.065 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -61.85 -33.45 84.6 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.671 2.247 . . . . 1.78 113.536 -165.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.42 -3.25 69.48 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.195 -1.336 . . . . 2.0 114.909 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.09 128.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 120.284 2.042 . . . . 1.53 107.91 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.2 t -100.81 -27.43 13.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 117.44 -1.266 . . . . 2.52 112.133 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.54 162.91 27.55 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.168 1.349 . . . . 3.26 113.978 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.98 126.49 7.39 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.189 1.796 . . . . 1.08 108.462 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -130.21 113.5 14.52 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.657 1.183 . . . . 2.72 109.137 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 p -100.57 115.18 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 122.402 1.096 . . . . 1.72 111.285 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -77.64 90.89 3.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.336 1.454 . . . . 2.26 108.941 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.2 tp -70.22 -22.36 62.92 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.016 0.926 . . . . 2.87 112.004 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.68 22.46 0.18 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.762 1.625 . . . . 2.9 114.003 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.5 m -161.05 -46.83 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.087 2.155 . . . . 3.25 111.204 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 99.58 62.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 130.159 3.383 . . . . 2.57 110.445 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.1 m -153.61 135.69 14.76 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.186 1.394 . . . . 1.25 109.997 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.8 t -106.93 123.57 48.37 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.918 1.687 . . . . 1.41 111.886 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -107.94 110.46 22.2 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.758 1.223 . . . . 1.57 108.62 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -116.56 142.05 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.821 0.848 . . . . 2.27 111.461 -167.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.32 130.01 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.141 1.377 . . . . 1.95 110.708 -172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.75 162.99 24.2 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.083 1.353 . . . . 3.16 114.594 -162.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.52 130.24 62.6 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.873 1.669 . . . . 2.96 111.442 171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.73 0.87 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.456 2.77 . . . . 3.21 114.896 -173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.96 -54.62 3.03 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 120.227 1.376 . . . . 3.03 111.506 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.91 12.11 16.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.54 1.136 . . . . 4.19 113.442 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 m -146.35 97.98 3.01 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.188 -1.57 . . . . 3.0 109.711 168.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.61 138.45 20.3 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.756 1.17 . . . . 2.34 110.792 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 t -53.32 -37.98 62.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.962 1.467 . . . . 2.38 114.962 -161.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.23 -23.81 64.35 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.144 1.164 . . . . 2.02 114.144 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.33 -19.74 64.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.264 1.026 . . . . 1.83 113.129 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.9 mt -74.42 -54.76 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.086 0.954 . . . . 2.14 110.389 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -64.83 -34.03 77.39 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.436 1.016 . . . . 3.2 111.913 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -61.06 -35.3 76.58 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.015 0.825 . . . . 3.95 112.432 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.77 30.58 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.631 1.345 . . . . 2.9 114.631 173.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -79.12 -56.19 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 120.349 1.431 . . . . 1.43 111.942 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -64.06 -19.99 65.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.122 0.969 . . . . 3.6 111.36 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -49.17 -29.27 5.28 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.863 2.465 . . . . 4.23 114.485 164.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -87.52 -13.76 42.16 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.081 0.952 . . . . 2.18 113.082 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.16 8.23 84.07 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.035 0.834 . . . . 2.43 114.142 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.54 148.99 21.59 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.568 1.184 . . . . 5.64 108.863 163.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -122.89 128.76 50.75 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.317 -0.865 . . . . 4.01 111.951 -164.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 71' ' ' VAL . 54.1 t -72.36 36.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 126.822 2.049 . . . . 3.79 112.967 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.272 12.4 p 39.97 50.03 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.493 2.717 . . . . 2.63 110.978 -176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 p -75.74 112.1 11.76 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.544 1.538 . . . . 2.96 111.22 -155.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -125.77 158.86 33.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.341 1.456 . . . . 3.37 108.707 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -106.41 147.14 29.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.552 0.575 . . . . 6.13 112.552 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -117.74 154.12 32.25 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.593 1.157 . . . . 1.78 109.312 164.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -133.28 136.27 45.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.446 1.098 . . . . 3.15 108.399 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -132.46 155.79 47.9 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.498 1.119 . . . . 2.18 111.386 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -97.93 130.47 44.8 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 126.177 1.791 . . . . 2.22 109.61 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 114' ' ' VAL . 25.8 mm -102.97 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.075 1.75 . . . . 1.68 109.59 -175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -75.56 67.56 2.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.607 1.194 . . . . 3.2 110.633 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.68 -10.27 0.02 OUTLIER Glycine 0 CA--C 1.536 1.376 0 CA-C-N 113.926 -1.488 . . . . 1.67 115.525 -172.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.5 142.83 47.16 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.206 2.003 . . . . 3.05 112.177 -170.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.7 p -141.46 29.07 1.79 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.68 1.592 . . . . 2.62 113.705 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -170.54 152.65 3.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.488 1.515 . . . . 3.28 111.66 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.63 75.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.574 0.75 . . . . 2.98 112.367 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.69 74.74 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.397 0.888 . . . . 3.18 113.397 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 m -72.64 -32.68 66.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.132 0.973 . . . . 2.73 112.059 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -53.14 56.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.721 0.809 . . . . 1.84 110.669 165.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -55.27 -35.15 64.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.024 0.829 . . . . 4.27 112.931 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -62.84 -26.92 68.99 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.274 1.212 . . . . 5.29 114.274 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -95.6 -28.98 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.115 1.325 . . . . 1.37 113.49 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -52.69 -49.86 64.47 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.687 1.13 . . . . 2.91 111.224 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -59.41 -19.51 47.78 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.543 1.312 . . . . 4.56 114.543 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -81.74 -56.34 4.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.277 1.031 . . . . 4.41 109.624 167.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -63.21 -36.09 82.49 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.809 2.044 . . . . 0.97 115.376 -172.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -42.33 -38.04 1.71 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.564 1.691 . . . . 2.97 115.564 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -158.23 18.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.747 1.388 . . . . 5.19 114.747 -165.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 73.2 mt -28.15 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 127.327 2.251 . . . . 2.54 113.206 -167.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -147.63 116.92 6.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.398 1.879 . . . . 4.43 106.613 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 8' ' ' ILE . . . 80.69 -27.52 2.93 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 125.845 1.688 . . . . 1.94 114.126 163.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.3 m -51.77 136.98 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.506 1.122 . . . . 2.76 110.308 156.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.17 -29.18 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.749 1.219 . . . . 1.23 113.275 -167.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.91 163.02 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.709 0.633 . . . . 2.36 112.709 178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.92 77.75 1.83 Allowed Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 114.632 1.345 . . . . 1.13 114.632 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.88 96.68 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.7 2.267 . . . . 1.84 111.115 166.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.12 125.73 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.876 0.871 . . . . 1.44 108.854 167.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -98.48 107.45 19.9 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 123.187 1.47 . . . . 4.95 111.821 -158.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -77.38 -3.85 42.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 117.698 2.481 . . . . 6.2 117.698 -145.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.74 -21.77 2.72 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.703 1.601 . . . . 2.49 112.191 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.44 -3.55 59.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.678 1.991 . . . . 2.3 112.626 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 60.03 33.73 21.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.711 1.605 . . . . 3.23 112.442 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 p -139.66 173.1 11.87 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.788 2.835 . . . . 1.25 108.586 -172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 80' ' ' ILE . 4.5 p -140.96 144.8 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.567 1.147 . . . . 0.93 109.273 172.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -109.57 134.59 51.74 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.303 1.041 . . . . 1.67 108.285 166.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.2 t -120.3 137.52 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.89 109.513 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.89 125.26 49.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.039 1.736 . . . . 2.49 108.343 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.37 174.87 14.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.439 1.644 . . . . 2.71 115.439 -171.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -99.08 130.93 26.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.825 1.25 . . . . 2.88 109.974 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.21 51.6 3.98 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.563 2.842 . . . . 2.2 111.233 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -132.42 -62.09 0.84 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.134 1.161 . . . . 3.5 114.134 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -84.86 -4.69 59.2 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.455 2.02 . . . . 4.12 116.455 -161.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.36 29.28 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.858 1.208 . . . . 2.03 112.184 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 79.3 p -133.45 167.56 20.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.857 1.263 . . . . 3.33 112.143 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 141' ' ' LEU . 44.1 t -66.18 -20.04 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 O-C-N 120.817 -1.177 . . . . 1.45 111.522 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -45.77 85.94 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.137 -0.977 . . . . 1.9 111.62 168.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.3 -41.37 76.87 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.395 1.078 . . . . 2.89 111.043 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.955 0.902 . . . . 1.67 111.612 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -58.95 -46.99 86.66 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 117.649 -1.167 . . . . 2.64 111.691 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -60.68 -35.13 75.49 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.219 1.372 . . . . 2.66 112.88 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.29 -27.56 64.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.056 1.132 . . . . 1.33 114.056 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.44 -28.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.779 1.632 . . . . 1.09 113.452 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -51.68 -36.37 46.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.413 1.485 . . . . 2.4 112.067 172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -62.5 -24.91 67.73 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.234 1.814 . . . . 3.23 113.901 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.07 -7.96 47.22 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.763 1.625 . . . . 1.58 112.598 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.46 -25.64 27.47 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.284 1.897 . . . . 1.31 114.341 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -73.94 -177.43 2.85 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 118.715 1.257 . . . . 3.5 111.482 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 149.92 47.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 120.134 -1.603 . . . . 2.31 107.559 162.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -95.3 127.44 41.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.377 -1.342 . . . . 1.23 107.377 171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 140' ' ' LYS . 38.4 mtmt -107.93 146.4 32.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.12 0.263 . . . . 3.75 110.732 170.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 125' ' ' VAL . 35.0 mt -83.65 144.21 29.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.938 0.875 . . . . 2.8 113.326 -174.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.5 tptt -98.3 120.55 38.91 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.087 1.755 . . . . 4.36 107.617 -171.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.61 0.32 47.65 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.314 -1.826 . . . . 1.98 114.387 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -129.81 0.88 4.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.154 1.977 . . . . 3.76 116.038 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -171.49 -68.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.283 -1.511 . . . . 3.0 110.904 -167.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -83.55 -19.9 34.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.656 1.982 . . . . 3.73 111.376 167.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.971 1.309 . . . . 4.23 112.612 149.102 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 117.308 -1.329 . . . . 10.29 113.399 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.74 -50.04 22.64 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.876 1.671 . . . . 8.68 113.037 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.1 p -153.38 -65.34 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.302 -1.74 . . . . 5.89 106.302 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 92.34 111.85 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 130.856 3.662 . . . . 5.89 109.451 168.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -96.95 159.84 14.69 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.766 1.227 . . . . 3.16 111.881 -162.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tptm -142.4 151.81 42.2 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.237 1.018 . . . . 6.93 113.208 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.81 158.88 30.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.785 1.234 . . . . 3.75 111.248 166.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -147.39 151.51 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.225 1.01 . . . . 2.64 108.344 150.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.61 156.12 44.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.342 1.057 . . . . 1.17 110.455 167.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.9 mtt -147.64 147.33 29.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.286 2.234 . . . . 2.25 109.77 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -72.76 130.99 41.75 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.61 -0.681 . . . . 3.58 109.55 164.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.24 103.53 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.938 1.295 . . . . 1.85 111.131 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -95.49 140.76 29.88 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.192 -0.943 . . . . 2.48 113.485 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.41 7.67 8.93 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.333 1.92 . . . . 0.98 114.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.2 mtm -101.03 54.56 0.84 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.463 1.632 . . . . 2.07 114.942 -171.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 m -82.21 59.43 4.47 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.764 -1.21 . . . . 2.85 110.982 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m 168.62 139.22 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 130.7 3.6 . . . . 3.34 107.78 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.61 -21.2 60.06 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.754 -0.591 . . . . 2.49 112.141 170.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.41 66.46 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.217 1.007 . . . . 1.24 113.167 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.1 m -75.94 -50.37 15.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.919 1.288 . . . . 1.55 110.612 173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.39 -44.81 62.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.337 0.655 . . . . 0.85 111.518 169.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -34.57 70.42 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.498 1.119 . . . . 0.95 113.726 173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -68.75 -37.18 79.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 120.144 1.338 . . . . 3.13 112.494 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -73.0 -50.38 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.015 0.926 . . . . 1.87 110.373 -170.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.3 -42.6 88.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.097 0.559 . . . . 1.42 110.683 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -59.58 -41.73 90.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.739 1.216 . . . . 3.16 112.907 173.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.94 -51.89 46.99 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.415 1.007 . . . . 0.91 112.957 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -67.9 -32.35 72.77 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.88 1.34 . . . . 1.67 112.343 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -64.74 -19.41 65.77 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.125 -0.984 . . . . 3.2 113.179 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -94.98 74.28 3.49 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.707 1.603 . . . . 4.72 111.401 171.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.1 mmt -146.56 161.76 36.86 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 127.3 2.24 . . . . 2.33 110.706 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -77.16 -43.9 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.593 2.195 . . . . 2.73 112.39 171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.52 -8.72 26.33 Favored Glycine 0 N--CA 1.478 1.461 0 N-CA-C 117.252 1.661 . . . . 1.39 117.252 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.8 t -75.98 120.66 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 119.16 1.48 . . . . 1.63 109.269 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.8 t -97.2 -22.6 16.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 117.611 -1.185 . . . . 1.62 111.842 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -152.49 149.95 29.08 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.755 1.162 . . . . 3.65 113.639 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.75 138.37 40.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.198 1.399 . . . . 0.94 109.196 161.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.19 122.55 9.03 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.456 1.503 . . . . 3.96 110.487 173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.91 128.5 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.11 -0.994 . . . . 1.74 112.964 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.65 85.95 7.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.351 1.06 . . . . 1.87 110.108 174.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.5 tp -55.03 -39.47 69.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.491 1.516 . . . . 2.43 111.809 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.09 28.7 0.14 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.852 1.661 . . . . 2.37 113.764 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.8 m -157.7 -51.96 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.674 1.589 . . . . 2.56 111.242 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 118.07 8.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 130.684 3.594 . . . . 2.69 112.931 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.0 m -99.89 122.95 43.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.461 -1.399 . . . . 1.65 110.532 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -96.82 136.54 37.22 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.21 1.404 . . . . 1.15 110.394 171.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -124.75 139.4 53.88 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.325 1.45 . . . . 1.36 109.015 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.3 m -140.29 159.96 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.641 0.776 . . . . 2.15 111.362 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mp -131.54 130.62 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.967 1.307 . . . . 1.32 108.479 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -145.24 165.45 28.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.715 1.376 . . . . 2.43 114.715 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -95.69 103.93 14.51 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 127.478 2.311 . . . . 2.69 109.958 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.34 91.0 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 124.32 3.347 . . . . 2.09 110.824 -170.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 174.7 -45.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.703 2.801 . . . . 2.05 110.302 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -92.96 -52.06 4.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.41 1.484 . . . . 3.2 111.487 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -97.16 138.32 34.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.098 -1.445 . . . . 1.85 107.098 166.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.41 161.64 16.1 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.426 1.012 . . . . 1.21 112.2 171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -49.07 76.51 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.692 0.746 . . . . 2.51 112.962 -172.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.35 -22.23 66.26 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.446 0.906 . . . . 1.16 113.446 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.71 -19.5 65.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.241 -0.912 . . . . 1.04 112.254 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.8 mm -68.65 -50.55 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 119.134 0.879 . . . . 1.85 110.885 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -70.15 -37.43 75.22 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 118.017 -0.992 . . . . 2.01 111.007 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -51.82 -46.06 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 4.39 112.059 171.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -16.86 64.05 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.686 -1.259 . . . . 2.23 113.761 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.481 HG22 ' CG ' ' A' ' 69' ' ' TYR . 20.2 mt -99.09 -31.78 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.935 0.894 . . . . 1.51 111.109 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.83 -29.25 66.77 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.7 -1.25 . . . . 4.59 110.861 166.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -54.54 -19.22 5.46 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.497 1.919 . . . . 5.62 113.612 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.08 2.12 34.31 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.728 1.611 . . . . 2.24 113.089 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.86 22.82 63.07 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.675 1.131 . . . . 2.43 114.087 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CG ' HG22 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -75.35 179.78 4.98 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.883 1.808 . . . . 10.76 115.883 -169.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -113.45 103.63 11.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.995 1.718 . . . . 4.93 109.29 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.52 -22.56 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 O-C-N 121.189 -0.944 . . . . 3.02 113.474 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 t 61.16 48.98 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.949 2.5 . . . . 2.91 110.838 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.9 p -107.45 166.83 10.37 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.383 1.073 . . . . 1.81 112.655 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.17 155.18 45.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.916 1.286 . . . . 3.92 109.103 164.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -93.78 112.16 23.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.321 0.648 . . . . 3.62 110.586 162.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.96 146.05 37.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.953 1.301 . . . . 1.03 110.826 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -100.35 132.23 45.84 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.031 0.92 . . . . 2.97 112.664 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -117.97 156.79 27.91 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.08 1.752 . . . . 1.85 109.453 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -111.3 141.33 44.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.184 0.993 . . . . 2.81 111.801 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.1 mm -98.65 101.21 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.032 1.333 . . . . 1.81 109.317 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -85.34 70.68 10.85 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.834 -1.173 . . . . 3.95 107.834 165.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.55 -5.76 0.03 OUTLIER Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.887 1.515 . . . . 2.1 116.887 -172.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -145.93 142.74 29.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.521 2.16 . . . . 2.57 114.992 -165.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.2 p -142.44 -17.7 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.567 1.692 . . . . 1.67 115.567 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.8 t -126.52 147.5 49.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.114 1.766 . . . . 2.59 109.921 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -44.49 -56.72 4.06 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.052 1.501 . . . . 1.78 115.052 -165.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.86 31.03 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.037 1.495 . . . . 2.39 115.037 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.8 m -70.23 -29.62 66.48 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.103 -0.998 . . . . 1.6 112.436 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.72 -54.52 34.15 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.168 -0.678 . . . . 1.36 109.168 164.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -57.56 -33.99 68.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.691 0.997 . . . . 2.38 113.691 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -54.86 -38.38 67.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.393 1.077 . . . . 3.95 113.767 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.8 pt -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.048 0.84 . . . . 1.03 113.199 171.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -52.98 -46.18 68.16 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.989 1.316 . . . . 3.69 111.286 -176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -55.94 -27.61 53.14 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.112 -0.992 . . . . 2.88 113.547 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -55.21 4.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.545 1.138 . . . . 3.9 110.803 170.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -52.72 -47.3 67.43 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.588 1.955 . . . . 0.97 113.698 -178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -46.63 -42.12 15.75 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.87 2.068 . . . . 1.8 112.106 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -148.57 81.0 1.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.828 1.651 . . . . 2.65 111.12 174.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 19.2 mt -72.5 -103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.159 0.984 . . . . 2.13 109.792 163.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -154.89 118.58 4.56 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 105.228 -2.138 . . . . 3.81 105.228 170.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.42 -25.03 16.63 Favored Glycine 0 N--CA 1.48 1.589 0 C-N-CA 125.172 1.368 . . . . 1.59 113.653 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.6 m -66.1 133.19 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.245 1.018 . . . . 2.12 110.282 156.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.05 -45.02 3.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.206 1.802 . . . . 0.93 112.082 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -131.57 145.37 51.68 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.445 0.466 . . . . 1.62 110.642 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.56 66.01 8.81 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.927 1.084 . . . . 0.96 113.927 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.56 90.34 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.11 2.54 . . . . 1.33 111.549 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.25 136.67 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.945 1.698 . . . . 1.37 111.958 174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -83.55 152.02 25.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.46 1.504 . . . . 4.12 111.496 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -85.09 -77.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.202 -0.936 . . . . 5.47 111.821 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.79 -27.69 44.54 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.107 1.363 . . . . 1.4 113.092 -163.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -75.14 -16.23 60.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.851 1.26 . . . . 1.52 111.891 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 64.02 11.83 6.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.704 2.002 . . . . 2.11 114.49 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.2 p -94.77 172.22 8.3 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.896 0.878 . . . . 0.94 110.896 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.35 127.97 28.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 107.623 -1.251 . . . . 0.77 107.623 163.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.3 m -86.42 120.56 27.89 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 106.603 -1.628 . . . . 0.8 106.603 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.0 t -115.83 122.26 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.644 1.178 . . . . 0.77 108.744 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -103.05 119.32 38.63 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.435 1.494 . . . . 3.22 108.88 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -161.08 158.72 28.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.45 1.1 . . . . 2.62 113.452 -164.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -100.16 114.29 65.63 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.688 -0.632 . . . . 2.11 112.521 170.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.54 -4.2 13.4 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.766 2.977 . . . . 1.53 114.937 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -55.33 -46.31 76.34 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.671 1.123 . . . . 3.5 111.62 162.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -80.07 -27.71 39.27 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.503 0.927 . . . . 5.05 113.503 -168.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.45 155.76 15.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.396 1.078 . . . . 1.66 111.98 -171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.2 t -143.07 -162.01 1.36 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.213 1.005 . . . . 4.0 111.256 168.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 t -52.52 -38.84 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.939 2.096 . . . . 1.59 113.47 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.1 m -70.73 -42.22 70.84 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.007 0.923 . . . . 2.41 112.739 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -45.91 82.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.094 1.758 . . . . 3.95 109.948 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.91 -41.13 91.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.856 1.263 . . . . 1.54 111.108 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -59.14 4.61 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 116.462 -1.732 . . . . 4.35 112.191 164.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -54.92 -36.01 64.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 121.141 1.791 . . . . 2.93 112.22 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.88 -22.14 64.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.012 1.486 . . . . 2.5 115.012 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.15 -22.09 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 125.523 1.529 . . . . 1.96 113.111 174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -35.33 77.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.7 1.2 . . . . 3.09 111.701 -175.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -61.74 -30.17 70.6 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.522 1.129 . . . . 3.12 113.45 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -85.94 -9.01 57.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.919 1.288 . . . . 2.06 112.677 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.76 -6.01 79.67 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 115.934 1.133 . . . . 2.08 115.934 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -82.46 178.02 8.44 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.571 1.686 . . . . 3.16 111.601 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.23 167.47 14.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.913 -1.117 . . . . 3.39 110.293 157.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.95 126.53 52.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.174 1.39 . . . . 2.19 108.141 -174.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -95.84 166.15 11.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 2.81 110.946 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.293 1.037 . . . . 1.47 112.712 -175.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.96 60.03 0.85 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.573 1.549 . . . . 4.42 109.552 -158.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.4 -53.1 0.79 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.296 1.903 . . . . 1.52 110.77 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.256 3.4 mm-40 -81.5 50.37 1.46 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.761 1.023 . . . . 3.83 113.761 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 151.75 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 130.853 3.661 . . . . 3.2 111.223 154.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -89.01 -7.05 56.69 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.338 1.055 . . . . 2.83 113.197 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.244 0.813 0 C-N-CA 129.364 3.065 . . . . 3.61 113.59 -174.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.893 -0.575 . . . . 14.98 109.962 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.13 125.33 23.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.743 1.217 . . . . 9.73 111.559 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 m 114.99 -130.48 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 1 C-N-CA 131.723 4.009 . . . . 7.6 104.155 -162.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -153.9 -172.31 4.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 121.12 1.782 . . . . 5.39 111.292 151.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -136.17 141.02 44.03 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.201 -1.407 . . . . 2.87 107.201 160.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -123.52 159.72 28.51 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.845 1.658 . . . . 3.75 109.726 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -135.03 122.89 22.44 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.854 1.262 . . . . 4.07 108.65 -169.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.9 mp -139.99 147.96 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.185 1.394 . . . . 4.55 108.268 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.15 165.46 16.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.869 1.267 . . . . 1.37 111.107 173.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 29.5 mtt -159.64 168.4 26.13 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.852 2.461 . . . . 2.42 110.719 -173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.13 164.13 11.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.538 1.135 . . . . 2.99 109.829 164.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -161.65 141.42 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.271 0.941 . . . . 1.49 110.691 -171.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -116.11 151.92 34.66 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.097 1.147 . . . . 1.8 114.097 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.75 15.49 24.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.168 1.842 . . . . 1.05 113.844 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.406 ' HA ' ' CB ' ' A' ' 20' ' ' CYS . 42.9 mtm -84.39 -2.88 57.85 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 116.519 2.044 . . . . 2.49 116.519 -167.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.98 58.1 4.22 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.826 1.25 . . . . 3.15 113.399 -160.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.8 t -165.7 9.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 126.427 1.891 . . . . 3.14 113.496 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 66.52 -56.8 0.39 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 128.594 2.757 . . . . 2.05 114.411 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.55 54.68 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.902 1.281 . . . . 1.75 113.8 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 15' ' ' MET . 39.4 m -61.48 -52.02 66.25 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.602 1.561 . . . . 1.96 112.075 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.31 99.07 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.035 0.934 . . . . 1.75 111.148 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.72 67.91 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.746 0.647 . . . . 1.41 112.746 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -26.02 63.88 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.084 1.142 . . . . 4.68 114.084 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mm -62.7 -56.96 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 120.006 1.275 . . . . 1.85 109.691 172.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.34 -53.97 20.55 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.743 0.417 . . . . 1.93 111.619 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.09 -26.1 64.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.603 -1.31 . . . . 3.26 113.145 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.59 -57.48 19.33 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.644 1.116 . . . . 0.92 112.65 167.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.1 mt -68.49 -24.64 64.7 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.369 1.085 . . . . 1.67 113.171 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -57.93 -21.29 43.15 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 121.103 -0.998 . . . . 4.29 113.563 175.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.7 mmt180 -95.43 81.36 3.57 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.3 1.04 . . . . 5.31 110.972 161.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -147.82 156.47 44.47 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 128.231 2.613 . . . . 2.46 108.156 172.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -76.0 -42.42 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.05 1.834 . . . . 2.78 113.415 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.57 1.78 34.4 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.523 0.969 . . . . 1.36 115.523 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 80.4 t -81.15 125.84 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.718 1.259 . . . . 1.71 109.164 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.24 -51.13 9.3 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 118.104 -0.95 . . . . 1.65 108.667 170.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -166.64 152.76 8.49 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.557 0.617 . . . . 3.92 112.253 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.25 142.8 47.11 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.14 109.667 169.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -140.08 132.83 29.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.391 1.076 . . . . 2.29 111.856 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.52 119.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.127 0.876 . . . . 2.07 112.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -89.6 84.44 6.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.099 0.96 . . . . 3.01 109.836 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.07 -33.7 69.34 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 2.75 113.498 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.0 18.42 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.258 1.577 . . . . 3.79 115.258 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 50.4 m -160.02 -41.82 0.05 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 128.444 2.697 . . . . 4.13 108.947 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 104.58 22.78 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.77 3.228 . . . . 3.71 113.283 161.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 m -93.43 129.78 39.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.436 1.494 . . . . 2.73 109.729 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 t -100.96 149.37 23.98 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.431 1.492 . . . . 1.6 110.748 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -141.66 143.01 33.38 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.257 1.423 . . . . 1.49 109.943 -168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.1 t -137.05 132.9 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.27 0.941 . . . . 2.05 110.619 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.04 116.22 51.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 126.72 2.008 . . . . 1.18 108.141 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -158.39 153.66 25.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.996 1.318 . . . . 2.8 113.313 -166.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.36 127.79 91.84 Favored Pre-proline 0 CA--C 1.546 0.819 0 O-C-N 121.247 -0.908 . . . . 3.5 109.929 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.94 -4.46 13.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.413 2.742 . . . . 3.02 115.529 -169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.94 -48.75 3.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.989 1.268 . . . . 3.34 111.387 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.25 -9.21 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.76 1.624 . . . . 5.12 112.992 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.2 m -148.15 130.22 15.41 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.592 -1.318 . . . . 1.9 109.379 162.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.83 151.27 26.04 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 124.112 0.863 . . . . 1.13 112.307 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.7 t -54.21 -40.01 67.23 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.418 1.087 . . . . 2.38 112.245 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.67 62.95 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.8 1.037 . . . . 1.18 113.8 174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.01 -36.65 64.5 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.913 -1.117 . . . . 1.16 110.661 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.05 -35.41 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 118.425 -0.798 . . . . 3.44 112.435 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.78 -47.3 72.57 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.652 1.115 . . . . 2.44 110.436 174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -56.04 -43.31 77.7 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.734 0.697 . . . . 3.29 110.838 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -67.46 -27.41 67.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 117.84 -1.076 . . . . 4.75 113.482 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.3 mt -71.48 -55.33 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.501 1.046 . . . . 1.14 110.385 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -55.41 -32.95 63.1 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.456 1.102 . . . . 2.96 111.085 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -57.97 -10.23 1.71 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 127.822 2.449 . . . . 3.92 116.455 172.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.44 -8.25 23.41 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 120.267 1.394 . . . . 1.34 113.074 171.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.66 69.5 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.415 1.007 . . . . 1.4 113.321 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -113.55 137.17 51.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.619 1.568 . . . . 5.85 107.711 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -119.63 137.32 53.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.23 0.826 . . . . 4.75 113.23 -157.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.1 t -75.06 -2.68 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 126.33 1.852 . . . . 3.5 112.792 -168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t 65.22 37.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 126.349 1.86 . . . . 2.83 110.361 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.3 p -82.49 116.69 22.04 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 122.303 1.049 . . . . 2.15 111.53 -170.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -103.26 143.08 33.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.382 1.473 . . . . 3.32 108.115 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -106.7 152.68 23.47 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.923 0.712 . . . . 3.54 112.923 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.33 166.27 34.06 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.252 1.421 . . . . 1.23 110.984 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -120.7 138.86 53.75 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.308 0.575 . . . . 3.42 111.471 164.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -115.5 155.68 27.08 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.423 1.489 . . . . 1.83 109.546 173.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -118.74 130.19 55.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.454 1.902 . . . . 2.09 110.585 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.4 mm -108.85 59.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.167 1.387 . . . . 1.54 110.61 -165.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.16 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.544 1.164 . . . . 4.02 111.589 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 157.75 -44.9 0.49 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.554 1.073 . . . . 1.3 112.171 -164.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.42 137.31 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.827 1.251 . . . . 2.42 110.452 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.2 p -123.7 -0.82 8.53 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 115.37 1.619 . . . . 1.81 115.37 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 t -168.82 159.65 9.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.509 1.523 . . . . 2.23 112.215 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -47.85 -39.13 17.68 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.5 1.92 . . . . 1.32 115.391 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.2 -27.05 67.69 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.493 0.923 . . . . 1.31 113.493 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 38.8 m -83.79 -36.53 23.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.294 1.438 . . . . 1.18 111.857 172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.38 13.12 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.734 0.814 . . . . 0.92 111.503 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -62.1 -28.58 69.72 Favored 'General case' 0 CA--C 1.549 0.928 0 O-C-N 121.154 -0.966 . . . . 2.86 113.094 -177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.6 mtt85 -59.48 -36.93 76.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.999 1.111 . . . . 4.43 113.999 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.5 pt -82.93 -35.36 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 120.318 1.417 . . . . 1.14 112.249 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.0 -47.18 71.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.518 1.127 . . . . 2.38 112.276 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -61.92 -5.26 1.98 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.737 1.384 . . . . 2.93 114.737 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 -63.24 1.15 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.804 -1.093 . . . . 5.27 111.378 153.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -46.37 -41.51 13.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.92 1.688 . . . . 1.11 113.8 -170.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -42.9 -42.17 3.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.453 1.901 . . . . 1.74 114.112 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -139.8 -26.89 0.78 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 126.161 1.784 . . . . 3.37 114.529 -170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 15.4 mt 20.45 -108.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 128.281 2.632 . . . . 2.37 113.346 -165.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -138.68 111.13 7.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 102.31 -3.219 . . . . 4.23 102.31 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.68 47.1 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 124.855 1.217 . . . . 1.41 115.298 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.7 t -91.24 130.62 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.6 1.2 . . . . 2.17 109.056 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.32 -44.99 10.99 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.345 1.058 . . . . 1.35 111.349 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -142.07 142.23 32.82 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.471 0.708 . . . . 1.81 110.878 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.21 85.71 1.99 Allowed Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.629 0.772 . . . . 0.91 112.381 163.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.96 123.49 6.81 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.305 2.67 . . . . 1.07 109.884 167.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.7 128.89 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.4 -0.593 . . . . 0.97 109.4 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -76.02 136.37 39.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.395 1.078 . . . . 2.44 111.892 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -94.64 -16.39 23.2 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.474 1.287 . . . . 3.79 114.474 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.79 -34.82 3.48 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.944 1.297 . . . . 1.6 112.149 -173.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -16.8 50.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.757 1.223 . . . . 1.55 111.977 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 66.27 17.69 10.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.208 1.803 . . . . 2.48 113.014 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.1 p -99.64 172.88 7.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.98 1.312 . . . . 1.03 110.851 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 p -133.78 135.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.448 1.099 . . . . 0.79 108.487 158.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -99.37 114.54 27.49 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.288 1.435 . . . . 1.48 107.391 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.2 t -117.06 144.45 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.298 1.439 . . . . 1.44 111.077 -164.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -136.19 123.42 21.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.65 1.98 . . . . 2.67 109.621 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -158.23 168.82 26.0 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.893 1.277 . . . . 2.5 113.385 -168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.02 110.47 44.27 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 120.965 -1.084 . . . . 2.39 111.491 167.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.22 84.34 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 123.752 2.968 . . . . 2.59 109.83 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -154.49 -59.59 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.557 1.143 . . . . 3.57 112.854 -170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -93.13 -9.93 37.74 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.014 1.487 . . . . 3.74 115.014 -162.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.45 171.8 18.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.105 1.762 . . . . 2.51 110.238 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.5 p -125.53 171.4 10.56 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.181 0.808 . . . . 2.98 113.181 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.3 t -55.29 -20.07 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.934 -1.104 . . . . 1.38 112.055 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.3 m -60.37 -44.57 95.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.23 0.923 . . . . 1.82 111.444 171.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -72.96 -33.23 65.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.212 1.005 . . . . 3.02 111.43 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.0 mt -62.64 -47.27 84.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.256 0.623 . . . . 1.44 110.189 170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -47.96 62.0 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 116.319 -1.8 . . . . 5.09 112.44 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -66.48 -40.1 89.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.983 1.719 . . . . 2.54 112.236 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.35 85.53 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.371 -0.831 . . . . 1.22 112.66 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.7 t -77.91 -24.53 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.813 1.245 . . . . 1.02 113.272 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.96 -29.31 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.937 1.244 . . . . 1.97 112.498 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -54.93 -34.28 63.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.25 1.02 . . . . 6.17 112.298 167.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.36 -5.0 50.52 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.972 1.309 . . . . 1.76 112.783 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.59 -1.35 88.85 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.098 1.332 . . . . 1.92 115.06 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -87.86 -171.96 3.64 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.821 1.81 . . . . 3.19 112.207 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 169.63 17.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.541 -1.349 . . . . 2.19 109.449 168.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 57.7 mt -115.1 118.2 32.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.622 1.169 . . . . 1.42 108.648 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -94.26 149.18 21.48 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.02 -1.104 . . . . 4.39 108.02 162.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.92 143.49 36.48 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.816 -0.809 . . . . 2.17 108.816 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -89.39 75.23 7.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.097 0.951 . . . . 4.72 110.841 -153.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.13 -46.01 1.21 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 127.204 2.335 . . . . 1.86 110.029 -161.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 54.3 mp0 -87.01 -13.04 45.58 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.227 1.195 . . . . 5.79 114.227 -164.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -156.28 103.15 2.15 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.0 0.818 . . . . 3.54 109.19 162.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 76.6 -35.01 0.23 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.594 3.158 . . . . 3.94 114.106 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.876 2.07 . . . . 4.65 115.599 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 108.204 -1.036 . . . . 14.8 108.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.18 -76.76 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.802 1.241 . . . . 8.84 109.938 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m 73.91 93.84 0.08 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.847 2.059 . . . . 7.04 113.235 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.65 4.15 53.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.281 -0.887 . . . . 7.94 112.817 -175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -95.99 109.09 21.53 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.242 -1.392 . . . . 2.94 107.242 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -107.91 166.65 10.55 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.443 1.497 . . . . 3.47 112.328 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 151.66 51.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.087 1.355 . . . . 5.27 113.151 -155.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -160.58 144.67 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.178 1.791 . . . . 2.98 109.604 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.26 154.33 46.82 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 1.42 109.962 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.3 mtt -153.99 163.81 39.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.748 2.019 . . . . 2.1 110.738 -174.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' C ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -76.84 141.46 40.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.001 -1.0 . . . . 3.87 108.323 161.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.35 112.09 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.684 1.129 . . . . 1.84 111.517 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 t -99.36 150.12 22.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.761 1.224 . . . . 2.23 111.668 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.78 14.86 41.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.653 1.12 . . . . 1.32 112.94 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.1 mtp -72.59 145.79 47.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.048 0.924 . . . . 3.35 112.416 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -139.01 100.22 3.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.809 2.444 . . . . 4.36 106.395 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 t 61.28 -174.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.39 2.276 . . . . 6.82 112.979 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.48 -9.18 5.13 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.685 1.194 . . . . 3.67 112.859 167.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -30.74 68.24 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.869 -1.144 . . . . 1.72 112.281 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 94.8 m -70.42 -38.82 74.64 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 1.51 112.144 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.01 -50.96 72.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.878 0.471 . . . . 1.36 110.464 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.13 -33.78 63.18 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.538 1.135 . . . . 1.1 113.6 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.1 mmt-85 -72.76 -41.38 65.13 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.724 1.009 . . . . 3.13 113.724 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.3 mt -68.27 -55.37 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.715 0.806 . . . . 2.53 110.499 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.03 -46.44 89.14 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.586 1.154 . . . . 1.46 111.231 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -59.18 -35.21 73.15 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.878 -1.139 . . . . 3.16 112.721 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.0 -45.18 93.09 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.547 -1.14 . . . . 0.91 113.285 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.5 -38.16 49.57 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.155 1.477 . . . . 3.08 111.981 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -58.44 -29.17 65.93 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.051 1.296 . . . . 3.14 112.445 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' HG3' HH11 ' A' ' 30' ' ' ARG . 4.4 mtt85 -85.37 66.61 9.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.555 1.942 . . . . 6.88 112.159 171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.6 mmm -145.56 158.25 50.63 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 126.235 1.814 . . . . 2.39 110.361 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.94 -64.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.704 2.269 . . . . 2.0 110.816 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.4 46.81 3.65 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 124.758 1.171 . . . . 1.85 113.643 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.34 138.47 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 118.436 1.118 . . . . 2.64 110.052 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.2 m -87.14 -58.47 2.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.642 1.177 . . . . 2.25 108.074 170.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -169.71 161.69 9.38 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.835 0.68 . . . . 3.16 112.835 -167.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.64 140.7 35.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.948 1.299 . . . . 0.95 110.628 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.91 122.49 14.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.659 1.183 . . . . 2.05 110.012 -173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.72 124.63 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.088 1.355 . . . . 2.54 110.356 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.98 -41.6 28.69 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.464 1.506 . . . . 3.18 113.975 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 tt 68.85 -63.25 0.37 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.811 2.044 . . . . 3.22 112.724 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.36 -20.03 57.91 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.662 1.727 . . . . 2.3 115.662 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.95 20.05 3.48 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.985 2.114 . . . . 3.13 111.196 168.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 72.35 13.82 5.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.828 1.651 . . . . 4.34 114.611 158.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.93 135.68 35.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.992 1.317 . . . . 2.62 111.044 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -109.63 134.5 51.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.039 1.335 . . . . 1.22 108.705 159.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -129.71 133.55 47.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.784 1.234 . . . . 1.61 109.36 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.79 140.19 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.24 0.927 . . . . 2.35 110.776 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.69 128.64 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.283 1.833 . . . . 1.41 108.504 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -148.06 169.08 20.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.828 1.251 . . . . 2.41 114.168 -163.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -99.78 124.06 45.35 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.122 1.769 . . . . 3.38 109.243 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -82.99 -0.93 10.24 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.009 3.139 . . . . 2.04 114.101 -173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.7 -33.44 12.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.279 0.945 . . . . 2.07 111.742 172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -105.44 -0.71 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.812 1.412 . . . . 3.45 114.812 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 m -153.19 138.87 17.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 120.279 1.4 . . . . 2.1 110.62 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.39 153.6 18.01 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.483 1.516 . . . . 1.7 112.745 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 56.0 m -54.61 -57.58 10.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.942 1.697 . . . . 2.51 113.206 -171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.74 68.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.104 . . . . 1.24 113.982 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.59 -19.39 65.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.23 1.012 . . . . 1.58 113.218 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.92 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.25 0.932 . . . . 1.8 110.18 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -65.6 -32.9 74.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.111 1.323 . . . . 3.21 112.393 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -60.92 -38.31 85.34 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.43 1.014 . . . . 3.98 111.1 172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -66.94 -21.91 65.96 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.838 1.199 . . . . 3.09 113.827 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.4 -52.92 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 120.338 1.426 . . . . 1.91 109.927 167.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.41 -18.22 64.39 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 112.696 0.628 . . . . 3.82 112.696 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -56.3 -23.36 36.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.797 2.039 . . . . 6.03 113.604 166.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.08 -15.12 37.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.372 0.987 . . . . 1.92 113.045 174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.49 9.78 64.41 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.137 0.875 . . . . 2.32 113.682 -170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -93.22 133.47 36.39 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.607 1.203 . . . . 5.47 109.286 169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -104.57 127.72 52.37 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.984 -1.072 . . . . 3.12 111.482 -167.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.56 -28.43 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.848 0.859 . . . . 3.7 110.105 164.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t 70.6 65.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.455 1.502 . . . . 3.71 108.895 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -82.81 120.83 26.13 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.735 1.214 . . . . 2.42 110.461 -175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.77 156.16 48.26 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.507 1.523 . . . . 4.65 109.989 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.61 141.91 51.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.839 1.422 . . . . 3.79 114.839 -157.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 151.45 44.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.803 1.641 . . . . 1.32 109.965 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -112.86 122.19 46.92 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.003 0.521 . . . . 2.5 110.524 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -103.13 144.24 31.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.392 1.077 . . . . 2.17 111.032 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -99.58 106.13 18.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 129.427 3.091 . . . . 2.84 108.513 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -89.07 73.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.988 1.315 . . . . 1.44 110.46 -169.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.7 65.78 0.33 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 126.33 1.852 . . . . 3.69 111.829 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.98 -24.6 0.06 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 115.919 1.127 . . . . 1.33 115.919 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.48 147.96 28.41 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.476 1.638 . . . . 3.15 110.986 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -140.71 15.85 2.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.775 1.23 . . . . 2.16 113.402 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -173.05 152.28 2.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.592 1.557 . . . . 2.54 110.81 -169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.0 -34.24 63.28 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.724 1.21 . . . . 1.26 113.059 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.77 97.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.78 0.718 . . . . 1.55 112.394 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.28 -41.67 73.09 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.787 0.835 . . . . 1.69 111.914 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -58.05 10.1 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.668 0.787 . . . . 0.89 111.236 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -62.64 -33.29 74.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.351 -0.843 . . . . 2.5 113.052 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -60.35 -37.67 81.41 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.666 0.987 . . . . 4.43 113.666 172.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 pt -82.39 -35.84 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 120.054 1.297 . . . . 1.05 112.496 170.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.38 -49.31 54.76 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.564 1.546 . . . . 2.75 111.258 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -53.5 -27.78 27.29 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.414 1.264 . . . . 3.47 114.414 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -89.7 -52.67 4.88 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.582 1.153 . . . . 3.89 110.761 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.73 -39.77 59.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.34 1.856 . . . . 1.29 113.588 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -50.96 -31.77 18.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.455 1.502 . . . . 2.15 114.871 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -134.53 -33.88 0.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.282 1.586 . . . . 4.04 115.282 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.269 28.8 mt 28.19 -108.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 126.644 1.977 . . . . 2.11 111.689 -163.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -129.32 117.75 21.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 104.139 -2.541 . . . . 4.52 104.139 158.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.23 -1.3 67.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.435 -1.758 . . . . 1.84 116.205 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.95 133.55 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.355 1.577 . . . . 2.38 110.221 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.24 -39.24 10.17 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.021 1.728 . . . . 2.46 112.334 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -145.19 147.08 32.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.833 1.253 . . . . 2.52 111.553 170.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.67 100.07 1.5 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 123.648 0.779 . . . . 1.11 112.002 158.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -89.64 134.16 2.29 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.437 3.424 . . . . 1.04 110.885 162.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.51 128.23 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.604 0.761 . . . . 0.98 111.05 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -80.94 141.01 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.786 0.803 . . . . 2.91 112.751 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -110.49 1.31 18.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.356 1.462 . . . . 3.35 114.565 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.02 -42.23 2.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.615 1.166 . . . . 1.51 110.997 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.34 -17.99 57.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.912 1.285 . . . . 1.52 112.948 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 70.98 8.59 6.57 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.945 2.098 . . . . 2.97 113.701 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.2 p -99.91 128.91 45.96 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.711 1.205 . . . . 1.56 110.275 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.04 130.24 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.828 -0.804 . . . . 0.65 108.828 160.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -91.76 107.58 19.31 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.254 -1.387 . . . . 1.29 107.254 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.96 139.11 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.633 1.173 . . . . 1.34 108.967 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -133.28 124.72 27.82 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.59 1.156 . . . . 4.3 109.678 171.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.17 -178.99 7.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.208 1.403 . . . . 2.65 112.204 -166.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -93.58 113.04 59.2 Favored Pre-proline 0 CA--C 1.554 1.096 0 O-C-N 121.608 -0.682 . . . . 2.64 110.548 165.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.76 -10.25 26.15 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.904 2.403 . . . . 1.93 112.663 174.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.73 -32.21 71.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.357 1.463 . . . . 4.13 113.504 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.6 mm-40 -111.85 -31.52 6.91 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.033 1.494 . . . . 4.81 115.033 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.11 149.94 42.87 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.053 1.297 . . . . 2.03 113.699 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 p -132.5 178.72 6.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.637 1.175 . . . . 2.24 113.46 -170.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.84 -20.13 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.878 -1.139 . . . . 1.5 111.373 -175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -64.56 -42.62 95.56 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.396 -0.815 . . . . 2.19 112.292 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -67.8 -44.99 76.03 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.529 0.732 . . . . 3.33 110.21 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.32 -40.32 97.01 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.442 1.097 . . . . 1.46 110.85 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -57.44 -60.42 3.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.69 -1.147 . . . . 3.33 111.422 169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -63.09 -24.48 67.92 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.527 1.512 . . . . 2.53 113.163 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.39 -26.67 62.88 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.907 1.447 . . . . 2.01 114.907 170.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.37 -32.31 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.279 1.432 . . . . 1.54 113.118 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.42 -36.7 83.21 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 2.38 112.986 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -70.31 -17.89 63.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.597 0.962 . . . . 3.92 113.597 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.2 -6.1 58.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.831 0.852 . . . . 2.47 112.738 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.79 -6.12 62.32 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.037 1.303 . . . . 1.7 115.386 170.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -102.17 -173.6 2.38 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.19 1.495 . . . . 3.36 111.227 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.29 173.26 11.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.33 -1.481 . . . . 3.06 109.127 167.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.4 mt -108.6 146.06 33.93 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.667 1.587 . . . . 1.39 109.562 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -120.67 178.81 4.55 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.484 0.713 . . . . 2.89 110.441 150.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.503 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 18.6 mt -110.36 162.81 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.024 1.33 . . . . 1.93 112.047 168.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -94.29 120.26 34.28 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.944 2.498 . . . . 4.58 106.688 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 -60.52 3.16 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.41 -1.076 . . . . 2.4 110.41 -169.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.255 9.3 tt0 -80.62 36.36 0.38 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.286 1.217 . . . . 3.19 114.286 -175.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.503 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 1.8 mt-30 175.04 -84.75 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.537 2.735 . . . . 2.54 111.223 170.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -74.2 -32.79 63.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.283 0.947 . . . . 3.23 111.526 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 130.973 3.709 . . . . 3.18 110.206 -177.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.557 -0.534 . . . . 11.72 109.557 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.64 -60.57 3.62 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.201 1.0 . . . . 10.69 110.714 168.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.4 m 149.05 -105.16 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 131.368 3.867 . . . . 5.84 108.261 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -148.05 21.03 1.11 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.363 1.246 . . . . 8.53 114.363 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -140.09 149.99 43.78 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 119.451 -2.031 . . . . 2.47 110.057 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -140.32 159.95 41.06 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.236 1.014 . . . . 6.78 113.051 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -105.72 147.35 28.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.521 2.728 . . . . 3.72 111.932 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.7 160.02 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 126.464 1.906 . . . . 3.75 110.301 157.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.69 121.25 11.77 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 1.31 112.052 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 43.1 mtt -129.68 132.07 46.55 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.757 1.223 . . . . 2.71 111.011 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -68.7 132.84 47.52 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.162 -1.051 . . . . 3.35 108.162 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 p -140.72 115.95 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.993 0.917 . . . . 1.74 109.761 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 t -99.56 130.61 45.81 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 113.169 0.803 . . . . 2.14 113.169 -156.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.74 19.22 2.06 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 127.164 2.316 . . . . 1.33 113.919 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.5 mtt -99.22 -5.18 30.4 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 116.95 2.204 . . . . 2.94 116.95 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.7 m -76.15 71.08 2.87 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.734 1.606 . . . . 5.15 111.137 178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -165.38 30.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.271 2.228 . . . . 3.35 111.241 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 57.44 -70.99 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.704 2.802 . . . . 2.12 115.026 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.99 -16.12 63.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.139 1.775 . . . . 1.18 114.155 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.8 m -53.38 -40.52 65.09 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.658 1.117 . . . . 1.69 112.091 171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.35 8.54 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.562 1.145 . . . . 0.88 111.215 171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.67 65.84 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.56 1.144 . . . . 0.99 113.16 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -67.36 -45.08 77.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.658 1.183 . . . . 2.75 112.617 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.96 -44.79 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.024 0.829 . . . . 2.14 111.487 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.8 -53.78 53.95 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.595 0.634 . . . . 1.48 111.588 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -65.94 -17.92 64.99 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.791 -1.193 . . . . 3.83 113.524 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.27 -60.09 3.16 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.658 1.123 . . . . 0.83 111.9 171.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.59 -38.31 74.03 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.176 0.988 . . . . 1.68 112.614 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -64.68 -14.27 57.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.73 0.812 . . . . 3.77 113.001 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -110.91 89.44 3.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.406 1.483 . . . . 5.92 109.426 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 60.1 mmm -161.19 164.5 18.6 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 128.969 2.908 . . . . 2.25 108.696 -165.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.39 -52.29 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.464 2.109 . . . . 2.08 112.358 171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.52 -10.44 29.13 Favored Glycine 0 N--CA 1.476 1.347 0 N-CA-C 116.667 1.427 . . . . 1.36 116.667 -171.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.0 t -77.68 121.49 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 119.66 1.73 . . . . 2.2 107.643 172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 t -89.14 -32.22 17.6 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 117.182 -1.39 . . . . 1.96 111.66 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.0 166.34 15.36 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.663 1.12 . . . . 3.46 112.567 170.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.3 141.27 18.25 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.98 0.912 . . . . 1.13 110.856 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -120.65 164.6 16.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.653 1.181 . . . . 2.05 111.164 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.72 119.4 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.553 1.141 . . . . 2.16 110.173 160.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -83.39 92.3 7.52 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.088 0.955 . . . . 1.83 108.833 161.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.97 -36.69 85.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.735 0.814 . . . . 2.78 111.262 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.12 -0.6 2.55 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.8 1.407 . . . . 2.02 114.8 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -146.66 25.86 1.17 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.418 1.487 . . . . 2.4 111.082 165.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 44.28 37.63 2.05 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.336 2.254 . . . . 2.49 115.153 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.3 m -123.77 118.76 27.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.555 1.142 . . . . 1.43 110.272 -168.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -87.11 146.9 25.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.471 0.653 . . . . 1.32 109.775 168.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -144.68 128.91 17.75 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.558 -0.714 . . . . 3.56 109.628 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.0 t -133.84 137.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.916 0.886 . . . . 1.85 110.004 -153.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.24 122.01 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.273 1.429 . . . . 1.43 109.152 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.9 161.46 39.97 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.936 1.828 . . . . 2.75 115.936 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.16 128.81 32.4 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 127.895 2.478 . . . . 2.64 110.46 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.1 -1.78 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.824 3.016 . . . . 2.17 113.65 -171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.81 -62.81 1.52 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.611 1.096 . . . . 2.48 111.5 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -95.77 16.88 16.31 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.225 1.01 . . . . 3.31 113.157 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 m -156.63 119.26 4.04 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.506 -1.371 . . . . 1.8 110.0 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.15 147.19 19.48 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.392 0.996 . . . . 1.84 110.673 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -51.51 -42.11 61.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.118 1.367 . . . . 3.0 114.425 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.59 -19.32 62.08 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.295 1.221 . . . . 1.72 114.295 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.64 63.06 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.695 -1.253 . . . . 1.35 112.837 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.9 mt -68.75 -54.23 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.238 0.615 . . . . 2.12 110.151 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -67.82 -38.7 83.58 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.52 1.054 . . . . 3.03 111.722 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -67.42 -15.28 63.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.899 1.68 . . . . 3.52 113.996 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -104.98 -32.5 8.72 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.052 1.13 . . . . 3.84 114.052 168.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.7 mt -71.44 -57.09 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 121.357 1.889 . . . . 1.05 112.048 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.21 -25.06 65.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.395 0.616 . . . . 3.37 110.968 -173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -56.6 -22.47 34.04 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.37 1.619 . . . . 4.36 115.37 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.46 -19.84 27.44 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.992 1.269 . . . . 2.19 113.625 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.95 11.1 59.23 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 119.688 1.131 . . . . 2.41 114.356 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -103.57 130.48 50.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.259 -1.386 . . . . 5.55 107.259 160.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -118.64 133.8 55.58 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.808 -0.557 . . . . 3.41 112.043 -160.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.58 31.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.208 . . . . 3.6 113.137 -162.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m 30.0 63.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 129.915 3.286 . . . . 2.44 112.022 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.7 p -89.94 142.78 27.38 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 112.937 -1.938 . . . . 2.43 111.791 -159.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -143.65 147.12 33.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.757 0.823 . . . . 3.63 108.784 158.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -100.82 88.27 3.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.968 0.889 . . . . 4.48 110.414 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.0 135.93 34.25 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.053 0.941 . . . . 1.41 110.396 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -105.63 126.88 52.66 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.406 0.891 . . . . 3.0 113.406 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -117.86 146.51 43.84 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.615 1.566 . . . . 1.97 109.744 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -98.98 124.96 44.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.285 1.434 . . . . 2.42 111.091 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.5 mm -86.83 59.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.557 1.543 . . . . 1.55 109.568 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -68.66 92.18 0.46 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.356 1.074 . . . . 3.76 110.995 -169.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.88 -18.2 1.6 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.333 1.921 . . . . 1.68 114.286 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.71 159.97 32.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.7 1.25 . . . . 2.91 111.342 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.9 p -146.52 -15.28 0.44 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.918 2.192 . . . . 1.73 116.918 -166.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.7 m -161.73 160.5 28.55 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.605 1.962 . . . . 2.97 109.68 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.15 -32.7 49.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.345 1.058 . . . . 1.3 113.141 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.78 93.76 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.248 0.833 . . . . 1.47 113.248 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 5.5 m -71.01 -38.23 72.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.017 0.927 . . . . 1.31 111.23 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.31 -59.81 4.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.137 0.975 . . . . 0.85 111.638 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -62.23 -30.84 71.39 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.259 -0.901 . . . . 2.0 113.009 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -53.79 -49.15 68.92 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.164 0.986 . . . . 3.43 113.237 169.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.1 pt -79.64 -32.18 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 118.082 -0.961 . . . . 0.98 112.054 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.0 -44.74 71.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.903 0.774 . . . . 2.54 110.554 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -54.74 -19.46 6.35 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 3.9 115.076 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -94.47 -58.76 2.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.344 0.975 . . . . 3.56 111.869 162.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -47.87 -43.08 28.1 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.397 1.479 . . . . 1.03 113.257 -174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -41.74 -40.47 2.02 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.354 2.261 . . . . 1.92 114.51 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -151.04 52.96 0.86 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.1 1.36 . . . . 3.3 112.981 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.7 mt -64.0 79.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 119.683 1.129 . . . . 2.63 111.315 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.05 17.82 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.597 1.959 . . . . 6.95 113.328 141.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.8 -22.86 1.47 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 126.531 2.015 . . . . 2.44 112.343 -155.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.57 128.02 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 117.633 0.716 . . . . 2.66 111.428 157.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.75 -49.7 6.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.665 1.186 . . . . 1.54 111.715 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -143.54 143.68 31.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.245 0.618 . . . . 1.81 110.947 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.26 109.04 1.7 Allowed Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 112.926 0.713 . . . . 1.3 112.926 165.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -90.67 136.09 2.13 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.14 3.227 . . . . 1.18 110.099 163.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -101.11 126.45 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.206 1.003 . . . . 1.07 108.743 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -70.63 138.04 50.44 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.782 1.633 . . . . 2.44 112.876 -173.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -89.78 -19.54 24.59 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.789 1.403 . . . . 4.29 114.789 -171.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.5 -41.92 2.68 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.94 0.896 . . . . 1.56 112.647 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -23.04 60.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.646 1.578 . . . . 1.76 111.588 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 64.51 50.18 2.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.892 1.277 . . . . 2.37 108.64 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 69.3 p -129.34 173.56 10.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.069 1.748 . . . . 1.13 110.113 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.89 138.52 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.284 1.433 . . . . 0.9 109.716 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.3 m -99.4 105.8 17.79 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.288 1.435 . . . . 1.04 107.966 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -103.03 107.67 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.625 0.77 . . . . 1.37 109.676 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.27 111.19 23.34 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.026 1.33 . . . . 2.92 110.142 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.33 -175.37 4.22 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.034 1.124 . . . . 3.66 114.034 -168.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.97 104.66 26.89 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.251 1.02 . . . . 3.1 109.763 168.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.88 -5.55 17.32 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.193 2.595 . . . . 2.47 114.206 -173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -61.58 -33.31 73.66 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.276 -0.89 . . . . 4.76 113.321 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.98 -54.77 5.7 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.607 1.094 . . . . 4.85 112.493 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.55 145.88 43.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.644 1.178 . . . . 2.32 111.811 -163.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 t -143.12 -157.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.442 0.697 . . . . 3.76 111.988 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -29.32 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.743 1.617 . . . . 1.73 113.254 -172.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.5 m -61.67 -60.58 3.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.574 1.079 . . . . 2.22 111.304 169.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.89 -48.61 72.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.62 1.568 . . . . 2.85 111.105 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.21 -42.95 58.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.441 1.096 . . . . 1.7 112.18 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -59.49 -47.48 85.34 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 120.905 -1.122 . . . . 3.23 111.403 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -69.74 -20.93 63.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.707 1.14 . . . . 4.29 113.124 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.62 -44.53 56.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.189 -0.945 . . . . 1.77 113.271 165.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.3 t -81.26 -22.15 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 N-CA-C 113.653 0.983 . . . . 1.1 113.653 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.99 -32.74 73.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.505 1.122 . . . . 3.37 111.744 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -67.8 -26.27 66.0 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.835 1.654 . . . . 3.67 112.683 172.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.0 -7.13 56.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.338 1.455 . . . . 1.56 113.125 170.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.18 4.01 56.56 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 118.103 -1.387 . . . . 1.32 116.125 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.613 1.706 . . . . 3.57 111.315 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -148.01 172.4 14.29 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.218 -1.552 . . . . 2.87 110.966 171.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 70.7 mt -125.4 101.7 7.07 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.096 1.358 . . . . 1.53 109.686 -172.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -89.82 123.81 34.12 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 122.233 -0.292 . . . . 2.53 111.441 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.65 150.12 41.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.806 -1.184 . . . . 2.26 112.819 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.74 111.1 22.0 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.145 2.178 . . . . 5.1 108.533 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.79 -45.03 1.3 Allowed Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.085 1.802 . . . . 2.4 111.799 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.48 12.09 9.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.035 1.334 . . . . 4.85 114.567 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.35 -61.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 117.839 -1.077 . . . . 3.19 113.543 151.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -76.26 -45.27 33.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.617 1.099 . . . . 3.87 111.728 -166.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.249 1.033 1 C-N-CA 132.355 4.262 . . . . 3.13 107.878 -173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.469 -0.567 . . . . 12.07 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.8 tp 34.39 60.45 0.59 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 129.064 2.945 . . . . 9.96 115.414 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.2 t -62.94 -17.09 61.45 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.446 1.647 . . . . 5.25 115.446 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -179.02 146.07 0.29 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.41 2.284 . . . . 5.5 108.853 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -96.2 136.97 35.95 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 107.313 -1.365 . . . . 4.12 107.313 172.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -120.72 148.38 44.04 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.787 1.403 . . . . 4.95 114.787 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 pm0 -108.36 149.17 29.05 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.496 1.919 . . . . 3.38 113.632 -160.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.2 tp -157.64 153.67 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.757 1.623 . . . . 3.0 110.545 165.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.12 153.4 40.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.703 0.683 . . . . 1.23 111.028 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 96.2 mtp -150.39 148.18 28.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.005 1.722 . . . . 2.97 111.539 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.87 144.75 48.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.685 -1.228 . . . . 2.52 107.685 164.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -140.44 150.33 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.952 1.701 . . . . 1.8 109.012 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -145.62 166.85 24.58 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.637 1.718 . . . . 2.45 115.637 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.43 15.37 47.44 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.317 1.437 . . . . 1.63 112.753 -165.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 35.5 mtm -87.31 14.74 7.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.44 1.62 . . . . 1.86 114.295 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -4.08 7.73 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.521 1.304 . . . . 3.27 114.521 -170.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -95.83 2.0 53.47 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.779 1.232 . . . . 4.26 112.263 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.27 -49.62 0.65 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.34 3.056 . . . . 3.24 114.131 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.66 44.83 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.035 1.334 . . . . 2.01 112.9 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.6 m -45.96 -45.06 15.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.858 1.663 . . . . 2.13 112.232 162.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.91 72.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.591 0.757 . . . . 1.16 112.07 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -41.31 84.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.048 0.939 . . . . 1.18 112.26 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -62.94 -38.73 92.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.502 1.521 . . . . 4.07 112.651 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.4 mm -68.86 -51.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 120.107 1.321 . . . . 2.01 111.828 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -63.01 -47.33 83.57 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.567 0.621 . . . . 1.29 110.884 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -57.65 -42.87 84.35 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.776 -1.202 . . . . 2.75 112.467 170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.48 97.56 Favored Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.847 1.689 . . . . 0.78 114.03 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.54 -46.22 33.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.713 1.256 . . . . 2.07 111.634 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.48 -8.32 1.18 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.01 1.485 . . . . 3.19 115.01 -170.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -69.14 -24.28 64.07 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.416 -1.427 . . . . 5.36 114.492 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -108.94 145.5 31.84 Favored Pre-proline 0 N--CA 1.481 1.104 0 N-CA-C 114.51 1.3 . . . . 2.52 114.51 -167.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.34 -21.37 72.57 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.998 3.132 . . . . 2.72 113.684 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.13 3.25 62.48 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.099 -1.389 . . . . 1.31 115.054 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.54 159.88 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.968 1.884 . . . . 1.93 110.569 171.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -140.66 -10.59 1.04 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.655 1.354 . . . . 2.17 114.655 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -160.12 149.71 17.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.162 0.892 . . . . 2.82 112.289 163.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.71 127.02 12.19 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.089 1.356 . . . . 0.81 108.67 173.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -133.37 123.33 25.18 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.556 1.142 . . . . 2.0 109.527 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.2 123.0 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 122.32 1.057 . . . . 1.88 110.779 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -91.57 106.45 18.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.012 1.725 . . . . 2.43 108.595 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.13 -29.08 61.64 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.15 0.887 . . . . 2.73 113.359 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.97 30.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.765 1.226 . . . . 1.97 113.972 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -140.49 25.48 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.393 1.477 . . . . 2.7 110.623 167.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 25.63 58.09 0.05 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 129.085 2.954 . . . . 2.81 115.354 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.1 m -138.01 132.82 32.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.214 1.406 . . . . 1.34 110.991 -171.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.2 t -109.48 142.89 39.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.108 1.763 . . . . 1.27 111.947 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -138.98 124.41 19.34 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.888 1.675 . . . . 1.19 108.219 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.8 140.6 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 119.132 0.878 . . . . 2.02 111.129 -168.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.47 123.87 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.484 1.514 . . . . 1.29 108.923 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.65 167.25 22.6 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.629 1.344 . . . . 3.28 114.629 -165.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -100.48 121.44 53.14 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.136 1.774 . . . . 3.51 110.503 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.87 -1.28 11.46 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.768 2.312 . . . . 2.25 114.364 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.99 -57.6 2.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 120.336 1.426 . . . . 2.84 112.821 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -87.97 9.67 21.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.066 0.946 . . . . 3.45 113.383 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -159.98 144.39 14.67 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.436 1.494 . . . . 2.03 110.251 176.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.62 160.42 28.97 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.211 1.386 . . . . 1.84 111.899 172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 t -70.7 -19.45 62.76 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.898 1.444 . . . . 3.09 114.898 -168.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.18 -42.47 20.78 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.207 0.912 . . . . 1.84 111.896 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.46 -23.26 37.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.553 1.141 . . . . 1.22 113.735 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mm -60.0 -56.13 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.851 1.26 . . . . 2.89 112.102 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.15 -27.89 29.78 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.546 1.066 . . . . 5.18 112.293 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.11 -30.65 70.49 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.12 0.873 . . . . 3.71 111.921 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -64.44 -29.25 70.3 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.277 -1.515 . . . . 2.43 112.907 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -66.44 -53.31 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.896 0.878 . . . . 1.33 109.086 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -49.9 -44.47 50.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.684 1.194 . . . . 3.45 111.723 170.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.48 0.82 13.46 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.277 1.955 . . . . 7.07 116.277 177.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.97 -8.79 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.61 1.095 . . . . 1.63 113.171 162.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.35 13.75 37.73 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.51 -1.161 . . . . 1.51 114.981 171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -122.8 147.55 46.4 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.912 1.685 . . . . 5.39 108.208 170.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -107.26 136.19 47.5 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.107 -0.996 . . . . 3.98 112.483 -161.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.37 33.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.888 -1.133 . . . . 4.23 113.405 -170.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.259 4.9 m 32.46 50.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 129.693 3.197 . . . . 2.77 111.669 -166.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 p -76.86 126.26 30.68 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 113.011 -1.904 . . . . 2.24 109.934 -166.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -133.37 161.2 35.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.544 1.138 . . . . 3.51 109.849 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -116.49 143.93 44.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.82 1.248 . . . . 5.63 110.958 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.82 158.72 43.55 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.999 1.32 . . . . 1.0 110.376 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.73 131.0 46.16 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.422 1.089 . . . . 2.34 109.191 171.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.19 156.91 27.92 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.041 1.336 . . . . 2.28 110.219 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -105.06 137.39 42.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.08 1.352 . . . . 2.18 110.179 167.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.6 mm -99.31 124.0 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 124.667 1.187 . . . . 2.31 109.398 168.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.11 90.32 4.56 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.577 -1.638 . . . . 4.42 106.577 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 137' ' ' TYR . . . 176.63 -52.75 0.11 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 117.539 1.776 . . . . 1.45 117.539 -168.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -99.97 143.69 29.88 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.021 1.119 . . . . 2.77 114.021 -162.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.8 p -136.75 7.58 3.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.617 1.567 . . . . 1.58 114.708 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.33 159.01 22.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.881 2.473 . . . . 2.68 110.02 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.64 84.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.499 0.72 . . . . 1.85 112.697 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.21 -32.69 64.64 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 119.45 1.023 . . . . 1.96 113.658 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.3 m -75.51 -32.45 60.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.961 0.904 . . . . 1.56 112.48 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.17 -51.12 65.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.345 0.658 . . . . 1.09 110.805 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -59.55 -29.47 67.94 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.77 -1.206 . . . . 3.84 113.376 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -57.11 -47.31 81.39 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.47 1.108 . . . . 3.3 112.891 170.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.4 pt -80.51 -37.56 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.402 -0.811 . . . . 1.04 112.493 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -51.54 -51.82 52.13 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.058 1.743 . . . . 3.29 111.955 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 tmpt? -62.31 -26.34 68.37 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.857 1.058 . . . . 4.5 113.857 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.2 mmt-85 -76.5 -59.99 2.53 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.469 -0.777 . . . . 4.83 110.416 167.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.16 -33.17 64.97 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.152 1.381 . . . . 1.1 114.166 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -57.01 -39.56 74.97 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.31 0.959 . . . . 3.23 112.327 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -142.35 54.67 1.44 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 2.78 111.155 -161.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.4 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 10.3 mt -78.9 -115.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.087 0.955 . . . . 2.1 109.147 164.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -122.93 118.61 28.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.895 -2.261 . . . . 4.55 104.895 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.36 -24.4 5.6 Favored Glycine 0 N--CA 1.482 1.717 0 O-C-N 120.42 -1.425 . . . . 1.25 114.628 166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 16.0 m -61.19 147.08 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.658 1.583 . . . . 2.19 112.011 158.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -116.89 -45.78 2.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.956 1.302 . . . . 1.17 113.442 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -144.34 155.74 43.93 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.91 0.884 . . . . 1.52 111.419 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 91.45 1.57 Allowed Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 113.302 0.853 . . . . 1.13 113.302 174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -80.82 127.03 6.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.81 2.34 . . . . 1.32 110.618 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -97.98 143.74 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.946 0.898 . . . . 1.62 111.215 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.21 141.36 28.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.479 1.512 . . . . 2.84 112.696 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -106.87 4.72 27.68 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.025 1.491 . . . . 5.6 115.025 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -133.93 -38.53 0.88 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.36 1.064 . . . . 2.25 111.988 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.87 -19.63 47.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.708 1.603 . . . . 2.25 112.759 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 72.49 14.93 5.19 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.662 2.385 . . . . 3.08 114.538 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 51.4 p -99.14 166.91 11.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.178 0.991 . . . . 1.32 110.695 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.78 131.64 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.445 1.098 . . . . 0.86 108.971 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.1 m -83.31 136.4 34.38 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 106.859 -1.534 . . . . 1.1 106.859 168.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.28 138.99 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.189 1.395 . . . . 0.8 109.344 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -125.45 121.29 33.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.578 1.951 . . . . 2.5 108.387 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.3 174.8 13.03 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.433 0.901 . . . . 2.72 113.433 -157.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -99.42 134.96 20.82 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.542 -0.723 . . . . 3.32 110.6 157.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.69 8.11 4.81 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.672 2.914 . . . . 1.57 113.3 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -98.71 -45.11 6.16 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.938 -1.101 . . . . 3.45 112.965 -167.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -112.97 7.14 18.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.615 1.166 . . . . 3.53 113.781 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.72 146.9 45.99 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.296 1.438 . . . . 1.73 109.787 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -157.48 160.01 37.84 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.315 -0.865 . . . . 2.27 112.684 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.67 -22.53 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.289 1.035 . . . . 1.34 112.616 -164.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.1 m -61.93 -49.55 75.71 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.499 1.045 . . . . 2.06 111.319 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -66.18 -38.59 88.41 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.051 0.941 . . . . 3.42 111.644 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.7 mt -64.45 -47.61 78.43 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.687 -0.633 . . . . 1.52 111.67 176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -62.33 -45.58 92.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 117.968 -1.015 . . . . 3.8 111.559 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.35 -32.53 68.62 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.656 0.984 . . . . 2.56 113.656 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 -42.5 26.25 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.721 0.808 . . . . 1.68 113.11 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.2 t -74.53 -26.53 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 118.524 -0.75 . . . . 1.13 112.335 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.88 -51.1 43.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.404 1.082 . . . . 2.43 110.265 165.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -67.12 -31.28 71.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.984 1.314 . . . . 3.75 113.028 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.29 -7.25 53.44 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.187 1.181 . . . . 1.63 114.187 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.28 10.03 52.18 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.737 1.055 . . . . 1.65 115.737 170.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CD1' ' HA3' ' A' ' 82' ' ' GLY . 18.0 m-85 -123.77 -161.82 1.01 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.77 1.628 . . . . 3.06 110.317 174.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 164.64 35.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.241 1.416 . . . . 2.84 109.251 167.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.6 mt -113.78 118.26 33.78 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.4 1.08 . . . . 1.04 110.209 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -92.4 156.05 17.47 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.306 0.642 . . . . 3.31 109.341 161.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 8.8 mt -113.29 149.42 33.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.271 1.028 . . . . 1.47 111.536 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -84.14 110.2 18.32 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.133 2.173 . . . . 3.91 106.747 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 -47.73 2.72 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.77 1.176 . . . . 2.03 111.848 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -76.51 -14.85 60.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.588 1.699 . . . . 4.54 115.588 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.574 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 44.3 mt-30 -141.07 -56.54 0.5 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.52 1.509 . . . . 2.32 114.283 171.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.2 -12.23 18.18 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.151 1.341 . . . . 3.0 113.862 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.246 0.874 0 C-N-CA 130.002 3.321 . . . . 2.58 110.592 175.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 119.276 -0.392 . . . . 14.7 110.245 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.2 mt -131.17 165.65 22.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.538 1.535 . . . . 12.46 109.911 166.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 167.92 97.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.85 2.46 . . . . 7.25 107.426 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 169.7 123.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.858 2.463 . . . . 5.68 109.207 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -84.66 120.63 26.6 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.597 -0.689 . . . . 4.06 110.099 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -123.92 156.25 36.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.66 1.184 . . . . 4.71 111.305 -172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.63 165.45 18.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.462 1.905 . . . . 3.63 111.933 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 tp -168.85 160.6 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 129.118 2.967 . . . . 3.96 108.806 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.66 145.69 36.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.001 0.92 . . . . 1.48 111.151 171.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -144.67 153.31 41.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.982 2.113 . . . . 3.47 110.115 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.74 154.41 40.8 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.608 -0.682 . . . . 4.87 111.173 164.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' CE2' ' A' ' 69' ' ' TYR . 2.5 p -142.1 94.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.704 1.602 . . . . 2.48 109.367 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t -100.61 161.0 13.89 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.622 -1.298 . . . . 2.24 114.345 -162.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.79 13.68 71.82 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.703 1.144 . . . . 1.2 114.924 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.8 mtm -75.28 8.81 2.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.327 1.973 . . . . 2.37 116.327 -171.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.9 p -79.45 22.54 0.44 Allowed 'General case' 0 N--CA 1.484 1.226 0 O-C-N 119.924 -1.735 . . . . 2.94 115.125 -164.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.6 t -102.45 -0.84 31.77 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.54 1.936 . . . . 3.81 111.673 159.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.24 -53.05 0.69 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.484 3.114 . . . . 2.59 113.656 172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.15 -11.0 17.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.969 1.308 . . . . 1.3 113.379 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 33.9 m -43.04 -47.99 5.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.488 . . . . 1.61 111.606 160.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.48 -59.66 4.01 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.05 0.94 . . . . 1.0 111.918 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.94 77.03 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.767 1.227 . . . . 0.99 112.593 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -65.25 -38.28 89.86 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.788 1.235 . . . . 3.77 112.846 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.55 -42.47 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.546 1.066 . . . . 2.17 110.531 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.75 -51.22 70.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.686 0.676 . . . . 1.38 110.569 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -58.77 -40.18 83.19 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.948 -1.095 . . . . 2.85 112.743 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.69 -38.25 94.33 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.377 0.989 . . . . 0.96 113.546 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.89 -40.16 65.81 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.743 1.271 . . . . 1.92 111.776 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.61 -9.59 9.43 Favored 'General case' 0 CA--C 1.555 1.162 0 O-C-N 121.131 -0.981 . . . . 4.74 113.263 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -92.45 4.11 54.13 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.565 1.946 . . . . 4.63 114.346 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.0 mtp -92.82 156.05 41.1 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 120.555 1.525 . . . . 2.11 111.257 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.97 -66.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.477 2.118 . . . . 2.19 112.268 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.44 16.08 15.47 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.529 1.062 . . . . 1.59 114.874 -170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -98.88 110.56 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.461 1.904 . . . . 1.66 107.563 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 t -87.84 -31.51 19.5 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 116.404 -1.76 . . . . 1.74 111.734 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -160.55 156.93 26.55 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 120.409 1.459 . . . . 2.74 114.009 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.26 137.9 18.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.033 1.333 . . . . 0.9 110.689 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -148.36 144.67 27.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.751 0.82 . . . . 3.74 112.384 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 p -102.65 137.07 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.144 0.977 . . . . 2.05 111.709 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -93.39 -4.17 51.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.923 1.823 . . . . 3.52 115.923 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.5 tt 66.24 -72.08 0.08 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.659 1.984 . . . . 3.79 111.965 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.91 -13.04 21.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.772 2.029 . . . . 2.25 115.466 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 p -118.61 -2.64 10.95 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.597 0.962 . . . . 2.84 113.597 168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 72.92 25.52 2.4 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.92 0.888 . . . . 2.91 110.166 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.6 m -110.88 134.72 52.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.223 2.209 . . . . 1.39 110.937 -172.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.9 m -98.61 135.72 39.72 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.251 1.021 . . . . 1.82 110.292 163.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -116.73 120.11 37.56 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.07 2.148 . . . . 1.68 107.188 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.58 150.39 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 118.492 0.587 . . . . 2.83 112.078 -165.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.11 123.67 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.894 1.278 . . . . 1.11 110.298 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -164.48 163.78 22.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.701 1.6 . . . . 3.54 114.794 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.89 137.77 31.48 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.962 1.705 . . . . 4.27 114.069 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.29 -2.1 7.78 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.152 3.235 . . . . 3.38 115.188 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.69 -54.39 2.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.415 1.461 . . . . 3.64 110.121 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.86 -4.86 14.06 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.441 1.897 . . . . 5.89 114.647 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 m -155.98 -61.74 0.11 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.004 1.275 . . . . 3.01 111.805 176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.67 152.52 9.8 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 122.121 0.845 . . . . 1.72 114.736 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -63.89 -39.6 94.56 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.234 1.414 . . . . 3.14 113.935 -167.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.25 75.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.468 0.544 . . . . 0.99 112.468 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.63 74.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.56 -0.712 . . . . 1.07 112.191 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.17 -58.03 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 118.767 0.712 . . . . 2.29 109.138 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -64.96 -36.19 83.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.012 0.824 . . . . 2.05 112.185 -171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.94 -39.84 95.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.559 0.744 . . . . 3.01 111.729 174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -69.42 -38.22 77.78 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.189 -0.944 . . . . 2.31 112.331 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.444 HG22 ' CE1' ' A' ' 69' ' ' TYR . 21.2 mt -65.62 -43.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.904 1.229 . . . . 2.01 110.004 174.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -63.22 -30.12 71.33 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.099 0.863 . . . . 3.1 112.239 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -66.13 -16.56 64.07 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.733 1.383 . . . . 3.9 114.733 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.12 -28.08 57.34 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.695 1.589 . . . . 1.36 111.899 166.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.34 18.54 13.04 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 119.746 1.157 . . . . 1.32 115.398 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -74.96 -164.71 0.31 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 124.905 1.282 . . . . 9.94 112.794 168.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -124.13 116.64 23.08 Favored 'General case' 0 CA--C 1.554 1.097 0 O-C-N 121.456 -0.777 . . . . 4.98 111.953 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.61 -17.82 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.12 1.368 . . . . 2.8 114.548 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.313 7.9 p 58.39 48.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 127.932 2.493 . . . . 2.53 113.382 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 p -99.17 152.25 20.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.899 1.68 . . . . 1.91 114.224 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -135.97 159.49 41.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.274 1.829 . . . . 3.2 108.56 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -117.91 146.78 43.69 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.788 0.835 . . . . 3.32 112.525 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.84 159.71 42.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.575 1.55 . . . . 1.0 110.848 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -128.68 137.75 51.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.857 0.837 . . . . 2.65 109.83 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -127.06 155.27 43.53 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.203 1.801 . . . . 1.93 110.469 -170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -109.1 125.28 51.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.473 1.509 . . . . 2.94 108.628 169.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.57 133.59 29.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.946 -1.502 . . . . 1.51 106.946 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -112.17 123.8 51.05 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.193 -1.41 . . . . 3.88 107.193 158.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 133.09 -36.79 2.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.957 1.265 . . . . 2.02 113.812 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.1 ptt? -95.54 148.55 22.38 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.981 0.89 . . . . 2.86 112.597 -176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 p -135.73 -10.14 2.1 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.981 1.845 . . . . 2.74 115.981 -160.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.2 t -168.64 178.5 4.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.985 1.314 . . . . 1.8 111.769 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.707 2.003 . . . . 1.74 114.015 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.64 74.04 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.666 0.667 . . . . 1.69 112.424 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.86 -36.93 70.28 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.472 1.109 . . . . 1.3 112.108 -177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.65 71.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.377 1.071 . . . . 1.13 111.609 165.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.57 -40.27 78.59 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.151 -0.968 . . . . 2.92 112.639 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -43.15 -47.85 6.27 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 126.221 1.808 . . . . 4.84 114.629 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.3 pt -84.64 -33.04 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 116.452 -1.737 . . . . 1.55 112.891 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -49.31 -54.17 18.38 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.626 1.557 . . . . 3.96 112.009 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -55.49 -19.88 11.04 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.153 1.168 . . . . 3.86 114.153 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -101.22 -45.12 5.46 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.105 1.362 . . . . 3.86 113.317 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -55.89 -36.62 67.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.96 1.704 . . . . 1.28 111.626 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -47.88 -39.21 18.14 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.878 1.671 . . . . 2.45 113.291 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -153.77 76.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.974 1.71 . . . . 4.68 111.491 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.528 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 13.2 mt -78.4 -111.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.846 1.258 . . . . 2.07 110.298 168.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.52 121.58 27.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.305 -2.109 . . . . 3.92 105.305 166.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.69 -18.28 30.96 Favored Glycine 0 N--CA 1.481 1.695 0 C-N-CA 125.263 1.411 . . . . 1.54 114.463 165.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.528 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 17.1 m -64.72 137.83 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.626 1.97 . . . . 1.87 112.962 165.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -114.52 -36.63 4.53 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.394 1.077 . . . . 1.16 113.227 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -139.56 146.22 39.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.517 0.727 . . . . 2.07 109.796 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.86 63.52 3.13 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 114.621 1.341 . . . . 0.94 114.621 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.36 107.36 1.57 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.79 2.326 . . . . 1.06 112.031 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.36 131.63 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.148 1.779 . . . . 1.04 111.451 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -87.18 135.93 33.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.376 1.87 . . . . 2.96 111.879 169.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -104.48 -10.12 17.89 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 115.303 1.594 . . . . 3.64 115.303 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.75 -37.04 5.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.355 1.062 . . . . 1.95 111.767 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -18.56 44.82 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.71 1.604 . . . . 1.85 112.082 176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 70.57 17.22 6.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.45 2.3 . . . . 2.63 113.582 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 p -99.35 165.8 11.5 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.861 -1.149 . . . . 1.22 111.49 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.9 136.88 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 108.976 -0.75 . . . . 0.66 108.976 165.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.7 m -97.78 129.1 44.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 106.774 -1.565 . . . . 0.83 106.774 174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.11 138.11 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.83 109.924 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -134.38 124.99 26.63 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.014 1.326 . . . . 4.26 109.69 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.38 164.82 27.09 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.086 0.773 . . . . 2.66 113.086 -155.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . 0.351 27.9 p30 -99.15 120.79 57.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 119.71 1.141 . . . . 2.41 112.672 164.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.16 1.13 9.5 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 123.849 3.033 . . . . 1.46 113.843 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -54.28 -39.24 66.73 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.81 1.041 . . . . 3.67 113.81 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -128.79 -3.11 5.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.686 1.195 . . . . 4.05 113.454 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.96 131.41 56.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.675 1.19 . . . . 2.26 111.601 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.2 t -156.04 -175.05 5.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.669 0.788 . . . . 3.29 112.464 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.55 -20.07 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.087 1.755 . . . . 1.36 112.639 -172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.8 m -63.3 -51.01 67.83 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.318 -0.864 . . . . 1.91 111.42 168.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -63.39 -46.32 86.98 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.389 1.076 . . . . 2.87 110.645 178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.9 -44.16 93.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.466 0.706 . . . . 1.46 111.301 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -64.03 -52.71 58.16 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.271 -1.347 . . . . 2.57 111.636 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.9 -20.12 65.61 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 121.035 1.743 . . . . 2.32 113.83 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.4 56.36 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.678 1.362 . . . . 2.0 114.678 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.5 t -98.64 -24.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 125.908 1.683 . . . . 1.4 113.439 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -50.73 -53.54 30.65 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.153 1.781 . . . . 3.15 112.861 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -72.74 -12.38 60.99 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.786 1.234 . . . . 3.17 113.264 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.24 -5.11 59.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 2.15 112.601 168.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.76 0.44 24.43 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.74 1.638 . . . . 1.74 115.68 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.09 -168.77 2.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.228 1.514 . . . . 3.43 112.839 -164.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 161.05 41.67 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.112 1.365 . . . . 3.2 111.13 162.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 53.0 mt -111.21 106.55 15.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.337 1.455 . . . . 1.64 110.482 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -77.88 148.62 34.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.974 0.91 . . . . 3.65 110.37 162.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.5 mt -86.38 149.64 24.88 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 120.717 -1.239 . . . . 1.87 111.29 168.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -95.44 117.65 30.75 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.545 1.538 . . . . 5.29 107.796 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.28 -44.56 1.38 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.561 1.553 . . . . 2.05 112.444 -168.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.267 37.1 tt0 -82.07 -2.22 51.11 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.703 1.372 . . . . 3.28 114.703 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -143.74 -74.73 0.26 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.956 1.095 . . . . 2.24 113.956 164.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -104.83 -1.78 25.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.747 1.018 . . . . 3.36 113.747 -163.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 129.942 3.297 . . . . 3.28 112.177 164.32 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 118.215 -0.897 . . . . 14.28 109.549 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 pp -81.03 176.57 9.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.464 0.574 . . . . 8.72 110.73 163.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 m 164.83 -40.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 128.934 2.894 . . . . 6.22 111.951 170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -149.84 155.27 39.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.571 1.548 . . . . 6.16 110.477 -177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -104.32 171.88 7.1 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.661 1.184 . . . . 3.1 111.291 -174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.91 168.45 26.92 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.268 1.21 . . . . 3.85 114.268 174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -119.72 148.7 43.08 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.509 1.67 . . . . 2.71 115.509 -158.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 mp -141.24 142.85 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.35 1.86 . . . . 3.3 108.984 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.77 106.18 9.18 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.917 1.235 . . . . 2.1 111.369 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mtp -109.64 134.25 52.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.263 1.025 . . . . 3.27 111.769 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.66 123.06 26.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.936 -0.764 . . . . 3.06 108.936 176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.51 90.78 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.27 1.428 . . . . 1.89 109.885 -163.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.9 p -90.75 127.5 36.35 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.649 1.351 . . . . 2.07 114.649 -155.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.57 20.85 1.49 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.564 1.554 . . . . 1.05 114.682 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.7 mtm -81.88 23.76 0.66 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.517 1.658 . . . . 2.13 114.236 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.5 p -65.35 -6.48 10.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.104 1.762 . . . . 2.95 115.418 -171.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.6 t -101.24 -0.41 35.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.428 1.891 . . . . 3.3 112.326 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 70.55 -48.18 0.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.723 2.809 . . . . 2.28 114.345 175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.81 -9.21 18.93 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.31 1.444 . . . . 1.27 113.02 175.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 26.9 m -50.18 -38.54 40.27 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.367 1.467 . . . . 1.48 112.42 162.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.5 21.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.356 1.062 . . . . 1.05 111.753 171.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.56 -47.11 57.94 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.7 1.2 . . . . 1.03 112.204 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -57.64 -38.11 74.47 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 2.81 113.208 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.2 mt -70.93 -55.19 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.575 1.08 . . . . 2.78 110.8 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.54 -46.41 86.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.388 0.54 . . . . 1.61 111.313 -175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 7.6 ptpt -70.94 -27.77 64.0 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.219 -0.926 . . . . 3.98 113.06 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.53 -42.44 55.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.936 1.255 . . . . 0.93 112.806 174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -70.36 -35.53 73.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.453 1.126 . . . . 1.75 111.993 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -58.06 -9.67 1.51 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 114.324 1.231 . . . . 3.49 114.324 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -70.61 -30.96 67.76 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.38 -1.45 . . . . 3.97 114.602 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.6 ptm -104.27 108.28 59.86 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 119.751 1.16 . . . . 2.45 111.32 -167.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.77 -13.1 37.63 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.244 2.629 . . . . 2.35 114.614 -166.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.97 -10.22 72.52 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.592 -1.116 . . . . 1.91 113.683 168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.9 136.94 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.966 1.706 . . . . 2.09 107.2 164.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -116.08 -30.29 6.05 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 117.975 -1.012 . . . . 1.97 112.338 174.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.66 136.67 54.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.58 1.082 . . . . 4.74 111.901 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.98 136.61 49.62 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.056 1.343 . . . . 1.12 109.336 160.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -147.0 98.61 3.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.124 1.37 . . . . 2.52 109.2 -170.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.15 118.77 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 120.888 -1.132 . . . . 1.83 112.657 -170.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -83.54 97.25 8.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.902 1.281 . . . . 2.0 108.551 169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.31 -38.58 89.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.522 0.729 . . . . 2.49 111.767 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.8 -31.17 72.1 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 115.019 1.488 . . . . 2.2 115.019 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.6 t -114.62 10.1 16.67 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.022 . . . . 3.27 113.332 167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 67.6 39.59 2.75 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.08 1.352 . . . . 3.02 113.549 168.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.8 m -125.68 130.8 52.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.693 1.597 . . . . 1.6 112.08 -173.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.7 t -99.69 118.64 36.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.818 1.247 . . . . 1.52 111.647 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -99.77 118.5 36.39 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.815 1.646 . . . . 1.46 108.714 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.86 153.45 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.248 1.019 . . . . 2.21 112.238 -170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.04 129.35 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.874 1.269 . . . . 1.48 110.653 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.95 158.07 44.46 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.184 1.394 . . . . 2.78 114.608 -165.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -99.03 134.48 21.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.964 2.106 . . . . 3.02 110.95 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.03 -13.64 15.6 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.847 2.364 . . . . 2.11 115.473 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.08 -32.55 10.08 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.962 1.467 . . . . 2.02 114.962 -163.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -93.43 1.64 56.78 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.01 0.924 . . . . 3.34 113.217 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 m -154.5 -108.76 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.083 1.353 . . . . 3.25 108.975 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.07 161.14 9.21 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.116 1.341 . . . . 1.15 111.604 -164.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.0 t -70.55 -45.34 65.67 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.202 1.001 . . . . 2.24 112.972 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.57 -30.34 68.58 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.628 0.973 . . . . 0.97 113.628 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.72 69.9 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.895 0.878 . . . . 0.96 112.908 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.86 -49.73 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.689 0.796 . . . . 1.66 109.754 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -68.85 -37.46 79.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 117.827 -1.082 . . . . 2.67 111.502 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.53 -43.02 84.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.385 1.448 . . . . 2.77 112.605 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.09 -30.59 67.85 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.899 0.772 . . . . 2.08 112.706 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.19 -53.97 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.508 1.123 . . . . 1.07 111.266 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.88 -19.76 65.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 118.329 0.513 . . . . 4.14 111.552 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.66 -19.91 43.47 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.206 -1.559 . . . . 4.17 114.357 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.66 -13.19 52.22 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.723 1.147 . . . . 1.67 112.895 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.72 21.66 36.14 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.509 1.052 . . . . 1.62 115.156 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -74.25 -164.36 0.24 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.374 1.07 . . . . 5.27 110.623 163.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -140.63 129.15 22.71 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.396 -0.815 . . . . 4.09 112.479 144.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.39 24.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.153 1.781 . . . . 3.11 114.923 -174.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 m 34.04 40.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.8 2.84 . . . . 2.29 116.045 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -102.12 150.28 23.42 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.543 1.537 . . . . 3.21 111.928 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.79 154.91 42.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.424 1.49 . . . . 3.67 110.133 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -98.58 141.69 31.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.017 0.747 . . . . 4.78 113.017 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.11 158.25 44.35 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.314 1.845 . . . . 1.18 111.166 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -114.41 129.94 56.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.76 1.224 . . . . 2.3 111.073 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -123.37 160.38 26.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.337 1.455 . . . . 2.14 110.459 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -114.08 121.73 44.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.269 1.828 . . . . 2.85 110.516 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 114' ' ' VAL . 8.2 mm -88.2 57.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.965 2.506 . . . . 1.88 109.009 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.05 111.17 2.77 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 121.209 -0.932 . . . . 3.95 109.502 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.08 -11.69 6.15 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.745 1.64 . . . . 1.24 114.338 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -82.41 130.23 35.06 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.541 1.671 . . . . 2.27 111.794 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.4 p -118.47 -6.02 10.76 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 114.979 1.474 . . . . 2.38 114.979 -168.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 43.3 t -149.53 153.93 37.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.019 1.728 . . . . 2.83 109.853 -174.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.54 -30.1 40.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.039 0.936 . . . . 1.45 113.008 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.1 77.6 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.142 0.793 . . . . 1.66 113.142 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 85.6 m -70.72 -38.25 73.58 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.253 -0.904 . . . . 1.53 111.769 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.72 -56.44 22.15 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.296 0.638 . . . . 1.02 110.802 168.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -54.06 -42.18 68.97 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.795 0.838 . . . . 2.7 112.756 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -55.23 -36.24 65.79 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.78 1.232 . . . . 3.52 114.288 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.96 -43.18 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.006 0.821 . . . . 1.11 111.952 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -53.01 -39.92 63.46 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.766 1.226 . . . . 2.35 111.995 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -58.47 -25.14 61.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.888 1.675 . . . . 2.99 114.489 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -104.21 -39.53 6.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.032 0.933 . . . . 3.38 112.498 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -60.69 -35.06 75.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.756 1.222 . . . . 1.81 112.239 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -26.82 -61.15 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.208 2.603 . . . . 1.95 114.546 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -141.02 70.31 1.35 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.073 1.349 . . . . 3.03 111.196 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.32 81.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.138 -1.601 . . . . 2.88 110.609 167.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 68.7 16.89 8.95 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.029 2.131 . . . . 3.79 112.399 144.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.26 -26.41 0.78 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.775 2.131 . . . . 1.67 111.432 -164.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.5 133.17 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 117.192 0.496 . . . . 1.65 111.374 161.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.91 -47.14 6.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.34 1.456 . . . . 1.01 112.816 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -139.67 155.41 47.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.983 0.913 . . . . 1.58 111.072 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -157.47 61.27 2.24 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.449 1.278 . . . . 1.3 114.449 171.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 120.41 6.02 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.152 2.568 . . . . 1.44 111.885 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.55 146.59 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.88 1.672 . . . . 1.05 110.058 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -77.38 -141.75 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.386 1.475 . . . . 2.93 110.768 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -164.22 -77.32 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.396 2.278 . . . . 6.77 107.5 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.59 -27.24 63.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.251 1.42 . . . . 1.73 114.709 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.24 -15.54 56.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.321 0.964 . . . . 1.51 111.585 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 71.35 17.54 5.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.133 2.573 . . . . 2.31 113.157 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 25.1 p -103.89 171.78 7.16 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.761 -1.212 . . . . 1.12 112.807 -171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -141.22 147.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.145 1.778 . . . . 0.89 108.608 165.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -103.73 125.16 50.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.071 -1.455 . . . . 1.1 107.071 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.67 140.96 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.991 1.316 . . . . 0.89 108.643 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -133.97 117.84 17.18 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.985 1.714 . . . . 2.56 109.452 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.43 160.81 21.01 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.483 1.29 . . . . 2.25 114.483 -169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -98.55 122.56 53.05 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.7 0.8 . . . . 2.39 111.118 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.54 3.1 7.94 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.322 2.681 . . . . 1.76 114.735 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -57.31 -36.38 71.01 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 120.166 -1.584 . . . . 6.15 112.239 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -123.52 18.8 9.65 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.828 1.251 . . . . 3.51 112.305 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 156.99 37.87 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.282 -1.511 . . . . 1.84 112.641 -172.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.5 t -165.16 -174.25 3.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.628 1.171 . . . . 2.64 111.195 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 t -61.44 -25.1 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.147 -0.971 . . . . 1.56 110.973 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.6 m -45.91 -60.24 2.36 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.716 1.606 . . . . 2.29 113.231 168.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.38 -40.25 90.17 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.25 1.42 . . . . 3.31 111.169 -173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.3 mt -69.81 -52.15 27.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.638 1.175 . . . . 1.63 109.687 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -49.1 -57.68 6.22 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.047 -1.033 . . . . 4.29 112.392 167.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.89 -11.13 60.26 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.755 0.707 . . . . 3.3 112.637 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.01 -45.53 15.2 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.393 1.257 . . . . 1.3 114.393 158.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.37 -25.81 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 119.601 1.092 . . . . 0.88 113.046 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -29.93 68.83 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.096 2.159 . . . . 2.36 112.09 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -64.1 -25.89 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.825 1.65 . . . . 2.81 112.59 173.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.46 -12.44 21.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.461 1.905 . . . . 2.06 112.472 172.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.17 89.16 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.717 1.627 . . . . 2.09 115.397 173.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.77 -177.04 5.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 119.129 1.464 . . . . 3.25 110.874 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.84 158.18 44.1 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.435 -1.416 . . . . 2.64 111.043 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.6 mt -114.05 92.7 4.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.595 1.158 . . . . 1.45 109.888 -171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -80.65 118.67 22.42 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.748 -0.66 . . . . 4.18 110.199 171.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.45 150.38 41.7 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.718 -1.239 . . . . 1.81 111.478 172.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -96.49 115.23 27.09 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.788 2.035 . . . . 4.48 107.107 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.52 -67.46 3.12 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.005 -1.238 . . . . 1.69 110.005 -164.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.263 63.0 mt-10 -81.09 37.24 0.43 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.687 1.736 . . . . 4.61 115.687 -170.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -175.88 -73.59 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.648 1.979 . . . . 2.95 109.954 165.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.32 -32.9 70.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.134 0.973 . . . . 3.09 111.297 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 127.808 2.443 . . . . 3.35 111.193 176.322 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 119.471 -0.3 . . . . 10.6 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.79 -163.65 0.15 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.393 1.877 . . . . 10.12 111.485 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.5 p -84.07 59.66 5.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.002 1.321 . . . . 6.42 111.875 -171.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.13 60.42 1.45 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.628 1.204 . . . . 5.57 110.266 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -92.71 159.14 15.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.565 1.946 . . . . 2.64 110.256 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 142.05 50.25 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.17 -0.956 . . . . 5.05 112.23 -173.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -98.38 159.71 14.76 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.112 1.365 . . . . 3.6 112.102 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -158.39 147.0 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 127.049 2.14 . . . . 2.77 108.843 177.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' N ' HD13 ' A' ' 8' ' ' ILE . . . -129.01 149.45 50.82 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.929 0.892 . . . . 0.94 110.812 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.5 mtt -148.88 139.99 23.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.152 1.781 . . . . 2.66 110.124 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.44 136.66 37.0 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.379 -1.341 . . . . 2.8 107.379 168.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.57 119.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.34 1.456 . . . . 1.62 109.336 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -111.03 125.31 53.61 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 114.007 1.114 . . . . 1.79 114.007 -161.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.86 20.48 2.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.08 1.8 . . . . 1.06 114.607 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.8 mtm -89.31 131.77 35.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.335 1.567 . . . . 1.72 112.642 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -115.46 108.99 17.2 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.598 1.959 . . . . 5.31 108.653 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m 64.05 -176.29 0.16 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.204 2.202 . . . . 5.98 112.825 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.42 -15.91 0.17 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.432 1.493 . . . . 4.14 114.832 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.02 -43.22 16.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.26 . . . . 1.93 112.85 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 95.7 m -66.4 -34.74 78.64 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.257 -0.902 . . . . 1.75 111.357 169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.22 70.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.937 0.495 . . . . 1.09 111.988 169.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.79 -40.5 66.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.914 0.886 . . . . 1.09 112.123 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -68.64 -35.18 76.93 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.871 1.063 . . . . 3.1 113.871 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.5 mm -64.02 -54.04 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 120.12 1.327 . . . . 1.58 110.863 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.54 -48.11 67.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.309 0.644 . . . . 1.62 111.254 -172.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -70.58 -7.56 44.95 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.901 -1.124 . . . . 3.46 113.736 174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.88 -57.69 3.19 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.287 1.422 . . . . 1.04 111.51 166.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.37 -38.61 78.15 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.951 -1.023 . . . . 1.59 113.286 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -57.77 -11.73 2.47 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.913 1.449 . . . . 5.69 114.913 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -77.96 -15.65 58.81 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.458 1.903 . . . . 5.11 112.841 176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.0 mmt -65.14 121.72 75.84 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 117.716 -1.135 . . . . 3.32 108.25 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -56.15 -39.67 89.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.576 2.851 . . . . 1.74 112.764 -162.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.89 51.38 0.8 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.636 1.112 . . . . 1.56 113.01 169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.9 p -76.71 124.95 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 106.18 -1.785 . . . . 1.6 106.18 143.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.439 ' H ' ' HA ' ' A' ' 50' ' ' TYR . 88.7 m -67.17 -51.16 57.07 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.358 1.063 . . . . 3.38 108.437 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.57 153.3 10.85 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.693 0.621 . . . . 2.92 112.302 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.52 129.3 42.69 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.832 1.253 . . . . 0.94 109.232 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.72 105.41 4.91 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.766 1.227 . . . . 2.48 108.808 -169.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.74 119.09 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 122.66 1.219 . . . . 1.92 113.492 -171.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -83.65 86.91 7.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.171 1.389 . . . . 2.14 109.748 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.7 pp -60.88 -31.77 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.173 0.805 . . . . 3.52 113.173 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -7.7 32.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.727 1.211 . . . . 2.12 113.982 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -136.91 26.12 3.01 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.356 1.462 . . . . 2.61 110.255 167.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 32.65 49.98 0.18 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.958 2.503 . . . . 3.21 115.315 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.3 m -133.72 127.97 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.97 1.308 . . . . 1.6 110.322 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.1 t -99.16 147.86 24.67 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.209 1.404 . . . . 1.41 111.709 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -132.39 111.02 10.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.795 1.638 . . . . 1.19 107.542 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.11 141.25 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.832 0.853 . . . . 1.69 109.904 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.98 135.61 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.313 1.445 . . . . 1.1 108.191 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 35' ' ' THR . 12.5 p90 -143.24 162.54 35.38 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.568 1.692 . . . . 3.0 115.568 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -99.34 115.5 65.66 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 126.442 1.897 . . . . 3.12 110.863 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -81.08 72.68 6.37 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.336 3.358 . . . . 2.42 111.4 -167.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -175.73 -42.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.964 2.506 . . . . 1.92 109.832 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -88.32 -18.6 28.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.917 1.687 . . . . 3.38 113.011 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.2 t -163.85 178.94 7.41 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.93 1.692 . . . . 2.31 111.044 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.46 169.83 26.32 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 126.157 1.836 . . . . 1.35 114.486 -173.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.2 t -64.24 -41.99 96.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.497 1.119 . . . . 2.09 112.645 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.61 -37.41 73.86 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.935 -0.555 . . . . 0.92 111.667 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.25 71.52 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.257 0.935 . . . . 0.96 112.684 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.8 mt -67.65 -51.06 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.892 0.877 . . . . 1.61 111.657 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.55 -33.31 70.99 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.056 0.844 . . . . 3.32 112.251 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -60.62 -42.18 96.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.951 0.9 . . . . 4.31 110.451 169.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -65.7 -27.92 68.69 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.735 1.607 . . . . 2.67 113.788 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.66 -53.29 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.823 1.192 . . . . 1.23 109.552 172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -58.36 -44.3 88.73 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.332 1.053 . . . . 2.87 111.307 175.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -14.27 62.59 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.032 -1.668 . . . . 4.57 114.624 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -87.9 -6.97 57.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.14 0.976 . . . . 1.66 112.56 168.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.32 5.82 54.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.116 1.341 . . . . 1.41 114.667 172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -102.11 139.13 38.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.851 1.326 . . . . 5.41 110.293 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -82.12 123.4 28.93 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.982 -1.074 . . . . 4.41 108.957 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 p -78.19 -3.52 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 119.934 1.243 . . . . 3.07 113.939 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m 51.69 47.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.994 2.517 . . . . 2.67 113.906 160.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 p -95.77 153.64 17.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.542 1.937 . . . . 1.79 110.855 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.19 151.12 37.56 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.07 1.748 . . . . 4.52 107.714 163.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 150.74 23.21 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.817 -0.552 . . . . 3.65 111.646 162.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.39 156.06 46.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.94 1.696 . . . . 0.99 109.541 172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -127.14 132.88 50.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.289 -1.004 . . . . 2.47 108.289 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -125.11 157.53 36.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.634 1.574 . . . . 2.62 110.207 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -105.57 139.65 39.85 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.81 2.044 . . . . 2.65 109.961 167.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.79 120.2 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.225 -1.028 . . . . 1.53 108.225 171.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -90.54 118.29 29.89 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 105.65 -1.981 . . . . 3.27 105.65 150.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 132.95 -3.97 4.96 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 116.402 1.321 . . . . 1.54 116.402 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -146.17 149.38 33.87 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.41 2.105 . . . . 2.34 114.14 -175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.0 p -145.15 4.5 1.08 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.762 2.025 . . . . 1.91 113.596 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 52.4 t -167.42 156.22 9.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.49 1.516 . . . . 2.18 111.467 -166.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.18 74.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.42 1.488 . . . . 1.53 113.969 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.84 99.42 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.346 -0.846 . . . . 1.38 111.882 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.11 -35.49 74.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.299 1.04 . . . . 1.33 112.05 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.36 -53.81 51.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.503 0.721 . . . . 0.82 111.868 168.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -59.32 -31.39 69.11 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.494 -0.754 . . . . 2.88 112.878 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.52 -42.36 15.58 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 126.019 1.728 . . . . 4.82 115.069 168.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.8 pt -91.76 -34.97 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 117.84 -1.076 . . . . 0.93 112.422 172.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.61 -45.66 66.66 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.07 0.85 . . . . 2.59 111.95 -176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -57.89 -23.07 51.53 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.047 1.128 . . . . 3.35 114.047 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -45.43 7.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.08 1.352 . . . . 4.29 111.794 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.73 -44.28 69.77 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.353 1.461 . . . . 0.94 112.705 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -44.05 -39.12 3.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.961 1.704 . . . . 1.96 114.579 -171.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -148.26 72.34 1.2 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.52 1.928 . . . . 2.55 110.976 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 100' ' ' GLU . 2.0 mt -75.26 -171.16 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 O-C-N 121.081 -1.012 . . . . 2.47 109.213 158.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 99' ' ' ILE . 71.5 mt-10 -75.72 113.38 13.11 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 120.16 -1.587 . . . . 4.14 106.783 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.24 0.93 90.41 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 117.4 -1.778 . . . . 1.48 114.789 -172.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.8 117.73 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.206 2.003 . . . . 1.66 111.528 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.58 -35.49 12.87 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.482 1.913 . . . . 1.27 112.67 -172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -149.16 151.82 35.0 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.278 1.831 . . . . 1.38 110.446 168.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.1 83.1 2.2 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 113.277 0.843 . . . . 1.11 113.277 168.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -81.88 126.41 5.13 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.483 2.789 . . . . 1.14 111.955 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.3 t -92.84 147.34 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 125.163 1.385 . . . . 1.13 109.411 176.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -76.16 -145.36 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.443 1.097 . . . . 2.94 111.127 170.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -171.86 -27.65 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.375 1.87 . . . . 3.83 113.775 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.52 -39.52 3.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 1.4 112.074 -176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.36 -9.42 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.343 1.457 . . . . 1.61 112.244 171.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 73.31 13.09 4.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.021 2.128 . . . . 2.52 114.386 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 65.0 p -98.83 172.65 7.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.812 1.245 . . . . 1.1 112.97 -172.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.32 140.82 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.67 1.588 . . . . 0.61 108.763 163.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -99.57 127.44 45.65 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 106.94 -1.504 . . . . 1.03 106.94 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.29 138.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.631 1.572 . . . . 1.08 108.777 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -139.85 109.01 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.124 1.37 . . . . 3.89 108.579 -169.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -161.62 172.11 16.87 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.423 1.268 . . . . 3.5 114.423 -159.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -91.24 106.54 16.56 Favored Pre-proline 0 CA--C 1.552 1.048 0 O-C-N 121.336 -0.852 . . . . 2.31 111.333 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -65.75 -18.1 57.65 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.952 2.435 . . . . 1.77 112.686 175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -46.52 -28.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.66 1.984 . . . . 3.77 113.838 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.57 2.34 5.01 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 116.008 1.855 . . . . 3.66 116.008 -175.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.44 157.64 30.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.448 1.476 . . . . 2.04 112.721 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.0 t -147.45 -168.43 3.05 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.068 -1.02 . . . . 3.56 113.055 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.8 -29.65 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 121.075 -1.015 . . . . 1.87 111.907 -168.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.8 t -57.28 -49.05 77.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.323 0.51 . . . . 2.43 111.411 171.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -65.48 -38.12 88.83 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.821 0.848 . . . . 2.84 111.453 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.2 -37.43 72.11 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.803 0.841 . . . . 1.48 111.738 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -60.88 -59.13 5.87 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 119.258 0.936 . . . . 3.04 110.921 163.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -54.06 -36.66 63.34 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.827 1.651 . . . . 3.6 113.598 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.97 -21.33 57.09 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.214 1.191 . . . . 1.6 114.214 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.01 -29.9 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.373 1.869 . . . . 1.03 112.589 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -55.24 -38.77 68.93 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.899 1.28 . . . . 2.35 110.622 169.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.97 -22.69 62.84 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.148 1.379 . . . . 3.89 113.951 174.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.13 -20.19 18.82 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 2.07 113.56 169.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 108.13 12.09 22.7 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 116.817 1.487 . . . . 1.36 116.817 172.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -107.31 -151.83 0.47 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.603 2.202 . . . . 2.92 110.117 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.61 172.22 18.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.852 2.061 . . . . 2.83 109.678 160.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.6 mt -121.01 111.19 17.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.105 0.962 . . . . 1.14 110.666 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -77.24 139.39 39.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.164 -0.926 . . . . 2.95 111.162 161.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.42 157.89 21.24 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.674 -1.266 . . . . 1.73 112.071 169.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -92.47 122.88 35.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.813 2.045 . . . . 4.65 106.572 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.68 -69.02 2.91 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.242 -1.543 . . . . 2.96 109.242 -162.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -80.01 22.91 0.48 Allowed 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 116.459 2.022 . . . . 5.69 116.459 -166.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -171.75 -53.45 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 120.181 -1.575 . . . . 3.73 114.688 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -79.62 -30.21 41.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.732 0.813 . . . . 5.16 111.044 169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.563 1.945 . . . . 2.98 111.063 -165.803 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 118.864 -0.588 . . . . 16.02 109.476 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -121.35 117.28 26.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.863 0.865 . . . . 14.66 110.107 172.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -174.81 35.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.721 2.008 . . . . 9.08 110.141 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -168.33 -87.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.013 -1.054 . . . . 6.72 108.812 -165.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -78.64 166.59 22.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.062 0.945 . . . . 2.55 110.583 167.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.14 143.34 42.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.158 1.383 . . . . 7.15 110.243 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -114.35 146.43 40.54 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.33 1.852 . . . . 3.48 111.58 176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.24 151.86 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.152 1.381 . . . . 2.92 107.6 164.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.42 149.98 50.97 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.911 0.885 . . . . 1.3 110.65 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.6 mtt -147.39 148.0 30.85 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.69 1.196 . . . . 3.02 111.854 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.55 137.97 33.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.501 -0.555 . . . . 3.08 109.501 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.39 165.93 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.069 0.948 . . . . 2.42 110.377 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.5 t -116.92 103.6 10.45 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 126.089 1.756 . . . . 2.68 109.182 160.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 140.12 13.35 0.6 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.517 1.532 . . . . 1.94 116.589 172.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.8 mtm -81.36 32.38 0.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 121.386 2.593 . . . . 2.4 113.187 175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -57.93 150.28 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.701 2.8 . . . . 4.13 113.376 -173.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.7 m 65.72 7.47 4.53 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.995 2.518 . . . . 3.31 113.486 172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.73 -15.54 0.09 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 127.55 2.34 . . . . 1.94 113.959 -171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.84 -40.08 66.04 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.831 -1.168 . . . . 1.38 111.532 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 99.4 m -65.89 -29.78 70.28 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.274 -0.891 . . . . 2.93 111.829 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.59 77.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.451 1.1 . . . . 1.48 112.54 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.87 -41.43 77.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.968 0.907 . . . . 0.97 112.401 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.499 1.119 . . . . 3.38 113.988 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.7 mm -87.19 -51.12 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 120.548 1.522 . . . . 1.99 112.486 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.28 -44.01 88.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.136 1.334 . . . . 1.59 111.549 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -75.56 -30.01 59.56 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 120.574 -1.329 . . . . 2.91 113.171 171.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.28 -36.36 78.79 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.251 1.405 . . . . 0.93 114.083 -173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -70.84 -46.83 62.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.987 1.394 . . . . 2.35 110.179 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -63.42 6.92 0.11 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.906 2.187 . . . . 3.94 116.906 -168.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -0.39 56.2 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.549 1.539 . . . . 7.39 114.678 163.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mmt -86.19 135.11 37.35 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 120.563 -1.335 . . . . 3.72 110.682 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.09 -14.61 46.13 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.422 2.748 . . . . 1.56 115.354 -164.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.03 -0.0 14.74 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-O 117.588 -1.673 . . . . 1.64 116.191 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 p -74.5 129.73 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 120.88 2.34 . . . . 2.02 109.333 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.22 -48.48 15.7 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.254 1.021 . . . . 1.76 109.007 174.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.07 166.39 13.06 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.612 1.338 . . . . 3.28 114.612 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 132.6 23.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.43 1.492 . . . . 0.92 109.322 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -140.35 129.21 23.24 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.01 1.324 . . . . 1.97 109.233 -171.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 p -107.07 129.68 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.061 1.301 . . . . 2.27 112.46 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -85.74 101.4 12.75 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.118 -1.067 . . . . 2.01 108.118 160.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -75.94 -29.01 58.17 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.867 -0.521 . . . . 2.3 111.611 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.72 -11.81 3.55 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.663 1.357 . . . . 1.87 114.663 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.5 t -138.2 25.46 2.71 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.527 1.531 . . . . 3.23 112.887 167.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 41.28 38.42 0.78 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.937 2.495 . . . . 3.72 115.633 176.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 m -117.93 123.34 45.56 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.783 1.233 . . . . 1.74 110.209 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.2 t -99.27 138.03 36.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.777 0.831 . . . . 1.55 110.501 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -123.43 118.14 26.76 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.764 2.025 . . . . 1.27 107.933 -171.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.46 136.12 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.832 0.853 . . . . 2.43 111.42 -167.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.58 127.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.236 1.814 . . . . 1.01 109.441 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -149.96 161.46 42.27 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 115.0 1.482 . . . . 2.53 115.0 -167.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -83.52 118.51 71.71 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.462 1.505 . . . . 2.3 110.234 166.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.44 8.4 4.42 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.307 3.338 . . . . 1.77 115.614 -175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.51 -45.67 11.58 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.522 1.055 . . . . 1.61 110.075 166.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.61 -35.53 58.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.915 1.286 . . . . 3.85 112.787 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.53 108.75 11.91 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.317 0.962 . . . . 2.66 110.934 -165.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.58 151.47 29.42 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 124.074 0.845 . . . . 1.18 113.083 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 t -58.24 -42.89 87.37 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.217 1.007 . . . . 2.91 113.227 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.75 80.74 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.75 66.72 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.595 0.758 . . . . 0.99 112.681 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mm -69.57 -47.35 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.441 0.696 . . . . 2.05 111.268 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.09 -43.25 68.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.621 0.646 . . . . 2.86 111.0 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.19 -36.93 85.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 119.164 -0.446 . . . . 2.86 112.09 -173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 1.3 tpmt? -68.87 -28.48 66.74 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.196 1.362 . . . . 2.61 112.626 176.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.43 -51.65 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.412 1.005 . . . . 1.05 109.983 172.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -54.16 -31.61 53.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.216 1.007 . . . . 2.9 111.689 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.3 -19.77 66.11 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.364 -1.46 . . . . 6.0 114.607 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.63 -12.12 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.892 1.224 . . . . 1.26 112.551 171.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.71 36.39 11.89 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.82 1.191 . . . . 1.39 112.768 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.97 153.5 38.44 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.712 2.405 . . . . 5.43 107.372 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 122.71 46.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.894 1.225 . . . . 3.37 111.374 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.66 140.25 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.183 -1.043 . . . . 3.27 108.183 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.261 14.8 m -84.02 54.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 122.328 1.061 . . . . 2.49 112.186 -166.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.9 p -101.07 140.44 35.37 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.644 1.578 . . . . 1.68 112.82 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.51 173.57 11.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.35 1.46 . . . . 4.25 110.021 168.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -104.95 154.78 19.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.588 1.155 . . . . 4.09 112.711 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.54 166.63 29.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.835 1.654 . . . . 0.83 111.533 173.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.97 144.28 51.13 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.379 1.071 . . . . 2.88 111.289 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -133.72 157.42 45.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.255 1.822 . . . . 2.06 110.389 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -107.66 129.77 54.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.572 1.949 . . . . 2.77 110.631 -174.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.03 59.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.042 0.937 . . . . 1.99 111.585 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.73 107.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.789 0.804 . . . . 4.38 110.686 170.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.27 -44.6 1.01 Allowed Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.657 -0.652 . . . . 1.25 111.686 -164.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.77 132.98 34.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.026 1.33 . . . . 2.74 109.275 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -133.01 4.03 3.76 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.382 1.253 . . . . 1.69 114.382 -171.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.1 t -164.55 151.58 11.33 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.628 1.171 . . . . 1.96 111.42 -160.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.69 59.52 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.57 -0.706 . . . . 1.74 112.668 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.3 -19.89 63.06 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.03 1.122 . . . . 2.15 114.03 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.8 m -83.25 -47.24 11.75 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.193 0.997 . . . . 1.55 110.329 167.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.37 -55.4 25.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.536 1.135 . . . . 1.31 111.712 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -54.59 -35.02 62.9 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.461 1.028 . . . . 2.48 113.336 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -66.71 -47.92 70.86 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.056 -1.028 . . . . 5.14 112.446 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.8 pt -75.08 -37.73 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 118.756 -0.64 . . . . 1.53 112.466 176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.76 -46.58 77.84 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.827 1.651 . . . . 3.36 110.27 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -56.84 -18.82 14.38 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.93 1.455 . . . . 4.63 114.93 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -93.68 -56.58 2.85 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.785 1.175 . . . . 3.54 111.927 162.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -48.93 -41.74 34.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.687 1.595 . . . . 1.38 113.251 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -55.13 -28.71 54.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.174 1.79 . . . . 2.51 113.974 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.8 -13.38 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.16 1.541 . . . . 3.2 115.16 -170.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.0 mt 8.71 -91.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 129.713 3.205 . . . . 3.27 114.7 -167.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 167.83 86.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 130.89 3.676 . . . . 3.45 103.166 -167.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.66 5.48 18.38 Favored Glycine 0 N--CA 1.475 1.245 0 N-CA-C 115.997 1.159 . . . . 1.46 115.997 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 m -122.87 153.52 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.415 1.886 . . . . 2.5 109.79 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.97 -49.83 4.63 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.25 1.02 . . . . 1.22 112.191 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -139.96 156.76 46.5 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.553 0.533 . . . . 1.5 112.161 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.43 112.68 1.23 Allowed Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.594 0.758 . . . . 1.2 112.681 160.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -96.89 130.66 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.372 2.715 . . . . 1.27 111.181 168.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.59 136.26 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.351 1.46 . . . . 1.36 110.567 -177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -81.72 137.44 35.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.65 1.98 . . . . 2.84 112.487 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -96.57 -20.29 18.45 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.413 1.264 . . . . 5.48 114.413 -173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.97 -26.89 9.04 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.732 1.213 . . . . 2.69 113.458 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 -28.37 18.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.066 1.346 . . . . 3.24 112.094 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 70.12 43.24 0.89 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.414 1.885 . . . . 2.68 110.255 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 58.3 p -124.28 170.71 10.51 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.372 2.269 . . . . 1.37 109.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -140.74 137.8 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.855 1.262 . . . . 0.64 109.175 171.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -96.9 138.59 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.579 -1.267 . . . . 1.07 107.579 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -132.37 141.34 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.272 1.029 . . . . 0.91 110.601 -174.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.44 117.24 23.97 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 127.297 2.239 . . . . 2.25 108.993 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -164.95 172.16 13.14 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.316 1.228 . . . . 2.53 114.316 -166.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -105.38 147.92 35.43 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.677 0.791 . . . . 2.5 111.83 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -81.93 14.81 2.11 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.109 3.206 . . . . 1.93 113.931 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -102.17 -44.38 5.45 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.994 -1.066 . . . . 3.28 112.27 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -101.75 -4.6 26.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.319 1.447 . . . . 6.52 114.658 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.46 145.12 29.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.506 1.048 . . . . 2.49 112.371 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.3 t -139.5 -176.66 4.62 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.546 1.939 . . . . 2.45 111.548 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 m -64.91 -17.96 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.971 -1.08 . . . . 3.86 112.588 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 74.8 m -60.79 -55.42 33.28 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.192 0.906 . . . . 3.48 111.103 165.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.33 -46.61 88.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.315 1.446 . . . . 4.3 111.627 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.05 -50.89 62.57 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.387 1.475 . . . . 1.93 110.944 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -59.44 -54.09 50.61 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 116.945 -1.502 . . . . 3.23 110.969 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.55 -31.13 69.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.272 1.851 . . . . 4.92 113.027 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.07 -29.09 69.37 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.343 1.238 . . . . 2.44 114.343 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.12 -31.09 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.702 1.201 . . . . 1.58 114.041 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.18 -52.85 62.89 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.619 1.568 . . . . 2.65 110.68 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -70.75 -11.77 61.15 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.141 1.163 . . . . 2.96 114.141 -177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.76 -12.03 54.55 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 1.84 112.021 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.46 -21.01 10.9 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.422 1.963 . . . . 1.77 114.526 171.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -92.54 -161.62 0.85 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.005 1.322 . . . . 3.26 112.1 -174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 170.46 15.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 2.85 110.151 166.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.9 mt -118.01 135.3 54.25 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.897 0.879 . . . . 1.71 110.25 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -122.33 143.5 49.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.517 1.127 . . . . 3.67 109.526 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.38 148.73 24.89 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.029 -1.044 . . . . 3.31 111.928 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -97.86 126.74 43.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.081 -1.081 . . . . 3.98 108.081 -176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.91 -56.58 1.78 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.015 1.293 . . . . 2.07 111.139 -164.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -69.36 -7.24 35.68 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.891 1.441 . . . . 4.6 114.891 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -151.1 -74.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 120.452 -1.405 . . . . 3.08 113.011 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.81 -6.47 22.54 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.964 1.098 . . . . 4.36 113.964 -167.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.484 1.254 0 C-N-CA 128.19 2.596 . . . . 2.51 114.741 158.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.446 -0.576 . . . . 15.5 109.446 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.93 157.85 20.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.531 -0.914 . . . . 12.62 108.531 162.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.8 m -62.32 -37.86 87.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.678 0.992 . . . . 5.98 113.678 -167.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -153.37 -13.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.852 1.427 . . . . 7.71 114.852 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.65 138.26 56.22 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.789 1.631 . . . . 2.64 109.344 169.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -132.54 144.51 50.46 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.212 -0.93 . . . . 3.66 113.295 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -102.05 159.09 15.68 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.436 1.894 . . . . 3.86 114.489 -168.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.3 tt -161.66 151.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 127.845 2.458 . . . . 2.64 110.228 170.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.45 143.9 35.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.766 0.826 . . . . 0.97 111.096 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 ttt -161.35 147.14 14.1 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.923 0.783 . . . . 3.3 112.852 -168.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.443 ' HB3' HD21 ' A' ' 119' ' ' ASN . 41.1 tt0 -82.35 128.98 34.75 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.605 1.548 . . . . 3.17 110.461 175.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 121.06 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.127 1.771 . . . . 1.64 108.355 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 t -117.04 140.54 49.37 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 115.722 1.749 . . . . 2.23 115.722 -164.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.78 22.45 5.36 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.329 1.919 . . . . 1.3 112.816 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.9 mtm -83.8 18.99 1.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.413 1.606 . . . . 1.88 114.905 -172.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.8 p -71.43 12.87 0.29 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.668 1.729 . . . . 3.03 115.668 -172.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.5 t -104.01 3.83 33.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.889 1.276 . . . . 3.58 111.67 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 69.93 -58.04 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 129.0 2.92 . . . . 2.46 112.929 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.91 -11.84 15.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.743 1.617 . . . . 1.22 113.825 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 m -46.05 -45.73 16.25 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.894 1.278 . . . . 1.68 111.689 161.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -58.14 8.94 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.566 1.146 . . . . 0.99 111.808 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -24.13 57.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.731 1.212 . . . . 1.07 113.987 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -81.55 -35.07 30.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.401 1.481 . . . . 3.39 112.294 175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.71 -52.82 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.095 1.316 . . . . 1.68 110.661 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -59.31 -46.51 88.38 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.006 0.367 . . . . 2.42 111.19 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -23.34 63.03 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.965 -1.085 . . . . 4.27 113.739 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.36 64.14 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.178 1.37 . . . . 0.81 112.495 170.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.1 mt -70.74 -52.96 17.43 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.978 0.889 . . . . 1.54 111.077 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -58.61 -10.03 2.03 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.188 1.795 . . . . 3.39 114.722 -174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -25.97 68.16 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.488 1.915 . . . . 5.33 113.086 168.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 55.7 mmm -77.38 141.54 66.14 Favored Pre-proline 0 N--CA 1.471 0.576 0 C-N-CA 126.07 1.748 . . . . 2.37 112.565 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -64.97 -36.16 39.83 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.133 1.889 . . . . 1.77 111.225 169.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.84 30.36 10.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.974 1.273 . . . . 1.71 115.058 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.16 137.56 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.514 1.657 . . . . 1.67 108.89 161.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -109.57 -25.69 10.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 117.63 -1.176 . . . . 1.64 112.275 -175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -162.37 155.64 20.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 119.462 1.028 . . . . 2.66 112.65 160.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.64 131.04 23.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.547 1.539 . . . . 0.71 109.745 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -138.57 113.18 8.96 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.256 1.423 . . . . 1.83 109.348 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.74 121.85 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 122.271 1.034 . . . . 1.81 112.369 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -78.31 98.17 5.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.839 1.656 . . . . 2.16 111.409 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.33 -14.82 59.65 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.289 1.035 . . . . 2.87 113.143 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.19 7.11 6.77 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 120.992 -1.068 . . . . 1.99 112.679 167.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 79.9 m -146.17 -113.3 0.09 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 128.146 2.578 . . . . 4.41 104.56 156.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -159.28 35.22 0.2 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 120.528 1.513 . . . . 3.04 110.493 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -112.65 112.09 23.35 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.645 -1.284 . . . . 1.56 111.26 -156.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -88.89 116.01 26.86 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.142 0.977 . . . . 1.42 110.645 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -103.19 123.29 46.44 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.371 1.868 . . . . 1.19 108.0 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 t -134.79 141.56 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 119.12 0.873 . . . . 1.68 110.426 -168.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.32 124.86 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.887 1.275 . . . . 1.17 108.927 175.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -132.6 170.38 15.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.848 1.659 . . . . 2.82 114.563 -167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -100.43 117.46 62.9 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.526 1.93 . . . . 2.86 110.494 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -81.07 -1.15 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.919 3.079 . . . . 1.94 114.733 -174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.4 -43.83 7.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.86 1.209 . . . . 1.85 111.114 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -94.05 3.15 55.73 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.586 0.958 . . . . 3.33 113.586 -175.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 m -168.19 165.72 13.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 127.616 2.366 . . . . 1.99 109.428 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.7 160.18 26.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.643 1.116 . . . . 1.3 113.382 176.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.0 t -48.81 -48.8 41.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.589 1.556 . . . . 2.22 112.214 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.67 -29.62 68.95 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.206 -0.934 . . . . 1.26 113.391 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.26 -30.12 61.98 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.152 -0.968 . . . . 1.45 111.334 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.1 pt -80.11 -36.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 117.171 -1.395 . . . . 4.19 113.437 170.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -63.28 -40.18 96.68 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 121.014 1.734 . . . . 2.37 110.55 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -58.15 -39.42 78.75 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.749 1.219 . . . . 3.28 111.831 170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -8.66 56.73 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.566 1.321 . . . . 3.14 114.566 174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.32 -54.79 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 120.322 1.419 . . . . 1.07 109.329 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -52.36 -36.88 54.79 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.22 1.008 . . . . 2.91 113.039 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -60.56 -12.8 10.99 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.157 1.54 . . . . 3.98 115.157 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -89.28 -13.35 38.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.071 1.305 . . . . 1.35 113.736 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.88 22.8 57.18 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.771 1.169 . . . . 1.46 114.231 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -123.74 131.78 53.67 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.658 -1.978 . . . . 6.04 105.658 163.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -113.42 137.42 51.55 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.411 1.263 . . . . 4.63 114.411 -150.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.86 124.23 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.694 1.197 . . . . 2.75 109.747 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.5 t -75.07 111.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 t -162.05 149.87 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.856 0.862 . . . . 3.08 111.786 -175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.52 172.1 16.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.74 0.416 . . . . 3.01 111.278 160.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -90.95 114.15 26.57 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.377 0.608 . . . . 5.28 111.903 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -89.68 151.11 22.04 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.59 -0.694 . . . . 1.32 109.414 159.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.8 149.64 50.17 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.69 0.796 . . . . 2.93 109.972 172.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -140.37 150.93 44.54 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.855 1.262 . . . . 1.79 110.601 -171.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.16 128.18 53.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.674 1.59 . . . . 3.3 108.869 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 114' ' ' VAL . 3.3 mp -100.11 148.41 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 107.935 -1.135 . . . . 2.3 107.935 172.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -126.6 100.31 6.17 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.862 -1.162 . . . . 3.69 107.862 159.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.13 1.88 0.04 OUTLIER Glycine 0 CA--C 1.537 1.408 0 N-CA-C 117.411 1.724 . . . . 1.14 117.411 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -145.65 61.01 1.27 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.161 1.98 . . . . 2.87 114.288 -160.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -64.87 19.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.894 2.478 . . . . 2.03 116.463 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.8 t -154.89 146.35 23.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.705 1.602 . . . . 1.79 111.186 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.59 -30.48 65.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.006 0.923 . . . . 1.73 113.22 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.7 88.09 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.156 -0.965 . . . . 1.65 112.157 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.19 -35.8 74.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.103 0.961 . . . . 1.31 112.157 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.94 -57.49 12.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.285 0.634 . . . . 0.98 111.412 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -58.84 -32.76 69.71 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.38 -0.825 . . . . 1.97 113.131 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 mtp180 -51.83 -40.75 61.01 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.434 1.494 . . . . 4.67 114.336 168.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.9 pt -87.94 -35.9 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.123 1.329 . . . . 0.96 112.699 173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.05 -43.3 40.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.712 1.605 . . . . 2.81 112.302 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -54.39 -27.3 35.7 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.493 1.294 . . . . 4.33 114.493 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -101.27 -35.77 9.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.319 1.048 . . . . 4.62 112.848 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.89 -45.69 71.15 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.842 1.201 . . . . 0.96 112.371 173.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -36.59 -47.08 0.62 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.45 2.3 . . . . 2.16 114.415 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -146.14 87.66 1.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.429 1.492 . . . . 2.51 110.208 171.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.9 mt -74.53 -111.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.169 -0.678 . . . . 1.87 109.169 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.43 123.4 37.8 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.318 -2.105 . . . . 4.63 105.318 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.33 -16.79 21.9 Favored Glycine 0 N--CA 1.474 1.196 0 O-C-N 121.788 -0.57 . . . . 1.48 114.091 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 37.5 t -64.29 125.76 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.417 1.487 . . . . 2.13 111.548 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.76 -44.61 8.44 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.675 1.59 . . . . 1.03 111.974 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -144.51 132.64 21.65 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.41 0.55 . . . . 1.43 110.888 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.81 97.67 5.37 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 119.156 0.889 . . . . 0.95 112.881 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -89.39 139.0 3.37 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.154 3.236 . . . . 0.94 110.537 166.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.6 148.12 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.336 1.055 . . . . 0.9 108.726 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.15 -146.21 0.06 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.974 0.91 . . . . 3.41 110.365 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -151.49 -84.38 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.3 -1.5 . . . . 5.94 109.815 176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.7 -37.53 84.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.299 1.04 . . . . 2.35 113.559 -169.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.93 -25.51 66.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.003 2.121 . . . . 2.49 113.05 170.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 44.79 67.67 0.67 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.868 2.067 . . . . 3.65 109.798 -160.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.5 p -135.93 165.64 25.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.721 1.609 . . . . 0.98 110.381 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 80' ' ' ILE . 7.5 p -141.56 143.85 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.473 1.109 . . . . 0.7 110.215 172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.0 m -105.75 134.63 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.235 1.414 . . . . 0.97 107.98 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.37 106.31 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.414 1.086 . . . . 1.16 109.314 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -87.45 113.15 22.89 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.566 1.547 . . . . 2.73 108.43 170.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.09 163.69 39.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.022 1.86 . . . . 2.18 116.022 -168.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 11' ' ' GLN . 23.2 t-20 -98.38 130.35 28.44 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 127.899 2.48 . . . . 2.5 110.068 162.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -86.16 -18.47 3.43 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.998 2.466 . . . . 3.42 115.071 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -69.29 -16.25 63.52 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.205 1.558 . . . . 3.86 115.205 -163.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -107.03 10.91 30.19 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.023 1.729 . . . . 4.16 112.632 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.32 -178.17 6.49 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.668 -1.27 . . . . 2.64 113.017 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.8 p -164.46 175.95 9.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.285 1.834 . . . . 3.9 109.892 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -64.78 -18.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 120.849 -1.157 . . . . 1.7 111.758 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 t -61.39 -51.74 67.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.273 0.942 . . . . 4.49 110.914 171.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.64 -35.73 76.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.379 1.472 . . . . 3.07 111.674 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.9 mt -70.11 -48.52 57.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.673 1.189 . . . . 1.33 111.139 175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -61.13 -43.98 98.04 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 121.004 -1.06 . . . . 2.73 111.08 173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -70.15 -1.21 9.43 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.011 1.724 . . . . 2.99 113.692 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.78 -46.72 10.41 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.153 -1.592 . . . . 2.42 113.572 155.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.1 t -78.62 -33.65 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.085 1.354 . . . . 1.8 114.296 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.04 -26.72 67.64 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.055 1.742 . . . . 2.68 112.317 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -63.15 -27.18 69.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.833 1.653 . . . . 4.0 112.378 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.91 -15.21 19.25 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.609 1.564 . . . . 2.47 113.124 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.26 9.4 36.47 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.524 1.535 . . . . 1.64 116.259 169.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.21 -169.9 1.83 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.555 1.677 . . . . 2.85 111.283 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.35 158.18 44.41 Favored 'General case' 0 C--N 1.344 0.338 0 O-C-N 120.055 -1.653 . . . . 2.71 110.876 166.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 39.2 mt -108.91 131.62 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.947 1.699 . . . . 1.26 109.364 175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -109.53 139.09 44.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.09 1.356 . . . . 3.3 109.674 164.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.2 151.41 38.47 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.096 -1.003 . . . . 1.81 112.454 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -110.93 90.12 3.24 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.955 1.302 . . . . 4.91 109.87 -166.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 147' ' ' SER . . . 100.76 -18.08 55.49 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.257 1.408 . . . . 2.16 113.307 -171.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -120.76 32.07 6.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.678 1.191 . . . . 4.13 113.577 170.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -164.76 -90.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.858 -1.151 . . . . 2.97 112.288 165.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.17 -27.29 35.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.204 0.526 . . . . 3.09 111.55 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' A' ' 143' ' ' GLY . 19.2 t . . . . . 0 C--O 1.254 1.314 0 C-N-CA 129.505 3.122 . . . . 3.14 112.457 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 118.929 -0.558 . . . . 14.82 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.48 -176.62 4.27 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.758 1.623 . . . . 7.97 110.011 171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -156.23 68.86 0.62 Allowed 'General case' 0 N--CA 1.478 0.975 0 O-C-N 120.0 -1.687 . . . . 6.57 110.955 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -162.12 27.33 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.916 1.45 . . . . 5.93 114.916 -163.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.4 155.29 23.56 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.601 -1.312 . . . . 3.83 110.369 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.39 164.12 11.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.052 1.341 . . . . 4.03 113.605 -165.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -133.04 139.2 47.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.968 1.707 . . . . 2.86 110.32 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.3 tp -161.86 152.82 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 125.123 1.369 . . . . 2.83 111.507 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.05 150.0 30.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.122 1.369 . . . . 1.16 111.795 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 73.3 mtp -150.67 145.93 26.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.71 1.604 . . . . 2.78 111.956 -175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.63 147.66 51.57 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.098 0.863 . . . . 4.86 110.353 161.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.14 167.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.398 1.479 . . . . 2.0 110.165 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -120.03 122.59 41.46 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.233 1.813 . . . . 2.08 110.931 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.9 8.04 9.12 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.68 1.61 . . . . 1.08 114.912 170.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.4 mtm -97.11 9.03 43.26 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.556 1.687 . . . . 2.57 115.556 -175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.6 m -68.2 83.57 0.24 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.122 -0.986 . . . . 4.49 109.164 161.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.9 t 179.24 -33.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.948 2.499 . . . . 3.55 111.134 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.66 -51.9 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 128.258 2.623 . . . . 2.05 112.714 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.46 -17.23 63.61 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.077 -1.015 . . . . 1.19 113.487 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -52.98 -39.56 63.11 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.901 1.68 . . . . 2.67 113.089 159.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.1 98.82 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.393 -0.817 . . . . 1.38 111.152 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.77 67.53 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.135 0.88 . . . . 1.44 112.588 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -72.44 -40.08 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.765 1.024 . . . . 3.46 113.765 170.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mm -69.81 -53.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 119.915 1.234 . . . . 2.08 111.105 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.06 -43.17 95.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.726 1.211 . . . . 2.54 110.223 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -69.54 -30.6 68.45 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.671 0.989 . . . . 2.92 113.671 174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.4 -37.13 90.07 Favored Glycine 0 N--CA 1.473 1.164 0 C-N-CA 124.818 1.199 . . . . 1.25 112.315 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 31.6 mt -71.68 -60.04 2.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.559 1.144 . . . . 1.55 110.726 170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -56.99 -16.97 8.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.595 1.958 . . . . 5.36 114.229 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -46.05 54.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.012 1.725 . . . . 4.74 112.475 171.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -103.91 143.69 27.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 113.473 0.916 . . . . 2.27 113.473 -171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.22 -7.41 13.76 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.932 3.088 . . . . 2.34 113.345 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' ' HB ' ' A' ' 55' ' ' THR . . . -66.89 -10.75 56.56 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.942 1.258 . . . . 2.24 114.707 168.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.92 154.96 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 119.33 1.565 . . . . 1.85 109.961 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -103.87 -46.31 4.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 118.021 -0.99 . . . . 2.0 111.289 161.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.24 135.98 29.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.767 0.712 . . . . 3.62 111.603 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.71 134.39 51.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.03 1.332 . . . . 0.98 109.899 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.67 105.26 4.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.473 1.109 . . . . 2.19 110.293 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.75 138.62 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.229 -0.919 . . . . 2.41 111.21 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -104.4 90.44 3.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.995 1.318 . . . . 2.06 107.504 158.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.8 tp -65.98 -42.1 90.3 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.704 -0.68 . . . . 2.5 112.079 -168.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.95 -13.38 15.67 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.717 1.747 . . . . 1.82 115.717 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 t -121.85 -8.2 8.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.865 1.266 . . . . 2.82 113.713 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 75.47 39.87 0.33 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.102 2.161 . . . . 2.84 112.979 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 m -110.7 140.12 45.36 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.506 1.522 . . . . 1.36 110.644 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.2 t -108.43 134.66 50.91 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.178 0.991 . . . . 1.25 110.145 168.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -123.35 134.04 54.06 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.585 1.554 . . . . 1.2 109.052 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.89 153.32 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.857 1.208 . . . . 1.91 113.058 -175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.3 123.64 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.817 1.647 . . . . 1.07 107.479 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -137.85 158.64 43.93 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.924 1.453 . . . . 2.56 114.924 -161.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -94.49 124.16 56.15 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.421 1.088 . . . . 3.54 111.562 -177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.81 2.52 8.15 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.85 2.367 . . . . 2.11 114.436 -173.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.69 -33.34 4.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.147 1.339 . . . . 2.12 113.45 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -87.05 13.8 8.62 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.692 0.997 . . . . 4.49 113.692 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.405 ' HB ' ' HA3' ' A' ' 33' ' ' GLY . 1.4 t -161.63 -164.32 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.626 1.17 . . . . 2.89 112.579 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.55 178.93 17.89 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.326 1.917 . . . . 1.69 112.008 171.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.3 m -67.55 -62.97 1.16 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.321 1.048 . . . . 3.33 111.475 -175.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.59 66.98 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.022 0.749 . . . . 1.21 113.022 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.05 -29.44 21.2 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.737 1.215 . . . . 1.0 113.659 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.72 -51.75 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.972 0.909 . . . . 1.78 110.862 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -70.46 -31.23 68.29 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.549 -0.719 . . . . 2.24 111.625 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.98 -49.78 70.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.169 1.388 . . . . 3.08 111.08 172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -19.93 60.69 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.136 1.161 . . . . 3.08 114.136 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -71.5 -52.97 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.556 1.071 . . . . 0.97 110.394 167.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.49 -34.6 72.79 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.887 1.275 . . . . 2.92 112.692 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.06 -19.68 54.18 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.996 1.48 . . . . 4.99 114.996 176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.37 -24.14 59.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.015 1.28 . . . . 1.55 112.761 172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.54 9.66 43.23 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.438 1.017 . . . . 1.64 114.499 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -86.86 -160.09 0.55 Allowed 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 118.328 1.064 . . . . 5.55 109.399 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -144.01 140.41 29.56 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 121.207 1.821 . . . . 4.12 113.813 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.25 145.85 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.372 0.987 . . . . 2.96 110.064 163.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.9 m -101.72 62.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.826 0.85 . . . . 2.51 110.845 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.0 p -99.41 155.97 17.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.236 1.015 . . . . 1.86 112.618 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -136.53 141.21 43.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.085 1.354 . . . . 3.17 109.744 166.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -96.49 61.42 1.96 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.639 2.776 . . . . 3.36 112.706 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.06 136.68 52.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.929 0.892 . . . . 1.03 112.208 -172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -96.58 115.23 27.09 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.401 0.68 . . . . 2.72 110.94 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -99.75 154.9 17.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.894 1.278 . . . . 2.13 110.908 171.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.6 133.84 52.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.989 2.116 . . . . 2.47 109.162 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 114' ' ' VAL . 1.0 OUTLIER -122.68 51.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.96 1.304 . . . . 1.72 111.11 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -45.93 119.1 2.1 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.349 -0.845 . . . . 4.65 112.218 170.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.94 -24.26 7.12 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.23 1.872 . . . . 1.82 114.005 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.7 ptt? -79.69 42.72 0.54 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.018 1.909 . . . . 2.87 114.927 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.6 p -70.81 29.56 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.101 2.16 . . . . 2.41 116.456 -166.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -149.74 148.29 29.06 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.99 1.716 . . . . 2.45 109.757 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.29 64.02 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.506 -0.746 . . . . 1.52 112.702 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.24 86.44 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.685 0.794 . . . . 1.75 112.634 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 57.7 m -66.92 -45.96 76.3 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.368 1.067 . . . . 1.53 111.804 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.41 -54.06 50.08 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.446 0.698 . . . . 0.83 111.071 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -60.52 -37.27 80.61 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 121.324 -0.86 . . . . 3.27 112.475 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -61.68 -37.73 85.15 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.914 -1.116 . . . . 3.54 113.45 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 pt -78.02 -44.94 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 120.135 1.334 . . . . 0.94 111.989 167.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.1 -51.38 58.13 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.335 1.054 . . . . 2.42 111.383 -174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -57.45 -16.67 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.744 1.387 . . . . 3.75 114.744 -173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -101.08 -50.54 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 116.624 -1.655 . . . . 5.66 113.174 161.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -45.03 -47.76 11.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.367 1.439 . . . . 1.01 113.032 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -34.65 -50.52 0.45 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.085 2.554 . . . . 1.55 114.256 -172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -139.61 58.71 1.61 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.688 1.595 . . . . 3.64 113.088 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 26.4 mt -68.46 74.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 119.746 -1.846 . . . . 2.64 111.494 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 55.91 44.06 26.42 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.138 0.975 . . . . 3.93 113.32 137.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 137.21 -38.69 1.71 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.585 2.041 . . . . 1.3 111.418 -156.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.9 t -73.72 124.63 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.12 1.368 . . . . 1.67 110.482 163.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.62 -48.02 7.86 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.823 1.649 . . . . 1.06 111.512 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -142.34 140.98 32.29 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.928 0.785 . . . . 1.41 110.711 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.98 88.87 3.47 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.258 0.623 . . . . 1.06 111.993 169.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.26 129.34 6.69 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.898 3.065 . . . . 1.11 109.553 166.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.9 t -96.48 131.33 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 122.092 0.948 . . . . 0.87 110.35 -173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -97.54 109.43 22.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.961 1.704 . . . . 2.34 112.599 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.45 -68.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.303 -0.873 . . . . 6.31 112.82 -167.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.88 74.6 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.118 0.784 . . . . 1.56 113.118 -172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 -28.11 61.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 1.86 111.589 175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 72.49 34.94 1.2 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.238 2.215 . . . . 3.16 111.634 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.1 p -124.28 173.32 8.44 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.343 1.457 . . . . 1.15 110.998 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 80' ' ' ILE . 6.0 p -144.79 134.73 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.477 -0.934 . . . . 0.83 108.477 167.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.3 m -98.2 101.63 13.15 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.56 -1.274 . . . . 1.13 107.56 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.81 106.94 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.682 1.193 . . . . 1.51 109.31 -170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -88.85 108.43 19.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.62 0.768 . . . . 3.06 109.593 167.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.39 166.36 24.97 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.354 1.062 . . . . 3.81 112.032 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -91.24 109.35 35.09 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.376 -0.827 . . . . 3.21 110.737 171.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.86 -1.99 8.71 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 123.779 2.986 . . . . 1.62 113.868 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -68.72 -20.18 64.38 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.288 1.035 . . . . 3.14 113.481 173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -132.08 9.77 4.51 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.023 1.861 . . . . 3.24 116.023 -165.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -161.86 152.66 17.76 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.782 1.173 . . . . 1.91 112.205 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.4 p -113.49 166.92 11.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.124 1.37 . . . . 3.08 112.296 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.19 -28.63 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 O-C-N 121.304 -0.873 . . . . 1.29 112.135 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.6 m -61.67 -38.28 87.18 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.411 1.005 . . . . 2.43 113.017 176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.51 -39.31 85.13 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.856 0.862 . . . . 2.72 110.707 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.5 -40.39 73.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.222 1.009 . . . . 1.5 111.456 174.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -60.47 -48.63 80.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 118.249 -0.881 . . . . 2.87 111.673 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.62 -29.36 64.47 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.617 0.969 . . . . 2.43 113.617 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.56 -49.25 16.88 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.42 0.688 . . . . 1.9 112.715 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.65 -25.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.1 0.778 . . . . 1.43 113.1 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -52.94 -43.2 66.13 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.57 1.148 . . . . 2.47 111.931 171.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -66.55 -31.74 72.64 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.951 1.7 . . . . 3.35 112.197 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.84 -14.09 52.1 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.236 1.014 . . . . 1.71 113.07 172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.77 18.95 16.6 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 116.61 1.404 . . . . 1.82 116.61 163.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -117.57 -161.38 0.82 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.869 1.334 . . . . 3.48 111.804 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.34 144.63 36.41 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 120.523 -1.36 . . . . 3.45 110.281 170.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.6 mt -95.98 97.96 10.02 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.992 0.917 . . . . 1.44 108.778 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -75.14 169.77 17.37 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.148 -0.933 . . . . 3.41 110.051 159.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -133.5 143.03 48.52 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.702 -1.249 . . . . 1.44 112.181 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -86.41 113.27 22.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.566 -1.272 . . . . 5.02 107.566 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.43 -47.23 1.71 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.559 1.552 . . . . 1.54 111.272 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.32 -12.33 60.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.376 1.621 . . . . 3.94 115.376 -169.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -150.81 -47.35 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.137 1.335 . . . . 2.87 113.99 161.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.43 -28.94 11.03 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.691 0.997 . . . . 2.69 113.691 -163.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . 0.257 96.4 p . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 130.936 3.694 . . . . 3.66 114.344 167.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.133 -0.321 . . . . 17.26 110.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 68.2 tp -162.17 141.68 9.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.769 1.627 . . . . 9.45 109.622 -175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t 166.78 -169.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 130.9 3.68 . . . . 5.94 105.578 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.63 148.56 36.0 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.676 -1.231 . . . . 5.16 107.676 153.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -139.3 148.34 42.86 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.744 -0.598 . . . . 2.65 109.811 -167.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -106.71 137.46 44.7 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.606 0.763 . . . . 5.12 109.206 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.86 126.54 28.99 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.804 1.242 . . . . 3.69 110.473 -169.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.09 164.7 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.399 1.079 . . . . 4.1 112.302 -171.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.62 163.38 14.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.281 1.833 . . . . 1.54 112.372 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.6 mtt -152.67 151.89 31.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 128.346 2.658 . . . . 2.62 110.098 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -93.2 151.52 19.78 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.529 -0.915 . . . . 2.94 108.529 167.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.9 121.07 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.057 1.343 . . . . 1.35 107.758 172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.9 m -94.3 131.22 40.14 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.974 0.91 . . . . 2.73 111.171 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.11 20.85 5.81 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.497 1.522 . . . . 1.42 114.892 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 44.6 mtm -83.06 17.7 1.89 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.423 2.112 . . . . 2.0 115.391 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -67.36 3.02 1.39 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.022 2.129 . . . . 3.17 115.301 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -107.1 5.01 27.51 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.98 1.312 . . . . 2.84 112.609 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.18 -53.8 0.67 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 128.711 2.804 . . . . 2.37 113.691 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -13.47 8.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.76 1.624 . . . . 1.71 113.321 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.5 m -48.53 -44.31 36.2 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.902 1.681 . . . . 1.65 112.338 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -60.06 3.96 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.078 0.951 . . . . 1.43 111.39 170.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.5 -36.72 64.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.501 1.121 . . . . 1.41 113.403 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -68.92 -41.39 78.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.646 1.178 . . . . 3.61 112.507 174.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -66.7 -43.62 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.151 0.887 . . . . 1.94 110.307 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -59.7 -49.01 79.41 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.827 1.251 . . . . 2.2 111.011 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -56.11 -41.17 74.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.846 1.258 . . . . 2.91 112.772 172.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.46 -42.37 64.51 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.936 1.255 . . . . 0.92 113.913 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.1 mt -70.99 -51.43 25.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.896 1.348 . . . . 1.44 111.55 177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -58.42 -10.71 2.26 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.93 1.826 . . . . 3.82 115.93 -164.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.48 -13.6 42.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.998 1.719 . . . . 4.82 114.141 173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.463 ' SD ' ' HE3' ' A' ' 63' ' ' LYS . 53.4 mtm -66.79 128.28 93.8 Favored Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 120.416 1.462 . . . . 2.54 109.938 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.9 -35.05 88.15 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.961 2.441 . . . . 1.99 114.229 -164.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.85 -5.09 61.37 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 117.459 -1.745 . . . . 1.24 116.571 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.13 124.91 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 121.297 2.548 . . . . 1.53 109.513 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 53.9 m -93.01 -45.29 8.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.847 0.859 . . . . 3.08 110.33 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -154.1 155.23 35.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.49 0.586 . . . . 2.62 112.494 169.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.45 136.69 34.9 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.388 1.475 . . . . 0.93 108.598 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -140.24 112.77 7.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.408 1.083 . . . . 2.08 108.962 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.5 t -104.28 98.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 122.259 1.028 . . . . 3.24 108.823 -170.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.72 102.5 13.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.326 1.05 . . . . 2.51 110.994 -172.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.18 -35.92 67.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.418 1.087 . . . . 3.19 111.947 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.83 6.05 2.23 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 114.192 1.182 . . . . 3.27 114.192 -170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -154.85 22.47 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 128.576 2.75 . . . . 3.09 110.939 167.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 33.3 48.85 0.18 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.581 2.752 . . . . 2.46 114.869 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.6 m -125.66 133.59 52.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.272 1.029 . . . . 1.47 110.669 -172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.1 t -93.56 120.47 33.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.153 1.381 . . . . 1.73 110.128 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -101.88 133.32 46.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.514 1.526 . . . . 1.6 108.968 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -139.01 141.15 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.741 1.155 . . . . 2.09 111.629 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.9 124.71 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.636 1.975 . . . . 1.12 109.454 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -141.32 154.08 45.51 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.697 1.74 . . . . 3.06 115.697 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.07 121.52 78.98 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.136 1.774 . . . . 2.82 108.974 171.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -82.31 62.45 7.98 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.377 3.385 . . . . 1.98 112.135 -167.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.1 -72.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.538 1.935 . . . . 2.3 108.028 170.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -83.99 25.9 0.78 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.481 1.512 . . . . 3.93 113.592 -173.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.1 m -171.4 153.15 3.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 129.513 3.125 . . . . 1.76 107.908 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.7 25.36 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 126.697 2.094 . . . . 1.49 110.216 169.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 p -60.79 -37.59 82.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.342 1.571 . . . . 2.93 112.666 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.2 74.76 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.385 0.883 . . . . 1.08 113.385 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.54 67.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.143 -0.973 . . . . 1.08 112.78 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.6 mt -70.77 -53.35 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.769 0.828 . . . . 2.06 110.09 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -66.18 -36.17 82.38 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.199 -0.429 . . . . 2.17 110.894 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -53.63 -49.46 67.82 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.312 1.445 . . . . 3.73 111.452 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' SD ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -70.44 -35.87 73.61 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.858 -1.151 . . . . 2.7 113.059 -179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.02 -49.96 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.058 0.844 . . . . 1.17 110.525 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -61.08 -33.52 73.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.79 0.436 . . . . 2.98 111.272 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -12.88 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 116.497 -1.716 . . . . 4.5 115.268 171.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.11 -36.18 48.33 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 121.777 2.08 . . . . 1.4 111.068 163.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.88 9.35 26.53 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.887 1.232 . . . . 1.33 114.359 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -88.38 152.64 21.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.617 1.167 . . . . 5.63 109.856 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -87.57 112.22 22.04 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.21 -0.931 . . . . 3.41 110.287 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -76.11 33.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-N 120.38 1.446 . . . . 2.96 113.348 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -1.02 80.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.797 1 C-N-CA 132.138 4.175 . . . . 2.88 114.083 -171.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.5 m -106.64 137.88 43.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.104 0.962 . . . . 2.83 109.779 -169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 75' ' ' LYS . 5.1 tt0 -140.45 177.51 7.96 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.697 0.799 . . . . 3.13 109.012 163.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 74' ' ' GLU . 2.0 ptpt -140.27 151.9 45.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.719 0.808 . . . . 3.95 112.466 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.75 149.43 46.43 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.304 1.442 . . . . 0.88 109.812 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -114.5 113.55 24.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.729 1.212 . . . . 2.49 108.646 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -97.62 153.12 18.41 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.472 1.909 . . . . 2.18 110.421 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -103.19 125.27 49.79 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.983 1.713 . . . . 2.29 109.668 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 mm -110.06 58.97 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.095 1.758 . . . . 1.53 109.406 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 10.2 mt-10 -49.62 99.86 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.783 -1.198 . . . . 3.49 109.489 157.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.44 -27.76 2.83 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.157 1.837 . . . . 1.31 113.146 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.24 117.02 5.06 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.395 1.078 . . . . 3.96 109.217 169.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.5 p -140.54 13.11 2.34 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.467 1.507 . . . . 2.8 113.634 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.7 t 174.27 152.27 0.1 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.915 2.886 . . . . 2.45 109.04 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.62 -30.21 20.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.79 0.836 . . . . 1.42 113.254 169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.42 80.93 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.356 -0.84 . . . . 1.77 113.192 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.3 m -70.08 -37.16 75.36 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.766 1.226 . . . . 1.44 111.29 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.04 -55.64 20.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.327 0.651 . . . . 0.85 111.145 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -48.24 -45.51 34.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.333 1.453 . . . . 4.81 112.231 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -47.48 -49.63 25.21 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.591 1.156 . . . . 4.13 113.741 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 pt -84.75 -40.73 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.233 -1.365 . . . . 1.07 112.17 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -47.61 -57.16 5.8 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.561 1.544 . . . . 3.55 110.604 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -57.83 -13.44 4.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 115.244 1.572 . . . . 3.77 115.244 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -33.24 5.86 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.563 -1.208 . . . . 3.87 113.377 168.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.78 -41.8 98.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.854 1.661 . . . . 1.03 111.453 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -45.04 -48.99 11.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.942 2.097 . . . . 1.79 111.626 169.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -135.42 78.16 1.71 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.192 1.797 . . . . 3.53 111.458 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.545 ' H ' HG21 ' A' ' 102' ' ' VAL . 41.8 mt -75.32 -106.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.428 1.091 . . . . 2.62 108.509 166.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -159.87 71.94 0.49 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.408 -1.33 . . . . 4.94 107.408 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.78 103.08 2.84 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.855 -1.698 . . . . 3.46 108.855 -148.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.545 HG21 ' H ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER 169.12 149.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 130.833 3.653 . . . . 2.83 109.935 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -108.44 -53.84 2.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.557 0.743 . . . . 1.2 111.849 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -145.04 152.67 40.49 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.124 0.97 . . . . 1.44 111.757 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.34 54.02 0.92 Allowed Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 115.806 1.78 . . . . 1.44 115.806 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.32 104.69 0.78 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.501 2.8 . . . . 0.96 112.94 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.1 t -72.73 136.15 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.565 1.546 . . . . 0.85 112.286 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.28 141.05 28.87 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.719 1.608 . . . . 2.64 112.505 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -111.54 9.33 21.23 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.558 1.318 . . . . 3.72 114.558 -171.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.71 -29.98 0.84 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.307 1.043 . . . . 1.44 113.097 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 -13.56 35.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.994 1.718 . . . . 1.5 112.59 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 69.73 16.9 7.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.029 2.132 . . . . 3.26 113.515 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -100.58 168.18 9.88 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.169 0.988 . . . . 1.06 112.093 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.19 134.46 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.602 0.761 . . . . 0.63 109.993 157.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.9 m -98.39 114.81 27.28 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.664 -1.235 . . . . 0.94 107.664 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.94 134.94 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.895 1.278 . . . . 0.79 109.314 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.92 132.6 55.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.257 1.423 . . . . 2.76 110.274 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -173.77 -179.38 1.76 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 126.398 1.879 . . . . 7.62 111.89 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -88.86 127.69 55.02 Favored Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 119.841 -1.787 . . . . 2.88 111.484 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.2 60.79 7.56 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.51 2.807 . . . . 3.74 110.186 171.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -146.19 -12.6 0.47 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.146 1.906 . . . . 4.31 116.146 -171.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -153.1 161.13 42.84 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.782 1.174 . . . . 3.94 111.079 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 71.97 174.92 0.29 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.849 2.459 . . . . 2.38 112.922 -171.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -137.17 167.77 20.9 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.635 1.174 . . . . 2.78 111.4 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.67 -26.04 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.286 1.034 . . . . 1.35 110.951 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -41.75 78.43 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.855 1.262 . . . . 1.8 113.052 172.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -68.34 -39.82 81.78 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.449 0.643 . . . . 2.77 110.448 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.7 mt -67.65 -45.62 74.78 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.575 1.15 . . . . 1.63 110.063 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -55.99 -50.12 71.74 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.207 1.003 . . . . 3.55 111.039 173.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -79.33 -13.17 59.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.449 1.277 . . . . 3.66 114.449 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.69 -51.81 31.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.691 -1.256 . . . . 1.44 111.152 158.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.19 -30.13 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.959 1.096 . . . . 0.9 113.959 -174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -45.39 -46.41 13.25 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.924 2.09 . . . . 2.35 111.726 166.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -73.66 -16.96 61.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.993 1.317 . . . . 5.12 113.054 -172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.58 -12.29 32.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.513 1.525 . . . . 1.35 113.442 167.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.06 19.65 16.3 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.011 1.291 . . . . 1.39 115.914 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -127.16 -164.13 1.32 Allowed 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 119.52 1.66 . . . . 3.03 110.921 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -141.15 -179.62 6.2 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.221 -1.55 . . . . 3.44 109.634 170.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.1 mt -127.8 113.7 16.29 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.048 0.939 . . . . 1.2 110.335 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.57 171.06 9.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.478 -0.564 . . . . 2.58 109.478 156.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mt -133.5 142.88 48.44 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.661 -1.274 . . . . 1.89 110.25 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -90.0 116.78 28.3 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.047 -1.464 . . . . 5.11 107.047 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.73 -60.15 4.12 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.847 -0.901 . . . . 1.99 110.847 -162.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -77.36 -0.39 25.5 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 117.652 2.464 . . . . 3.44 117.652 -166.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -149.64 -64.87 0.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.699 1.59 . . . . 2.7 109.581 163.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -84.98 -19.72 31.66 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.981 1.313 . . . . 3.13 112.493 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.729 2.412 . . . . 3.73 112.331 173.87 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.41 -0.589 . . . . 10.99 109.41 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.77 145.49 52.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.477 0.581 . . . . 9.81 109.458 155.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 m -179.0 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.589 1.699 . . . . 5.24 115.589 -167.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -155.8 121.06 4.83 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 120.436 1.471 . . . . 4.93 111.643 -166.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -97.18 130.11 44.46 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.447 -0.783 . . . . 2.76 109.474 -169.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 146.39 47.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.284 1.434 . . . . 4.32 110.092 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.81 166.6 17.82 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.384 1.073 . . . . 4.66 113.454 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 ' CD1' HG23 ' A' ' 57' ' ' THR . 2.2 mt -146.05 151.82 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 130.394 3.478 . . . . 2.49 107.23 161.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.07 135.27 48.68 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.108 1.363 . . . . 0.95 108.97 165.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 69.3 mtp -147.77 150.0 33.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.035 1.334 . . . . 2.14 113.063 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.64 144.59 33.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.456 1.902 . . . . 2.8 111.311 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.41 139.83 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.877 1.671 . . . . 1.67 111.073 -156.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.8 t -100.03 149.87 23.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.26 1.424 . . . . 2.72 112.774 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.98 1.87 57.15 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.984 1.278 . . . . 1.4 114.012 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.9 mtt -72.95 10.6 0.86 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.11 1.522 . . . . 2.87 115.11 178.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -71.97 59.22 0.36 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.964 2.906 . . . . 3.3 111.647 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 p -177.37 -20.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.337 2.255 . . . . 4.92 114.489 -171.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 71.35 -41.32 0.5 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.667 2.387 . . . . 2.55 114.13 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.23 -15.99 40.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.626 1.17 . . . . 1.5 114.029 174.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.4 p -44.87 -50.07 10.57 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.308 1.443 . . . . 3.29 113.243 160.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.24 -58.06 8.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.189 1.396 . . . . 1.19 110.977 174.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.96 -19.64 7.21 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.624 1.57 . . . . 1.23 114.655 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -93.95 -36.61 12.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.839 1.256 . . . . 3.33 113.976 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.6 -54.98 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 120.557 1.526 . . . . 2.43 110.926 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -56.05 -48.9 75.15 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.294 1.438 . . . . 2.19 110.818 -175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -66.85 -33.42 75.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.148 1.379 . . . . 3.77 113.026 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.77 -48.06 70.29 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 125.655 1.598 . . . . 1.5 112.05 174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.88 -42.04 70.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.54 0.67 . . . . 2.31 111.683 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -57.52 -23.44 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 120.843 -1.161 . . . . 3.96 113.713 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.17 -5.75 59.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.186 1.794 . . . . 3.91 114.67 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.6 mmt -74.21 164.44 61.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.042 1.337 . . . . 3.73 111.799 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.08 -70.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.048 2.499 . . . . 1.78 112.711 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.9 -10.62 86.01 Favored Glycine 0 N--CA 1.48 1.582 0 N-CA-C 116.421 1.328 . . . . 1.88 116.421 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -75.46 127.38 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.48 1.512 . . . . 1.62 108.991 175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -83.67 -52.52 6.36 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 117.565 -1.207 . . . . 2.22 109.587 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.269 10.0 p-10 -173.37 164.81 4.7 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.084 1.142 . . . . 3.21 114.084 -173.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.66 152.68 37.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.271 1.429 . . . . 1.09 111.139 -173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -142.73 135.92 28.42 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.023 1.329 . . . . 2.36 110.138 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 41' ' ' LEU . 2.3 p -77.19 151.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.27 1.028 . . . . 2.31 111.113 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.37 1.63 54.34 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.204 1.402 . . . . 4.3 113.46 171.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' VAL . 4.8 tt 47.94 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.024 2.93 . . . . 2.92 113.324 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.49 -30.32 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.385 0.993 . . . . 2.86 112.314 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.81 7.55 30.02 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.599 1.16 . . . . 2.56 112.208 174.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 69.81 17.9 7.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.869 1.063 . . . . 3.62 113.869 148.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 94.1 m -124.48 141.12 52.33 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 126.387 1.875 . . . . 1.66 107.7 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.7 m -100.06 127.51 46.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.574 0.75 . . . . 2.11 109.398 167.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.38 126.8 53.27 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.14 0.976 . . . . 1.34 109.047 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.33 142.24 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.608 0.763 . . . . 2.32 110.906 -166.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.08 125.48 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.875 1.27 . . . . 1.23 110.677 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -152.65 156.78 39.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.269 1.828 . . . . 2.3 114.659 -169.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.84 128.82 61.66 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.94 1.296 . . . . 4.03 110.318 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.43 81.28 2.7 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.643 2.896 . . . . 2.91 110.738 -174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.96 -65.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.717 2.007 . . . . 1.99 109.846 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.7 29.32 0.62 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.253 1.421 . . . . 3.48 112.32 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.2 m -170.76 152.98 3.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.192 2.997 . . . . 2.42 107.764 -176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.19 23.86 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.904 2.192 . . . . 1.69 111.549 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 103' ' ' ALA . 55.2 m -77.59 -53.79 7.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.174 0.987 . . . . 2.75 112.466 -173.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.29 -30.27 68.2 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.039 0.836 . . . . 1.38 112.846 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.96 -24.15 64.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.678 1.191 . . . . 1.26 113.765 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -67.58 -51.77 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 119.262 0.937 . . . . 2.17 110.249 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -67.65 -35.43 78.88 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.0 -1.0 . . . . 3.46 111.16 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -44.52 87.92 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.991 1.269 . . . . 2.97 112.476 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.92 -24.0 62.37 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.773 -1.204 . . . . 2.24 112.875 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 90.1 mt -70.5 -52.84 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.386 0.994 . . . . 1.21 110.878 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -54.01 -31.59 51.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.682 1.593 . . . . 2.75 111.748 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -19.4 20.83 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.078 1.51 . . . . 4.37 115.078 174.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.09 -23.69 21.34 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.326 1.421 . . . . 1.85 113.629 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.74 2.53 69.53 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-N 118.845 0.748 . . . . 1.45 113.536 -165.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -79.44 148.88 31.76 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.766 -1.198 . . . . 5.77 107.766 149.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -136.6 143.37 43.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.765 1.166 . . . . 5.25 112.146 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.1 p -74.09 152.08 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.236 1.014 . . . . 3.08 112.618 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.4 53.28 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 122.096 0.951 . . . . 2.6 112.189 170.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -82.05 150.31 27.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.322 1.449 . . . . 2.17 109.7 166.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -113.17 147.61 37.08 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.007 1.723 . . . . 4.25 107.802 170.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -99.55 130.6 45.81 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.959 0.503 . . . . 3.16 109.684 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.16 154.94 50.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.057 0.943 . . . . 0.95 111.026 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -112.96 139.66 48.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.13 0.972 . . . . 2.48 110.581 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -129.13 157.45 41.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.079 1.751 . . . . 2.22 110.187 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.14 132.66 53.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.185 0.994 . . . . 2.49 109.753 165.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.7 mp -95.14 103.05 14.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.269 -1.382 . . . . 1.68 107.269 168.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -87.43 74.31 9.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.542 -1.281 . . . . 3.58 107.542 170.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 177.96 -26.63 0.06 OUTLIER Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.97 1.148 . . . . 1.1 115.97 -172.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.83 146.42 24.46 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.477 1.138 . . . . 3.33 110.832 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.6 p -138.08 5.13 2.54 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.86 1.43 . . . . 1.82 114.86 -167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 33.4 t -176.2 154.47 1.39 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.999 1.72 . . . . 1.97 109.884 -164.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.04 51.69 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.4 0.889 . . . . 1.37 113.4 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.03 82.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.992 0.738 . . . . 1.4 112.992 172.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.8 -36.15 70.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.556 1.142 . . . . 1.28 112.071 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.06 -55.67 23.55 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.017 0.927 . . . . 0.88 111.086 168.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -52.39 -42.48 64.06 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.411 1.084 . . . . 2.3 112.799 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -59.91 -22.43 62.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.69 1.367 . . . . 3.9 114.69 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 pt -96.8 -46.56 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 120.549 1.522 . . . . 0.93 112.841 165.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -46.52 -50.76 16.65 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.465 1.906 . . . . 3.25 111.997 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -59.73 -19.41 49.88 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.212 1.405 . . . . 3.88 114.086 -177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.09 -38.23 8.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.469 1.508 . . . . 3.63 111.781 172.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -31.53 66.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.635 1.574 . . . . 1.67 113.761 176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -44.85 -6.04 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 129.567 3.147 . . . . 2.37 119.162 -177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.77 29.42 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.068 1.507 . . . . 4.64 115.068 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 mt -73.4 78.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 119.708 -1.87 . . . . 3.0 112.589 -172.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 64.9 43.92 3.74 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.188 0.994 . . . . 4.07 112.622 141.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.48 7.3 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.573 1.558 . . . . 1.33 112.012 -162.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.18 131.05 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.93 1.365 . . . . 2.02 111.071 165.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.459 ' O ' HG21 ' A' ' 57' ' ' THR . . . -97.81 -69.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.826 1.651 . . . . 2.0 111.067 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -129.75 153.67 47.97 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.423 1.011 . . . . 1.83 112.577 -172.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.43 72.78 5.51 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.371 1.249 . . . . 1.31 114.371 -176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.44 91.91 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.303 2.669 . . . . 1.25 111.518 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -70.35 132.93 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.58 1.152 . . . . 0.94 111.461 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.27 110.53 21.92 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.264 1.826 . . . . 2.46 113.041 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -81.1 -7.31 59.53 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.6 1.333 . . . . 3.79 114.6 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.34 -38.69 6.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.447 1.099 . . . . 2.11 111.352 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.7 mt -92.92 -21.96 19.51 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.899 1.28 . . . . 2.47 113.356 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 78.44 15.28 1.29 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.679 2.792 . . . . 2.04 113.545 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.6 p -103.51 177.98 4.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.588 1.555 . . . . 0.96 111.142 -175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.44 136.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.674 0.789 . . . . 0.74 109.429 167.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.5 m -93.96 123.46 37.34 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.723 -1.584 . . . . 1.22 106.723 166.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.61 133.34 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.473 1.109 . . . . 0.88 109.508 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.45 121.13 43.64 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.192 2.197 . . . . 2.85 108.683 172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -164.02 165.79 22.11 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.407 0.892 . . . . 2.66 113.407 -167.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -95.59 105.41 20.47 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.418 -1.426 . . . . 2.56 110.733 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.07 9.32 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.59 2.86 . . . . 1.62 113.523 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -88.35 0.05 56.62 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.395 1.478 . . . . 4.97 112.52 174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -158.28 -43.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.437 1.095 . . . . 4.61 112.145 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.56 130.33 35.0 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.247 -0.908 . . . . 1.75 110.906 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 p -111.5 164.76 12.62 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.421 0.897 . . . . 3.51 113.421 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 t -62.9 -27.79 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 121.342 -0.849 . . . . 1.32 111.35 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.8 m -69.85 -39.02 76.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.361 0.664 . . . . 1.84 111.163 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.39 -38.03 77.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.814 0.846 . . . . 3.14 112.201 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.2 mt -61.29 -44.7 96.79 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.922 -0.486 . . . . 1.32 110.554 170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -46.55 81.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 115.175 -2.345 . . . . 5.55 113.493 167.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -64.85 -28.27 69.44 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.074 2.215 . . . . 3.27 112.748 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.39 -53.32 17.05 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.256 -0.902 . . . . 1.24 111.312 170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.8 t -70.97 -24.09 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 113.308 0.855 . . . . 0.89 113.308 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.89 -37.41 71.35 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.288 1.435 . . . . 1.88 113.576 178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -75.03 -21.19 59.22 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.114 0.966 . . . . 3.3 113.15 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.26 -3.64 53.29 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.129 1.372 . . . . 1.5 112.819 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.21 -24.51 31.97 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.553 1.549 . . . . 1.64 116.318 163.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -74.43 -178.79 3.66 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.113 1.457 . . . . 3.02 113.719 -173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 161.53 28.95 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.469 -1.394 . . . . 2.53 110.473 162.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.4 mt -120.23 116.34 25.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.136 1.375 . . . . 1.12 109.583 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -85.65 153.75 22.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.336 -0.616 . . . . 2.96 109.336 161.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mt -99.23 144.45 28.34 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.543 -0.723 . . . . 1.45 109.677 166.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -95.77 120.29 35.77 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.498 1.519 . . . . 4.35 107.172 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.54 -61.38 2.81 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.549 -1.021 . . . . 1.72 110.549 -164.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -70.68 -3.03 16.42 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.397 1.628 . . . . 5.04 115.397 -171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -140.7 -82.48 0.24 Allowed 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.615 -1.303 . . . . 3.0 110.544 158.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -87.42 -2.38 58.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.057 0.943 . . . . 4.04 113.145 -159.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 129.548 3.139 . . . . 3.41 113.442 169.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 mtt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 117.324 -1.322 . . . . 14.88 109.116 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.99 60.51 3.57 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 121.279 1.854 . . . . 11.35 112.951 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m 141.06 124.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 1 C-N-CA 132.861 4.464 . . . . 6.44 109.995 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 178.42 98.9 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.578 2.751 . . . . 6.11 108.928 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -81.47 129.96 34.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.442 -0.786 . . . . 2.63 109.321 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -141.27 167.73 21.48 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.481 1.512 . . . . 3.73 112.013 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -93.18 153.69 18.48 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.727 1.211 . . . . 3.77 113.21 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.5 tt -156.95 155.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.848 1.659 . . . . 2.54 109.657 172.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.0 154.24 41.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.818 0.847 . . . . 1.85 112.761 -171.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.37 136.8 15.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.23 1.812 . . . . 3.78 111.843 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.11 134.92 41.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.51 1.524 . . . . 3.07 109.996 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.6 t -117.82 165.87 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.873 2.069 . . . . 3.23 110.16 -165.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.0 t -130.33 140.15 50.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.536 -0.727 . . . . 3.45 110.141 148.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.75 15.25 13.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.187 1.375 . . . . 1.85 114.901 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -94.37 -1.04 54.42 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.658 1.729 . . . . 2.68 113.637 166.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -49.5 -18.41 0.41 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 128.619 2.768 . . . . 3.58 117.618 -170.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.39 4.47 53.36 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.733 1.152 . . . . 3.12 113.104 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.21 -41.85 0.49 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.992 2.517 . . . . 2.03 114.291 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.64 67.93 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.99 -1.069 . . . . 1.83 111.611 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -58.25 -45.4 87.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.202 1.401 . . . . 2.24 111.9 166.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.05 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.838 0.745 . . . . 0.95 111.387 174.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.88 -39.3 74.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.474 0.709 . . . . 1.6 112.587 172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -69.51 -31.23 69.35 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.606 1.162 . . . . 3.31 113.794 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -70.25 -51.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 120.034 1.288 . . . . 2.07 109.632 174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -57.5 -52.1 66.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.396 0.998 . . . . 1.84 111.593 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -59.99 -32.33 70.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.62 1.168 . . . . 4.13 113.168 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.3 -44.96 41.14 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.149 1.357 . . . . 1.21 112.363 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.55 -33.4 74.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.44 1.12 . . . . 2.48 111.832 169.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -56.46 -18.58 11.79 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.104 1.15 . . . . 4.65 114.104 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -98.28 24.02 7.7 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.488 1.515 . . . . 4.43 114.784 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -91.75 135.39 27.64 Favored Pre-proline 0 N--CA 1.482 1.139 0 O-C-N 120.039 -1.663 . . . . 3.58 110.41 164.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.01 -20.52 71.74 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.186 2.591 . . . . 2.86 114.442 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.91 -2.63 58.29 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.62 -1.656 . . . . 1.87 115.744 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.97 126.05 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 121.099 2.449 . . . . 1.54 111.237 -170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -92.71 -33.47 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 116.583 -1.675 . . . . 1.77 111.507 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -162.18 163.06 28.58 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.538 1.681 . . . . 2.51 115.538 175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.69 145.91 33.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.702 1.201 . . . . 1.12 111.793 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -142.87 133.7 25.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.744 1.218 . . . . 2.32 110.325 -173.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -120.74 127.91 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.273 0.942 . . . . 2.16 111.679 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -95.32 109.64 21.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.835 1.254 . . . . 2.36 109.016 162.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.2 -35.2 55.93 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.809 -0.557 . . . . 2.6 112.102 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.85 -26.2 33.78 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.77 1.396 . . . . 2.29 114.77 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -126.59 27.62 6.07 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.951 1.301 . . . . 3.57 112.849 167.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 28.37 57.99 0.11 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.035 2.934 . . . . 5.65 115.531 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.8 m -130.76 133.78 46.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.677 1.191 . . . . 2.15 110.949 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 99.2 p -99.57 142.09 31.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.814 1.646 . . . . 2.3 110.81 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -140.03 123.22 16.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.314 1.845 . . . . 1.98 107.69 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 8.8 m -136.46 156.53 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.42 1.009 . . . . 2.32 111.765 -169.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -126.7 124.3 64.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 C-N-CA 125.346 1.458 . . . . 1.11 109.557 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.95 159.41 39.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.597 1.159 . . . . 2.76 114.088 -166.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -99.57 126.06 38.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.298 1.839 . . . . 3.45 112.424 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.87 -10.38 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.686 2.924 . . . . 2.55 114.216 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.24 -50.1 56.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.491 1.041 . . . . 2.08 111.659 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -86.3 -2.43 58.39 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.374 1.25 . . . . 3.15 114.374 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.4 m -154.97 126.53 7.41 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.287 -1.508 . . . . 2.1 110.928 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.53 138.6 21.26 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.278 -1.129 . . . . 2.05 110.278 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.8 t -68.44 -19.87 64.6 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.335 1.605 . . . . 2.34 115.335 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.46 -21.23 59.77 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.864 1.061 . . . . 1.26 113.864 168.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.34 -21.0 66.0 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.885 -1.134 . . . . 1.39 113.367 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.1 mm -62.08 -46.72 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.2 1.0 . . . . 2.71 110.93 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.5 pm0 -70.92 -45.37 64.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.121 0.873 . . . . 2.26 112.136 170.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -54.58 -42.24 70.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.274 1.029 . . . . 4.29 112.18 -172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -22.12 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.286 0.847 . . . . 1.98 113.286 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 69' ' ' TYR . 73.5 mt -83.27 -43.47 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.411 1.084 . . . . 1.38 110.584 172.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -51.07 -38.05 49.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.486 1.114 . . . . 4.0 110.799 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -58.54 -17.03 18.25 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.414 1.265 . . . . 5.0 114.414 177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -90.77 -3.13 57.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.233 1.379 . . . . 1.56 113.199 173.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.72 44.66 8.28 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.695 1.134 . . . . 1.86 113.007 174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CD2' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -82.63 -159.17 0.3 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.29 1.436 . . . . 10.5 113.408 -177.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -146.23 174.98 10.85 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.751 1.62 . . . . 4.47 109.717 154.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.2 p -164.86 167.59 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 120.742 -1.224 . . . . 4.63 111.175 -160.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.29 129.64 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.3 1.04 . . . . 4.18 108.487 160.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 p -141.87 148.34 38.61 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.519 1.528 . . . . 2.84 109.742 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -137.77 150.03 46.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.788 0.835 . . . . 3.82 110.463 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -117.35 137.23 52.59 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.273 1.035 . . . . 3.12 111.226 162.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.51 157.19 47.09 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.582 1.153 . . . . 1.02 110.016 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.85 151.63 31.85 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.173 0.589 . . . . 3.37 111.366 165.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -136.31 145.46 45.51 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.162 1.385 . . . . 2.06 110.212 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.73 124.63 33.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.849 1.26 . . . . 2.96 110.109 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.42 HD11 ' CG1' ' A' ' 114' ' ' VAL . 22.2 mm -87.84 75.16 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.753 1.621 . . . . 1.87 108.474 175.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.92 51.6 0.97 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 123.119 1.438 . . . . 3.7 111.617 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.44 4.45 0.04 OUTLIER Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.665 1.602 . . . . 1.89 115.336 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.73 148.29 49.89 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.47 1.635 . . . . 2.82 110.245 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -132.99 -0.01 3.43 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.502 1.297 . . . . 1.84 114.502 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.9 t -166.72 161.18 15.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.444 1.497 . . . . 1.98 111.36 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.69 -44.92 63.31 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.819 1.648 . . . . 1.63 114.471 -172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.79 -37.97 69.3 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.631 1.105 . . . . 1.67 112.602 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.1 m -73.68 -32.46 63.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.823 0.849 . . . . 1.68 112.517 177.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.08 -56.52 12.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.955 0.902 . . . . 1.22 111.362 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -52.51 -37.27 57.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.358 1.063 . . . . 2.65 112.704 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.2 mtp85 -57.46 -33.14 67.65 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.491 1.293 . . . . 4.62 114.491 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.81 -33.73 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.718 1.145 . . . . 1.31 112.899 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -52.74 -44.95 66.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.598 1.09 . . . . 2.39 112.228 -174.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -58.45 -28.64 65.49 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.412 0.893 . . . . 3.95 113.412 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -38.78 13.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 117.991 -1.004 . . . . 4.52 112.165 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -55.5 -40.96 72.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.885 1.274 . . . . 0.96 112.144 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -47.76 -45.12 28.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.232 1.413 . . . . 2.08 112.964 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.5 76.7 1.6 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.933 1.693 . . . . 2.78 110.346 -177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.554 ' H ' HG21 ' A' ' 102' ' ' VAL 0.25 22.5 mt -74.5 -121.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.763 -1.199 . . . . 2.03 107.763 160.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -122.26 125.84 46.88 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.167 -2.531 . . . . 3.77 104.167 166.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.87 -7.48 66.05 Favored Glycine 0 N--CA 1.481 1.658 0 O-C-N 120.781 -1.199 . . . . 1.45 115.231 164.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 99' ' ' ILE . 29.2 m -60.66 149.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 126.342 1.857 . . . . 2.45 112.624 161.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -107.46 -50.71 3.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.569 1.548 . . . . 1.04 112.317 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -136.23 157.09 47.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 1.47 113.282 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.74 124.08 1.91 Allowed Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.464 1.106 . . . . 1.7 112.13 161.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -105.01 136.51 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.771 3.647 . . . . 1.19 110.9 157.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.2 t -102.65 122.03 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 1.5 109.521 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -76.81 134.54 39.04 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.513 -0.742 . . . . 2.9 112.898 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -99.71 -3.63 32.51 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.619 1.34 . . . . 3.91 114.619 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.76 -35.62 2.49 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.429 1.092 . . . . 1.67 112.847 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -17.33 52.21 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.719 1.208 . . . . 1.68 111.915 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 69.8 11.13 7.76 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.146 2.178 . . . . 2.19 113.637 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.1 p -110.81 124.95 53.01 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.036 -1.04 . . . . 1.34 110.888 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.6 p -87.01 140.56 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.913 -0.773 . . . . 0.95 108.913 168.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.3 m -99.08 134.84 41.34 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.441 -1.318 . . . . 1.28 107.441 168.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -128.49 137.31 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.774 1.23 . . . . 0.86 109.821 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -123.85 119.13 28.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.688 2.395 . . . . 2.83 107.963 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -158.88 166.32 32.13 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.975 1.472 . . . . 2.63 114.975 -163.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -85.85 120.05 72.41 Favored Pre-proline 0 CA--C 1.549 0.93 0 O-C-N 121.363 -0.836 . . . . 3.27 110.267 166.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.15 17.67 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.066 3.177 . . . . 2.07 114.644 -173.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -129.02 -21.81 3.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.63 1.344 . . . . 6.63 114.63 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.19 -34.82 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.526 1.057 . . . . 4.9 111.348 176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.22 16.78 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.103 1.761 . . . . 1.72 110.505 178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.3 t -156.7 -163.29 1.4 Allowed 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.321 -0.862 . . . . 3.82 113.293 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.0 t -65.43 -15.79 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.912 1.285 . . . . 1.9 112.664 -168.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -70.96 -42.85 69.21 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.024 -1.047 . . . . 2.19 112.789 170.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.55 -40.33 73.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.428 1.091 . . . . 2.53 110.836 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mt -60.93 -42.57 98.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.299 1.44 . . . . 2.14 111.669 170.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -57.35 -58.23 9.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 116.493 -1.718 . . . . 2.92 111.106 168.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.27 -41.22 65.3 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 121.061 1.755 . . . . 3.04 112.822 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.78 -27.2 69.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.416 1.265 . . . . 1.69 114.416 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 76.8 t -100.68 -33.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.483 1.513 . . . . 1.01 113.09 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -57.1 -41.75 79.48 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.656 1.982 . . . . 2.16 110.249 172.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -28.64 54.53 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 2.84 114.443 174.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.15 -8.31 42.91 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.632 1.173 . . . . 1.57 113.445 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.21 21.99 33.67 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.195 0.907 . . . . 1.55 114.436 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.4 m-30 -108.12 -163.32 0.88 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 118.303 1.052 . . . . 3.2 109.455 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.37 169.93 16.75 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.172 -1.58 . . . . 2.59 107.896 151.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.23 146.57 26.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.895 0.878 . . . . 1.47 110.012 167.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -119.75 139.42 52.33 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.359 0.412 . . . . 3.74 110.337 158.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 144' ' ' GLU . 8.1 mt -66.68 159.47 27.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.057 0.932 . . . . 1.71 111.97 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -113.39 124.03 51.47 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.373 -2.084 . . . . 4.48 105.373 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.31 -84.19 1.6 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 108.734 -1.746 . . . . 2.32 108.734 -153.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 141' ' ' LEU . 6.1 mt-10 -79.14 47.53 0.79 Allowed 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.774 1.768 . . . . 4.95 115.774 -169.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 173.97 -82.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 129.217 3.007 . . . . 2.88 108.636 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.39 -11.35 59.83 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.909 1.284 . . . . 5.16 113.385 -171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.247 0.97 0 C-N-CA 127.675 2.39 . . . . 2.72 112.291 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 117.702 -1.142 . . . . 16.7 108.241 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.5 mt 137.11 151.69 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 131.665 3.986 . . . . 11.88 109.815 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 m -78.6 36.01 0.25 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.088 1.755 . . . . 6.77 112.997 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 85.9 -32.66 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.012 2.925 . . . . 7.96 109.947 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -64.22 114.98 4.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.192 0.52 . . . . 3.9 110.726 157.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -105.25 145.41 30.7 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.522 0.729 . . . . 6.33 109.556 158.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -117.99 145.71 44.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.164 0.985 . . . . 3.83 111.813 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.583 HD13 ' H ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -150.35 157.91 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.36 1.864 . . . . 2.5 109.108 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' ILE . . . -136.98 145.37 44.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.95 0.9 . . . . 1.14 111.359 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -140.21 143.38 36.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.619 1.968 . . . . 3.12 110.402 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.13 126.27 38.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.153 0.981 . . . . 2.67 109.345 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -126.68 119.38 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.521 1.528 . . . . 1.43 111.579 -170.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.1 t -93.61 145.41 24.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.891 1.276 . . . . 1.83 113.048 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.75 8.79 17.77 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.387 1.47 . . . . 1.12 115.214 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.4 mtm -76.67 132.13 39.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.133 1.467 . . . . 2.44 113.0 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.1 p -135.51 169.69 17.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.672 1.989 . . . . 4.78 110.696 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t 65.03 -3.27 0.61 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.418 2.287 . . . . 4.08 115.404 165.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.28 -16.73 0.1 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.944 2.498 . . . . 2.26 113.852 -164.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.99 53.15 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.926 1.291 . . . . 1.5 113.317 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.9 m -55.28 -35.04 64.63 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.551 1.069 . . . . 1.59 112.528 167.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.38 -49.54 77.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.338 0.655 . . . . 0.91 111.947 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.32 77.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.682 0.793 . . . . 0.95 111.699 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -36.67 85.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.263 1.025 . . . . 5.25 113.275 177.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 -58.14 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.545 1.066 . . . . 2.53 110.29 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.21 -53.23 60.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.446 1.099 . . . . 1.39 111.848 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.15 -30.3 69.22 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 119.847 1.203 . . . . 3.81 112.818 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.12 -35.7 78.56 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.875 1.226 . . . . 1.07 114.776 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.75 -40.85 19.97 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.271 1.535 . . . . 2.49 111.486 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -59.51 -5.31 0.79 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.148 1.779 . . . . 4.35 114.246 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -30.89 69.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.182 2.193 . . . . 4.68 115.208 166.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -95.33 130.03 33.43 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 120.544 1.52 . . . . 2.44 113.292 -173.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.5 -16.77 48.05 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 123.547 2.831 . . . . 2.65 114.338 -170.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -4.76 90.43 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.744 -1.031 . . . . 1.33 114.58 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 t -101.72 125.53 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 119.103 1.451 . . . . 1.75 107.813 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.5 t -94.09 -31.96 13.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 118.761 -0.638 . . . . 1.84 110.906 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -156.17 154.41 30.79 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.351 0.871 . . . . 2.9 113.351 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 126.5 10.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.804 1.642 . . . . 1.13 108.536 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -140.15 121.46 14.94 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.874 1.27 . . . . 2.5 110.383 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.79 117.32 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.993 0.902 . . . . 1.87 111.354 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -77.53 106.65 9.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.724 1.21 . . . . 1.89 108.792 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 30.5 tp -62.65 -44.8 95.34 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.155 0.582 . . . . 2.22 111.315 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.8 1.22 4.55 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.094 1.758 . . . . 2.02 114.84 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -141.8 14.86 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.458 1.503 . . . . 2.42 111.514 170.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 52.68 27.19 4.99 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 126.728 2.011 . . . . 2.54 115.367 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.2 m -125.92 127.9 46.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.118 1.367 . . . . 1.77 111.485 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.2 m -93.07 127.61 38.66 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.185 1.394 . . . . 1.83 110.454 173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -117.94 127.59 53.99 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.002 1.721 . . . . 1.35 107.952 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.61 153.97 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.194 0.906 . . . . 1.95 112.002 -170.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.39 128.07 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.778 1.631 . . . . 1.02 109.095 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -156.06 162.8 40.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.51 1.524 . . . . 2.36 113.066 -160.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -108.39 135.52 19.97 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.78 1.632 . . . . 2.48 112.592 -172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.08 61.4 7.78 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.943 3.762 . . . . 2.4 112.594 -173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.49 -70.38 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.484 1.514 . . . . 2.37 110.868 -177.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -81.73 13.73 3.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.722 1.209 . . . . 3.61 113.106 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.2 t -177.83 -176.63 0.59 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 130.093 3.357 . . . . 2.19 108.705 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.44 168.45 37.39 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.061 1.315 . . . . 1.6 112.938 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.1 m -53.53 -52.37 59.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.937 1.295 . . . . 2.67 112.519 -172.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.49 -26.65 68.81 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.068 1.136 . . . . 1.15 114.068 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.49 -18.63 62.96 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.759 -1.213 . . . . 0.93 112.558 174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -66.58 -57.76 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.819 0.736 . . . . 2.29 109.777 169.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.95 -37.18 78.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.644 -0.694 . . . . 2.41 111.982 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.94 -33.82 76.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.0 0.818 . . . . 3.13 111.783 173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.66 -40.97 76.13 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.353 -1.467 . . . . 2.95 111.991 170.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.36 -50.08 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.624 1.102 . . . . 1.04 110.446 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -51.82 -51.84 53.6 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.537 1.135 . . . . 2.78 111.681 170.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -62.04 -9.69 7.95 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.73 1.752 . . . . 4.25 115.73 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 67' ' ' LEU . 3.6 mm? -89.36 -7.54 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.872 1.669 . . . . 1.77 113.429 169.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.99 49.19 0.63 Allowed Glycine 0 N--CA 1.472 1.09 0 C-N-CA 125.208 1.385 . . . . 1.83 114.504 168.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.56 -178.3 5.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.253 1.021 . . . . 5.22 113.498 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -114.71 113.31 24.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.61 0.764 . . . . 3.83 109.601 164.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.37 129.55 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.967 1.258 . . . . 2.59 108.841 166.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.87 52.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-O 121.647 0.737 . . . . 2.25 112.217 -166.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.0 p -99.29 127.7 45.32 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.785 1.234 . . . . 2.35 110.797 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -99.45 137.61 37.71 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.22 1.408 . . . . 3.41 109.373 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 pttt -87.02 137.92 31.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.306 0.642 . . . . 3.32 110.789 165.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.82 159.0 43.82 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.456 1.102 . . . . 1.27 110.737 167.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -107.36 115.95 31.08 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.926 0.89 . . . . 2.45 108.759 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -99.0 152.2 20.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 2.05 110.534 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -113.25 129.48 56.51 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.454 2.302 . . . . 3.16 109.367 -164.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.446 HD11 HG12 ' A' ' 114' ' ' VAL . 3.8 mp -104.61 144.37 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 122.481 1.134 . . . . 2.75 109.579 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -127.75 91.74 3.34 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 105.887 -1.894 . . . . 4.14 105.887 157.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.73 -14.86 0.03 OUTLIER Glycine 0 CA--C 1.535 1.282 0 N-CA-C 120.392 2.917 . . . . 1.19 120.392 -161.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -146.17 113.2 6.14 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 122.67 3.235 . . . . 2.47 116.594 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.7 p -102.78 5.77 38.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.204 1.402 . . . . 2.13 114.458 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 50.2 t -143.52 145.54 32.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.678 1.191 . . . . 2.27 112.566 -178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.41 -30.34 66.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.724 1.21 . . . . 1.44 112.963 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.08 78.11 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.518 0.727 . . . . 1.34 112.341 173.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.3 m -68.89 -47.32 66.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.282 0.633 . . . . 1.29 111.507 174.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.14 -53.58 51.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.329 0.652 . . . . 1.13 111.358 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -68.45 -32.51 72.58 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.446 -0.784 . . . . 2.09 113.002 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -57.98 -44.85 87.37 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.79 1.177 . . . . 3.92 112.33 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.9 pt -73.89 -40.15 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.782 0.719 . . . . 1.73 111.868 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -52.24 -49.39 64.09 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.126 1.771 . . . . 2.85 110.745 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -65.96 -0.99 2.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 115.437 1.643 . . . . 3.03 115.437 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.46 -41.83 4.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.816 1.189 . . . . 3.68 112.178 160.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -54.93 -44.54 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.753 1.221 . . . . 0.99 113.341 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -48.97 -29.49 4.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.969 2.107 . . . . 1.52 115.601 -168.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.03 80.68 0.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.105 0.962 . . . . 5.32 111.767 163.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.727 HG22 ' H ' ' A' ' 100' ' ' GLU . 19.2 mt -65.83 -179.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 O-C-N 121.623 -0.673 . . . . 2.52 109.304 159.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.727 ' H ' HG22 ' A' ' 99' ' ' ILE . 92.3 mt-10 -77.45 116.86 18.38 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.336 -2.103 . . . . 3.67 107.591 -172.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.28 6.59 69.94 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 117.934 -1.481 . . . . 1.61 113.891 -168.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.7 t -96.49 122.5 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 119.331 1.565 . . . . 2.02 107.582 165.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.38 -48.03 8.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.59 1.156 . . . . 1.15 111.927 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -142.81 151.67 41.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.491 0.587 . . . . 1.67 112.578 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.96 115.99 1.5 Allowed Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 113.756 1.021 . . . . 1.03 113.756 162.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -96.44 137.03 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 124.714 3.609 . . . . 0.87 111.425 161.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 109' ' ' PHE . 98.1 t -97.35 135.84 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 124.585 1.154 . . . . 1.01 110.232 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -89.8 9.77 26.11 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.294 1.038 . . . . 3.98 113.612 -171.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.489 ' H ' HG12 ' A' ' 107' ' ' VAL . 2.6 t80 48.7 -105.48 0.15 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.429 2.291 . . . . 6.01 112.754 176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.35 14.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.895 1.278 . . . . 2.13 113.609 -168.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.28 -0.65 53.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.684 1.994 . . . . 1.53 111.879 167.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.34 28.5 mt-10 33.78 49.18 0.25 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.829 2.851 . . . . 3.6 113.59 -168.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.6 p -142.28 162.32 35.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.633 1.973 . . . . 1.19 110.281 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 80' ' ' ILE . 4.0 p -144.77 138.83 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.313 1.445 . . . . 0.64 108.406 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -95.6 128.59 42.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.998 -1.482 . . . . 0.83 106.998 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.1 t -126.87 135.61 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.751 0.82 . . . . 0.85 109.06 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -122.95 122.46 38.62 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.636 1.575 . . . . 3.07 109.597 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -158.68 157.1 31.18 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 2.77 113.433 -161.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -82.85 109.3 15.95 Favored Pre-proline 0 CA--C 1.548 0.88 0 O-C-N 120.672 -1.268 . . . . 2.45 109.961 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.86 -13.18 38.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.2 2.6 . . . . 1.78 113.266 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -55.51 -59.74 4.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.438 1.495 . . . . 3.37 112.742 166.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -114.2 -27.59 7.59 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.949 1.092 . . . . 3.72 113.949 -164.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.29 151.22 25.7 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.814 0.734 . . . . 2.23 109.677 165.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.1 t -154.18 171.79 18.61 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 121.074 -1.016 . . . . 2.15 112.028 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -62.83 -22.9 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.898 0.879 . . . . 1.41 110.373 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 m -58.99 -58.45 8.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.582 0.753 . . . . 2.27 112.373 166.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.54 -37.68 82.0 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.141 0.976 . . . . 3.07 111.808 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 mt -64.16 -61.81 2.02 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.87 1.268 . . . . 2.1 110.33 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -58.28 -46.21 86.46 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.128 -0.939 . . . . 2.8 112.928 -178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -66.32 -29.43 69.62 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.71 1.141 . . . . 2.4 112.525 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.44 -36.53 57.89 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.679 0.992 . . . . 1.39 113.679 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 137' ' ' TYR . 2.5 t -71.85 -33.05 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.854 1.662 . . . . 1.38 113.51 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -51.28 -38.8 54.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.479 2.312 . . . . 2.97 113.158 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -62.54 -23.86 67.2 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.441 1.896 . . . . 3.4 113.419 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.32 -7.27 29.27 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.872 1.669 . . . . 1.57 112.672 176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.62 3.91 80.36 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 116.315 1.286 . . . . 1.37 116.315 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' A' ' 132' ' ' VAL . 5.6 p90 -108.32 -168.27 1.34 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.26 1.53 . . . . 7.63 111.576 175.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.26 146.58 46.87 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 120.26 -1.525 . . . . 2.58 111.007 173.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.07 130.16 45.38 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.239 1.019 . . . . 1.52 110.558 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -109.13 175.81 5.32 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.497 2.719 . . . . 2.58 109.929 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.47 142.04 51.63 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.792 -1.192 . . . . 1.84 111.88 175.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.47 104.86 16.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 5.57 108.498 -170.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.85 -46.65 2.67 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.293 1.425 . . . . 1.45 111.884 -168.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -77.93 41.58 0.36 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 125.719 1.608 . . . . 4.27 114.063 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 152.0 -49.8 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 131.34 3.856 . . . . 4.69 112.501 157.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.75 -47.38 12.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.435 0.561 . . . . 3.89 111.502 -167.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.255 1.36 1 C-N-CA 132.018 4.127 . . . . 3.2 109.77 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.992 -0.527 . . . . 10.8 109.736 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.87 -153.12 0.45 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.616 1.566 . . . . 7.81 110.156 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -176.39 -36.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.506 2.323 . . . . 5.68 111.042 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -124.07 165.85 16.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.505 1.922 . . . . 6.9 109.407 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -131.34 149.63 52.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.245 1.418 . . . . 3.63 107.904 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -111.83 162.53 15.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.619 1.568 . . . . 4.44 113.831 -161.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -113.53 163.03 15.44 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.043 1.737 . . . . 3.0 114.27 -161.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.0 tt -161.69 148.41 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.61 1.964 . . . . 2.24 110.091 168.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.36 145.36 51.81 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.464 0.575 . . . . 1.05 110.779 167.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 78.1 mtp -146.86 173.06 12.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.304 1.842 . . . . 2.88 110.684 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -122.78 145.11 48.71 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.146 -0.971 . . . . 6.09 108.865 168.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 p -141.06 136.25 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.509 0.724 . . . . 1.54 112.311 -169.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -99.38 156.02 17.23 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.584 1.554 . . . . 1.91 113.372 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.03 69.16 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.676 1.607 . . . . 1.36 112.721 -165.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.1 mtm -80.42 72.41 7.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.671 1.236 . . . . 1.99 113.531 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -104.36 132.97 50.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.61 1.564 . . . . 3.82 109.337 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t 78.27 156.29 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 129.206 3.002 . . . . 3.61 111.418 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.33 -10.61 0.14 Allowed 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.741 -1.224 . . . . 2.74 114.024 164.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 -28.24 60.17 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.587 0.958 . . . . 2.18 113.587 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.3 p -70.85 -48.84 51.78 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.406 1.003 . . . . 3.02 112.17 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -48.51 65.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.083 1.353 . . . . 1.07 111.926 168.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.44 -56.83 11.14 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.287 0.635 . . . . 1.83 111.103 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -54.57 -46.84 73.78 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.049 1.34 . . . . 5.82 114.241 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.4 mm -68.63 -47.17 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.483 1.038 . . . . 2.03 111.28 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -65.22 -46.15 81.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.955 0.798 . . . . 2.14 110.372 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -19.62 65.84 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.526 1.512 . . . . 5.69 114.167 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.69 -49.31 8.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.685 1.136 . . . . 1.42 113.358 168.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.5 mt -68.02 -43.96 77.61 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.168 0.984 . . . . 1.52 111.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -57.0 -14.49 3.66 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.475 1.51 . . . . 3.5 114.806 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -83.6 -25.59 30.73 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.246 1.202 . . . . 4.52 114.246 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.4 ptp -74.05 122.95 88.76 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-N 121.437 1.926 . . . . 2.67 110.211 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.59 -8.8 22.12 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.246 2.63 . . . . 1.71 114.287 -166.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.96 -27.63 58.05 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 117.634 -1.648 . . . . 2.02 114.288 170.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.73 129.88 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.184 2.492 . . . . 2.51 110.983 -172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.9 t -108.82 -20.85 12.92 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 117.97 -1.014 . . . . 2.18 112.679 173.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.03 115.54 4.17 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.988 0.813 . . . . 2.8 110.319 173.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.26 127.54 50.55 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.284 -1.006 . . . . 1.0 108.284 162.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -125.83 119.4 27.76 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.022 0.929 . . . . 1.76 109.601 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.52 132.57 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.758 0.823 . . . . 2.88 110.857 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -117.68 81.89 1.73 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.463 1.905 . . . . 2.83 108.43 168.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -31.14 72.23 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.726 -0.609 . . . . 3.46 111.603 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.56 -24.64 21.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.916 1.286 . . . . 3.03 114.256 175.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.81 32.26 4.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.879 1.271 . . . . 3.59 111.239 173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 67.36 9.52 7.05 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.786 1.634 . . . . 4.46 114.305 166.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.22 132.54 43.63 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.907 1.283 . . . . 3.09 110.651 -159.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.2 t -118.26 130.21 55.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.013 -1.106 . . . . 1.23 108.013 165.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.43 122.19 10.56 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.743 0.817 . . . . 3.06 111.169 -170.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.0 t -140.08 143.64 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 122.669 0.388 . . . . 1.82 111.517 -152.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.88 127.15 67.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.438 1.895 . . . . 1.03 110.162 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -147.0 158.8 44.03 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.176 2.19 . . . . 3.48 113.567 -163.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -71.48 116.26 45.63 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.279 1.832 . . . . 2.65 110.554 172.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -9.17 22.43 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.813 2.342 . . . . 2.34 114.013 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.03 -39.17 10.77 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.66 1.118 . . . . 2.09 112.362 174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.54 -21.58 41.65 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.576 0.584 . . . . 3.39 112.576 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -136.47 110.47 8.26 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.121 -0.987 . . . . 2.69 110.438 -171.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.99 157.37 41.19 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.705 1.145 . . . . 1.87 111.352 169.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -51.44 -48.55 62.7 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.766 1.226 . . . . 2.99 112.56 -171.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.93 -27.58 66.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.719 1.208 . . . . 1.58 114.136 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.61 67.2 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.575 1.08 . . . . 1.63 112.763 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.5 mm -70.64 -48.29 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 118.401 0.546 . . . . 2.11 110.464 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -59.16 -48.6 81.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.826 1.251 . . . . 2.59 110.971 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -57.57 -52.55 64.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.282 1.033 . . . . 3.0 111.441 176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -75.18 -12.08 60.22 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.869 -1.145 . . . . 2.83 114.054 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.71 -52.31 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.178 0.899 . . . . 1.45 110.728 162.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.87 -53.72 53.89 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.301 1.04 . . . . 3.2 111.882 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -59.85 -10.29 3.79 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.42 1.488 . . . . 6.79 114.463 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.34 -7.22 58.65 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.224 1.194 . . . . 2.35 114.224 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.38 27.38 2.88 Favored Glycine 0 N--CA 1.476 1.341 0 C-N-CA 125.045 1.307 . . . . 1.51 114.638 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -137.16 176.58 8.58 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.788 1.635 . . . . 5.2 110.712 -169.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.72 124.52 17.14 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.947 -1.095 . . . . 5.36 110.985 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 m -64.6 146.11 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.373 0.988 . . . . 2.88 110.869 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.1 m -78.39 28.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 113.757 1.021 . . . . 3.11 113.757 -168.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.2 p -77.43 154.35 32.71 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 114.391 1.256 . . . . 2.61 114.391 -157.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.96 157.35 20.0 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.135 1.774 . . . . 4.93 106.789 156.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -124.92 142.32 51.54 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.646 -0.659 . . . . 3.74 110.564 163.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.91 153.6 45.74 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.206 1.002 . . . . 1.21 110.434 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -118.95 133.96 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.238 1.015 . . . . 2.58 108.706 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -125.11 148.08 48.71 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.594 1.558 . . . . 1.7 109.279 -171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.02 128.71 49.76 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.38 1.872 . . . . 2.29 110.047 172.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.33 134.59 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 107.876 -1.157 . . . . 2.14 107.876 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.2 128.25 56.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.333 -1.358 . . . . 4.58 107.333 152.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 130.58 -9.94 5.81 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.13 1.348 . . . . 1.18 114.85 -175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -121.75 138.43 54.36 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.933 1.366 . . . . 2.49 112.371 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.0 p -140.43 15.79 2.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.602 1.561 . . . . 1.92 113.634 -168.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.9 t -166.96 149.51 6.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.438 1.895 . . . . 1.93 110.603 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.15 -34.23 65.96 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.964 1.306 . . . . 1.57 113.655 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.82 -30.3 71.41 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.463 -0.773 . . . . 1.68 112.713 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 62.9 m -75.3 -41.49 56.84 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.055 0.942 . . . . 1.41 111.715 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.96 66.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.278 0.631 . . . . 1.02 111.094 170.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -56.08 -41.32 74.97 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.243 -0.911 . . . . 2.42 112.722 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 45.4 mtm-85 -59.12 -26.85 65.06 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.181 1.178 . . . . 4.98 114.181 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.9 pt -91.53 -40.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.303 1.411 . . . . 0.97 113.698 164.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -51.38 -46.16 62.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.97 1.308 . . . . 2.74 112.47 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -51.91 -36.39 48.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.94 1.296 . . . . 3.24 112.758 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -42.79 13.04 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.095 1.358 . . . . 3.86 111.115 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.73 -44.1 73.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.615 1.566 . . . . 0.97 112.368 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -41.75 -45.92 3.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.372 1.869 . . . . 1.62 113.586 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 89.97 2.24 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.287 1.435 . . . . 2.79 110.781 171.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 102' ' ' VAL . 11.8 mt -83.05 -124.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.362 1.065 . . . . 2.12 108.334 155.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -115.49 118.0 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 105.323 -2.103 . . . . 5.12 105.323 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.25 -22.13 7.55 Favored Glycine 0 N--CA 1.479 1.531 0 O-C-N 119.966 -1.708 . . . . 1.45 114.899 165.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 99' ' ' ILE . 13.9 m -56.63 142.28 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.796 1.639 . . . . 2.41 112.324 163.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -120.64 -36.13 3.25 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.994 1.318 . . . . 1.43 113.62 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -139.11 149.51 44.61 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.592 0.757 . . . . 1.46 111.51 170.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.98 64.94 1.1 Allowed Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 114.412 1.264 . . . . 1.06 114.412 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.67 131.96 19.49 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.279 2.653 . . . . 1.11 111.511 171.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.39 141.43 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.359 1.463 . . . . 1.05 110.014 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -94.29 139.63 30.82 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.83 1.652 . . . . 2.45 112.619 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -99.09 -9.12 24.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.115 1.524 . . . . 4.26 115.115 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.55 -41.98 2.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.601 1.161 . . . . 1.92 111.776 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -18.2 60.63 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.384 1.474 . . . . 1.88 112.242 178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 69.24 19.54 7.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.985 2.114 . . . . 2.66 113.693 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 47.9 p -104.0 165.52 11.0 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.6 1.16 . . . . 1.25 112.114 -176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.91 135.89 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.914 1.286 . . . . 0.61 108.701 163.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.5 m -110.45 117.89 34.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.864 1.266 . . . . 1.11 107.864 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -116.88 136.88 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.197 0.999 . . . . 1.02 110.132 -169.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -119.3 125.84 50.03 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.142 1.777 . . . . 3.6 108.699 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -160.89 159.09 29.3 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.116 0.784 . . . . 2.64 113.116 -162.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.02 123.13 69.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 O-C-N 120.373 -1.455 . . . . 3.75 111.012 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.86 -1.14 10.79 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.639 2.893 . . . . 1.93 112.585 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -71.98 -34.41 68.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.312 1.045 . . . . 3.77 112.791 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -135.57 -19.29 1.64 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 116.084 1.883 . . . . 3.82 116.084 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.72 138.67 31.37 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 121.069 1.758 . . . . 2.17 110.837 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -148.93 154.42 39.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.691 0.796 . . . . 2.31 112.092 -163.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.8 t -64.62 -19.56 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.207 -0.933 . . . . 1.32 111.537 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.9 m -55.39 -55.57 30.15 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.277 -0.89 . . . . 1.87 111.98 163.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.64 -38.55 91.39 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.647 1.179 . . . . 2.61 110.381 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.98 -58.93 4.84 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.673 1.589 . . . . 1.96 111.348 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -64.41 -41.44 96.62 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.312 -0.868 . . . . 3.25 112.354 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -70.63 -28.93 65.2 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.246 0.93 . . . . 3.03 112.432 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.31 -46.85 63.43 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.987 -1.071 . . . . 1.62 112.306 168.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -70.67 -27.76 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 113.158 0.799 . . . . 1.16 113.158 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.23 -43.83 53.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.308 1.443 . . . . 2.25 112.678 170.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.51 -19.21 60.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.507 1.523 . . . . 2.74 112.805 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.91 -26.34 27.32 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.249 1.02 . . . . 1.48 112.618 164.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.77 -1.02 17.8 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.671 1.605 . . . . 1.55 116.093 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.73 -170.08 1.71 Allowed 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.573 1.686 . . . . 2.9 112.329 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 144.44 30.76 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.586 -1.321 . . . . 2.46 111.055 167.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.23 87.91 4.31 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.351 1.86 . . . . 1.47 108.608 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -58.17 138.46 56.18 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.243 -0.89 . . . . 4.04 110.087 160.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 3.5 mt -97.47 150.85 20.61 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.066 -1.646 . . . . 1.39 112.225 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -93.26 110.74 22.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.175 1.39 . . . . 4.56 108.19 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 -12.57 6.33 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.294 1.426 . . . . 1.94 113.837 -174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -125.8 5.01 7.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.539 1.681 . . . . 3.69 115.539 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.463 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 33.0 mt-30 -146.67 -48.52 0.19 Allowed 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.406 -0.809 . . . . 2.45 110.651 155.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -99.79 -44.53 6.05 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.849 0.75 . . . . 2.88 112.659 -170.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.495 1.799 0 C-N-CA 130.969 3.707 . . . . 3.01 113.549 163.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 108.885 -0.784 . . . . 12.35 108.885 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.6 tp -142.07 108.88 5.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.226 1.01 . . . . 8.24 109.706 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 t -103.34 59.5 0.76 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.751 0.82 . . . . 5.46 111.804 -172.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.49 155.56 13.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.113 1.365 . . . . 4.83 110.507 161.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -128.73 159.42 35.71 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.757 1.223 . . . . 2.31 108.638 173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.61 159.44 21.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.346 1.458 . . . . 3.54 110.595 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -122.14 144.84 48.7 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.402 1.081 . . . . 3.84 109.703 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -140.93 150.34 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.675 1.59 . . . . 3.13 108.52 164.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.12 137.56 54.54 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 1.23 108.635 160.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 42.6 mtp -140.97 150.69 43.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.462 1.505 . . . . 2.21 111.527 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.28 135.09 40.41 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.311 1.444 . . . . 2.8 109.222 -175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.74 123.83 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.306 1.442 . . . . 1.48 109.644 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.1 m -83.57 124.46 30.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.083 0.953 . . . . 2.35 111.074 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.86 16.79 0.86 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.919 1.247 . . . . 1.24 114.797 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm -92.85 10.31 31.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.925 1.863 . . . . 2.04 114.962 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 p -70.55 68.54 0.38 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 126.963 2.105 . . . . 3.5 112.178 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.5 t 177.0 -24.23 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.348 3.059 . . . . 3.07 111.265 -169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 74.32 -46.45 0.61 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.839 2.456 . . . . 2.15 112.896 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -16.43 41.43 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 1.23 113.473 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.0 m -52.7 -41.21 63.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.571 1.148 . . . . 1.52 112.712 163.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.61 -54.92 38.16 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.092 0.957 . . . . 0.97 110.4 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.24 65.04 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.628 0.771 . . . . 0.91 112.744 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmt-85 -73.52 -31.24 63.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.292 1.219 . . . . 4.57 114.292 173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.0 mt -71.66 -49.81 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 119.811 1.187 . . . . 2.42 110.047 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -61.69 -56.93 14.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.808 1.643 . . . . 2.58 110.29 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -68.6 -10.66 57.34 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 120.445 -1.409 . . . . 2.81 112.819 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.24 -60.3 4.18 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.628 1.585 . . . . 0.85 111.559 170.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.54 -46.23 73.37 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.126 0.963 . . . . 2.73 111.246 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 36' ' ' ASP . 35.6 tttt -65.99 4.85 0.58 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.594 1.701 . . . . 3.89 115.594 -167.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -92.86 -6.9 47.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.974 1.71 . . . . 6.1 114.078 167.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 34.2 mmm -75.56 135.43 71.94 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.83 1.252 . . . . 2.16 110.42 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.06 -27.93 79.71 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.252 1.968 . . . . 1.54 111.562 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.45 22.16 31.61 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 117.641 -1.644 . . . . 1.36 116.0 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 p -127.6 145.07 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 120.312 2.056 . . . . 2.08 111.972 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.3 m -105.45 -39.8 6.01 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.623 1.569 . . . . 2.26 110.95 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -152.59 152.02 31.33 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.935 0.717 . . . . 2.5 112.935 176.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.78 131.91 17.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.5 1.52 . . . . 0.93 106.998 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.61 134.72 10.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.2 1.0 . . . . 2.7 112.137 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -81.93 149.26 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.237 0.829 . . . . 2.84 113.237 -172.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -86.84 -46.83 9.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.812 1.245 . . . . 2.89 111.695 162.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tt 67.72 -53.29 0.5 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.125 2.57 . . . . 2.91 114.058 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -37.37 70.85 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.493 1.294 . . . . 2.25 114.493 -173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -118.35 20.95 12.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.305 1.842 . . . . 3.76 111.331 166.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 68.08 35.53 3.62 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.822 1.649 . . . . 2.58 113.046 158.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.37 152.11 19.25 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.849 1.66 . . . . 1.57 109.469 176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -115.63 143.63 45.08 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.593 1.157 . . . . 1.63 109.12 159.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -119.54 130.26 55.09 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.076 1.75 . . . . 1.36 108.325 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -135.14 135.47 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.077 0.951 . . . . 1.92 110.968 -169.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.35 119.35 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.295 1.838 . . . . 1.17 109.44 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -146.55 168.52 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.988 1.847 . . . . 2.95 115.988 -157.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -95.5 124.37 53.34 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 127.0 2.12 . . . . 3.11 111.271 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.28 11.87 3.03 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.099 2.533 . . . . 1.65 114.713 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.83 -42.94 3.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.592 1.087 . . . . 1.7 113.169 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -79.37 0.65 28.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.229 1.012 . . . . 3.63 113.153 177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 0.7 OUTLIER -142.92 177.82 8.09 Favored 'General case' 0 C--N 1.341 0.199 0 O-C-N 121.026 -1.046 . . . . 2.73 113.103 169.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.79 158.03 27.56 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.533 2.016 . . . . 1.49 111.123 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.11 -32.75 70.94 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.231 1.197 . . . . 3.06 114.231 -158.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.18 -24.97 29.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.824 0.738 . . . . 1.53 112.346 172.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.98 -30.41 67.75 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.629 -1.294 . . . . 1.84 111.13 -175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 pt -72.77 -33.2 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 117.844 -1.074 . . . . 3.85 113.843 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -74.81 -38.8 61.99 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.55 1.523 . . . . 2.24 111.127 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -56.24 -40.68 74.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.621 0.768 . . . . 4.81 110.62 169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.13 -13.72 58.79 Favored 'General case' 0 CA--C 1.55 0.954 0 O-C-N 120.395 -1.441 . . . . 2.08 113.857 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -84.65 -49.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 120.064 1.302 . . . . 1.22 110.664 168.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.86 -25.22 67.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.346 0.658 . . . . 3.12 112.11 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -57.15 -9.02 0.8 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.751 2.02 . . . . 4.0 115.054 168.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.63 -7.16 20.95 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.556 1.142 . . . . 1.43 113.351 170.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.53 6.07 57.57 Favored Glycine 0 N--CA 1.475 1.294 0 N-CA-C 116.387 1.315 . . . . 1.96 116.387 171.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -73.91 -168.53 0.61 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.434 1.494 . . . . 5.13 113.616 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -116.01 100.94 8.32 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.301 -0.875 . . . . 4.15 109.486 153.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.46 126.86 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 107.58 -1.267 . . . . 2.5 107.58 162.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -88.14 44.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-O 122.097 0.951 . . . . 2.73 111.362 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.9 p -86.19 121.74 29.21 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.591 1.556 . . . . 2.08 108.781 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.84 150.97 50.1 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.634 -0.876 . . . . 3.66 108.634 168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -99.19 146.3 26.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.839 0.856 . . . . 3.08 113.2 -176.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.29 152.1 45.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.724 2.01 . . . . 0.87 109.594 176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -121.42 141.44 50.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.281 1.032 . . . . 2.48 110.184 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -135.11 154.78 51.54 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.51 1.524 . . . . 2.22 109.349 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -110.24 127.02 54.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.544 1.538 . . . . 4.43 109.025 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.8 mm -77.49 177.37 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.882 1.673 . . . . 2.73 108.903 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.2 mt-10 -178.34 118.9 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 102.516 -3.142 . . . . 3.58 102.516 172.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 125.62 -30.83 4.34 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.413 1.006 . . . . 1.42 114.687 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.3 153.7 21.78 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.212 1.005 . . . . 3.49 110.898 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.8 p -141.91 -2.61 1.16 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 116.252 1.945 . . . . 1.91 116.252 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.6 t -167.22 163.99 15.47 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.696 1.198 . . . . 1.99 110.73 -171.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.62 72.56 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.568 0.951 . . . . 1.48 113.568 -174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.56 -36.99 69.95 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.542 0.941 . . . . 1.45 113.542 170.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.7 m -70.83 -43.1 69.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.986 0.914 . . . . 1.12 111.35 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.95 -54.9 41.75 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.614 0.765 . . . . 1.02 110.584 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.93 -39.35 68.75 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.555 1.142 . . . . 2.25 113.284 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -63.3 -30.43 71.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.633 1.346 . . . . 4.29 114.633 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.2 pt -86.15 -43.23 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 120.403 1.456 . . . . 1.21 112.024 164.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -54.72 -46.69 74.24 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.428 1.091 . . . . 2.61 112.393 -170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -62.26 -16.65 55.02 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 120.495 1.498 . . . . 3.86 114.491 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -95.9 -38.01 10.45 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.25 0.932 . . . . 4.48 113.052 165.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.68 -36.29 80.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.336 1.054 . . . . 1.79 113.34 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -44.32 -45.67 8.86 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.754 2.022 . . . . 1.65 113.814 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.87 85.58 1.83 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.907 1.683 . . . . 2.89 111.218 170.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG22 ' H ' ' A' ' 100' ' ' GLU . 5.1 mt -77.13 -161.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 CA-C-O 122.101 0.953 . . . . 2.64 109.781 160.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.57 ' H ' HG22 ' A' ' 99' ' ' ILE . 33.0 tt0 -87.81 103.36 15.56 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.621 1.968 . . . . 4.08 107.72 -158.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.47 10.22 77.47 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.965 -1.464 . . . . 1.51 114.418 -164.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.7 t -97.48 133.71 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.991 1.895 . . . . 1.83 110.334 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.52 -44.84 6.99 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.134 1.374 . . . . 0.99 112.542 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.68 150.63 45.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.944 0.897 . . . . 1.81 110.459 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.84 98.52 1.21 Allowed Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.628 0.973 . . . . 1.26 113.628 158.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -93.42 135.33 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.175 3.25 . . . . 1.3 111.553 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.23 139.04 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.284 1.433 . . . . 1.04 109.965 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -91.41 137.56 32.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.241 1.416 . . . . 2.8 112.274 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -103.72 -0.04 29.93 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.673 1.36 . . . . 3.51 114.673 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.14 -36.84 2.47 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.805 1.242 . . . . 1.49 112.125 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -17.68 52.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.895 1.278 . . . . 1.54 112.516 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 67.29 16.99 10.21 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.331 2.252 . . . . 2.32 112.513 -172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 42.1 p -99.92 166.22 11.17 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.921 1.237 . . . . 1.26 111.594 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.61 141.13 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.819 1.247 . . . . 0.94 108.49 166.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.5 m -99.41 140.97 32.81 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.708 -1.219 . . . . 1.43 107.708 172.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -127.35 145.36 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.876 1.27 . . . . 0.93 108.353 170.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -133.81 117.01 16.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.763 1.625 . . . . 2.56 108.432 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 174.01 16.05 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.629 1.344 . . . . 2.56 114.629 -161.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -99.45 102.96 18.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.997 1.319 . . . . 2.46 110.92 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.56 -13.39 38.46 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.586 2.191 . . . . 1.58 113.474 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.99 -15.41 43.77 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 115.119 1.525 . . . . 5.02 115.119 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -150.85 -25.58 0.22 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.734 1.614 . . . . 3.06 113.919 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.28 146.47 27.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.794 1.237 . . . . 2.17 111.358 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.1 p -153.4 170.21 21.24 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.969 1.1 . . . . 2.73 113.969 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.5 t -56.26 -22.98 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.808 0.843 . . . . 1.4 112.12 167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.8 m -70.42 -46.39 64.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.257 1.39 . . . . 1.91 111.854 176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.39 -43.23 98.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.064 0.945 . . . . 2.64 110.438 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 69.7 mt -65.64 -48.41 72.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.874 1.27 . . . . 1.57 110.721 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -58.69 5.11 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 117.227 -1.368 . . . . 3.67 111.766 170.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -57.7 -41.17 81.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.083 1.31 . . . . 2.97 111.908 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.07 64.07 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 114.384 1.253 . . . . 1.42 114.384 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.37 -35.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.44 1.096 . . . . 1.04 112.132 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.26 -26.99 64.08 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.881 1.272 . . . . 2.74 111.87 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -53.85 -24.18 14.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.232 1.413 . . . . 2.73 113.083 167.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.43 -36.08 8.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.826 1.651 . . . . 2.24 112.039 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.76 -9.9 7.16 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.499 1.524 . . . . 2.3 116.272 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.59 -167.33 0.79 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 119.063 1.431 . . . . 3.41 112.734 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' CD ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -136.44 169.09 18.25 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 120.389 -1.444 . . . . 5.55 111.367 174.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.36 108.55 12.31 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.734 1.614 . . . . 1.31 109.21 173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -83.46 131.05 35.04 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.623 -1.251 . . . . 3.37 107.623 162.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD13 HE21 ' A' ' 145' ' ' GLN . 7.1 mp -88.88 138.28 31.55 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.214 1.37 . . . . 2.13 111.131 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -104.19 116.82 32.86 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.317 1.847 . . . . 4.49 106.229 -169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.35 -58.95 4.46 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.412 -0.675 . . . . 2.41 111.412 -160.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -72.89 -30.16 63.73 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.15 1.537 . . . . 3.94 115.15 -165.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.404 HE21 HD13 ' A' ' 141' ' ' LEU . 36.3 mt-30 -130.36 -59.42 1.03 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.463 1.028 . . . . 3.22 112.053 174.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -70.43 -20.72 62.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.095 0.958 . . . . 4.1 110.93 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.41 -1.757 . . . . 4.46 108.618 -167.481 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 116.774 -1.584 . . . . 10.94 112.42 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 47.66 -151.62 0.11 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.016 1.726 . . . . 8.3 113.383 -177.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -164.78 -58.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.792 -1.193 . . . . 7.21 114.16 162.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 172.37 140.93 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.868 2.067 . . . . 5.64 111.009 -171.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -79.97 162.47 24.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.09 1.356 . . . . 2.84 111.532 -177.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.19 158.59 43.69 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.414 1.085 . . . . 3.86 113.219 -159.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.29 156.8 19.51 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.514 1.926 . . . . 4.02 114.742 -167.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 tp -167.46 152.81 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.419 2.687 . . . . 2.74 111.233 164.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.29 153.82 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.768 1.227 . . . . 1.18 112.578 158.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.11 149.64 33.42 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.763 2.025 . . . . 2.28 110.915 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -95.07 121.6 36.87 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.333 -0.855 . . . . 3.32 109.367 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.02 124.35 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 127.985 2.514 . . . . 1.66 109.169 -173.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -104.56 134.28 48.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.882 0.873 . . . . 2.36 112.854 -164.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.36 17.46 2.67 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.72 2.105 . . . . 1.97 114.3 173.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.3 mtt -84.84 83.71 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.471 1.635 . . . . 2.78 112.804 -173.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 95.6 m -140.3 56.12 1.61 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.952 1.301 . . . . 3.83 108.958 163.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -153.35 -11.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.253 1.821 . . . . 3.85 114.541 -171.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.81 -55.18 0.36 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.154 2.581 . . . . 2.65 113.927 -171.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.13 52.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.909 1.684 . . . . 1.72 113.845 -178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 p -51.45 -47.12 63.2 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.88 1.672 . . . . 2.81 113.049 168.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.27 -49.78 76.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.461 -0.774 . . . . 1.16 111.777 172.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.29 -23.27 65.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.907 1.283 . . . . 1.46 113.86 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.3 mmt-85 -71.27 -48.48 50.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.012 0.925 . . . . 2.77 112.245 168.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -69.9 -54.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.225 0.92 . . . . 1.62 111.232 -170.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.61 -40.84 96.22 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.742 0.417 . . . . 1.31 111.616 -173.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -65.32 -42.89 92.52 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.84 -1.162 . . . . 2.98 112.193 173.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.1 97.2 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.656 0.646 . . . . 0.74 111.976 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.26 -47.44 61.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.079 0.939 . . . . 1.66 111.833 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -68.34 -10.42 54.79 Favored 'General case' 0 CA--C 1.555 1.144 0 O-C-N 120.431 -1.418 . . . . 3.29 114.417 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -74.53 -10.17 59.29 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.125 1.37 . . . . 4.97 113.58 167.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.6 mmm -77.07 155.97 82.29 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.803 1.241 . . . . 2.1 111.699 175.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.35 -58.43 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.093 2.529 . . . . 1.58 111.38 166.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.14 41.96 3.04 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.55 1.072 . . . . 1.55 114.363 -170.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -138.33 123.39 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.681 1.24 . . . . 1.86 109.634 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -99.99 -35.73 9.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 117.666 -1.159 . . . . 1.65 112.116 -174.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.77 139.27 13.74 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 120.136 1.335 . . . . 2.99 112.089 -176.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.61 133.06 28.49 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.926 0.89 . . . . 0.72 110.716 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -143.71 124.21 13.98 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.995 0.918 . . . . 2.03 111.306 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.9 131.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.674 0.79 . . . . 1.75 112.096 177.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -87.32 86.73 7.28 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 107.399 -1.334 . . . . 2.12 107.399 158.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.75 -35.69 77.04 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.387 0.675 . . . . 2.19 111.979 -175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.85 -10.23 8.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.403 1.26 . . . . 1.91 114.403 175.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -128.69 11.13 6.15 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.521 1.928 . . . . 2.29 110.926 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 47.49 26.48 0.8 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.387 1.875 . . . . 2.87 114.584 -176.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.4 m -114.32 121.29 43.19 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.896 -1.128 . . . . 1.68 110.403 -168.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -99.43 128.89 45.58 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.442 1.497 . . . . 1.36 110.274 179.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -118.22 126.39 52.09 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.812 1.645 . . . . 1.41 108.167 -173.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -136.71 137.71 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 118.469 0.577 . . . . 1.76 111.431 -162.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 121.13 64.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.887 1.675 . . . . 0.86 109.28 176.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -138.25 170.33 16.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.668 1.987 . . . . 3.12 112.585 -166.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -110.54 108.69 58.27 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 121.244 -0.91 . . . . 2.71 112.844 -171.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.17 2.18 4.6 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.781 2.987 . . . . 1.68 113.204 -177.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.06 58.07 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.9 0.773 . . . . 2.27 111.478 173.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -124.06 -11.0 7.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.142 1.164 . . . . 3.28 114.142 -175.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.25 135.46 37.22 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.489 1.495 . . . . 2.23 112.467 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.94 147.84 19.94 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.874 -0.89 . . . . 1.31 110.874 166.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.4 m -57.79 -35.7 71.16 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.113 1.365 . . . . 3.52 114.272 -169.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.78 -31.04 62.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.352 0.871 . . . . 1.48 113.352 178.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.76 -21.61 60.97 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.489 0.922 . . . . 1.13 113.489 175.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.2 mm -69.29 -48.59 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.645 0.778 . . . . 2.34 110.792 174.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.93 -29.86 62.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.263 0.938 . . . . 3.6 112.378 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -55.61 -45.82 77.42 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.289 0.949 . . . . 4.03 110.976 167.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -81.38 -0.96 43.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.459 1.281 . . . . 2.54 114.459 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.82 -56.74 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.381 -0.825 . . . . 1.28 109.296 156.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -57.74 -44.91 86.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.203 1.401 . . . . 3.11 113.319 -175.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt -70.78 -8.58 53.46 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.578 1.325 . . . . 3.93 114.578 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.02 1.21 42.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.943 1.297 . . . . 2.16 113.141 179.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.32 6.96 33.2 Favored Glycine 0 N--CA 1.473 1.102 0 N-CA-C 116.155 1.222 . . . . 1.89 116.155 162.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -130.87 144.56 51.55 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.872 1.269 . . . . 6.41 110.556 -176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -99.69 122.2 42.35 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.13 0.789 . . . . 3.63 113.13 -159.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.3 p -76.14 135.03 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 122.034 -0.416 . . . . 2.39 110.912 -178.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.2 p -76.81 12.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 114.886 1.439 . . . . 3.17 114.886 -173.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.9 m -58.06 141.05 51.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.335 1.854 . . . . 3.16 112.686 -173.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -139.29 164.25 30.32 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.115 1.766 . . . . 3.36 109.092 172.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -130.07 155.08 46.75 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.759 -1.213 . . . . 3.57 113.71 -176.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.19 168.5 26.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.268 1.827 . . . . 1.25 111.671 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.2 142.8 51.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.129 0.972 . . . . 3.0 113.018 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -130.88 155.54 46.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.374 1.87 . . . . 1.88 111.921 -173.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.59 134.97 41.71 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.473 3.109 . . . . 2.62 108.906 173.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.445 HD11 ' CG1' ' A' ' 114' ' ' VAL . 4.4 mm -110.47 57.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.441 1.096 . . . . 1.64 110.34 176.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 141.35 57.42 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 120.14 -1.6 . . . . 4.75 111.105 171.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.66 -15.42 63.18 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.478 -1.179 . . . . 1.8 113.938 -167.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.4 ptt? -93.63 160.86 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.488 1.644 . . . . 2.3 111.36 161.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.6 p -123.63 -46.09 2.02 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.822 1.249 . . . . 2.19 113.421 -174.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.8 t -160.85 -169.18 2.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.487 1.115 . . . . 3.02 111.663 -174.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -45.82 -50.91 13.66 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.959 2.104 . . . . 1.76 114.944 -169.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.03 64.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.228 1.196 . . . . 1.94 114.228 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.25 -38.9 13.88 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.616 -1.302 . . . . 1.82 111.981 172.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.46 -59.85 4.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.708 1.203 . . . . 1.13 112.009 173.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -59.98 -31.56 70.02 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.34 -0.85 . . . . 3.03 112.576 -176.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -61.07 -38.07 84.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.893 1.071 . . . . 4.08 113.893 173.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.0 pt -84.21 -33.28 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.005 1.275 . . . . 1.1 112.655 171.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -50.95 -39.13 54.32 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.436 1.495 . . . . 2.43 113.222 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.38 -32.55 70.25 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.883 1.068 . . . . 5.37 113.883 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 ttt85 -95.1 -37.86 10.89 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.157 -0.925 . . . . 4.06 112.712 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.46 -36.06 70.95 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.142 1.337 . . . . 1.13 112.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -35.58 -69.45 0.1 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.039 1.336 . . . . 1.8 111.923 162.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -138.03 99.2 3.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.401 1.48 . . . . 3.43 109.417 -178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.442 ' H ' ' HB ' ' A' ' 102' ' ' VAL 0.269 34.3 mt -69.13 -5.92 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 114.317 1.229 . . . . 3.18 114.317 178.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.83 131.36 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 123.848 1.785 . . . . 5.71 109.424 -128.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.44 -29.13 1.72 Allowed Glycine 0 N--CA 1.473 1.135 0 C-N-CA 128.249 2.833 . . . . 1.49 113.596 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 99' ' ' ILE . 61.6 t -72.1 133.47 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.861 -0.792 . . . . 2.47 108.861 157.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.25 -48.01 5.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.978 1.711 . . . . 1.4 112.816 -171.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -145.81 147.6 32.02 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.64 0.776 . . . . 2.03 111.915 176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.45 107.99 1.09 Allowed Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 112.841 0.682 . . . . 0.95 112.841 165.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.31 124.4 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.538 2.825 . . . . 1.17 109.621 165.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.24 135.43 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.943 0.897 . . . . 1.15 109.164 -175.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -85.93 106.68 17.3 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.67 1.188 . . . . 2.69 112.455 -175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.96 -19.74 61.18 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.196 1.184 . . . . 4.01 114.196 -175.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.69 -29.44 7.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.485 1.114 . . . . 2.05 113.49 -175.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.9 3.63 47.25 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.662 1.185 . . . . 2.07 112.851 177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 60.5 31.5 20.3 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.524 1.53 . . . . 3.09 113.086 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.2 p -133.69 -179.88 5.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.545 2.338 . . . . 1.39 109.969 -170.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 80' ' ' ILE . 7.2 p -150.77 143.89 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.156 1.382 . . . . 0.76 109.768 170.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 m -99.7 124.76 45.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.994 1.318 . . . . 1.15 107.594 170.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.0 138.41 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.657 1.183 . . . . 1.04 110.772 -169.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.99 125.65 41.84 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.13 2.172 . . . . 2.74 109.367 176.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -152.52 162.66 40.9 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.343 1.608 . . . . 2.78 115.343 -165.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.87 109.32 61.03 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 125.33 1.452 . . . . 2.72 110.282 170.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.89 -7.28 20.29 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.57 2.847 . . . . 1.89 114.753 -177.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -73.29 -5.84 42.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.802 1.408 . . . . 3.22 114.802 177.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -144.97 -37.32 0.29 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.956 1.095 . . . . 3.82 113.956 173.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.54 127.08 39.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.995 1.27 . . . . 1.77 111.618 -179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.3 m -122.34 179.8 4.44 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.749 1.22 . . . . 3.03 112.211 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 t -69.87 -19.9 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.315 -1.49 . . . . 1.35 111.187 -177.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.3 m -52.22 -55.12 23.21 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.659 1.584 . . . . 1.85 112.045 165.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -70.18 -38.49 75.4 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.497 1.119 . . . . 2.28 111.349 -172.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.8 mt -58.43 -50.16 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.407 1.483 . . . . 2.1 111.02 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -58.88 -53.3 59.89 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.552 -1.213 . . . . 3.05 111.299 172.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -58.35 -35.07 71.38 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.272 1.396 . . . . 2.3 113.269 -177.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.73 -38.79 92.18 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.78 0.718 . . . . 1.37 112.921 175.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.02 -30.66 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.347 1.059 . . . . 1.13 113.476 -178.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.48 -37.9 79.42 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.148 1.779 . . . . 2.37 112.317 179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -63.94 -27.41 69.12 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.132 1.373 . . . . 2.61 113.248 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.9 -38.14 23.28 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.435 -0.791 . . . . 2.31 110.934 169.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 106.99 30.3 4.27 Favored Glycine 0 N--CA 1.472 1.068 0 C-N-CA 124.477 1.037 . . . . 1.67 114.997 171.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.7 -140.86 0.22 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 118.235 1.018 . . . . 3.01 109.18 170.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.08 -166.97 2.6 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 118.919 -2.363 . . . . 2.93 108.542 142.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.3 mt -126.63 143.44 51.22 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.096 0.958 . . . . 1.37 109.217 165.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -128.19 145.74 50.94 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.87 0.868 . . . . 3.3 109.802 167.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.3 mt -89.12 143.9 26.51 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.756 -1.215 . . . . 1.77 111.929 178.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 147' ' ' SER . 13.8 tptm -94.4 121.16 35.65 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.516 -1.661 . . . . 3.81 106.516 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.41 -9.43 54.92 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.833 -1.537 . . . . 2.34 113.43 -169.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . 0.317 61.5 tt0 -129.16 -13.43 4.48 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.213 2.301 . . . . 3.27 117.213 -174.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -145.33 -43.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 120.041 -1.662 . . . . 2.39 111.984 167.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.22 -23.81 35.19 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.94 1.696 . . . . 4.83 113.066 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.445 ' O ' ' HE2' ' A' ' 142' ' ' LYS . 19.4 m . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 114.908 -2.473 . . . . 2.9 110.95 -167.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.023 -0.513 . . . . 11.2 111.221 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -142.9 150.48 39.86 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.568 1.547 . . . . 8.88 110.466 174.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 t -77.84 -26.29 49.34 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.684 0.794 . . . . 6.82 112.994 176.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.265 3.6 pt-20 76.99 18.04 1.56 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.476 2.71 . . . . 7.57 114.242 148.196 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -66.17 151.6 46.61 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.738 1.014 . . . . 2.74 113.738 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -103.73 147.91 26.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.637 . . . . 4.2 110.615 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -112.29 146.02 38.97 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.409 1.083 . . . . 2.94 110.879 171.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.16 156.07 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.843 2.057 . . . . 2.54 109.303 -179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' H ' ' HA2' ' A' ' 101' ' ' GLY . . . -142.69 125.04 15.55 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.529 -0.732 . . . . 1.03 111.056 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.2 mtt -108.68 134.98 50.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.121 0.968 . . . . 2.68 110.67 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -83.63 126.08 32.49 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.569 -0.707 . . . . 4.13 109.13 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.64 169.6 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.466 1.106 . . . . 2.32 111.913 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 t -131.98 86.82 2.37 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 123.17 1.462 . . . . 2.25 109.386 166.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.47 -13.68 0.07 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 117.225 1.65 . . . . 1.58 117.225 -177.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.2 mtm -90.99 -0.62 57.79 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.347 2.074 . . . . 3.14 115.617 -166.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -72.75 57.35 0.42 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.363 1.465 . . . . 4.93 112.808 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.3 t -161.12 33.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.856 1.663 . . . . 3.35 111.154 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 62.01 -80.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 127.391 2.276 . . . . 1.98 113.693 177.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.57 -12.6 61.67 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.6 1.56 . . . . 1.64 113.434 -169.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 58.8 m -52.09 -35.96 49.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 118.479 -0.772 . . . . 1.45 111.928 164.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.79 -64.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.328 1.051 . . . . 1.0 110.67 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.19 -41.72 60.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.683 1.193 . . . . 1.21 112.492 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -70.35 -38.52 74.85 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.458 1.103 . . . . 4.04 113.759 178.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -70.75 -52.07 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.979 1.263 . . . . 1.93 109.753 175.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -55.16 -53.55 54.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.529 1.532 . . . . 1.82 110.93 -178.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.274 10.3 ptpt -73.0 -17.57 61.44 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 113.961 1.097 . . . . 4.26 113.961 177.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.22 -44.65 59.2 Favored Glycine 0 N--CA 1.475 1.296 0 C-N-CA 127.505 2.479 . . . . 0.74 113.817 168.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.8 mp -70.56 -44.42 67.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.249 1.525 . . . . 2.11 110.008 170.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -60.06 -14.43 16.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.056 1.132 . . . . 4.57 114.056 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -27.33 66.67 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.563 1.945 . . . . 4.3 114.134 173.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -92.35 138.34 24.23 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-N 120.058 1.299 . . . . 2.55 110.921 173.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.13 -24.9 58.63 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.684 2.256 . . . . 2.36 112.979 -174.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.15 32.89 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.547 -1.696 . . . . 1.46 115.603 -177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -106.46 136.38 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 120.628 2.214 . . . . 1.9 110.418 168.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.52 -38.75 12.33 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.736 1.614 . . . . 1.86 110.428 177.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.48 152.41 18.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.584 1.554 . . . . 2.97 112.148 178.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.71 140.14 28.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.75 109.734 168.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.69 136.87 12.81 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.929 0.892 . . . . 3.31 113.11 171.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.25 135.1 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.634 0.774 . . . . 2.25 112.221 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 75.02 9.98 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.201 1.0 . . . . 4.62 109.845 161.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tt -43.81 -42.47 5.63 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.318 1.847 . . . . 2.55 114.483 -166.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.97 -7.15 0.29 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.704 2.113 . . . . 2.49 116.704 -178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.5 t -145.57 15.74 1.44 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.226 1.41 . . . . 4.31 112.857 165.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.06 20.36 12.04 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 115.688 1.736 . . . . 3.61 115.688 171.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.44 117.81 25.47 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.476 1.489 . . . . 1.5 109.6 174.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -101.22 109.49 21.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.403 1.881 . . . . 1.13 110.238 179.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -99.37 123.71 43.88 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.531 1.532 . . . . 1.47 109.573 -171.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.1 148.27 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 118.642 0.656 . . . . 2.28 112.211 -168.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.2 mp -134.03 124.81 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.148 1.379 . . . . 1.06 108.848 -177.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -142.15 165.84 26.34 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.264 1.579 . . . . 2.46 115.264 -161.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.95 114.81 65.83 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 127.093 2.157 . . . . 2.84 111.028 -175.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -81.62 72.07 6.51 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.781 2.987 . . . . 2.0 111.853 -169.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.27 -59.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.366 1.066 . . . . 2.34 110.721 173.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -78.63 -43.63 25.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.503 2.321 . . . . 6.62 111.72 176.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.1 m -99.78 115.07 28.69 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.818 -1.178 . . . . 1.9 107.818 172.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.38 160.2 26.69 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.604 -0.998 . . . . 1.31 110.604 165.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.09 91.97 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.167 -0.608 . . . . 2.38 112.625 -167.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.23 -16.96 62.52 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.246 1.202 . . . . 1.06 114.246 -179.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.34 -18.04 63.07 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.927 -1.108 . . . . 1.14 112.677 173.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.52 -49.91 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.706 0.802 . . . . 1.91 110.199 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.3 pm0 -70.44 -22.23 62.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.171 0.896 . . . . 2.62 113.142 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -61.64 -39.97 93.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.741 1.155 . . . . 3.66 111.046 175.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -69.21 -19.58 63.96 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.746 1.612 . . . . 2.37 113.446 173.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.54 -45.96 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.672 1.124 . . . . 1.97 110.345 171.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.11 -48.35 81.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.529 0.68 . . . . 5.17 110.815 170.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 66' ' ' LYS . 7.9 mmpt? -69.25 -11.14 60.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.343 1.457 . . . . 3.77 114.452 -176.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -94.67 -14.21 25.07 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.331 0.969 . . . . 1.81 113.283 166.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.39 42.68 3.63 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 119.564 1.075 . . . . 1.91 113.903 174.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -130.53 -179.12 5.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.715 1.206 . . . . 5.56 111.872 175.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -107.8 167.83 9.69 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.834 -1.167 . . . . 3.3 109.089 167.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.77 141.98 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 107.102 -1.444 . . . . 2.43 107.102 170.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.283 14.0 p -95.16 51.25 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-O 122.37 1.081 . . . . 2.63 111.299 -169.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.7 p -101.56 138.79 38.09 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.886 1.674 . . . . 2.19 110.291 177.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -114.92 159.1 21.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.702 1.601 . . . . 5.22 110.364 173.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -92.02 142.15 27.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.961 -1.018 . . . . 3.42 110.26 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.44 160.11 40.72 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.501 1.52 . . . . 1.16 110.297 175.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -130.17 133.59 46.7 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.178 0.991 . . . . 2.49 109.39 177.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -122.85 162.58 21.9 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.775 2.03 . . . . 2.18 110.545 -176.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.97 150.65 38.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.577 1.951 . . . . 4.4 110.06 178.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.33 137.69 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.199 1.399 . . . . 2.43 109.444 174.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -119.09 81.99 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.932 -1.136 . . . . 3.09 107.932 162.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 173.48 2.85 0.03 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 118.7 2.24 . . . . 1.2 118.7 -168.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -156.84 146.6 20.78 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.974 2.887 . . . . 2.39 115.734 -176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.9 p -119.33 -22.67 6.98 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.592 1.557 . . . . 2.19 113.587 176.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 93.3 m -131.55 157.13 44.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.528 1.131 . . . . 3.63 113.731 -164.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.63 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.004 1.483 . . . . 1.43 115.004 -171.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.1 77.12 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.052 0.842 . . . . 1.58 112.74 176.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 88.6 m -76.01 -37.67 58.16 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.523 0.729 . . . . 1.52 112.59 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.19 -44.26 83.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.242 0.474 . . . . 1.06 110.951 170.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -67.38 -41.36 85.15 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.118 0.872 . . . . 2.68 113.24 175.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.3 mtt-85 -47.33 -48.74 25.26 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.547 1.067 . . . . 3.96 111.591 172.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.21 -42.56 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 117.64 -1.172 . . . . 1.43 111.848 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -48.43 -56.74 7.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.875 1.67 . . . . 3.5 111.835 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -61.48 -17.77 56.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.774 1.027 . . . . 4.06 113.774 -172.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -32.57 10.68 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 116.957 -1.497 . . . . 3.72 113.611 170.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.43 -46.46 76.43 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.986 1.714 . . . . 1.28 111.494 174.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -70.82 38.3 0.05 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 129.396 3.079 . . . . 2.53 113.317 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm 130.91 75.63 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 1 C-N-CA 134.064 4.946 . . . . 3.32 110.175 -172.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.59 -90.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 108.485 -0.931 . . . . 3.07 108.485 169.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -137.49 128.97 28.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.794 -2.298 . . . . 4.31 104.794 152.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' HA2' ' H ' ' A' ' 9' ' ' ALA . . . 83.57 -31.51 3.26 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.744 1.164 . . . . 2.65 113.772 176.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.3 t -49.01 133.31 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.634 1.174 . . . . 1.73 111.638 168.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.85 -63.76 1.25 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.715 1.206 . . . . 1.46 111.384 -177.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -132.92 152.02 51.96 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.705 0.684 . . . . 1.66 111.946 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.88 99.24 2.02 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 115.115 1.524 . . . . 1.15 115.115 170.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.78 114.24 2.61 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.74 2.293 . . . . 1.29 111.1 170.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.05 138.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.211 1.805 . . . . 0.99 110.673 176.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -88.39 137.46 32.31 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.875 1.27 . . . . 2.93 112.304 172.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -104.9 11.09 34.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.063 1.505 . . . . 3.48 115.063 -170.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -144.19 -28.92 0.5 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.955 0.902 . . . . 1.76 113.212 175.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.95 -7.39 52.22 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.259 1.424 . . . . 2.03 112.936 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 58.28 28.24 16.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.53 1.532 . . . . 3.16 114.191 -177.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 16.4 p -98.91 159.37 15.01 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.13 -0.981 . . . . 1.16 110.297 170.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -144.13 137.24 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 108.779 -0.822 . . . . 0.63 108.779 162.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.7 m -98.48 140.95 31.96 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.256 -1.387 . . . . 0.8 107.256 175.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.6 t -131.17 138.65 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.159 1.384 . . . . 0.94 109.639 -176.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -120.6 112.02 18.38 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 127.902 2.481 . . . . 3.63 107.623 176.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -165.83 172.36 11.75 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.047 1.499 . . . . 2.22 115.047 -166.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -89.1 114.44 60.21 Favored Pre-proline 0 CA--C 1.547 0.839 0 O-C-N 120.914 -1.116 . . . . 2.62 111.718 169.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.48 20.51 0.59 Allowed 'Trans proline' 0 CA--C 1.547 1.168 0 C-N-CA 123.62 2.88 . . . . 1.72 112.746 171.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -111.59 -12.74 13.89 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.665 1.586 . . . . 4.47 114.491 -172.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.22 -26.36 5.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.962 1.305 . . . . 4.02 112.367 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.95 148.46 50.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.977 1.311 . . . . 1.7 109.875 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.0 p -133.94 -171.87 2.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.032 0.533 . . . . 2.53 111.151 173.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.8 t -66.49 -24.61 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.526 -1.358 . . . . 1.45 112.17 -164.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.9 m -62.42 -41.91 99.04 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.413 1.006 . . . . 2.13 113.167 170.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -67.27 -40.27 86.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.738 0.699 . . . . 2.77 110.581 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.9 mt -62.36 -56.39 18.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.407 1.083 . . . . 1.57 110.165 175.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -50.82 -48.32 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.868 1.267 . . . . 3.22 113.225 173.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.48 -35.54 79.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.587 1.539 . . . . 2.55 113.069 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.34 -43.96 69.18 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.01 0.823 . . . . 1.73 112.0 171.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 137' ' ' TYR . 3.4 t -67.54 -27.24 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.832 1.653 . . . . 2.02 113.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -62.65 -37.27 85.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.985 1.314 . . . . 2.77 111.282 171.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -76.29 -22.81 54.58 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.074 -1.016 . . . . 4.65 113.717 173.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -72.73 -24.73 61.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.875 1.216 . . . . 2.37 112.074 162.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.99 20.44 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.932 1.253 . . . . 1.63 115.366 171.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 132' ' ' VAL . 6.7 p90 -135.88 -159.88 1.0 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.506 1.653 . . . . 8.07 112.398 -177.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 150.2 48.91 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.739 -1.226 . . . . 2.73 110.819 171.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.1 mt -101.39 131.68 47.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.913 0.885 . . . . 1.06 108.914 175.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -101.41 167.68 10.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.022 2.129 . . . . 2.51 110.563 166.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.33 139.78 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.878 -1.139 . . . . 1.41 113.328 -177.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -88.03 45.94 1.33 Allowed 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 122.622 1.201 . . . . 4.62 113.177 -154.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 135.94 -46.79 1.01 Allowed Glycine 0 N--CA 1.465 0.588 0 C-N-CA 126.865 2.174 . . . . 1.53 110.038 -161.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -80.19 45.65 0.76 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 113.688 0.996 . . . . 3.29 113.688 178.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 150.02 -51.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 131.473 3.909 . . . . 3.53 112.124 163.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -106.51 -13.04 15.44 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.58 0.956 . . . . 5.69 113.58 -160.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 129.767 3.227 . . . . 2.61 112.516 162.679 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.17 -0.307 . . . . 10.95 110.17 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.49 153.62 31.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.456 1.102 . . . . 9.69 109.597 170.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 76.3 p 179.24 75.24 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.974 1.31 . . . . 5.09 108.586 -168.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.27 89.8 2.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.758 1.223 . . . . 5.78 109.068 -173.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -70.26 131.97 45.0 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.774 -0.578 . . . . 3.49 111.7 -175.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -141.32 173.27 11.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.399 1.88 . . . . 4.48 112.415 -172.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -122.7 158.88 29.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.942 1.697 . . . . 3.45 112.928 -162.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.6 tt -161.46 147.94 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.3 1.84 . . . . 2.69 109.762 166.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -134.59 150.95 50.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.089 1.356 . . . . 1.22 110.467 171.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.9 mtt -150.27 153.08 35.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.997 1.319 . . . . 2.79 111.074 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -74.69 125.28 28.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.41 -0.959 . . . . 3.19 108.41 169.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -114.86 128.67 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.637 1.575 . . . . 2.02 109.028 -170.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.2 m -113.37 154.84 26.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.023 0.929 . . . . 1.97 111.968 -176.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.53 29.33 12.31 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.266 -0.896 . . . . 1.43 114.714 177.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.3 mtm -86.96 22.57 1.98 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.709 1.374 . . . . 2.84 114.709 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.9 p -82.9 66.57 8.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.701 1.6 . . . . 3.83 112.869 -169.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 t -171.09 7.59 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.715 2.006 . . . . 3.85 113.997 173.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 64.72 -61.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.318 2.647 . . . . 2.49 113.336 -171.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -10.63 3.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.501 1.921 . . . . 1.66 114.351 177.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 81.1 m -45.84 -45.7 15.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.391 1.076 . . . . 1.72 112.316 159.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 39' ' ' VAL . . . -54.3 -53.85 48.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.67 0.788 . . . . 1.4 111.602 175.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -39.84 83.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.586 1.154 . . . . 1.13 112.597 177.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -62.54 -41.63 99.01 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.558 1.143 . . . . 3.43 112.332 174.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.2 mm -68.17 -53.82 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 120.193 1.361 . . . . 1.69 110.463 178.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.0 -50.58 70.18 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.33 0.514 . . . . 1.52 111.899 -174.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -68.34 -30.89 69.96 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.944 -1.097 . . . . 4.35 112.32 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.0 -34.87 64.86 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.234 1.397 . . . . 1.01 113.047 177.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.0 mt -70.47 -47.21 61.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.558 1.179 . . . . 1.89 110.92 166.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -55.31 -9.56 0.46 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.924 1.69 . . . . 3.34 115.344 -177.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -20.27 43.85 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.579 1.326 . . . . 5.76 114.579 171.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.0 ptp -89.5 122.96 67.86 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-N 120.783 1.629 . . . . 2.34 110.924 176.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.17 -17.16 58.01 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.054 2.503 . . . . 2.19 113.782 -170.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.37 -11.35 82.36 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 117.337 -1.813 . . . . 1.38 114.857 172.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -90.56 134.83 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.581 2.19 . . . . 2.41 109.874 172.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.5 t -89.18 -49.42 6.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 119.102 -0.475 . . . . 2.26 109.739 166.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -147.31 140.64 25.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 3.64 111.403 -170.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.82 133.43 46.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.836 1.254 . . . . 0.96 109.488 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.81 112.42 7.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.153 0.981 . . . . 1.76 110.907 -174.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 21' ' ' ALA . 7.7 p -110.3 125.66 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.554 0.742 . . . . 1.58 111.157 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -112.36 110.92 21.42 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.604 1.562 . . . . 2.1 110.086 -177.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 26.4 mt -66.05 -39.13 89.88 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.556 0.742 . . . . 2.74 111.736 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.229 0.612 . . . . 2.06 112.597 -171.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.8 p -106.51 2.95 26.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.006 1.322 . . . . 3.09 113.046 171.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 57.05 26.8 12.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.036 2.135 . . . . 3.08 112.8 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -105.81 131.55 53.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.988 1.715 . . . . 1.58 110.798 -168.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -99.67 123.31 43.8 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.217 0.607 . . . . 1.17 109.445 159.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -110.14 134.86 51.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.478 1.511 . . . . 1.3 109.368 177.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.9 t -132.19 135.23 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 1.7 109.947 -176.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -126.61 120.64 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.335 1.454 . . . . 1.43 108.631 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -142.85 165.57 27.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.442 1.897 . . . . 3.5 112.202 -161.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -113.41 117.08 45.68 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.685 1.194 . . . . 3.48 109.423 167.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.48 -4.83 16.0 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.372 2.715 . . . . 2.13 114.139 -166.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.06 -39.8 79.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.534 1.134 . . . . 2.03 112.931 176.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -108.93 -4.54 16.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.488 1.115 . . . . 3.07 113.157 -171.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 m -158.65 119.96 3.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.019 1.328 . . . . 1.8 110.434 -176.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.0 144.84 29.1 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.154 -0.778 . . . . 1.25 111.154 168.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.93 -34.66 65.82 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.638 1.347 . . . . 3.22 114.638 -170.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.61 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.419 1.009 . . . . 0.97 112.255 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.36 63.85 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.876 -1.14 . . . . 1.48 113.463 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.78 -40.37 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.555 -0.715 . . . . 1.87 110.162 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -34.8 76.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.33 0.968 . . . . 3.08 112.184 -173.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.45 -41.62 94.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.674 1.19 . . . . 4.89 111.134 168.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -67.51 -15.95 63.94 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.882 1.067 . . . . 2.09 113.882 176.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.3 mt -83.58 -42.24 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.672 1.123 . . . . 1.64 111.137 166.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -56.11 -37.65 69.69 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 119.623 1.101 . . . . 4.4 110.944 175.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -56.03 -8.89 0.51 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.111 1.893 . . . . 4.53 116.111 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -97.41 -18.48 19.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.266 1.393 . . . . 1.85 113.977 171.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.46 57.09 1.91 Allowed Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.37 0.986 . . . . 2.41 112.821 -173.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.43 -169.98 1.56 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.879 1.272 . . . . 10.01 113.127 176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -137.38 157.23 47.04 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.761 1.624 . . . . 5.69 110.27 174.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -151.93 159.51 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 120.806 -1.184 . . . . 3.43 110.528 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 m -113.69 110.44 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 2.9 109.451 173.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.6 p -151.66 148.34 27.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.41 1.484 . . . . 1.84 110.803 -173.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -155.07 -174.2 4.88 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 5.64 109.506 164.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -89.19 132.99 34.59 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.714 -0.616 . . . . 5.85 111.751 163.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.22 147.25 25.33 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.769 1.227 . . . . 1.88 108.992 162.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -138.83 137.3 36.48 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.54 0.736 . . . . 2.75 110.156 -177.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.56 160.73 38.84 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.15 1.38 . . . . 2.44 111.364 -168.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.94 142.59 31.22 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.558 2.343 . . . . 2.91 109.425 169.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.42 66.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.544 1.138 . . . . 1.92 109.299 173.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -53.36 103.21 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.425 0.631 . . . . 3.56 109.492 160.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.61 -35.9 1.28 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.631 -1.094 . . . . 1.32 112.992 -172.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -99.61 139.64 34.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.676 1.238 . . . . 2.3 112.124 179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 34.1 p -137.57 14.34 2.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.329 1.051 . . . . 1.93 113.727 176.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 45.6 t -157.75 156.95 32.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.451 1.5 . . . . 1.9 111.648 -177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.9 64.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.94 1.296 . . . . 1.55 113.026 175.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.93 -17.64 65.0 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.033 1.123 . . . . 2.19 114.033 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 80.4 m -83.48 -46.44 12.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.287 1.035 . . . . 1.53 111.62 170.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -56.78 17.22 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.158 1.383 . . . . 1.25 112.7 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -60.0 -28.17 67.48 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 112.913 0.708 . . . . 2.51 112.913 -171.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -64.36 -27.52 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.385 1.254 . . . . 3.73 114.385 176.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.62 -37.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.837 1.199 . . . . 1.07 112.305 166.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.59 -49.44 46.64 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.124 1.77 . . . . 2.78 113.06 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -62.03 -21.34 64.81 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.082 1.142 . . . . 3.31 114.082 -177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -53.64 4.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 117.536 -1.221 . . . . 4.47 110.607 167.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -43.04 -47.55 5.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.643 1.977 . . . . 1.04 113.166 -179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -44.75 -48.09 10.8 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.581 1.552 . . . . 1.44 112.649 179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.08 86.57 2.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.502 1.521 . . . . 3.36 111.333 173.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' H ' ' CG2' ' A' ' 102' ' ' VAL 0.255 9.6 mt -86.89 -81.57 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 2.12 111.76 165.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -155.63 117.68 4.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.516 -2.031 . . . . 4.82 105.516 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.95 -25.6 4.06 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 125.455 1.503 . . . . 1.54 113.509 169.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 19.3 m -60.36 131.63 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 126.511 1.924 . . . . 1.95 111.03 156.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -100.2 -40.19 7.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.692 1.997 . . . . 1.36 113.892 174.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -144.98 157.27 44.19 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.849 0.749 . . . . 2.43 112.902 178.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -161.67 118.08 1.33 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.764 -1.112 . . . . 1.43 113.848 173.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -96.18 132.57 0.45 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.564 3.509 . . . . 1.45 111.806 160.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 84.1 t -95.79 128.47 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.374 1.069 . . . . 1.37 109.754 177.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.1 79.72 6.44 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.236 1.017 . . . . 3.06 110.819 -174.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -60.43 -25.82 66.25 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.245 1.942 . . . . 3.77 116.245 -164.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.1 -24.0 17.74 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.435 1.494 . . . . 1.87 113.034 178.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -22.68 23.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.614 1.966 . . . . 2.11 111.812 -178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 75.71 36.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.759 2.024 . . . . 2.62 111.089 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.6 p -140.32 174.86 10.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.051 2.141 . . . . 1.3 111.196 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.9 145.28 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.696 1.599 . . . . 0.98 109.081 175.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -119.78 142.06 48.92 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.103 1.361 . . . . 1.23 108.662 176.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.1 t -138.22 127.16 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.485 1.114 . . . . 1.39 110.468 -169.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.96 120.27 30.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.476 2.31 . . . . 4.17 108.637 173.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -159.59 147.01 16.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.471 2.026 . . . . 2.91 116.471 -155.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -104.81 124.29 37.31 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 127.292 2.237 . . . . 2.65 110.447 171.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -83.56 -1.44 10.14 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.604 2.869 . . . . 1.65 115.592 -168.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -85.25 -35.63 21.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.991 1.478 . . . . 3.41 114.991 -169.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -82.72 -19.7 37.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.274 1.213 . . . . 5.06 114.274 -166.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -160.71 -155.24 0.41 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.979 2.112 . . . . 2.53 109.372 179.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.5 t -162.43 -171.1 2.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.467 1.03 . . . . 3.24 110.608 169.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.93 -13.07 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.915 2.086 . . . . 2.85 112.416 -174.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.0 p -51.57 -60.48 3.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.117 1.767 . . . . 3.16 112.471 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -69.69 -31.75 69.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.749 0.82 . . . . 3.91 112.398 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.2 mt -63.96 -42.71 97.21 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.593 -0.692 . . . . 1.98 110.516 173.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -60.57 -47.28 86.9 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 116.483 -1.723 . . . . 3.32 110.814 173.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -57.8 -39.96 78.77 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.997 1.726 . . . . 2.32 112.872 176.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.1 89.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.032 0.753 . . . . 1.53 113.032 177.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.48 -30.13 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.964 0.906 . . . . 1.15 112.808 179.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.05 -43.51 98.78 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.527 1.531 . . . . 2.73 111.561 174.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.41 -26.02 68.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.39 1.476 . . . . 2.92 113.123 176.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.98 -6.29 57.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.025 1.33 . . . . 1.85 113.244 172.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 102.25 12.18 34.4 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.962 1.268 . . . . 1.53 115.572 170.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.45 -157.66 0.78 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 119.239 1.519 . . . . 2.65 111.941 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.23 152.05 25.66 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.156 1.783 . . . . 2.28 109.689 170.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 29.4 mt -94.74 91.1 6.33 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.048 1.339 . . . . 1.73 109.1 175.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -76.65 108.94 10.01 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.602 -0.686 . . . . 2.44 110.029 172.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.82 143.37 57.9 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.402 -1.437 . . . . 1.45 112.695 179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -85.31 118.91 25.14 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.86 1.664 . . . . 4.97 108.454 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.42 -13.83 5.88 Favored Glycine 0 N--CA 1.478 1.486 0 O-C-N 121.766 -0.584 . . . . 1.85 113.876 -174.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -124.3 0.18 8.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.487 1.515 . . . . 3.31 114.32 -162.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -165.89 -45.86 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.076 1.351 . . . . 2.87 111.628 175.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.68 -35.57 24.41 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.165 0.893 . . . . 2.99 112.289 167.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.718 2.007 . . . . 3.0 108.586 -159.719 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 118.357 -0.83 . . . . 11.17 112.507 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -169.89 -161.32 0.27 Allowed 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 119.752 1.16 . . . . 8.72 110.006 -150.669 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.48 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 19.2 m -162.41 93.45 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.342 -1.474 . . . . 6.51 112.529 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -156.63 130.22 8.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.246 0.618 . . . . 5.28 110.894 148.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -140.23 159.79 41.41 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.866 2.466 . . . . 3.47 105.58 173.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.9 150.31 51.34 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.633 1.346 . . . . 3.79 114.633 -162.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -86.93 168.69 13.15 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.234 1.814 . . . . 2.88 113.728 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.67 146.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 129.027 2.931 . . . . 2.95 108.575 165.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.72 150.33 52.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.774 0.716 . . . . 1.36 111.592 173.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 mtt -148.73 157.31 43.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.746 2.018 . . . . 2.21 110.392 -179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -87.33 147.76 25.35 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.299 -1.0 . . . . 3.72 108.299 158.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.69 118.77 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.352 1.461 . . . . 1.66 110.245 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t -100.16 161.27 13.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.328 1.051 . . . . 2.37 113.667 -174.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.99 5.06 53.9 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.42 1.486 . . . . 1.42 114.065 -175.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 71.1 mtm -79.57 50.01 1.08 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.016 1.408 . . . . 1.82 113.058 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -83.79 35.11 0.51 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.087 1.355 . . . . 3.08 113.079 -165.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.4 t -179.24 137.43 0.13 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.449 3.5 . . . . 3.66 107.347 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.29 -26.34 11.8 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.22 1.563 . . . . 2.11 115.22 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.43 -6.35 35.15 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.002 -1.061 . . . . 1.65 113.801 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.1 m -71.61 -41.46 68.89 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.883 0.873 . . . . 1.8 111.649 168.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.25 -49.75 71.21 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.034 0.934 . . . . 1.2 111.682 173.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.07 3.06 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.959 1.704 . . . . 1.63 114.352 171.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -25.85 14.81 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.723 1.379 . . . . 4.97 114.723 173.151 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 35.4 mm -71.24 -54.82 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 120.616 1.553 . . . . 1.57 110.21 173.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.09 -51.97 64.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.198 0.454 . . . . 1.63 111.061 -176.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -69.89 -34.39 73.47 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.026 -1.046 . . . . 2.96 112.267 178.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.01 -36.12 86.86 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 117.647 -1.641 . . . . 1.15 114.273 171.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -84.28 -49.31 8.89 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.925 1.863 . . . . 1.56 112.801 175.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -52.31 -17.96 1.37 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 116.436 2.013 . . . . 3.86 116.436 -162.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -82.71 -12.83 57.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.228 2.611 . . . . 6.35 114.903 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 65.0 mtm -66.44 132.63 94.29 Favored Pre-proline 0 N--CA 1.474 0.74 0 CA-C-N 119.197 0.908 . . . . 2.82 109.418 173.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.46 -31.59 94.52 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.628 2.885 . . . . 1.55 113.959 -159.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.67 7.64 36.49 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 116.894 -2.059 . . . . 1.33 115.874 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.1 p -81.95 113.66 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 121.557 2.678 . . . . 1.71 108.156 176.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -84.36 -34.12 23.69 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 116.933 -1.508 . . . . 1.62 111.179 -175.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -164.6 164.15 21.65 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.265 1.393 . . . . 2.55 114.255 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.16 154.01 48.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.21 1.004 . . . . 1.62 111.357 167.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.01 130.61 52.69 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.874 1.67 . . . . 3.03 107.546 161.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -114.75 147.96 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.91 0.777 . . . . 1.87 110.675 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.37 128.1 32.95 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.569 0.748 . . . . 3.03 112.243 175.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.7 mt -64.2 -49.84 70.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.783 1.233 . . . . 2.94 110.516 171.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.21 -16.59 64.04 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.126 1.158 . . . . 2.03 114.126 -165.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.5 p -122.03 6.85 9.77 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.372 1.469 . . . . 3.14 112.502 171.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 58.49 27.72 15.94 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.445 1.498 . . . . 2.55 112.535 176.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -107.2 140.66 39.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 1.59 111.708 -164.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 m -110.4 135.61 50.83 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.993 1.317 . . . . 1.68 110.657 159.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -128.49 117.04 20.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.647 1.579 . . . . 1.5 106.962 -178.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.85 142.47 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 119.407 1.003 . . . . 1.7 110.811 -164.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.6 127.6 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.415 1.486 . . . . 1.18 109.723 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -143.34 164.09 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.473 1.657 . . . . 2.7 115.473 -171.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.52 130.39 28.17 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 128.2 2.6 . . . . 2.43 112.048 177.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.37 11.95 2.88 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.848 3.032 . . . . 2.14 114.89 -171.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.28 -42.75 5.91 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.16 1.346 . . . . 2.26 111.976 178.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -86.62 -4.76 59.22 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.321 0.86 . . . . 3.71 113.321 -177.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -166.48 161.26 16.1 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.354 0.979 . . . . 2.04 113.123 -169.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.0 -179.8 26.31 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.688 1.137 . . . . 1.68 111.732 154.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.0 t -80.52 -23.28 40.16 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.661 1.185 . . . . 2.95 113.77 -179.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.82 -28.56 65.81 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.244 0.929 . . . . 1.7 111.68 -174.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.56 -24.05 4.89 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.478 1.511 . . . . 1.76 114.185 170.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.5 mt -69.11 -46.69 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.104 0.962 . . . . 2.36 110.561 172.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.52 -38.52 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.975 0.807 . . . . 4.23 110.505 176.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -56.41 -50.18 72.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.917 0.781 . . . . 3.15 112.265 173.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -34.53 77.98 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.203 -0.936 . . . . 2.34 112.26 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.2 mt -63.96 -47.64 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 117.976 -1.011 . . . . 1.49 111.359 175.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 69' ' ' TYR . 5.9 mt-10 -56.78 -42.27 79.16 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.693 1.133 . . . . 4.73 111.077 175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -65.99 -2.65 4.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.794 1.405 . . . . 4.26 114.794 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.23 -23.35 19.37 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.069 1.304 . . . . 1.82 113.184 164.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.87 41.47 2.28 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 119.97 1.259 . . . . 1.5 113.557 -175.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.417 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -70.37 -177.79 1.55 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 116.734 2.124 . . . . 11.87 116.734 -174.36 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -145.03 175.51 10.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 127.995 2.518 . . . . 4.22 108.376 154.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -168.99 149.51 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 121.234 1.834 . . . . 4.23 114.56 -164.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.2 t -100.78 88.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.28 1.832 . . . . 3.87 108.167 168.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -142.63 148.93 38.23 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.284 1.434 . . . . 2.2 110.564 179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.79 173.64 16.5 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.666 1.586 . . . . 4.56 110.268 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -114.95 147.84 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.615 0.766 . . . . 3.37 112.45 171.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.67 45.72 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.901 1.28 . . . . 0.88 111.492 -177.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.27 122.23 45.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.759 1.223 . . . . 2.67 109.541 177.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -107.52 148.08 29.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.222 1.409 . . . . 1.95 109.756 174.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -99.06 134.77 41.42 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.5 1.92 . . . . 2.78 110.364 177.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.24 59.54 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.847 1.259 . . . . 1.62 111.128 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -53.01 94.19 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.36 1.076 . . . . 3.77 112.147 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.53 -32.07 0.69 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.707 -1.052 . . . . 1.75 114.549 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -89.99 144.63 25.75 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.783 1.292 . . . . 2.54 112.988 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.2 p -133.61 -8.63 2.83 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.507 1.669 . . . . 1.66 115.507 -160.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 m -166.55 161.5 16.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.642 2.377 . . . . 3.14 109.881 -166.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.29 -38.3 73.73 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 1.32 112.772 176.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.14 66.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.303 1.223 . . . . 1.88 114.303 174.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.1 m -82.24 -51.44 7.93 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.056 0.942 . . . . 1.67 110.576 174.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.18 -52.31 63.73 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.585 1.154 . . . . 1.26 112.748 176.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.74 -30.78 71.5 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.954 -1.091 . . . . 2.0 113.258 -173.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -58.37 -38.03 76.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.93 -1.106 . . . . 4.55 113.281 173.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 pt -86.81 -34.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-O 117.82 -1.086 . . . . 2.1 113.008 174.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.27 -42.97 21.76 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.511 1.524 . . . . 3.09 112.38 172.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -59.58 -27.64 66.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.472 1.909 . . . . 5.0 113.317 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -90.58 -43.99 9.84 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 4.42 112.336 167.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -54.06 -42.03 68.83 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.868 1.267 . . . . 1.22 112.674 -178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.32 -41.9 4.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.569 1.548 . . . . 2.42 114.605 -172.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -146.78 73.87 1.33 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.134 1.374 . . . . 3.19 111.029 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 100' ' ' GLU 0.261 3.4 mt -71.77 -170.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-O 122.808 1.29 . . . . 2.78 109.255 159.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 99' ' ' ILE . 15.8 tt0 -91.06 89.65 7.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 119.524 -1.985 . . . . 5.2 108.686 -152.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.31 3.67 44.27 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-O 118.312 -1.271 . . . . 1.33 114.673 -161.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.83 138.29 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.721 1.761 . . . . 1.91 111.275 -178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -56.01 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.441 1.496 . . . . 1.17 111.232 172.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -145.3 153.15 40.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.845 0.858 . . . . 1.64 112.221 -175.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.53 88.02 1.08 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 114.478 1.288 . . . . 1.04 114.478 172.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.59 136.94 15.91 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.622 2.881 . . . . 1.2 110.987 166.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -93.8 131.04 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.777 0.831 . . . . 1.3 110.441 -176.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -80.64 72.62 7.59 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.919 1.688 . . . . 4.91 112.073 -176.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -60.91 -21.09 63.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 117.72 2.489 . . . . 3.48 117.72 -158.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.28 -22.74 11.93 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.777 1.231 . . . . 1.45 113.424 176.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.49 -26.71 38.05 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.108 1.763 . . . . 1.96 111.476 177.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 85.48 18.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.678 3.191 . . . . 3.11 113.635 176.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 71.8 p -107.13 -179.7 4.01 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.98 1.264 . . . . 1.25 111.413 172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.35 136.8 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.055 1.342 . . . . 0.82 107.94 157.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.8 m -106.77 116.22 31.55 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.158 -1.053 . . . . 1.36 108.158 -175.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.2 t -111.9 139.15 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.982 1.713 . . . . 0.98 110.422 -168.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -116.17 119.57 36.22 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.785 2.434 . . . . 2.54 108.123 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.16 170.42 22.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.579 1.696 . . . . 2.52 115.579 -167.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -102.66 97.07 8.42 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 126.17 1.788 . . . . 2.43 110.414 176.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.07 1.22 8.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.518 2.812 . . . . 1.58 114.434 -171.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -64.48 -40.88 96.51 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.252 1.387 . . . . 4.79 111.656 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -127.54 28.59 5.64 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.964 1.306 . . . . 4.12 111.667 -174.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.65 137.62 22.85 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 120.496 -1.378 . . . . 2.08 111.135 -178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.1 p -156.14 175.28 14.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.757 1.021 . . . . 2.43 113.757 -170.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.77 -18.57 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.687 1.195 . . . . 1.46 113.711 -176.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.6 -51.95 50.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.839 1.199 . . . . 3.13 111.787 171.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -58.7 -41.17 85.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.581 0.752 . . . . 3.19 110.647 -179.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.55 -57.4 8.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.551 1.54 . . . . 2.75 110.982 179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -59.27 -47.54 84.99 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.533 -0.746 . . . . 3.12 111.407 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -70.45 -27.39 64.21 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.426 1.012 . . . . 2.27 112.899 -175.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.17 -30.43 67.56 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.775 -1.203 . . . . 1.32 113.507 169.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 65.0 t -92.01 -24.95 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.882 1.273 . . . . 1.02 113.854 -179.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -51.5 -48.37 62.95 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.827 1.651 . . . . 2.31 110.988 175.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -55.32 -27.23 45.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.637 1.975 . . . . 2.81 113.269 177.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.49 -10.1 25.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.575 1.55 . . . . 1.69 113.37 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.81 28.89 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 119.449 1.022 . . . . 1.44 115.646 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -114.92 -179.51 3.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 118.711 1.256 . . . . 2.85 110.732 171.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 150.09 50.4 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 120.622 -1.299 . . . . 2.64 109.255 166.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.0 mt -107.39 107.4 18.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 122.206 1.003 . . . . 1.13 109.358 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -80.46 168.14 19.31 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.623 -1.171 . . . . 2.76 110.174 165.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.407 ' H ' ' HB2' ' A' ' 145' ' ' GLN . 6.9 mt -128.34 149.32 50.57 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.177 0.991 . . . . 1.56 111.759 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -87.59 108.46 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.687 1.995 . . . . 4.18 107.138 -175.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.44 -53.64 3.94 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.853 1.216 . . . . 2.27 110.842 -167.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -75.34 3.0 9.82 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 115.807 1.78 . . . . 4.08 115.807 -170.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' HB2' ' H ' ' A' ' 141' ' ' LEU . 41.2 mt-30 -152.1 -66.9 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.009 -1.057 . . . . 2.47 112.639 164.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -93.12 -32.72 14.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.219 0.608 . . . . 3.0 111.847 -165.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.245 0.854 0 C-N-CA 131.183 3.793 . . . . 3.13 110.169 173.27 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 118.995 -0.526 . . . . 11.41 111.394 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -177.79 4.12 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.872 2.069 . . . . 8.87 110.473 177.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 t -106.4 -28.06 10.58 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.867 1.062 . . . . 6.51 113.867 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -169.75 158.95 7.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.876 2.07 . . . . 5.89 108.549 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -120.41 160.26 23.45 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.69 -1.596 . . . . 3.4 106.69 160.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 145.23 49.1 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.161 -0.962 . . . . 3.58 110.281 169.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -120.17 138.16 53.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.532 1.133 . . . . 3.55 109.76 175.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 pt -144.95 163.38 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.264 1.426 . . . . 2.98 111.435 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.23 156.83 42.74 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.09 1.356 . . . . 0.98 111.632 175.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.6 mtt -155.4 157.01 36.37 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.634 1.974 . . . . 3.42 111.281 174.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 tm0? -81.02 147.85 29.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.359 0.664 . . . . 3.16 109.734 166.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -142.02 146.29 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.843 0.857 . . . . 1.38 112.773 -162.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.7 t -102.83 136.68 42.21 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.903 1.446 . . . . 2.69 114.903 -169.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.31 3.66 41.16 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.942 1.734 . . . . 1.11 115.588 168.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.6 mtt -75.86 16.65 0.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 116.783 2.142 . . . . 3.1 116.783 -167.08 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 2.42 2.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.234 2.214 . . . . 2.62 115.666 -167.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.4 t -116.82 24.37 11.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.794 1.638 . . . . 3.1 112.194 -177.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 65.27 -63.67 0.19 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.851 2.86 . . . . 1.97 114.565 175.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.33 -12.06 27.04 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.259 1.824 . . . . 1.49 113.273 -177.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.7 m -51.14 -40.39 58.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.757 1.623 . . . . 1.51 112.354 167.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.75 42.68 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.795 0.838 . . . . 0.98 111.183 170.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.54 59.41 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.056 0.942 . . . . 1.48 111.802 177.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -44.92 -46.1 10.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.201 1.8 . . . . 2.95 113.299 172.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.01 -46.64 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 119.401 1.0 . . . . 1.77 111.709 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -57.57 -49.17 77.26 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.667 0.667 . . . . 2.21 110.604 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -60.43 -51.39 69.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.849 1.66 . . . . 3.17 112.259 174.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.97 -35.44 63.9 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.238 0.923 . . . . 0.86 113.619 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 mt -78.9 -52.2 8.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.429 1.114 . . . . 1.65 111.845 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -58.28 -21.52 49.13 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.166 1.386 . . . . 4.16 113.589 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -65.75 -19.78 66.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.329 1.452 . . . . 4.54 113.959 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.1 mmt -81.37 144.12 53.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.044 1.338 . . . . 4.28 111.846 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.56 -54.07 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.955 2.436 . . . . 2.08 111.606 176.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.28 32.71 1.34 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 125.295 1.426 . . . . 1.56 114.413 -176.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.5 t -134.24 129.95 53.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 127.689 2.396 . . . . 2.15 106.05 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 m -77.33 -63.48 1.36 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.17 -1.418 . . . . 2.98 107.17 -179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -167.72 166.62 13.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.166 0.802 . . . . 3.4 113.166 -175.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.53 145.26 33.45 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.224 1.41 . . . . 0.76 110.582 -177.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -146.66 117.35 7.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.554 1.542 . . . . 1.95 108.891 -170.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.77 113.63 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.876 0.846 . . . . 2.3 110.631 -176.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -85.92 76.75 9.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.162 1.385 . . . . 1.85 110.03 168.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 tt -54.72 -36.53 64.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 2.98 111.057 175.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.22 -3.47 5.8 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.371 1.619 . . . . 1.98 115.371 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 m -124.59 -9.21 7.39 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.956 1.303 . . . . 2.54 112.009 165.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 83.3 19.05 0.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 129.328 3.051 . . . . 2.57 112.233 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.9 m -110.2 129.84 55.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.544 1.937 . . . . 1.39 111.643 -167.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.1 t -101.72 139.08 37.85 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.743 1.617 . . . . 1.11 110.895 170.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -131.4 131.78 43.88 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.267 1.427 . . . . 1.3 110.019 -173.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.7 t -140.4 139.71 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.037 0.935 . . . . 1.65 111.651 -165.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.82 129.46 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.798 1.639 . . . . 0.88 109.811 177.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -145.09 168.53 20.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 116.955 2.206 . . . . 2.6 116.955 -166.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -94.75 110.67 50.72 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 127.689 2.396 . . . . 2.81 110.511 178.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -87.99 30.58 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.263 3.309 . . . . 1.92 113.402 -173.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -125.23 -26.3 3.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.062 0.945 . . . . 1.89 112.452 166.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -94.9 -33.46 12.79 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.712 1.205 . . . . 4.23 112.066 170.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.3 m -117.48 135.83 53.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.059 1.343 . . . . 1.81 111.651 -174.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.6 157.69 19.82 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.122 1.344 . . . . 1.2 112.704 170.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.3 t -47.87 -48.97 30.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.304 1.841 . . . . 2.81 113.271 -174.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.97 -19.56 65.24 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.236 1.199 . . . . 1.21 114.236 -176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.8 66.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.164 0.893 . . . . 1.38 112.385 174.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.48 -45.55 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.202 1.001 . . . . 1.8 111.338 -178.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -68.76 -38.6 80.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.162 0.892 . . . . 2.24 110.906 174.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -57.02 -41.07 77.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.353 1.061 . . . . 3.51 111.652 172.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -26.35 65.48 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.887 1.069 . . . . 2.57 113.887 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.76 -55.06 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.248 0.931 . . . . 1.5 109.573 173.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -59.04 -32.76 70.03 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.399 1.08 . . . . 2.77 111.714 179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -60.9 -24.55 66.06 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.348 -1.47 . . . . 4.28 114.6 175.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.39 -15.58 28.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.278 0.944 . . . . 1.69 113.119 -178.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.69 1.72 61.77 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.418 1.009 . . . . 1.52 114.33 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -84.19 167.86 16.3 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.465 1.106 . . . . 5.96 109.333 159.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -123.84 147.11 47.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.317 0.962 . . . . 4.13 113.545 -177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.51 154.7 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 110.096 -0.335 . . . . 3.17 110.096 160.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.34 124.43 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.347 -0.983 . . . . 3.08 108.347 163.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.8 p -148.96 146.2 27.71 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.393 1.477 . . . . 1.87 109.538 -175.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -111.0 155.42 22.75 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.546 -0.909 . . . . 3.24 108.546 162.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -107.99 139.48 42.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.566 0.747 . . . . 3.62 111.043 169.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.74 43.32 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.292 1.037 . . . . 0.97 111.03 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -107.01 110.64 22.83 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.628 1.171 . . . . 2.54 108.009 173.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -91.44 146.73 23.56 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.822 1.249 . . . . 1.88 109.94 177.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.33 119.29 39.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.47 1.908 . . . . 2.84 109.961 -174.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.544 HD11 HG12 ' A' ' 114' ' ' VAL . 3.7 mm -121.45 61.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.08 1.352 . . . . 2.0 111.329 -156.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 95.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.718 1.207 . . . . 3.85 111.117 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 154.71 3.5 0.11 Allowed Glycine 0 CA--C 1.532 1.094 0 CA-C-O 117.926 -1.485 . . . . 1.23 116.803 -173.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 17.7 ptp -150.45 64.37 0.95 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.902 2.351 . . . . 5.14 114.892 -169.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 53.2 p -67.78 18.83 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.222 1.809 . . . . 3.06 114.084 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -154.23 139.61 17.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.405 1.482 . . . . 1.93 112.577 -166.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -52.46 -46.32 66.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.658 1.583 . . . . 1.2 113.938 179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.73 71.25 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.532 1.06 . . . . 1.29 113.199 -178.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.35 -46.26 56.25 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.165 -0.959 . . . . 1.14 111.5 174.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.76 79.06 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.591 0.756 . . . . 0.78 112.254 172.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -52.02 -40.47 61.08 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.822 1.249 . . . . 3.41 112.026 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -71.11 -21.27 62.24 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.834 1.42 . . . . 4.33 114.834 178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.8 pt -85.43 -38.97 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 120.931 1.696 . . . . 1.28 112.133 162.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -54.9 12.4 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.178 1.791 . . . . 3.54 112.081 -173.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -53.89 -27.3 29.49 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.942 1.09 . . . . 2.88 113.942 -176.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -41.55 9.39 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.538 1.135 . . . . 3.51 112.01 172.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.86 -38.48 70.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.584 1.554 . . . . 1.32 112.758 177.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.06 -52.19 15.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.427 1.491 . . . . 1.71 112.259 173.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -141.97 79.53 1.68 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.404 1.881 . . . . 3.58 111.098 -177.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' H ' ' CG2' ' A' ' 102' ' ' VAL . 69.1 mt -69.54 -52.84 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.247 1.019 . . . . 2.72 113.216 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 133.4 82.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 1 C-N-CA 131.756 4.022 . . . . 4.06 105.001 -160.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.39 7.5 14.03 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 117.109 1.604 . . . . 1.61 117.109 175.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.603 ' CG2' ' H ' ' A' ' 99' ' ' ILE . 28.2 m -115.1 156.0 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 128.118 2.567 . . . . 2.25 110.368 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -113.42 -47.42 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.177 0.991 . . . . 1.18 112.887 175.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -138.21 149.63 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.508 0.595 . . . . 1.64 111.755 -177.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.11 70.18 3.44 Favored Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.658 1.725 . . . . 1.3 115.658 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -68.38 106.96 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.339 2.693 . . . . 1.48 112.543 171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.1 t -78.57 142.21 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.04 1.736 . . . . 1.11 111.689 178.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -97.02 102.34 14.1 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.258 1.423 . . . . 4.2 112.634 -177.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -70.05 9.7 0.52 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 118.209 2.67 . . . . 6.77 118.209 -158.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -160.98 -34.08 0.05 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.044 1.337 . . . . 2.71 111.869 178.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.93 -19.92 66.03 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.591 1.956 . . . . 2.69 112.836 173.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 66.43 40.66 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.847 1.659 . . . . 3.14 113.027 174.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 33.1 p -116.62 171.84 7.61 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.596 -0.69 . . . . 0.89 110.247 161.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.544 HG12 HD11 ' A' ' 80' ' ' ILE . 4.2 p -138.79 130.59 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.093 -1.077 . . . . 0.67 108.093 155.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.0 m -91.75 123.51 35.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.324 -1.362 . . . . 1.2 107.324 174.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.8 t -122.0 142.33 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.895 1.278 . . . . 1.04 109.881 -171.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.79 123.44 43.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.907 1.683 . . . . 2.75 108.983 166.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.8 163.73 38.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.728 1.211 . . . . 2.6 113.567 -165.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -99.65 114.13 65.42 Favored Pre-proline 0 CA--C 1.551 1.016 0 O-C-N 121.118 -0.989 . . . . 3.53 110.755 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.77 -18.31 28.56 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.955 2.437 . . . . 1.71 114.212 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -64.99 -11.18 35.83 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 120.726 1.603 . . . . 5.29 114.903 -174.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -117.98 3.88 12.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.917 1.287 . . . . 4.11 114.239 -178.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.77 175.77 11.67 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.571 1.532 . . . . 2.15 113.86 -174.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -137.6 165.53 26.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.326 1.451 . . . . 2.92 110.854 169.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.13 -14.02 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.847 -1.158 . . . . 1.37 111.627 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.4 m -67.62 -46.55 72.22 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.534 -1.354 . . . . 2.48 110.811 169.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -57.99 -41.39 82.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.163 0.585 . . . . 2.95 111.026 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.75 -46.03 73.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.764 0.826 . . . . 1.62 112.096 178.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -58.75 -47.21 85.44 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.501 -0.749 . . . . 4.15 111.202 173.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -62.39 -32.96 73.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.587 1.155 . . . . 3.57 112.866 178.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.78 -50.41 24.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.18 0.992 . . . . 1.61 113.188 172.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.2 -23.85 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.982 0.734 . . . . 1.22 112.982 -176.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -49.0 -47.5 44.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.924 1.29 . . . . 2.21 112.329 167.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -67.16 -28.01 67.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.034 0.934 . . . . 3.51 112.43 -179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.29 -15.15 58.41 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.515 1.052 . . . . 2.42 113.474 172.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.31 32.79 3.34 Favored Glycine 0 N--CA 1.472 1.051 0 N-CA-C 116.08 1.192 . . . . 2.4 116.08 168.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.61 -161.35 1.17 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.366 1.583 . . . . 3.24 111.95 -176.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 146.31 34.05 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.277 -1.515 . . . . 2.7 108.251 161.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 82.6 mt -99.89 107.5 19.52 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.217 -0.66 . . . . 1.23 109.217 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -85.72 -179.63 6.89 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.525 0.678 . . . . 3.01 109.915 156.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mt -146.55 157.26 43.7 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.542 -1.348 . . . . 1.61 110.956 -176.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -92.37 121.07 33.5 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.969 1.707 . . . . 3.9 107.239 -176.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.01 -72.11 2.12 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.665 -1.774 . . . . 2.27 108.665 -154.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.97 -19.42 64.94 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.742 2.127 . . . . 3.31 116.742 -155.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -147.55 -22.17 0.38 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 121.608 2.004 . . . . 2.86 115.764 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -129.12 8.15 5.56 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.571 1.532 . . . . 2.75 113.669 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.255 1.356 0 C-N-CA 128.266 2.626 . . . . 2.81 113.405 172.499 . . . . . . . . 0 0 . 1 stop_ save_